data_1hi7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hi7 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.875 HG22 HG21 ' A' ' 8' ' ' THR . 86.2 m . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.706 0.288 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.787 ' N ' HG23 ' A' ' 6' ' ' THR . 77.1 m -123.71 -15.7 6.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.176 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.875 HG21 HG22 ' A' ' 6' ' ' THR . 10.2 t -70.88 69.28 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.757 HG23 HD21 ' A' ' 48' ' ' ASN . 60.1 t -114.89 171.81 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.154 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.818 ' C ' ' HG3' ' A' ' 14' ' ' ARG . . . -86.77 121.19 71.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.962 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.865 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 82.8 Cg_exo -45.22 -59.46 1.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.825 2.35 . . . . 0.0 112.44 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.613 ' HG3' ' HG3' ' A' ' 13' ' ' GLU . 37.9 ptt180 -46.42 -29.81 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.613 ' HG3' ' HG3' ' A' ' 12' ' ' ARG . 45.1 mt-10 -104.68 -17.83 14.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.865 ' HD2' ' HA ' ' A' ' 11' ' ' PRO . 99.4 mtt180 -51.96 139.4 22.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.758 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.52 ' O ' ' HD1' ' A' ' 46' ' ' TYR . 12.2 mm100 -90.85 98.48 11.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.786 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.568 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.6 t-20 -41.96 143.0 0.61 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.568 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 44.1 t -145.49 3.48 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.563 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.788 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 170.16 124.02 0.72 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.39 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.771 ' O ' HG21 ' A' ' 22' ' ' VAL . 52.6 p90 -44.88 163.88 0.19 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.812 0.339 . . . . 0.0 110.768 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.652 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 36.2 Cg_endo -65.5 -43.9 9.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.289 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.14 -13.67 1.07 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.771 HG21 ' O ' ' A' ' 19' ' ' PHE . 27.4 m -63.52 154.35 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 111.183 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.774 ' OG1' ' HG3' ' A' ' 26' ' ' GLN . 79.4 p -101.68 160.26 27.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.099 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 62.4 Cg_exo -51.21 -35.99 54.53 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.777 2.318 . . . . 0.0 112.306 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 80.2 p -75.74 -37.26 59.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.965 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.774 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 26.6 mt-30 -67.44 -55.67 12.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -55.67 -52.7 62.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.54 -22.54 66.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.015 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.571 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 27.4 t-20 -60.69 -19.09 57.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.834 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -102.21 -26.44 13.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.46 34.61 3.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.544 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.2 m -120.64 176.17 5.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.382 . . . . 0.0 111.037 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.9 m -86.02 155.27 20.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.958 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.646 ' HE2' HG22 ' A' ' 22' ' ' VAL . 19.5 t80 -135.55 108.1 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -125.58 103.24 7.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -96.24 24.23 5.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.0 p -90.71 -31.93 16.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.202 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.639 HG11 HG21 ' A' ' 41' ' ' VAL . 63.9 t -100.5 121.23 51.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -91.69 155.15 18.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.57 -42.3 2.7 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.431 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.872 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.7 m -93.65 170.04 9.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 111.101 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.872 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 45.7 Cg_endo -68.47 121.05 7.96 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.73 2.286 . . . . 0.0 112.238 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.636 ' CE3' ' O ' ' A' ' 20' ' ' PRO . 49.9 m0 -68.59 -44.73 73.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.788 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 51.3 t -97.36 118.87 34.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.712 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.654 ' CE2' ' HD3' ' A' ' 14' ' ' ARG . 51.3 p90 -147.34 157.59 43.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.959 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.52 ' HD1' ' O ' ' A' ' 15' ' ' GLN . 84.7 m-85 -63.75 157.48 66.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.94 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 46' ' ' TYR . 57.9 Cg_endo -71.68 -161.63 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.737 2.292 . . . . 0.0 112.309 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.757 HD21 HG23 ' A' ' 9' ' ' VAL . 35.4 p30 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.76 ' O ' ' CE2' ' B' ' 45' ' ' PHE . 62.2 m . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.909 0.385 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.574 HG22 ' O ' ' B' ' 8' ' ' THR . 9.1 t -87.01 69.92 10.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.987 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.648 HG13 ' N ' ' B' ' 10' ' ' ALA . 59.5 t -89.83 166.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.044 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.921 ' HB1' ' HB2' ' B' ' 13' ' ' GLU . . . -47.54 113.48 2.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.748 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 80.0 Cg_exo -44.83 -46.03 13.14 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.829 2.352 . . . . 0.0 112.467 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -73.96 -29.97 62.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.921 ' HB2' ' HB1' ' B' ' 10' ' ' ALA . 45.1 mt-10 -92.83 -5.47 50.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.03 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.833 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.3 mtt180 -58.98 125.66 24.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.82 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . 0.455 ' O ' ' HD1' ' B' ' 46' ' ' TYR . 8.1 tp-100 -80.29 98.29 7.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.682 HD21 ' CB ' ' B' ' 42' ' ' PRO . 27.3 t-20 -35.38 150.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.983 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' CYS . . . . . 0.435 ' O ' ' SG ' ' B' ' 17' ' ' CYS . 41.5 t -134.07 4.2 3.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.88 -133.72 2.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.437 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.81 ' CE1' HG13 ' B' ' 22' ' ' VAL . 35.6 p90 -105.13 164.29 15.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.907 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.691 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 37.5 Cg_endo -66.33 -31.02 44.34 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.721 2.281 . . . . 0.0 112.304 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.61 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -82.64 -2.64 90.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.458 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.811 HG23 ' CB ' ' B' ' 44' ' ' CYS . 29.1 m -47.11 147.79 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.915 0.388 . . . . 0.0 111.295 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' THR . . . . . 1.035 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 67.1 p -123.0 175.34 2.76 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 1.035 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 10.6 Cg_endo -53.6 -43.56 56.7 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.651 2.234 . . . . 0.0 112.091 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.5 p -76.88 -46.79 23.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.663 ' HG2' ' OG1' ' B' ' 23' ' ' THR . 15.2 mm100 -57.29 -50.48 72.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 46.4 t -60.05 -57.1 14.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.728 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.01 -35.58 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.773 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.616 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 38.4 t-20 -49.94 -36.85 29.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.952 ' HB3' ' HZ3' ' B' ' 30' ' ' LYS . 2.6 mmmp? -88.14 -41.35 13.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.537 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.89 58.39 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.734 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' CYS . . . . . 0.79 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 82.6 m -140.89 174.69 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.359 . . . . 0.0 110.971 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 1.029 ' SG ' ' HG3' ' B' ' 47' ' ' PRO . 73.6 m -92.82 134.2 35.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.904 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.797 ' CZ ' ' HB3' ' B' ' 36' ' ' ASP . 59.4 t80 -91.39 153.06 20.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.122 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.479 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 32.4 t0 -170.2 79.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.825 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 25.3 p30 -90.02 30.41 1.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' THR . . . . . 0.479 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 71.5 p -83.5 -4.9 58.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.083 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 61.0 t -138.3 128.03 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.309 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . 0.833 ' NH1' ' CZ2' ' B' ' 43' ' ' TRP . 22.1 mmm180 -80.92 -178.58 6.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.53 -32.44 0.22 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.563 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.578 ' H ' ' C ' ' B' ' 39' ' ' ARG . 33.2 m -104.29 158.95 30.86 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.883 0.373 . . . . 0.0 111.068 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.682 ' CB ' HD21 ' B' ' 16' ' ' ASN . 55.3 Cg_endo -69.9 136.78 33.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.733 2.288 . . . . 0.0 112.277 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.833 ' CZ2' ' NH1' ' B' ' 39' ' ' ARG . 48.7 m0 -79.73 -32.43 41.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' CYS . . . . . 0.811 ' CB ' HG23 ' B' ' 22' ' ' VAL . 50.6 t -95.01 115.25 27.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.522 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.79 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 6.0 p90 -145.73 172.98 12.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.816 -176.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.455 ' HD1' ' O ' ' B' ' 15' ' ' GLN . 92.7 m-85 -85.33 133.71 41.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.621 176.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . 1.029 ' HG3' ' SG ' ' B' ' 33' ' ' CYS . 56.2 Cg_endo . . . . . 0 N--CA 1.457 -0.66 0 C-N-CA 123.343 2.695 . . . . 0.0 112.629 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.927 HG23 ' H ' ' A' ' 8' ' ' THR . 86.1 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.762 0.315 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.79 ' N ' HG23 ' A' ' 6' ' ' THR . 71.4 m -133.93 -2.0 2.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.266 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.927 ' H ' HG23 ' A' ' 6' ' ' THR . 9.6 t -75.69 75.2 2.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.137 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.73 HG12 ' HA ' ' A' ' 14' ' ' ARG . 62.1 t -116.4 161.67 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.878 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -81.33 132.15 56.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.935 ' HB3' HG22 ' A' ' 41' ' ' VAL . 85.5 Cg_exo -40.62 -32.1 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.823 2.349 . . . . 0.0 112.507 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -90.04 -29.74 18.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 10' ' ' ALA . 81.6 mm-40 -92.43 -6.0 50.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.001 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.878 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.4 mtt180 -69.37 118.04 11.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.614 ' O ' ' O ' ' A' ' 16' ' ' ASN . 8.1 tp-100 -79.96 93.12 5.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.696 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 2.6 t-20 -24.98 148.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.752 ' HB2' ' N ' ' A' ' 46' ' ' TYR . 50.5 t -143.68 3.0 1.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.116 0.484 . . . . 0.0 110.188 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.63 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . -156.55 -142.85 3.51 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.113 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.907 ' CZ ' ' HA ' ' A' ' 22' ' ' VAL . 27.4 p90 -105.75 168.91 7.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.793 0.33 . . . . 0.0 111.064 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.821 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 40.7 Cg_endo -67.78 -20.08 46.35 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.258 . . . . 0.0 112.436 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.716 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -102.64 4.96 50.79 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.545 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.907 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 27.7 m -39.9 163.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.008 0.433 . . . . 0.0 111.39 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.988 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 76.4 p -143.94 175.75 2.65 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.762 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.988 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 17.2 Cg_endo -57.74 -35.46 98.79 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.654 2.236 . . . . 0.0 112.196 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 29' ' ' ASN . 51.2 m -89.41 -41.26 12.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.056 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.651 HE21 ' CG2' ' A' ' 23' ' ' THR . 48.6 mt-30 -69.06 -29.86 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.039 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.925 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.8 t -93.85 -36.58 12.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.921 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -79.25 -12.15 59.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 25' ' ' SER . 43.2 t30 -91.75 -16.97 26.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -101.34 -33.2 10.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.939 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.54 43.7 0.63 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.925 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 76.1 m -126.94 161.89 27.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.932 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.749 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 77.1 m -85.83 134.77 33.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.644 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 50.1 t80 -113.59 122.04 46.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.882 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.661 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 16.5 t70 -145.81 99.08 3.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -91.74 54.71 2.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.901 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.532 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 74.3 p -94.99 -31.88 13.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 41' ' ' VAL . 63.3 t -133.97 120.92 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.229 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.613 ' C ' ' H ' ' A' ' 41' ' ' VAL . 35.3 ptt180 -73.47 -175.61 2.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.83 -28.84 0.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.434 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.935 HG22 ' HB3' ' A' ' 11' ' ' PRO . 33.9 m -101.23 166.71 11.88 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.0 111.156 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.777 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 60.1 Cg_endo -72.5 120.01 6.47 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.826 2.35 . . . . 0.0 112.225 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.423 ' HE1' ' HA ' ' A' ' 39' ' ' ARG . 51.8 m0 -78.21 -34.07 49.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.876 ' CB ' HG23 ' A' ' 22' ' ' VAL . 51.3 t -101.77 110.29 22.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.789 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.767 ' CE1' ' HD3' ' A' ' 14' ' ' ARG . 51.7 p90 -134.04 175.83 9.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.752 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 92.4 m-85 -76.0 154.14 84.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.857 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 6' ' ' THR . 57.4 Cg_endo -71.35 -156.78 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.694 2.263 . . . . 0.0 112.431 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.723 HD22 ' CG2' ' A' ' 9' ' ' VAL . 75.9 m-20 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 86.0 m . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.805 0.336 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -117.73 49.19 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.106 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.687 HG11 ' N ' ' B' ' 10' ' ' ALA . 61.3 t -103.9 168.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.112 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.861 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -74.45 121.09 84.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.038 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.753 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 87.8 Cg_exo -46.17 -24.77 2.6 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.807 2.338 . . . . 0.0 112.542 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.634 ' HG3' ' HG2' ' B' ' 13' ' ' GLU . 13.8 ptp180 -87.69 -29.96 20.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.634 ' HG2' ' HG3' ' B' ' 12' ' ' ARG . 6.3 mm-40 -108.3 34.61 3.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.015 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.861 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.1 mtt180 -95.49 149.35 21.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . 0.732 ' HB2' ' HB2' ' B' ' 46' ' ' TYR . 17.1 mp0 -82.11 95.23 7.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.61 ' O ' ' CE2' ' B' ' 46' ' ' TYR . 27.4 t-20 -41.91 131.95 3.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' CYS . . . . . 0.659 ' HB2' ' CD2' ' B' ' 46' ' ' TYR . 44.3 t -145.82 3.99 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.792 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.59 123.02 0.65 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.504 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.737 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 52.5 p90 -45.02 166.71 0.12 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 120.835 0.35 . . . . 0.0 110.94 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.737 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 44.3 Cg_endo -68.28 -29.52 32.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.759 2.306 . . . . 0.0 112.323 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.629 ' H ' ' HD2' ' B' ' 19' ' ' PHE . . . -61.33 -10.65 23.27 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.449 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.689 HG21 ' O ' ' B' ' 19' ' ' PHE . 33.1 m -66.5 165.97 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.76 0.314 . . . . 0.0 111.159 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' THR . . . . . 0.808 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 72.8 p -126.29 175.03 3.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.808 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 56.8 Cg_exo -51.75 -44.19 46.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.722 2.281 . . . . 0.0 112.297 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 54.6 m -74.89 -47.74 28.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.559 ' HG3' ' OG1' ' B' ' 23' ' ' THR . 52.9 mt-30 -54.62 -46.56 73.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.894 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' B' ' 30' ' ' LYS . 42.6 t -65.32 -67.21 0.46 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.804 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.07 -42.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.805 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -50.18 -37.17 33.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.574 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' B' ' 27' ' ' CYS . 34.5 mmtp -84.02 -37.37 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.595 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.34 59.88 0.83 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.635 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 74.1 m -150.2 170.38 19.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 110.939 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.836 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.5 m -66.71 150.15 49.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.816 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -128.03 120.08 26.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.789 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' B' ' 43' ' ' TRP . 26.4 t0 -134.96 98.17 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.74 ' HA ' ' CD2' ' B' ' 43' ' ' TRP . 24.5 p-10 -96.81 46.16 1.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 74.9 p -119.77 -39.93 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.106 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.776 HG11 HG21 ' B' ' 41' ' ' VAL . 59.5 t -90.02 139.27 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.152 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . 0.646 ' NH1' ' HZ2' ' B' ' 43' ' ' TRP . 38.6 mmt180 -94.41 162.31 13.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.43 -47.71 1.15 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.776 HG21 HG11 ' B' ' 38' ' ' VAL . 32.8 m -77.12 151.43 81.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.46 120.03 6.91 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.705 2.27 . . . . 0.0 112.259 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.74 ' CD2' ' HA ' ' B' ' 36' ' ' ASP . 35.5 m0 -64.06 -46.39 84.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.878 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' CYS . . . . . 0.836 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 44.2 t -96.0 104.09 16.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.717 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.808 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 44.8 p90 -131.91 150.09 52.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.046 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.732 ' HB2' ' HB2' ' B' ' 15' ' ' GLN . 92.3 m-85 -54.08 144.72 37.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--N 1.341 0.154 0 C-N-CA 122.707 2.271 . . . . 0.0 112.311 179.717 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.877 ' HB ' ' HB2' ' A' ' 48' ' ' ASN . 96.4 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.808 0.337 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.418 ' N ' HG21 ' A' ' 6' ' ' THR . 72.0 m -133.83 6.55 3.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.765 HG23 ' CG2' ' A' ' 6' ' ' THR . 9.1 t -89.43 66.71 7.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.181 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.74 HG11 ' N ' ' A' ' 10' ' ' ALA . 61.4 t -97.19 171.44 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.817 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -88.52 112.59 51.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.072 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.832 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 83.7 Cg_exo -44.03 -20.02 0.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.795 2.33 . . . . 0.0 112.486 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 10' ' ' ALA . 37.6 mmt180 -90.11 -30.01 17.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 10' ' ' ALA . 44.5 mt-10 -108.12 -4.37 17.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.069 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.832 ' HD2' ' HA ' ' A' ' 11' ' ' PRO . 99.4 mtt180 -54.26 134.26 44.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.648 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 10.1 mm-40 -93.02 79.94 4.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.818 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.631 ' ND2' ' O ' ' A' ' 18' ' ' GLY . 51.6 t30 -27.63 150.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.833 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 41.3 t -125.26 8.18 7.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 110.567 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.631 ' O ' ' ND2' ' A' ' 16' ' ' ASN . . . -170.27 -132.39 1.46 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.216 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.92 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 30.8 p90 -105.76 173.77 3.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.798 0.333 . . . . 0.0 110.888 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.92 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 42.5 Cg_endo -68.15 -29.38 33.1 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.684 2.256 . . . . 0.0 112.457 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.657 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -89.28 -8.61 68.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.527 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.841 HG23 ' CB ' ' A' ' 44' ' ' CYS . 34.8 m -31.56 154.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.869 0.366 . . . . 0.0 111.327 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.999 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 74.5 p -123.99 172.72 5.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.134 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.999 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 28.1 Cg_endo -62.68 -33.08 78.29 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.756 2.304 . . . . 0.0 112.266 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.9 p -86.2 -38.0 18.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.689 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 24.0 mt-30 -69.9 -41.73 74.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.91 -45.89 39.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.792 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -33.07 70.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.058 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.612 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 38.9 t-20 -53.21 -20.67 4.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.817 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.76 -28.51 14.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.52 18.69 9.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.432 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.917 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 70.8 m -102.38 179.62 4.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 0.0 111.036 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.741 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 78.9 m -93.79 155.06 17.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.786 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.551 ' HE2' ' OD2' ' A' ' 36' ' ' ASP . 73.7 t80 -134.24 127.19 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.501 ' OD1' ' OG1' ' A' ' 37' ' ' THR . 26.6 t0 -137.27 92.32 2.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.551 ' OD2' ' HE2' ' A' ' 34' ' ' PHE . 4.6 p30 -89.62 38.02 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.501 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 76.8 p -109.33 -10.46 14.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 41' ' ' VAL . 62.6 t -117.61 104.61 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.164 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.723 ' HD2' ' N ' ' A' ' 39' ' ' ARG . 4.3 mpt_? -73.8 155.02 39.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.93 -49.44 1.98 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.438 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.923 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.1 m -92.4 170.55 8.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.753 0.311 . . . . 0.0 111.087 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.923 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 43.9 Cg_endo -68.1 145.64 67.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.604 2.203 . . . . 0.0 112.245 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -89.76 -30.98 17.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.898 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.841 ' CB ' HG23 ' A' ' 22' ' ' VAL . 43.1 t -97.38 128.03 43.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.692 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 33' ' ' CYS . 48.6 p90 -146.12 157.72 43.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.904 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.648 ' CD2' ' O ' ' A' ' 15' ' ' GLN . 83.1 m-85 -70.26 135.63 86.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.917 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 58.3 Cg_endo -72.0 172.81 13.9 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.29 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.877 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 35.3 m-80 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.734 0.302 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.434 ' O ' HG21 ' B' ' 8' ' ' THR . 8.8 t -97.77 55.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.992 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.649 HG11 ' N ' ' B' ' 10' ' ' ALA . 59.9 t -98.95 165.77 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.251 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.864 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -95.24 132.21 28.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.051 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.773 ' HB3' HG23 ' B' ' 41' ' ' VAL . 88.6 Cg_exo -43.84 -29.38 2.46 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.791 2.327 . . . . 0.0 112.49 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -86.71 -29.82 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.859 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' B' ' 10' ' ' ALA . 61.7 mt-10 -94.92 -11.52 28.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.989 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.864 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -61.89 127.14 29.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.971 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 8.1 tp-100 -92.89 99.74 12.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.776 HD21 ' HB3' ' B' ' 42' ' ' PRO . 27.3 t-20 -33.8 150.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.016 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' B' ' 17' ' ' CYS . 43.3 t -138.02 4.65 2.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.696 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.14 -136.85 2.12 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.379 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.809 ' CZ ' ' HA ' ' B' ' 22' ' ' VAL . 27.5 p90 -105.44 168.9 7.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 0.0 110.99 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.796 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 54.0 Cg_endo -70.13 -12.66 32.6 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.748 2.299 . . . . 0.0 112.408 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.744 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -107.85 5.6 34.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.508 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.809 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 34.0 m -47.94 158.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.166 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' THR . . . . . 0.874 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 79.8 p -133.77 178.83 1.58 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.068 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.874 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 56.8 Cg_exo -51.75 -54.79 4.72 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.7 m -72.89 -43.0 63.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.694 ' HG3' ' OG1' ' B' ' 23' ' ' THR . 24.8 mt-30 -57.66 -38.83 75.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.941 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 46.3 t -72.92 -60.58 2.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.81 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.11 -34.75 1.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.973 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -50.02 -35.08 23.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.674 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -93.84 -32.41 13.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.708 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.92 58.35 0.84 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.616 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' CYS . . . . . 0.671 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 76.8 m -143.07 165.0 28.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.958 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.677 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 73.4 m -70.98 155.11 41.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.89 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.597 ' CE1' ' HA ' ' B' ' 23' ' ' THR . 67.8 t80 -132.32 119.16 20.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.6 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 16.6 t70 -130.1 96.58 4.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.74 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 4.6 p-10 -94.78 46.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 74.9 p -113.73 -31.99 6.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.503 HG11 HG21 ' B' ' 41' ' ' VAL . 63.5 t -107.87 111.43 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.162 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . 0.677 ' NH1' ' HZ2' ' B' ' 43' ' ' TRP . 21.8 mmm180 -68.41 178.21 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.46 -54.82 0.9 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.475 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.773 HG23 ' HB3' ' B' ' 11' ' ' PRO . 33.2 m -82.22 156.32 69.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.814 0.34 . . . . 0.0 111.125 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.776 ' HB3' HD21 ' B' ' 16' ' ' ASN . 47.3 Cg_endo -68.7 140.35 46.61 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.662 2.241 . . . . 0.0 112.317 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.74 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 12.9 m0 -81.56 -47.51 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' CYS . . . . . 0.687 ' CB ' HG23 ' B' ' 22' ' ' VAL . 50.6 t -87.71 119.61 28.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.757 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.76 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 51.3 p90 -152.18 171.29 18.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.502 ' O ' ' HD2' ' B' ' 45' ' ' PHE . 84.9 m-85 -75.62 156.57 84.88 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.848 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 46' ' ' TYR . 54.7 Cg_endo . . . . . 0 C--N 1.341 0.161 0 C-N-CA 122.791 2.327 . . . . 0.0 112.305 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.832 HG23 ' N ' ' A' ' 7' ' ' CYS . 93.4 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.824 0.345 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.832 ' N ' HG23 ' A' ' 6' ' ' THR . 71.7 m -108.69 12.72 25.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.62 ' H ' HG23 ' A' ' 6' ' ' THR . 8.8 t -100.3 63.58 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.149 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.781 HG22 ' ND2' ' A' ' 48' ' ' ASN . 62.5 t -94.0 164.06 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.175 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.878 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -85.88 139.56 35.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.021 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.856 ' HB3' HG12 ' A' ' 38' ' ' VAL . 93.1 Cg_exo -42.07 -36.87 4.16 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.83 2.353 . . . . 0.0 112.481 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 1.057 ' HD3' ' N ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -90.23 -29.36 18.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.758 178.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 1.057 ' N ' ' HD3' ' A' ' 12' ' ' ARG . 85.4 mt-10 -80.85 -12.96 59.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.985 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.878 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 97.6 mtt180 -71.7 113.57 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.073 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.668 ' O ' ' O ' ' A' ' 16' ' ' ASN . 8.0 tp-100 -80.58 95.5 6.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.668 ' O ' ' O ' ' A' ' 15' ' ' GLN . 27.4 t-20 -23.48 150.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.022 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 41.0 t -141.7 4.8 1.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.485 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.1 -139.58 4.86 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.388 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.849 ' CE2' ' N ' ' A' ' 22' ' ' VAL . 40.3 p90 -105.62 167.41 9.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.799 0.333 . . . . 0.0 110.83 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.786 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 38.5 Cg_endo -66.86 -41.91 9.56 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.61 2.207 . . . . 0.0 112.304 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . -61.9 -26.64 67.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.544 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.849 ' N ' ' CE2' ' A' ' 19' ' ' PHE . 34.7 m -31.58 156.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 111.211 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.765 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 80.4 p -124.69 173.46 4.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.707 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 45.0 Cg_exo -56.27 -44.82 42.76 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.731 2.287 . . . . 0.0 112.308 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.537 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 80.1 p -75.73 -39.44 57.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.046 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.639 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 48.2 mt-30 -67.54 -38.1 83.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.1 t -82.23 -51.82 7.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.96 75.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 25' ' ' SER . 42.9 t30 -54.66 -16.76 2.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -100.47 -22.6 14.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 -28.73 5.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.585 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.653 ' HB3' ' O ' ' A' ' 45' ' ' PHE . 71.6 m -68.86 179.74 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.882 0.372 . . . . 0.0 111.068 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.3 m -107.22 155.24 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.003 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.765 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 15.5 t80 -115.31 134.15 55.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.484 ' OD1' ' NH1' ' A' ' 14' ' ' ARG . 17.4 t70 -158.77 99.26 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.782 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.4 p-10 -96.68 32.54 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 72.6 p -91.21 -6.68 53.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.856 HG12 ' HB3' ' A' ' 11' ' ' PRO . 61.6 t -132.66 114.91 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.74 ' HD3' ' N ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -78.44 -175.79 4.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.01 -35.19 0.29 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.548 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.728 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.1 m -107.38 164.82 13.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.728 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 59.5 Cg_endo -72.34 127.15 12.31 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.698 2.265 . . . . 0.0 112.282 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.782 ' CD1' ' HA ' ' A' ' 36' ' ' ASP . 35.0 m0 -68.2 -33.72 74.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.861 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.84 ' HB2' HG23 ' A' ' 22' ' ' VAL . 53.4 t -91.31 120.27 32.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.653 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 39.5 p90 -147.36 160.09 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.699 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 86.5 m-85 -67.89 165.0 35.48 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.699 ' HD2' ' HB3' ' A' ' 46' ' ' TYR . 39.8 Cg_endo -67.03 172.02 10.43 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.663 2.242 . . . . 0.0 112.306 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.781 ' ND2' HG22 ' A' ' 9' ' ' VAL . 8.2 p30 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.813 0.339 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.615 HG22 ' O ' ' B' ' 8' ' ' THR . 9.5 t -82.13 73.24 9.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.821 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.934 HG12 ' HA ' ' B' ' 14' ' ' ARG . 50.1 t -107.19 166.42 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.375 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.829 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -94.21 122.61 61.15 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.92 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.774 ' HB3' HG12 ' B' ' 41' ' ' VAL . 98.9 Cg_exo -42.56 -26.96 0.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.864 2.376 . . . . 0.0 112.523 -178.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.565 ' HG3' ' HG2' ' B' ' 13' ' ' GLU . 16.7 ptm180 -90.05 -29.87 18.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.973 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.565 ' HG2' ' HG3' ' B' ' 12' ' ' ARG . 81.6 mm-40 -99.96 -11.73 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.177 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.934 ' HA ' HG12 ' B' ' 9' ' ' VAL . 96.7 mtt180 -51.54 127.19 19.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.873 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . 1.001 HE21 ' HA ' ' B' ' 15' ' ' GLN . 0.0 OUTLIER -79.91 86.84 5.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.792 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.632 HD21 ' HB3' ' B' ' 42' ' ' PRO . 27.4 t-20 -30.01 133.67 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.105 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' CYS . . . . . 0.759 ' SG ' ' HD2' ' B' ' 30' ' ' LYS . 41.6 t -145.53 2.74 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.616 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.539 ' HA2' ' HB3' ' B' ' 44' ' ' CYS . . . 177.54 122.39 0.73 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.428 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.935 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 53.1 p90 -44.83 172.86 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.804 0.335 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.935 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 33.8 Cg_endo -64.61 -60.72 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.76 2.306 . . . . 0.0 112.226 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -39.3 -17.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.533 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.732 HG21 ' O ' ' B' ' 19' ' ' PHE . 32.1 m -52.13 158.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 111.138 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' THR . . . . . 0.787 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 74.5 p -135.27 173.99 5.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.787 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 54.5 Cg_exo -51.84 -42.63 56.54 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.779 2.319 . . . . 0.0 112.321 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.2 m -72.69 -48.61 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.982 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.541 ' O ' ' HB3' ' B' ' 29' ' ' ASN . 26.3 mt-30 -60.57 -54.4 45.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.3 t -54.27 -55.59 26.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.734 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.35 -40.21 11.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.957 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 38.3 t-20 -49.97 -41.51 46.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.759 ' HD2' ' SG ' ' B' ' 17' ' ' CYS . 39.6 ttmt -82.22 -36.22 27.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.55 63.57 0.86 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.704 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' CYS . . . . . 0.754 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 93.1 m -149.99 178.56 8.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 0.0 111.019 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.799 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 72.2 m -79.02 155.2 28.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.02 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.721 ' CE2' ' HA ' ' B' ' 23' ' ' THR . 42.6 t80 -123.4 111.06 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.661 ' O ' ' HA ' ' B' ' 43' ' ' TRP . 32.7 t0 -135.91 108.38 7.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.827 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 4.6 p-10 -111.9 31.28 6.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 81.1 p -84.09 -24.86 30.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.513 ' HB ' ' CG2' ' B' ' 41' ' ' VAL . 62.4 t -111.6 135.34 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.176 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -85.95 152.24 23.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.31 -43.6 3.16 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.542 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.774 HG12 ' HB3' ' B' ' 11' ' ' PRO . 32.8 m -81.59 154.58 71.2 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.905 0.383 . . . . 0.0 111.148 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.632 ' HB3' HD21 ' B' ' 16' ' ' ASN . 50.0 Cg_endo -69.21 136.84 35.55 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.783 2.322 . . . . 0.0 112.313 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.827 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 51.0 m0 -84.58 -54.37 4.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.002 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' CYS . . . . . 0.799 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 53.8 t -83.19 100.0 10.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.76 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.754 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 44.3 p90 -128.37 167.56 16.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.097 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.609 ' CD1' ' HB2' ' B' ' 17' ' ' CYS . 90.7 m-85 -74.46 147.46 84.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 0 C--N 1.341 0.181 0 C-N-CA 122.758 2.305 . . . . 0.0 112.335 179.635 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.893 ' HG1' HG23 ' A' ' 8' ' ' THR . 9.0 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.824 0.345 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.593 ' O ' ' HZ ' ' A' ' 45' ' ' PHE . 71.6 m -117.85 -8.24 10.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.952 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.893 HG23 ' HG1' ' A' ' 6' ' ' THR . 9.2 t -69.96 92.14 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.126 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.804 HG23 HD22 ' A' ' 48' ' ' ASN . 63.0 t -127.49 173.96 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.838 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -95.2 126.01 48.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.02 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.857 ' HB3' HG22 ' A' ' 41' ' ' VAL . 81.2 Cg_exo -44.91 -20.54 0.39 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.835 2.356 . . . . 0.0 112.443 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -89.1 -31.53 17.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' ALA . 62.3 mt-10 -109.77 45.6 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.838 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.1 mtt180 -111.02 142.92 42.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.652 ' O ' ' O ' ' A' ' 16' ' ' ASN . 17.0 mp0 -110.39 89.75 3.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.704 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 37.0 t-20 -23.02 147.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.716 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.746 ' SG ' ' CE1' ' A' ' 46' ' ' TYR . 43.5 t -137.64 2.83 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.126 0.488 . . . . 0.0 110.554 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -159.01 -137.91 2.35 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.242 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.933 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 41.1 p90 -105.86 172.82 3.64 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.746 0.308 . . . . 0.0 110.884 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.933 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 46.3 Cg_endo -68.95 -46.33 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.694 2.263 . . . . 0.0 112.366 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.622 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -75.25 6.56 28.43 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.587 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.799 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 26.7 m -50.39 122.9 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 111.309 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.922 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 82.2 p -107.66 -178.51 0.59 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.961 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.922 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 74.5 Cg_exo -49.56 -46.89 24.85 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 29' ' ' ASN . 53.8 m -84.29 -34.48 23.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 1.031 HE21 ' HA ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -65.55 -32.5 74.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 33' ' ' CYS . 49.1 t -84.19 -53.43 5.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.789 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.27 -23.99 64.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 25' ' ' SER . 6.9 t30 -76.68 -12.26 59.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.938 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 1.022 ' HB3' ' HZ3' ' A' ' 30' ' ' LYS . 2.7 mmmp? -108.98 -13.92 14.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.913 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.35 34.29 7.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.517 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.977 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 82.7 m -122.65 164.47 18.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 74.2 m -81.44 153.43 26.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.619 ' HE1' ' O ' ' A' ' 22' ' ' VAL . 72.1 t80 -128.55 136.93 51.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.959 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.65 ' OD2' ' NH2' ' A' ' 14' ' ' ARG . 26.6 t0 -159.79 79.94 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -80.46 46.0 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.88 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.431 ' HG1' HG22 ' A' ' 38' ' ' VAL . 73.9 p -104.49 -4.81 22.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.202 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.84 HG23 ' HG2' ' A' ' 11' ' ' PRO . 67.8 t -145.93 118.59 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.29 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.645 ' C ' ' H ' ' A' ' 41' ' ' VAL . 78.0 mtm180 -76.78 -170.05 1.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.831 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.32 -30.24 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.446 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.857 HG22 ' HB3' ' A' ' 11' ' ' PRO . 32.9 m -111.26 161.91 23.14 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 111.077 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.635 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 40.9 Cg_endo -67.49 132.58 27.62 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.197 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -77.85 -35.26 51.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.002 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.977 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 44.7 t -103.88 105.83 16.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.647 ' CD2' ' HD3' ' A' ' 14' ' ' ARG . 5.6 p90 -124.7 -169.95 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.055 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.746 ' CE1' ' SG ' ' A' ' 17' ' ' CYS . 90.5 m-85 -92.38 160.96 33.9 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 46' ' ' TYR . 57.4 Cg_endo -71.17 -158.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.313 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.804 HD22 HG23 ' A' ' 9' ' ' VAL . 34.5 m-80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.571 ' O ' ' HZ ' ' B' ' 45' ' ' PHE . 82.5 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.808 0.337 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.577 HG22 ' O ' ' B' ' 8' ' ' THR . 8.9 t -93.67 71.83 4.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' B' ' 14' ' ' ARG . 59.5 t -109.53 172.5 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.936 ' HB3' ' CZ ' ' B' ' 12' ' ' ARG . . . -85.86 129.05 55.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.015 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.659 ' HB3' HG22 ' B' ' 41' ' ' VAL . 78.0 Cg_exo -39.69 -34.45 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.827 2.351 . . . . 0.0 112.426 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.937 ' H ' ' HD3' ' B' ' 12' ' ' ARG . 0.0 OUTLIER -90.12 -29.78 18.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.895 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.674 ' HB2' ' HB2' ' B' ' 10' ' ' ALA . 6.4 mm-40 -96.24 -5.22 40.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.174 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.889 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -63.06 133.9 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.674 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . 1.018 HE21 ' HA ' ' B' ' 15' ' ' GLN . 0.0 OUTLIER -79.94 79.97 6.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.957 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 1.038 HD21 ' N ' ' B' ' 17' ' ' CYS . 0.2 OUTLIER -34.36 139.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.721 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' CYS . . . . . 1.038 ' N ' HD21 ' B' ' 16' ' ' ASN . 44.6 t -126.98 1.57 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.019 0.437 . . . . 0.0 110.593 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 1.009 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -179.36 -132.72 1.82 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.218 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.855 ' CE2' ' N ' ' B' ' 22' ' ' VAL . 21.3 p90 -105.8 165.61 12.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.349 . . . . 0.0 110.915 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.702 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 43.1 Cg_endo -67.96 -11.57 32.48 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.751 2.301 . . . . 0.0 112.288 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.646 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -98.53 -19.92 21.3 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.855 ' N ' ' CE2' ' B' ' 19' ' ' PHE . 34.5 m -27.7 139.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.0 111.141 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' THR . . . . . 0.796 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 75.9 p -109.7 176.25 1.62 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.091 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.796 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 51.6 Cg_exo -52.91 -49.83 16.19 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.75 2.3 . . . . 0.0 112.361 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 48.1 t -68.76 -41.09 79.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.004 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.501 ' HG3' ' HG1' ' B' ' 23' ' ' THR . 52.8 mt-30 -65.69 -40.45 92.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.02 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' B' ' 33' ' ' CYS . 42.3 t -74.58 -41.71 60.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.802 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.8 -33.46 73.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.078 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -49.77 -35.0 20.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.76 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 1.048 ' HE2' ' HA ' ' B' ' 30' ' ' LYS . 0.5 OUTLIER -95.53 -38.05 10.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.521 177.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.07 57.01 0.61 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.522 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' CYS . . . . . 0.738 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 78.1 m -129.84 177.07 7.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.938 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.9 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 74.1 m -80.03 155.33 27.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.953 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.602 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 41.3 t80 -128.5 114.56 16.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.863 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 16.7 t70 -135.2 94.33 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.992 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.667 ' HA ' ' CG ' ' B' ' 43' ' ' TRP . 25.2 p30 -91.88 22.45 4.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.974 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -97.26 -8.44 29.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.219 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.806 HG23 ' NH2' ' B' ' 14' ' ' ARG . 63.2 t -122.27 106.18 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.089 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . 0.453 ' C ' ' H ' ' B' ' 41' ' ' VAL . 95.3 mtt180 -77.45 -178.46 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.953 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.43 -43.29 0.56 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.405 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.88 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.2 m -105.85 169.25 7.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 110.986 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.88 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 51.6 Cg_endo -69.33 147.58 65.95 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.67 2.247 . . . . 0.0 112.312 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.667 ' CG ' ' HA ' ' B' ' 36' ' ' ASP . 46.5 m0 -91.42 -38.19 12.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.813 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' CYS . . . . . 0.9 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 53.6 t -94.67 121.62 36.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.733 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.571 ' HZ ' ' O ' ' B' ' 7' ' ' CYS . 45.0 p90 -150.99 169.74 21.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.698 ' HD2' ' HG3' ' B' ' 15' ' ' GLN . 89.3 m-85 -83.46 155.52 66.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.818 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--N 1.342 0.196 0 C-N-CA 122.705 2.27 . . . . 0.0 112.296 -179.794 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.809 HG21 HG21 ' A' ' 8' ' ' THR . 91.9 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.857 0.36 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.4 m -112.18 23.95 13.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.987 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.809 HG21 HG21 ' A' ' 6' ' ' THR . 10.0 t -74.27 64.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.079 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.808 HG12 ' HA ' ' A' ' 14' ' ' ARG . 57.2 t -97.47 124.69 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.184 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.969 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . . . -50.26 136.23 22.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.82 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.477 ' HA ' ' NE ' ' A' ' 14' ' ' ARG . 84.7 Cg_exo -41.19 -55.59 2.08 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.906 2.404 . . . . 0.0 112.805 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.833 ' HG3' ' OE2' ' A' ' 13' ' ' GLU . 15.8 ptp180 -81.03 -29.61 35.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.07 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.969 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 22.3 mp0 -80.77 7.85 9.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.039 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.917 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.2 mtt180 -74.94 120.9 21.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.839 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.669 ' O ' ' O ' ' A' ' 16' ' ' ASN . 10.4 mm100 -82.26 80.16 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.919 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.669 ' O ' ' O ' ' A' ' 15' ' ' GLN . 35.9 t-20 -22.51 148.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.037 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.657 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 42.5 t -134.96 0.23 2.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.639 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -166.86 -136.05 1.96 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.268 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.856 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 22.2 p90 -105.55 170.12 6.26 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.811 0.339 . . . . 0.0 110.95 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.856 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 53.4 Cg_endo -69.82 -12.55 33.0 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.749 2.299 . . . . 0.0 112.368 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.661 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -98.44 -21.29 17.46 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.461 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.848 ' N ' ' CE2' ' A' ' 19' ' ' PHE . 34.3 m -24.93 150.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.815 0.341 . . . . 0.0 111.255 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.713 ' HG1' HE21 ' A' ' 26' ' ' GLN . 68.8 p -120.34 165.25 18.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.093 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.693 ' HD3' ' CZ ' ' A' ' 34' ' ' PHE . 53.2 Cg_exo -52.5 -36.52 70.7 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.718 2.279 . . . . 0.0 112.304 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.6 t -79.14 -48.28 14.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.713 HE21 ' HG1' ' A' ' 23' ' ' THR . 48.4 mt-30 -60.37 -44.27 95.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.944 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.6 t -75.02 -58.86 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -53.54 -15.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -92.48 -14.3 28.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 22.8 tptm -98.84 -1.46 40.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.94 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.55 45.79 5.69 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.602 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.779 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 79.9 m -149.96 152.17 34.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 110.993 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.885 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 78.5 m -67.39 155.29 39.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.858 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.693 ' CZ ' ' HD3' ' A' ' 24' ' ' PRO . 59.8 t80 -129.79 109.8 11.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.817 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.607 ' OD1' ' OG1' ' A' ' 37' ' ' THR . 32.9 t0 -138.41 90.48 2.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.704 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.4 p-10 -88.92 -3.12 58.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.607 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 79.1 p -48.71 -7.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.598 ' H ' ' C ' ' A' ' 36' ' ' ASP . 62.2 t -141.26 103.46 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.749 ' HA ' ' HE1' ' A' ' 43' ' ' TRP . 15.9 ptp180 -69.27 -165.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.763 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.22 -34.87 0.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.359 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.816 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.6 m -108.39 167.74 8.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.944 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.816 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 42.9 Cg_endo -68.08 119.97 6.96 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.187 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.749 ' HE1' ' HA ' ' A' ' 39' ' ' ARG . 50.1 m0 -70.11 -37.67 75.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.82 ' HB2' HG23 ' A' ' 22' ' ' VAL . 50.5 t -96.84 128.57 43.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.829 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.576 ' CE2' ' CG2' ' A' ' 9' ' ' VAL . 52.4 p90 -152.81 161.75 42.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -67.02 137.19 94.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.004 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.885 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 99.0 Cg_endo -80.67 -177.05 3.49 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.933 2.422 . . . . 0.0 112.484 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.511 HD22 HG21 ' A' ' 9' ' ' VAL . 36.3 m-80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.781 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.827 0.346 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.599 HG22 ' O ' ' B' ' 8' ' ' THR . 9.1 t -98.05 72.72 2.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.087 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.851 HG13 ' N ' ' B' ' 10' ' ' ALA . 73.8 t -119.34 -179.53 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.851 ' N ' HG13 ' B' ' 9' ' ' VAL . . . -95.97 159.91 31.23 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.008 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.436 ' HB3' HG13 ' B' ' 41' ' ' VAL . 76.8 Cg_exo -50.08 -39.18 51.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.748 2.298 . . . . 0.0 112.462 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.431 ' C ' ' H ' ' B' ' 14' ' ' ARG . 39.4 ptt180 -89.97 -29.92 18.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.751 ' O ' HG12 ' B' ' 9' ' ' VAL . 45.2 mt-10 -77.0 17.46 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.077 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.813 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.2 mtt180 -98.56 114.39 26.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 8.1 tp-100 -80.48 98.85 7.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.659 ' ND2' ' H ' ' B' ' 18' ' ' GLY . 2.6 t-20 -32.95 150.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' CYS . . . . . 0.557 ' H ' ' ND2' ' B' ' 16' ' ' ASN . 41.5 t -143.26 5.17 1.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.73 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.659 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -170.85 -138.61 2.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.422 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.827 ' CE1' HG13 ' B' ' 22' ' ' VAL . 42.8 p90 -105.58 166.83 10.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 0.0 110.929 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.755 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 47.1 Cg_endo -68.9 -33.74 19.37 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.751 2.3 . . . . 0.0 112.313 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.663 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -84.05 13.47 49.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.54 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.827 HG13 ' CE1' ' B' ' 19' ' ' PHE . 34.0 m -65.07 164.43 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 111.207 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' THR . . . . . 0.753 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 75.2 p -133.75 173.15 6.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.054 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.753 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 55.7 Cg_exo -51.63 -32.75 45.97 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.727 2.285 . . . . 0.0 112.363 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 47.3 t -84.81 -66.74 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.476 ' NE2' ' HZ ' ' B' ' 19' ' ' PHE . 52.6 mt-30 -39.34 -34.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.863 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.6 t -80.58 -60.97 2.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.16 -34.14 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -49.84 -37.09 29.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.42 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -86.76 -30.85 21.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.518 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.01 24.03 9.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.709 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' CYS . . . . . 0.648 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 81.6 m -102.42 155.54 18.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 110.897 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' B' ' 47' ' ' PRO . 83.0 m -63.56 149.45 46.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.807 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.625 ' CZ ' ' HA ' ' B' ' 23' ' ' THR . 59.6 t80 -133.13 120.24 20.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.535 ' OD2' ' NH1' ' B' ' 14' ' ' ARG . 16.5 t70 -129.3 87.75 2.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.655 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 24.3 p-10 -91.83 51.53 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 75.8 p -117.8 -11.92 10.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.192 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.486 ' O ' HG21 ' B' ' 41' ' ' VAL . 62.2 t -136.01 115.54 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . 0.481 ' C ' ' H ' ' B' ' 41' ' ' VAL . 80.7 mtp180 -67.98 -178.17 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.22 -41.27 0.48 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.557 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.486 HG21 ' O ' ' B' ' 38' ' ' VAL . 33.0 m -92.49 153.07 42.62 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 0.0 111.107 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.29 122.2 9.0 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.749 2.299 . . . . 0.0 112.207 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.655 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 23.1 m0 -67.34 -47.45 70.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.009 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' CYS . . . . . 0.693 ' CB ' HG23 ' B' ' 22' ' ' VAL . 46.8 t -92.03 119.84 32.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.897 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.778 ' CE2' ' HD3' ' B' ' 14' ' ' ARG . 53.3 p90 -149.23 159.41 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.827 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.439 ' CE1' ' O ' ' B' ' 16' ' ' ASN . 91.6 m-85 -58.68 146.92 72.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . 0.565 ' HA ' ' SG ' ' B' ' 33' ' ' CYS . 59.0 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 C-N-CA 122.763 2.308 . . . . 0.0 112.371 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.957 HG21 ' H ' ' A' ' 8' ' ' THR . 86.0 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.731 0.301 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.768 ' N ' HG21 ' A' ' 6' ' ' THR . 71.9 m -131.29 2.43 4.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.24 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.957 ' H ' HG21 ' A' ' 6' ' ' THR . 10.1 t -75.21 63.16 1.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.084 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.904 HG23 HD22 ' A' ' 48' ' ' ASN . 58.0 t -96.65 155.55 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.892 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -69.66 136.3 88.07 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.786 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.557 ' HG3' HG23 ' A' ' 38' ' ' VAL . 88.9 Cg_exo -41.83 -66.69 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.793 2.329 . . . . 0.0 112.593 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -65.12 -30.0 70.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.992 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.89 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 81.0 mm-40 -88.96 27.69 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.097 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.892 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.2 mtt180 -97.83 129.31 44.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.865 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 45' ' ' PHE . 29.5 mm-40 -82.63 104.19 12.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.636 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 2.6 t-20 -35.29 122.02 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.905 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 46.4 t -138.8 -0.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.196 0.522 . . . . 0.0 110.229 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.764 ' N ' ' O ' ' A' ' 44' ' ' CYS . . . 174.77 122.34 0.68 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.313 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.776 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 53.2 p90 -44.78 167.87 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.751 0.31 . . . . 0.0 110.973 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.776 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 47.2 Cg_endo -68.9 -52.97 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.659 2.239 . . . . 0.0 112.263 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -40.46 -27.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.382 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.85 HG23 ' HB2' ' A' ' 44' ' ' CYS . 29.1 m -49.93 171.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.342 . . . . 0.0 111.122 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.865 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 74.1 p -137.25 178.71 1.6 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.865 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 58.0 Cg_exo -51.48 -36.58 59.68 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.627 2.218 . . . . 0.0 112.27 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 53.1 m -90.18 -40.01 12.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.792 ' HB2' ' H ' ' A' ' 23' ' ' THR . 24.9 mt-30 -65.23 -27.31 68.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.868 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.947 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 53.0 t -91.56 -52.9 4.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.789 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.84 -21.0 40.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.004 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.517 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 37.8 t-20 -72.01 -27.47 62.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.849 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.11 -24.52 18.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.937 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.32 29.35 5.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.4 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.947 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 61.9 m -108.52 -176.8 3.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.827 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.717 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 73.7 m -109.22 132.62 53.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.636 176.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.772 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 26.9 t80 -104.41 108.5 19.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.896 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.484 ' OD1' ' OG1' ' A' ' 37' ' ' THR . 32.5 t0 -128.98 90.31 3.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.541 ' OD2' ' HE1' ' A' ' 34' ' ' PHE . 25.0 p30 -89.1 60.55 5.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.484 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 75.3 p -114.8 -33.65 5.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.09 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.62 ' O ' HG21 ' A' ' 41' ' ' VAL . 63.5 t -119.48 120.38 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.074 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.617 ' C ' ' H ' ' A' ' 41' ' ' VAL . 98.8 mtt180 -74.24 179.33 4.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.06 -28.5 0.15 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.62 HG21 ' O ' ' A' ' 38' ' ' VAL . 33.0 m -98.84 158.84 31.68 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.8 0.333 . . . . 0.0 111.081 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 50.4 Cg_endo -69.18 120.2 7.09 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 0.0 112.302 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -73.51 -27.4 61.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.932 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 44.6 t -113.27 95.96 5.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.71 ' C ' ' HB3' ' A' ' 17' ' ' CYS . 52.8 p90 -122.71 -169.93 2.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.636 ' CE2' ' O ' ' A' ' 16' ' ' ASN . 96.3 m-85 -88.29 143.39 32.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.976 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 56.6 Cg_endo -70.87 -156.53 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.842 2.362 . . . . 0.0 112.408 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.904 HD22 HG23 ' A' ' 9' ' ' VAL . 76.2 m-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 71.2 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.677 0.275 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.697 ' O ' HG21 ' B' ' 8' ' ' THR . 9.4 t -74.52 82.95 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 111.099 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.806 HG13 ' N ' ' B' ' 10' ' ' ALA . 76.4 t -128.59 176.23 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.071 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.824 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -84.17 128.15 63.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.898 ' HD2' ' NH1' ' B' ' 12' ' ' ARG . 97.6 Cg_exo -42.45 -66.25 0.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.795 2.33 . . . . 0.0 112.416 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.898 ' NH1' ' HD2' ' B' ' 11' ' ' PRO . 0.1 OUTLIER -54.16 -29.9 47.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.823 179.076 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.706 ' HB2' ' HB1' ' B' ' 10' ' ' ALA . 87.3 mt-10 -93.82 22.71 5.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.824 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 98.8 mtt180 -98.91 141.54 31.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . 0.549 ' O ' ' HD1' ' B' ' 46' ' ' TYR . 84.9 mm-40 -88.18 80.04 7.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 1.026 HD21 ' N ' ' B' ' 17' ' ' CYS . 0.1 OUTLIER -24.36 138.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.585 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' CYS . . . . . 1.026 ' N ' HD21 ' B' ' 16' ' ' ASN . 40.9 t -133.09 2.82 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 110.559 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.862 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -156.83 -136.5 2.13 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.286 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.901 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 12.3 p90 -105.74 171.54 4.77 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.342 . . . . 0.0 111.007 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.901 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 30.4 Cg_endo -64.05 -10.01 21.5 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.821 2.348 . . . . 0.0 112.386 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.768 ' HA3' ' CZ3' ' B' ' 43' ' ' TRP . . . -128.93 29.07 4.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.606 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.854 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 35.7 m -49.66 161.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.391 . . . . 0.0 111.264 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' THR . . . . . 1.055 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 66.7 p -135.95 176.41 2.85 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.767 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 1.055 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 10.8 Cg_endo -54.03 -42.22 68.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.597 2.198 . . . . 0.0 112.088 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -81.07 -46.42 15.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.728 ' HG2' ' OG1' ' B' ' 23' ' ' THR . 15.2 mm100 -57.04 -38.63 73.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -73.76 -54.77 7.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.759 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.1 -35.7 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.83 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -54.03 -28.33 37.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.798 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.968 ' HB3' ' HZ3' ' B' ' 30' ' ' LYS . 2.7 mmmp? -100.17 -26.95 13.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.731 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.5 60.58 1.79 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.592 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' CYS . . . . . 0.51 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 78.6 m -142.88 176.41 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.91 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.649 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.0 m -74.27 148.66 41.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.765 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.624 ' CE1' HG22 ' B' ' 22' ' ' VAL . 75.6 t80 -126.76 130.8 51.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.885 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.571 ' OD2' ' NH2' ' B' ' 14' ' ' ARG . 27.5 t0 -148.19 80.02 1.46 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.873 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.722 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 24.4 p-10 -84.44 53.45 2.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -120.04 -4.84 10.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.554 HG11 HG21 ' B' ' 41' ' ' VAL . 61.8 t -132.7 106.87 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . 0.686 ' C ' ' H ' ' B' ' 41' ' ' VAL . 79.7 mtm180 -71.28 -171.81 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.66 -10.88 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.385 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.88 HG23 ' HB3' ' B' ' 11' ' ' PRO . 34.9 m -131.49 164.98 38.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 0.0 111.1 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.745 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 57.7 Cg_endo -71.31 144.17 45.33 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.751 2.301 . . . . 0.0 112.309 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.768 ' CZ3' ' HA3' ' B' ' 21' ' ' GLY . 27.1 m0 -93.25 -50.7 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.794 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' CYS . . . . . 0.768 ' H ' HG23 ' B' ' 22' ' ' VAL . 52.9 t -87.66 122.85 31.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.727 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.778 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 47.8 p90 -148.19 149.58 32.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.549 ' HD1' ' O ' ' B' ' 15' ' ' GLN . 81.0 m-85 -46.81 150.57 1.25 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.851 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.465 -0.199 0 C-N-CA 122.747 2.298 . . . . 0.0 112.37 -179.385 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.929 ' C ' HD21 ' A' ' 48' ' ' ASN . 95.7 m . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.746 0.308 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.609 ' N ' HG21 ' A' ' 6' ' ' THR . 70.9 m -130.31 -22.88 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.842 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.515 HG21 ' CG2' ' A' ' 6' ' ' THR . 8.9 t -74.37 51.33 0.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.853 ' CG2' HD22 ' A' ' 48' ' ' ASN . 62.8 t -90.06 177.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.886 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . . . -76.05 132.11 74.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.939 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.667 ' O ' ' HG3' ' A' ' 14' ' ' ARG . 88.6 Cg_exo -46.92 -74.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.746 2.297 . . . . 0.0 112.425 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.699 ' HB2' ' OE2' ' A' ' 13' ' ' GLU . 37.2 mmt180 -52.6 -30.65 32.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.975 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.886 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -89.66 35.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.781 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.0 mtt180 -107.89 124.04 49.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.976 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.572 ' CB ' ' HD2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER -79.93 92.71 5.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 15' ' ' GLN . 27.4 t-20 -30.31 150.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.642 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 43.5 t -135.96 4.67 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.336 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.19 -138.28 2.73 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.336 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.938 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 30.4 p90 -105.75 172.38 4.04 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.778 0.323 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.938 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 46.1 Cg_endo -68.79 -31.59 24.97 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.715 2.277 . . . . 0.0 112.325 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . -74.27 -27.98 64.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.527 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.842 HG23 ' HB2' ' A' ' 44' ' ' CYS . 34.4 m -26.21 152.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.266 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.684 ' OG1' ' HG3' ' A' ' 26' ' ' GLN . 74.8 p -122.33 164.53 25.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.074 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.756 ' HG3' ' CE1' ' A' ' 34' ' ' PHE . 50.2 Cg_exo -53.48 -32.48 63.16 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.709 2.273 . . . . 0.0 112.349 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 47.8 t -84.83 -46.45 11.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.684 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 26.3 mt-30 -59.71 -46.59 88.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.8 t -76.48 -48.34 19.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' PRO . . . -63.74 -15.29 58.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.086 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 25' ' ' SER . 42.9 t30 -83.4 -14.84 51.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -92.25 -35.96 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.74 11.79 1.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.568 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.746 ' HB3' ' O ' ' A' ' 45' ' ' PHE . 71.7 m -113.81 170.62 8.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 110.941 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 76.8 m -88.17 155.07 19.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.756 ' CE1' ' HG3' ' A' ' 24' ' ' PRO . 45.2 t80 -133.14 119.42 19.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.438 ' CG ' ' HG1' ' A' ' 37' ' ' THR . 16.4 t70 -130.64 79.99 1.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.782 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.3 p-10 -78.18 21.54 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.438 ' HG1' ' CG ' ' A' ' 35' ' ' ASP . 75.0 p -90.84 -16.77 27.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.763 HG13 HG21 ' A' ' 41' ' ' VAL . 62.8 t -108.66 126.71 65.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.093 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.551 ' C ' ' H ' ' A' ' 41' ' ' VAL . 82.9 mtm180 -91.09 176.41 6.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.95 -33.46 0.29 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.466 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.904 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.3 m -106.27 170.64 5.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.72 0.295 . . . . 0.0 111.119 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.904 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 60.0 Cg_endo -72.63 153.65 54.47 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.673 2.248 . . . . 0.0 112.223 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.782 ' CD1' ' HA ' ' A' ' 36' ' ' ASP . 34.1 m0 -97.81 -30.29 12.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.842 ' HB2' HG23 ' A' ' 22' ' ' VAL . 47.4 t -100.04 117.38 34.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.778 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.746 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 52.2 p90 -143.57 170.05 16.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.572 ' HD2' ' CB ' ' A' ' 15' ' ' GLN . 25.6 m-85 -76.97 134.94 67.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.746 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 18.0 Cg_endo -61.02 -150.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.52 -0.195 0 C-N-CA 122.976 2.45 . . . . 0.0 112.606 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.929 HD21 ' C ' ' A' ' 6' ' ' THR . 41.9 m-80 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.357 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.738 0.304 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.651 HG22 ' O ' ' B' ' 8' ' ' THR . 9.0 t -86.9 84.96 7.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.024 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.883 HG12 ' HA ' ' B' ' 14' ' ' ARG . 58.8 t -125.31 165.28 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.208 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.849 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -93.5 131.53 32.29 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.986 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.87 ' HB3' HG22 ' B' ' 41' ' ' VAL . 79.0 Cg_exo -40.07 -32.05 0.59 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.793 2.329 . . . . 0.0 112.516 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.885 ' NH2' HG11 ' B' ' 41' ' ' VAL . 2.0 mmp_? -90.25 -29.89 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' B' ' 10' ' ' ALA . 12.2 mm-40 -93.05 -5.93 49.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.085 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.883 ' HA ' HG12 ' B' ' 9' ' ' VAL . 99.4 mtt180 -69.29 122.2 18.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.823 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . 1.007 ' HA ' HE21 ' B' ' 15' ' ' GLN . 0.0 OUTLIER -79.9 91.18 5.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.869 -178.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 1.056 HD21 ' N ' ' B' ' 17' ' ' CYS . 0.1 OUTLIER -32.64 140.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.753 179.029 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' CYS . . . . . 1.056 ' N ' HD21 ' B' ' 16' ' ' ASN . 43.1 t -127.8 1.69 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.526 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 1.031 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -172.39 -134.45 1.8 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.084 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.863 ' CE1' HG13 ' B' ' 22' ' ' VAL . 37.8 p90 -106.15 156.58 36.59 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.732 0.301 . . . . 0.0 110.895 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.562 ' O ' ' CE3' ' B' ' 43' ' ' TRP . 36.4 Cg_endo -65.51 -18.91 60.56 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.681 2.254 . . . . 0.0 112.229 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.639 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -94.14 8.13 72.76 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.47 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.863 HG13 ' CE1' ' B' ' 19' ' ' PHE . 34.6 m -61.67 155.55 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.0 111.129 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' THR . . . . . 0.819 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 78.3 p -121.06 174.71 2.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.12 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.819 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 76.8 Cg_exo -50.26 -56.08 3.46 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 0.0 112.309 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 79.5 p -58.35 -55.05 39.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.836 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.812 HE21 ' H ' ' B' ' 23' ' ' THR . 24.6 mt-30 -50.04 -72.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' CYS . . . . . 0.612 ' N ' ' HZ2' ' B' ' 30' ' ' LYS . 49.6 t -32.02 -53.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.73 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.33 -35.79 51.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' B' ' 26' ' ' GLN . 42.1 t30 -49.64 -32.58 13.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.755 ' NZ ' ' C ' ' B' ' 26' ' ' GLN . 2.2 mppt? -95.63 -15.5 22.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.795 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.94 38.31 16.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.532 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' CYS . . . . . 0.722 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 79.6 m -119.46 161.8 19.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 110.979 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.2 m -65.43 155.19 36.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.851 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.585 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 57.8 t80 -129.56 118.06 21.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.564 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 16.6 t70 -128.55 100.04 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -91.75 24.7 3.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' THR . . . . . 0.564 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 69.0 p -89.11 -62.39 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.822 HG22 ' HG3' ' B' ' 11' ' ' PRO . 61.1 t -80.52 120.79 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . 0.546 ' C ' ' H ' ' B' ' 41' ' ' VAL . 83.6 mtm180 -89.15 -177.55 5.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.99 -35.52 0.29 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.894 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 27.5 m -100.44 170.43 6.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.745 0.307 . . . . 0.0 111.137 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.894 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 41.1 Cg_endo -67.41 127.99 17.49 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.183 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.562 ' CE3' ' O ' ' B' ' 20' ' ' PRO . 49.7 m0 -78.9 -47.54 16.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.882 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' CYS . . . . . 0.64 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 50.2 t -91.16 123.79 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.777 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.722 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 50.0 p90 -142.67 168.94 18.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.997 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.527 ' O ' ' HD1' ' B' ' 45' ' ' PHE . 88.2 m-85 -75.73 154.08 85.26 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.94 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--O 1.232 0.186 0 C-N-CA 122.798 2.332 . . . . 0.0 112.415 179.838 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.841 ' HB ' ' HB2' ' A' ' 48' ' ' ASN . 93.9 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.803 0.335 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.629 ' N ' HG23 ' A' ' 6' ' ' THR . 72.0 m -146.5 19.38 1.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.979 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.783 HG23 ' CG2' ' A' ' 6' ' ' THR . 9.5 t -100.22 63.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.11 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.797 HG23 HD22 ' A' ' 48' ' ' ASN . 61.2 t -103.44 168.08 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.182 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.841 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -78.47 120.94 82.92 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.104 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.761 ' HA ' ' CD ' ' A' ' 14' ' ' ARG . 88.5 Cg_exo -46.58 -37.75 20.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.691 2.26 . . . . 0.0 112.456 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.705 ' HG3' ' HG3' ' A' ' 13' ' ' GLU . 14.5 ptm180 -71.17 -29.91 65.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.925 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.705 ' HG3' ' HG3' ' A' ' 12' ' ' ARG . 87.2 mt-10 -111.09 42.44 1.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.965 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.841 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.3 mtt180 -107.23 117.85 35.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.944 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.645 ' O ' ' O ' ' A' ' 16' ' ' ASN . 84.6 mm-40 -87.55 100.14 12.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.665 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.4 t-20 -24.92 150.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.814 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.802 ' HB2' ' N ' ' A' ' 46' ' ' TYR . 53.0 t -140.79 2.17 1.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.54 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -148.44 -138.99 3.1 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.294 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 1.104 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 43.9 p90 -105.82 -177.9 0.55 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.595 0.236 . . . . 0.0 110.745 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 1.104 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 38.3 Cg_endo -67.49 -62.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.49 2.127 . . . . 0.0 112.38 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.659 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -78.03 29.91 1.85 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.55 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.939 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 27.5 m -56.95 133.05 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.359 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.819 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 79.2 p -117.01 178.24 1.04 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.954 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.819 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 50.6 Cg_exo -53.81 -40.05 81.73 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.677 2.252 . . . . 0.0 112.271 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.618 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 47.8 t -88.35 -31.56 18.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.737 ' HB2' ' H ' ' A' ' 23' ' ' THR . 52.9 mt-30 -73.46 -33.8 65.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.896 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.912 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.2 t -87.48 -50.2 6.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.32 70.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.003 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.618 ' HB2' ' O ' ' A' ' 25' ' ' SER . 38.1 t-20 -57.04 -21.0 27.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -102.45 -28.85 11.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.946 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.48 -6.36 14.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.405 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.912 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 85.4 m -70.67 -170.07 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 110.904 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.83 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 72.3 m -116.11 155.06 28.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.662 ' CZ ' ' HB3' ' A' ' 36' ' ' ASP . 66.3 t80 -131.35 118.25 20.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.594 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 16.9 t70 -131.03 79.89 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.662 ' HB3' ' CZ ' ' A' ' 34' ' ' PHE . 24.7 p-10 -72.94 13.47 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.576 ' OG1' ' OD2' ' A' ' 35' ' ' ASP . 76.4 p -79.56 -16.41 55.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.081 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.694 HG23 ' CG ' ' A' ' 11' ' ' PRO . 63.2 t -131.39 109.63 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.095 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.809 ' HG2' ' H ' ' A' ' 40' ' ' GLY . 59.9 ttt180 -79.01 -176.93 5.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.809 ' H ' ' HG2' ' A' ' 39' ' ' ARG . . . 73.07 -38.45 0.79 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.383 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.828 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.0 m -98.44 168.03 10.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 111.049 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.828 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 48.1 Cg_endo -68.75 120.9 7.78 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 0.0 112.207 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.8 m0 -67.43 -45.24 76.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.83 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 42.5 t -91.87 116.13 28.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.741 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.574 ' C ' ' CB ' ' A' ' 17' ' ' CYS . 52.1 p90 -139.17 168.91 18.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.965 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.802 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 83.6 m-85 -68.71 135.08 90.24 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.701 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 61.3 Cg_endo -73.35 -156.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.758 2.305 . . . . 0.0 112.318 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.841 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 77.3 m-20 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . 0.504 ' O ' ' HZ ' ' B' ' 45' ' ' PHE . 75.7 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.75 0.31 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.647 HG22 ' O ' ' B' ' 8' ' ' THR . 9.1 t -73.8 92.24 2.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.871 HG12 ' HA ' ' B' ' 14' ' ' ARG . 59.1 t -128.98 157.14 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.159 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.889 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -74.06 114.08 29.51 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.96 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.737 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 88.4 Cg_exo -40.31 -28.67 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.813 2.342 . . . . 0.0 112.461 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . 0.617 ' HG3' ' HG3' ' B' ' 13' ' ' GLU . 16.6 ptp180 -90.13 -29.82 18.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.71 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 44.6 mt-10 -104.58 9.59 35.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.076 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.889 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -69.89 145.93 51.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.921 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 17.6 mp0 -89.99 97.42 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.662 ' OD1' ' N ' ' B' ' 17' ' ' CYS . 36.5 t-20 -48.0 149.12 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.018 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' CYS . . . . . 0.894 ' SG ' ' HD3' ' B' ' 30' ' ' LYS . 44.7 t -135.26 1.02 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 110.764 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.611 ' N ' ' OD1' ' B' ' 16' ' ' ASN . . . -170.96 -134.42 1.76 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.289 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 0.843 ' CZ ' ' HA ' ' B' ' 22' ' ' VAL . 35.4 p90 -105.35 167.65 9.47 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 111.041 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.776 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 42.3 Cg_endo -68.15 -25.15 37.57 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.762 2.308 . . . . 0.0 112.436 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.711 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -95.56 6.44 67.87 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.535 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.843 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 35.0 m -49.55 137.05 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 111.275 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' THR . . . . . 0.902 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 80.2 p -110.95 -179.64 0.68 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.971 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.902 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 75.9 Cg_exo -49.79 -50.09 14.17 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.594 2.196 . . . . 0.0 112.393 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.0 m -74.7 -27.68 60.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.924 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.74 ' HB2' ' H ' ' B' ' 23' ' ' THR . 10.2 mm-40 -73.84 -32.09 63.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' CYS . . . . . 0.684 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 42.1 t -83.65 -53.87 5.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.817 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.95 67.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.988 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -49.94 -32.24 14.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.894 ' HD3' ' SG ' ' B' ' 17' ' ' CYS . 63.0 tttp -98.79 -25.8 14.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.88 66.82 1.13 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.665 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' CYS . . . . . 0.798 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 76.4 m -149.99 160.6 43.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 82.2 m -60.58 154.78 20.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.791 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.614 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 52.0 t80 -132.71 117.65 18.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.915 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.586 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 32.3 t0 -138.16 83.81 2.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -83.87 58.33 4.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' THR . . . . . 0.586 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 78.3 p -113.23 -25.29 8.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.108 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -122.77 118.83 56.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.149 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . 0.779 ' HG2' ' H ' ' B' ' 40' ' ' GLY . 37.4 ttm180 -75.31 -178.18 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . 0.779 ' H ' ' HG2' ' B' ' 39' ' ' ARG . . . 70.64 -37.08 0.47 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.44 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.735 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.1 m -99.5 165.19 15.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.822 0.344 . . . . 0.0 111.08 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.735 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 43.9 Cg_endo -68.18 130.94 22.39 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.763 2.309 . . . . 0.0 112.167 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.556 ' HE3' ' O ' ' B' ' 22' ' ' VAL . 50.2 m0 -78.31 -18.86 54.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' CYS . . . . . 0.798 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 51.4 t -121.3 124.32 44.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.68 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 36.9 p90 -142.56 170.5 15.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -80.3 154.86 74.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.87 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 C--O 1.232 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.216 179.473 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.784 ' CG2' HG23 ' A' ' 8' ' ' THR . 95.0 m . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.851 0.357 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.577 ' N ' HG21 ' A' ' 6' ' ' THR . 72.5 m -143.19 -2.3 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.033 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.784 HG23 ' CG2' ' A' ' 6' ' ' THR . 9.8 t -71.91 62.26 0.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.147 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.817 ' CG2' HD22 ' A' ' 48' ' ' ASN . 58.4 t -106.56 165.62 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.825 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -91.6 123.62 63.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.862 ' HB3' HG22 ' A' ' 41' ' ' VAL . 80.7 Cg_exo -44.91 -39.4 14.15 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.728 2.285 . . . . 0.0 112.395 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -66.63 -29.98 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.796 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -112.41 39.26 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.061 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.825 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 96.6 mtt180 -108.26 152.91 23.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.715 ' NE2' ' C ' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -108.24 93.79 4.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.066 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.683 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.5 t-20 -27.7 150.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.683 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 42.1 t -138.02 0.82 2.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.518 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.564 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -177.54 -139.28 3.29 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.36 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.845 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 39.7 p90 -105.71 170.93 5.33 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.867 0.365 . . . . 0.0 110.986 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.845 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 58.4 Cg_endo -71.84 -36.5 6.12 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.767 2.312 . . . . 0.0 112.415 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . -58.63 -38.98 92.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.525 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.824 ' N ' ' CE2' ' A' ' 19' ' ' PHE . 34.2 m -30.34 155.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.805 0.336 . . . . 0.0 111.224 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.829 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 75.3 p -122.74 176.22 2.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.096 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.829 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 53.1 Cg_exo -52.43 -49.09 18.62 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -77.33 -42.33 37.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.719 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 26.4 mt-30 -59.43 -37.9 79.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 34' ' ' PHE . 53.9 t -72.53 -59.24 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.92 -26.87 38.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -67.98 -11.66 59.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.828 ' C ' ' HD3' ' A' ' 30' ' ' LYS . 7.8 tmtt? -100.37 -51.98 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.44 37.69 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.484 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.884 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 71.2 m -149.56 163.07 38.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.832 0.348 . . . . 0.0 111.069 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.855 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 72.6 m -76.15 155.12 34.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.695 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.724 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 77.3 t80 -122.47 136.82 54.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.645 ' CB ' HH12 ' A' ' 14' ' ' ARG . 26.6 t0 -155.72 79.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.697 ' HA ' ' CG ' ' A' ' 43' ' ' TRP . 24.5 p-10 -88.18 40.5 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.455 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 76.5 p -113.45 -13.9 12.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.695 HG11 HG23 ' A' ' 41' ' ' VAL . 62.7 t -113.89 104.09 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.119 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.56 ' C ' ' H ' ' A' ' 41' ' ' VAL . 98.5 mtt180 -70.47 175.52 4.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.86 -20.19 0.4 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.397 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.862 HG22 ' HB3' ' A' ' 11' ' ' PRO . 33.0 m -119.87 163.1 29.69 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.784 0.325 . . . . 0.0 111.162 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.675 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 55.5 Cg_endo -70.08 127.29 14.14 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.696 2.264 . . . . 0.0 112.266 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.697 ' CG ' ' HA ' ' A' ' 36' ' ' ASP . 49.9 m0 -72.16 -50.21 29.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.801 ' CB ' HG23 ' A' ' 22' ' ' VAL . 47.3 t -93.81 112.27 24.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.738 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.788 ' CE1' ' HD3' ' A' ' 14' ' ' ARG . 40.0 p90 -136.44 163.72 29.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.545 ' HD2' ' CB ' ' A' ' 15' ' ' GLN . 35.2 m-85 -57.81 134.72 83.14 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.666 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.884 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 96.8 Cg_endo -80.85 -156.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.842 2.361 . . . . 0.0 112.578 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.817 HD22 ' CG2' ' A' ' 9' ' ' VAL . 78.0 m-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.851 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.869 0.366 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' THR . . . . . 0.643 ' O ' HG21 ' B' ' 8' ' ' THR . 9.0 t -76.7 80.16 3.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.059 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.828 HG11 ' N ' ' B' ' 10' ' ' ALA . 66.6 t -129.22 177.4 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.247 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.828 ' N ' HG11 ' B' ' 9' ' ' VAL . . . -85.38 151.87 57.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.894 ' HG3' HG13 ' B' ' 38' ' ' VAL . 43.2 Cg_exo -56.36 -16.57 18.3 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.787 2.325 . . . . 0.0 112.321 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -82.92 -29.92 28.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.063 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLU . . . . . 0.739 ' HB2' ' CG1' ' B' ' 9' ' ' VAL . 45.1 mt-10 -94.8 -20.07 19.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 96.5 mtt180 -63.29 94.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLN . . . . . 0.651 ' O ' ' O ' ' B' ' 16' ' ' ASN . 8.3 tt0 -79.66 98.75 7.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . 0.695 ' ND2' ' H ' ' B' ' 18' ' ' GLY . 2.6 t-20 -23.61 149.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.257 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' CYS . . . . . 0.544 ' O ' ' HD3' ' B' ' 30' ' ' LYS . 42.6 t -141.89 4.45 1.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.535 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.695 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -166.96 -137.68 2.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.395 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' PHE . . . . . 1.014 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 29.1 p90 -105.32 175.42 2.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.327 . . . . 0.0 110.84 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 1.014 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 38.4 Cg_endo -67.11 -32.74 33.5 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.604 2.203 . . . . 0.0 112.482 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.733 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -93.84 5.2 72.7 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.602 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.865 HG11 ' O ' ' B' ' 19' ' ' PHE . 27.0 m -37.86 153.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 111.316 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' THR . . . . . 1.022 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 76.1 p -128.35 173.89 5.05 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.816 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 1.022 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 15.3 Cg_endo -57.46 -32.0 92.92 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.58 2.187 . . . . 0.0 112.221 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -85.14 -50.06 7.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' GLN . . . . . 0.408 ' OE1' ' HZ ' ' B' ' 19' ' ' PHE . 52.7 mt-30 -61.01 -32.73 72.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.4 t -78.92 -55.4 5.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.787 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' B' ' 31' ' ' GLY . . . -48.35 -33.87 9.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -49.8 -29.44 7.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.424 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' LYS . . . . . 0.544 ' HD3' ' O ' ' B' ' 17' ' ' CYS . 27.9 mtpp -97.82 -13.53 21.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.544 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' B' ' 28' ' ' ALA . . . 78.27 49.47 6.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.555 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' CYS . . . . . 0.735 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 71.0 m -126.33 166.98 16.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 110.947 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 77.8 m -75.08 149.52 39.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' PHE . . . . . 0.547 ' HE1' ' O ' ' B' ' 22' ' ' VAL . 73.4 t80 -126.95 126.92 44.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.628 ' OD1' HG22 ' B' ' 38' ' ' VAL . 16.6 t70 -149.83 80.47 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.961 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.795 ' HA ' ' CG ' ' B' ' 43' ' ' TRP . 24.5 p-10 -72.14 4.6 3.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 72.3 p -75.3 -7.07 52.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.052 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.894 HG13 ' HG3' ' B' ' 11' ' ' PRO . 68.1 t -115.75 112.46 39.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.181 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -89.01 149.18 23.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.32 -37.3 3.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.412 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' VAL . . . . . 0.896 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.3 m -112.43 169.76 6.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.35 . . . . 0.0 111.108 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' PRO . . . . . 0.896 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 51.7 Cg_endo -69.35 121.0 7.77 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.744 2.296 . . . . 0.0 112.229 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' TRP . . . . . 0.795 ' CG ' ' HA ' ' B' ' 36' ' ' ASP . 36.7 m0 -62.13 -45.02 95.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' CYS . . . . . 0.777 ' CB ' HG23 ' B' ' 22' ' ' VAL . 51.0 t -86.31 120.91 28.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.803 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . 0.735 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 52.5 p90 -148.81 162.14 40.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' TYR . . . . . 0.45 ' O ' ' HD1' ' B' ' 45' ' ' PHE . 92.6 m-85 -68.94 155.92 92.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' B' ' 46' ' ' TYR . 28.2 Cg_endo . . . . . 0 C--O 1.232 0.178 0 C-N-CA 122.774 2.316 . . . . 0.0 112.179 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.827 0.346 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.35 77.44 1.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.122 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.73 ' H ' ' NE2' ' A' ' 3' ' ' GLN . 1.4 mp0 -94.91 159.16 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.0 p -149.21 151.89 35.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.574 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 45.0 mt-10 -102.3 127.61 49.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.875 HG22 HG21 ' A' ' 8' ' ' THR . 86.2 m -117.58 176.85 4.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.787 ' N ' HG23 ' A' ' 6' ' ' THR . 77.1 m -123.71 -15.7 6.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.176 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.875 HG21 HG22 ' A' ' 6' ' ' THR . 10.2 t -70.88 69.28 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.757 HG23 HD21 ' A' ' 48' ' ' ASN . 60.1 t -114.89 171.81 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.154 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.818 ' C ' ' HG3' ' A' ' 14' ' ' ARG . . . -86.77 121.19 71.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.962 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.865 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 82.8 Cg_exo -45.22 -59.46 1.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.825 2.35 . . . . 0.0 112.44 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.613 ' HG3' ' HG3' ' A' ' 13' ' ' GLU . 37.9 ptt180 -46.42 -29.81 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.613 ' HG3' ' HG3' ' A' ' 12' ' ' ARG . 45.1 mt-10 -104.68 -17.83 14.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.865 ' HD2' ' HA ' ' A' ' 11' ' ' PRO . 99.4 mtt180 -51.96 139.4 22.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.758 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.52 ' O ' ' HD1' ' A' ' 46' ' ' TYR . 12.2 mm100 -90.85 98.48 11.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.786 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.568 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.6 t-20 -41.96 143.0 0.61 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.568 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 44.1 t -145.49 3.48 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.563 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.788 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 170.16 124.02 0.72 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.39 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.771 ' O ' HG21 ' A' ' 22' ' ' VAL . 52.6 p90 -44.88 163.88 0.19 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.812 0.339 . . . . 0.0 110.768 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.652 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 36.2 Cg_endo -65.5 -43.9 9.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.289 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.14 -13.67 1.07 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.771 HG21 ' O ' ' A' ' 19' ' ' PHE . 27.4 m -63.52 154.35 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 111.183 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.774 ' OG1' ' HG3' ' A' ' 26' ' ' GLN . 79.4 p -101.68 160.26 27.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.099 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 62.4 Cg_exo -51.21 -35.99 54.53 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.777 2.318 . . . . 0.0 112.306 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 80.2 p -75.74 -37.26 59.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.965 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.774 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 26.6 mt-30 -67.44 -55.67 12.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -55.67 -52.7 62.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.54 -22.54 66.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.015 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.571 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 27.4 t-20 -60.69 -19.09 57.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.834 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -102.21 -26.44 13.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.46 34.61 3.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.544 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.2 m -120.64 176.17 5.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.382 . . . . 0.0 111.037 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.9 m -86.02 155.27 20.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.958 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.646 ' HE2' HG22 ' A' ' 22' ' ' VAL . 19.5 t80 -135.55 108.1 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -125.58 103.24 7.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -96.24 24.23 5.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.0 p -90.71 -31.93 16.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.202 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.639 HG11 HG21 ' A' ' 41' ' ' VAL . 63.9 t -100.5 121.23 51.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -91.69 155.15 18.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.57 -42.3 2.7 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.431 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.872 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.7 m -93.65 170.04 9.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 111.101 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.872 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 45.7 Cg_endo -68.47 121.05 7.96 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.73 2.286 . . . . 0.0 112.238 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.636 ' CE3' ' O ' ' A' ' 20' ' ' PRO . 49.9 m0 -68.59 -44.73 73.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.788 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 51.3 t -97.36 118.87 34.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.712 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.654 ' CE2' ' HD3' ' A' ' 14' ' ' ARG . 51.3 p90 -147.34 157.59 43.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.959 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.52 ' HD1' ' O ' ' A' ' 15' ' ' GLN . 84.7 m-85 -63.75 157.48 66.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.94 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.565 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 57.9 Cg_endo -71.68 -161.63 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.737 2.292 . . . . 0.0 112.309 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.757 HD21 HG23 ' A' ' 9' ' ' VAL . 35.4 p30 -139.1 139.29 37.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.5 p -92.7 122.05 34.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.6 mt -137.29 149.05 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.537 ' CG ' ' H ' ' A' ' 52' ' ' VAL . 16.5 t70 -124.84 177.88 5.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.875 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 52' ' ' VAL . 33.3 m -138.71 84.84 17.7 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 57.8 Cg_endo -71.5 123.16 9.26 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.676 2.251 . . . . 0.0 112.341 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 13.9 Cg_exo -69.54 179.25 3.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.915 2.41 . . . . 0.0 112.11 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.756 ' O ' ' OE1' ' A' ' 56' ' ' GLU . 17.4 pt-20 -169.95 -19.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.756 ' OE1' ' O ' ' A' ' 55' ' ' GLU . 14.2 mm-40 -165.66 -29.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.673 ' N ' ' HE1' ' A' ' 60' ' ' PHE . 45.1 mt-10 -150.78 -139.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.947 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 46.2 t -137.99 0.8 2.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -94.35 29.23 2.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.819 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.673 ' HE1' ' N ' ' A' ' 57' ' ' GLU . 86.9 m-85 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' GLU . . . . . 0.608 ' O ' HG22 ' B' ' 52' ' ' VAL . 12.8 mm-40 . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.852 ' O ' ' HA ' ' B' ' 51' ' ' ASP . . . -115.48 -132.84 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.034 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . 0.605 ' OE1' ' CB ' ' B' ' 51' ' ' ASP . 12.2 mm-40 -79.96 136.86 36.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.41 . . . . 0.0 110.855 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.952 ' OG1' ' HB ' ' B' ' 50' ' ' ILE . 64.1 p -138.34 -158.42 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.178 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.954 ' O ' HG22 ' B' ' 49' ' ' THR . 87.2 mt-10 -48.3 -174.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.365 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 1.019 ' HA ' ' OG1' ' B' ' 49' ' ' THR . 56.8 m -150.29 -178.17 6.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.485 -167.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.879 ' H ' HG23 ' B' ' 6' ' ' THR . 62.2 m -78.6 -6.41 55.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.505 176.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.669 HG21 ' HB ' ' B' ' 6' ' ' THR . 9.1 t -87.01 69.92 10.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.987 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.648 HG13 ' N ' ' B' ' 10' ' ' ALA . 59.5 t -89.83 166.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.044 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.921 ' HB1' ' HB2' ' B' ' 13' ' ' GLU . . . -47.54 113.48 2.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.748 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 80.0 Cg_exo -44.83 -46.03 13.14 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.829 2.352 . . . . 0.0 112.467 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -73.96 -29.97 62.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.921 ' HB2' ' HB1' ' B' ' 10' ' ' ALA . 45.1 mt-10 -92.83 -5.47 50.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.03 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.833 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.3 mtt180 -58.98 125.66 24.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.82 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . 0.455 ' O ' ' HD1' ' B' ' 46' ' ' TYR . 8.1 tp-100 -80.29 98.29 7.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.682 HD21 ' CB ' ' B' ' 42' ' ' PRO . 27.3 t-20 -35.38 150.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.983 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' CYS . . . . . 0.435 ' O ' ' SG ' ' B' ' 17' ' ' CYS . 41.5 t -134.07 4.2 3.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.88 -133.72 2.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.437 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.81 ' CE1' HG13 ' B' ' 22' ' ' VAL . 35.6 p90 -105.13 164.29 15.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.907 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.691 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 37.5 Cg_endo -66.33 -31.02 44.34 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.721 2.281 . . . . 0.0 112.304 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.61 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -82.64 -2.64 90.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.458 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.811 HG23 ' CB ' ' B' ' 44' ' ' CYS . 29.1 m -47.11 147.79 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.915 0.388 . . . . 0.0 111.295 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 1.035 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 67.1 p -123.0 175.34 2.76 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 1.035 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 10.6 Cg_endo -53.6 -43.56 56.7 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.651 2.234 . . . . 0.0 112.091 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.5 p -76.88 -46.79 23.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.663 ' HG2' ' OG1' ' B' ' 23' ' ' THR . 15.2 mm100 -57.29 -50.48 72.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' CYS . . . . . 0.567 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 46.4 t -60.05 -57.1 14.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.728 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.01 -35.58 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.773 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.616 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 38.4 t-20 -49.94 -36.85 29.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.952 ' HZ3' ' HB3' ' B' ' 30' ' ' LYS . 2.6 mmmp? -88.14 -41.35 13.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.537 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.89 58.39 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.734 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . 0.79 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 82.6 m -140.89 174.69 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.359 . . . . 0.0 110.971 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 1.029 ' SG ' ' HG3' ' B' ' 47' ' ' PRO . 73.6 m -92.82 134.2 35.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.904 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.797 ' CZ ' ' HB3' ' B' ' 36' ' ' ASP . 59.4 t80 -91.39 153.06 20.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.122 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.479 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 32.4 t0 -170.2 79.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.825 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 25.3 p30 -90.02 30.41 1.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' THR . . . . . 0.479 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 71.5 p -83.5 -4.9 58.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.083 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 61.0 t -138.3 128.03 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.309 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . 0.833 ' NH1' ' CZ2' ' B' ' 43' ' ' TRP . 22.1 mmm180 -80.92 -178.58 6.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.53 -32.44 0.22 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.563 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.578 ' H ' ' C ' ' B' ' 39' ' ' ARG . 33.2 m -104.29 158.95 30.86 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.883 0.373 . . . . 0.0 111.068 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.682 ' CB ' HD21 ' B' ' 16' ' ' ASN . 55.3 Cg_endo -69.9 136.78 33.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.733 2.288 . . . . 0.0 112.277 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.833 ' CZ2' ' NH1' ' B' ' 39' ' ' ARG . 48.7 m0 -79.73 -32.43 41.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' CYS . . . . . 0.811 ' CB ' HG23 ' B' ' 22' ' ' VAL . 50.6 t -95.01 115.25 27.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.522 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.79 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 6.0 p90 -145.73 172.98 12.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.816 -176.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.455 ' HD1' ' O ' ' B' ' 15' ' ' GLN . 92.7 m-85 -85.33 133.71 41.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.621 176.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 1.029 ' HG3' ' SG ' ' B' ' 33' ' ' CYS . 56.2 Cg_endo -93.18 177.5 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.343 2.695 . . . . 0.0 112.629 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.929 ' ND2' ' O ' ' B' ' 6' ' ' THR . 0.2 OUTLIER -150.24 78.52 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.004 0.43 . . . . 0.0 110.831 171.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 1.019 ' OG1' ' HA ' ' B' ' 6' ' ' THR . 1.2 m -120.69 125.03 46.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.27 176.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.952 ' HB ' ' OG1' ' B' ' 4' ' ' THR . 5.3 mt -126.37 129.67 71.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.851 0.358 . . . . 0.0 111.099 -173.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.852 ' HA ' ' O ' ' B' ' 2' ' ' ALA . 24.7 p-10 -164.96 167.27 18.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -177.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.913 ' N ' ' HD2' ' B' ' 53' ' ' PRO . 64.2 t -108.07 -11.05 0.12 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.372 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . 0.993 ' HB2' ' HD2' ' B' ' 54' ' ' PRO . 50.4 Cg_endo -69.8 -169.17 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.782 2.322 . . . . 0.0 112.29 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.993 ' HD2' ' HB2' ' B' ' 53' ' ' PRO . 51.2 Cg_endo -69.54 170.13 17.03 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.655 2.237 . . . . 0.0 112.311 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -112.0 37.5 2.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.168 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.59 ' O ' ' OE2' ' B' ' 57' ' ' GLU . 62.8 tt0 -169.98 126.65 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.747 ' O ' ' SG ' ' B' ' 58' ' ' CYS . 12.7 mm-40 -132.56 -123.45 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' CYS . . . . . 0.747 ' SG ' ' O ' ' B' ' 57' ' ' GLU . 77.7 m -167.06 143.05 4.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.022 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -149.16 71.75 1.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.82 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.898 -179.938 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.582 ' CD ' ' H1 ' ' A' ' 1' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.1 -128.51 0.26 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.841 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 1.2 mp0 -85.23 179.12 7.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.5 p -142.08 130.11 21.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.709 ' HG2' ' OG1' ' A' ' 49' ' ' THR . 44.8 mt-10 -97.54 148.88 22.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.041 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.927 HG23 ' H ' ' A' ' 8' ' ' THR . 86.1 m -139.38 176.66 8.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.011 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.79 ' N ' HG23 ' A' ' 6' ' ' THR . 71.4 m -133.93 -2.0 2.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.266 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.927 ' H ' HG23 ' A' ' 6' ' ' THR . 9.6 t -75.69 75.2 2.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.137 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.73 HG12 ' HA ' ' A' ' 14' ' ' ARG . 62.1 t -116.4 161.67 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.878 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -81.33 132.15 56.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.935 ' HB3' HG22 ' A' ' 41' ' ' VAL . 85.5 Cg_exo -40.62 -32.1 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.823 2.349 . . . . 0.0 112.507 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -90.04 -29.74 18.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 10' ' ' ALA . 81.6 mm-40 -92.43 -6.0 50.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.001 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.878 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.4 mtt180 -69.37 118.04 11.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.614 ' O ' ' O ' ' A' ' 16' ' ' ASN . 8.1 tp-100 -79.96 93.12 5.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.696 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 2.6 t-20 -24.98 148.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.752 ' HB2' ' N ' ' A' ' 46' ' ' TYR . 50.5 t -143.68 3.0 1.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.116 0.484 . . . . 0.0 110.188 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.63 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . -156.55 -142.85 3.51 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.113 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.907 ' CZ ' ' HA ' ' A' ' 22' ' ' VAL . 27.4 p90 -105.75 168.91 7.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.793 0.33 . . . . 0.0 111.064 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.821 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 40.7 Cg_endo -67.78 -20.08 46.35 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.258 . . . . 0.0 112.436 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.716 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -102.64 4.96 50.79 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.545 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.907 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 27.7 m -39.9 163.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.008 0.433 . . . . 0.0 111.39 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.988 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 76.4 p -143.94 175.75 2.65 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.762 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.988 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 17.2 Cg_endo -57.74 -35.46 98.79 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.654 2.236 . . . . 0.0 112.196 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 29' ' ' ASN . 51.2 m -89.41 -41.26 12.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.056 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.651 HE21 ' CG2' ' A' ' 23' ' ' THR . 48.6 mt-30 -69.06 -29.86 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.039 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.925 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.8 t -93.85 -36.58 12.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.921 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -79.25 -12.15 59.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 25' ' ' SER . 43.2 t30 -91.75 -16.97 26.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -101.34 -33.2 10.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.939 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.54 43.7 0.63 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.925 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 76.1 m -126.94 161.89 27.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.932 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.749 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 77.1 m -85.83 134.77 33.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.644 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 50.1 t80 -113.59 122.04 46.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.882 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.661 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 16.5 t70 -145.81 99.08 3.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -91.74 54.71 2.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.901 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.532 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 74.3 p -94.99 -31.88 13.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.587 ' O ' HG23 ' A' ' 41' ' ' VAL . 63.3 t -133.97 120.92 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.229 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.613 ' C ' ' H ' ' A' ' 41' ' ' VAL . 35.3 ptt180 -73.47 -175.61 2.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.83 -28.84 0.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.434 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.935 HG22 ' HB3' ' A' ' 11' ' ' PRO . 33.9 m -101.23 166.71 11.88 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.0 111.156 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.777 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 60.1 Cg_endo -72.5 120.01 6.47 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.826 2.35 . . . . 0.0 112.225 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.423 ' HE1' ' HA ' ' A' ' 39' ' ' ARG . 51.8 m0 -78.21 -34.07 49.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.876 ' CB ' HG23 ' A' ' 22' ' ' VAL . 51.3 t -101.77 110.29 22.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.789 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.767 ' CE1' ' HD3' ' A' ' 14' ' ' ARG . 51.7 p90 -134.04 175.83 9.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.752 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 92.4 m-85 -76.0 154.14 84.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.857 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 6' ' ' THR . 57.4 Cg_endo -71.35 -156.78 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.694 2.263 . . . . 0.0 112.431 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.723 HD22 ' CG2' ' A' ' 9' ' ' VAL . 75.9 m-20 -138.81 89.13 2.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.709 ' OG1' ' HG2' ' A' ' 5' ' ' GLU . 88.6 m -80.3 88.96 5.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.9 mt -99.56 150.62 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.948 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.841 ' HB2' ' HG3' ' A' ' 3' ' ' GLN . 16.4 t70 -164.3 112.46 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.155 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 1.01 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 64.1 t -117.32 2.63 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.475 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 1.01 ' HD3' ' N ' ' A' ' 52' ' ' VAL . 13.0 Cg_exo -69.52 167.35 24.38 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.659 2.239 . . . . 0.0 112.231 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HG2' ' H ' ' A' ' 55' ' ' GLU . 74.4 Cg_endo -74.8 -84.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.806 2.337 . . . . 0.0 112.387 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.788 ' HG2' ' H ' ' A' ' 56' ' ' GLU . 62.6 tt0 -157.63 -177.16 6.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.849 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.788 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 17.0 pt-20 -82.2 -164.46 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.845 ' HG2' ' H ' ' A' ' 58' ' ' CYS . 62.7 tt0 -101.75 -123.5 0.18 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.845 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 52.8 t -114.39 -70.31 0.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.831 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -95.36 -110.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.698 ' CD2' ' OXT' ' A' ' 60' ' ' PHE . 51.3 p90 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.905 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' GLU . . . . . 0.586 ' O ' ' HG2' ' B' ' 1' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.763 0.316 . . . . 0.0 110.914 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.75 -152.25 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . 0.642 ' HG2' ' HB3' ' B' ' 51' ' ' ASP . 52.7 mt-30 -142.63 150.21 39.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 75.1 p -143.36 151.27 40.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.613 ' HB3' ' HB2' ' B' ' 47' ' ' PRO . 87.1 mt-10 -91.16 156.08 18.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.769 ' HB ' ' OD1' ' B' ' 48' ' ' ASN . 92.5 m -146.25 167.89 22.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.673 ' N ' HG23 ' B' ' 6' ' ' THR . 86.0 m -129.48 40.41 3.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.734 HG21 ' CG2' ' B' ' 6' ' ' THR . 9.8 t -117.73 49.19 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.106 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.687 HG11 ' N ' ' B' ' 10' ' ' ALA . 61.3 t -103.9 168.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.112 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.861 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -74.45 121.09 84.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.038 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.753 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 87.8 Cg_exo -46.17 -24.77 2.6 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.807 2.338 . . . . 0.0 112.542 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.634 ' HG3' ' HG2' ' B' ' 13' ' ' GLU . 13.8 ptp180 -87.69 -29.96 20.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.634 ' HG2' ' HG3' ' B' ' 12' ' ' ARG . 6.3 mm-40 -108.3 34.61 3.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.015 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.861 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.1 mtt180 -95.49 149.35 21.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . 0.732 ' HB2' ' HB2' ' B' ' 46' ' ' TYR . 17.1 mp0 -82.11 95.23 7.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.61 ' O ' ' CE2' ' B' ' 46' ' ' TYR . 27.4 t-20 -41.91 131.95 3.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' CYS . . . . . 0.659 ' HB2' ' CD2' ' B' ' 46' ' ' TYR . 44.3 t -145.82 3.99 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.792 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.59 123.02 0.65 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.504 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.737 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 52.5 p90 -45.02 166.71 0.12 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 120.835 0.35 . . . . 0.0 110.94 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.737 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 44.3 Cg_endo -68.28 -29.52 32.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.759 2.306 . . . . 0.0 112.323 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.629 ' H ' ' HD2' ' B' ' 19' ' ' PHE . . . -61.33 -10.65 23.27 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.449 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.689 HG21 ' O ' ' B' ' 19' ' ' PHE . 33.1 m -66.5 165.97 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.76 0.314 . . . . 0.0 111.159 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.808 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 72.8 p -126.29 175.03 3.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.808 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 56.8 Cg_exo -51.75 -44.19 46.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.722 2.281 . . . . 0.0 112.297 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 54.6 m -74.89 -47.74 28.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.559 ' HG3' ' OG1' ' B' ' 23' ' ' THR . 52.9 mt-30 -54.62 -46.56 73.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.894 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' B' ' 30' ' ' LYS . 42.6 t -65.32 -67.21 0.46 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.804 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.07 -42.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.805 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -50.18 -37.17 33.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.574 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' B' ' 27' ' ' CYS . 34.5 mmtp -84.02 -37.37 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.595 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.34 59.88 0.83 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.635 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . . . . . . . . . 74.1 m -150.2 170.38 19.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 110.939 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.836 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.5 m -66.71 150.15 49.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.816 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -128.03 120.08 26.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.789 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' B' ' 43' ' ' TRP . 26.4 t0 -134.96 98.17 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.74 ' HA ' ' CD2' ' B' ' 43' ' ' TRP . 24.5 p-10 -96.81 46.16 1.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 74.9 p -119.77 -39.93 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.106 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.776 HG11 HG21 ' B' ' 41' ' ' VAL . 59.5 t -90.02 139.27 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.152 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . 0.646 ' NH1' ' HZ2' ' B' ' 43' ' ' TRP . 38.6 mmt180 -94.41 162.31 13.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.43 -47.71 1.15 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.776 HG21 HG11 ' B' ' 38' ' ' VAL . 32.8 m -77.12 151.43 81.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.46 120.03 6.91 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.705 2.27 . . . . 0.0 112.259 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.74 ' CD2' ' HA ' ' B' ' 36' ' ' ASP . 35.5 m0 -64.06 -46.39 84.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.878 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' CYS . . . . . 0.836 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 44.2 t -96.0 104.09 16.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.717 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.808 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 44.8 p90 -131.91 150.09 52.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.046 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.732 ' HB2' ' HB2' ' B' ' 15' ' ' GLN . 92.3 m-85 -54.08 144.72 37.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 0.613 ' HB2' ' HB3' ' B' ' 5' ' ' GLU . 58.2 Cg_endo -71.67 -173.71 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.707 2.271 . . . . 0.0 112.311 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.769 ' OD1' ' HB ' ' B' ' 6' ' ' THR . 34.5 p30 -122.73 131.51 53.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 70.1 p -94.76 125.13 39.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.107 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.501 HG21 ' N ' ' B' ' 51' ' ' ASP . 62.4 mt -131.61 158.41 43.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.642 ' HB3' ' HG2' ' B' ' 3' ' ' GLN . 24.9 p30 -152.67 178.23 9.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.69 110.22 59.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.048 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.7 111.34 2.77 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.874 2.383 . . . . 0.0 112.131 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.814 ' HG3' ' HB3' ' B' ' 58' ' ' CYS . 55.5 Cg_endo -70.01 -135.77 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.671 2.247 . . . . 0.0 112.251 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . 0.431 ' H ' ' HB2' ' B' ' 54' ' ' PRO . 17.4 pt-20 -150.32 -43.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.951 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.909 ' HG3' ' H ' ' B' ' 57' ' ' GLU . 22.8 pt-20 -121.7 -69.76 0.82 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.051 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.909 ' H ' ' HG3' ' B' ' 56' ' ' GLU . 45.1 mt-10 -115.02 113.29 23.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.946 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' CYS . . . . . 0.814 ' HB3' ' HG3' ' B' ' 54' ' ' PRO . 28.9 p -83.23 43.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.557 ' OE1' ' N ' ' B' ' 60' ' ' PHE . 0.0 OUTLIER -160.3 111.63 1.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.913 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.61 ' CE2' ' O ' ' B' ' 57' ' ' GLU . 93.8 m-85 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.81 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.669 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 86.9 mt-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.783 0.325 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.678 ' N ' HE22 ' A' ' 3' ' ' GLN . . . -107.68 70.76 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.153 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.747 ' NE2' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -86.64 106.16 17.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.875 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.0 p -154.3 146.34 23.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.13 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.794 ' HG2' ' HG1' ' A' ' 49' ' ' THR . 85.0 mt-10 -93.93 133.63 37.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.744 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.877 ' HB ' ' HB2' ' A' ' 48' ' ' ASN . 96.4 m -107.89 152.91 23.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.168 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.418 ' N ' HG21 ' A' ' 6' ' ' THR . 72.0 m -133.83 6.55 3.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.765 HG23 ' CG2' ' A' ' 6' ' ' THR . 9.1 t -89.43 66.71 7.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.181 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.74 HG11 ' N ' ' A' ' 10' ' ' ALA . 61.4 t -97.19 171.44 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.817 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -88.52 112.59 51.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.072 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.832 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 83.7 Cg_exo -44.03 -20.02 0.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.795 2.33 . . . . 0.0 112.486 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 10' ' ' ALA . 37.6 mmt180 -90.11 -30.01 17.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 10' ' ' ALA . 44.5 mt-10 -108.12 -4.37 17.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.069 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.832 ' HD2' ' HA ' ' A' ' 11' ' ' PRO . 99.4 mtt180 -54.26 134.26 44.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.648 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 10.1 mm-40 -93.02 79.94 4.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.818 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.631 ' ND2' ' O ' ' A' ' 18' ' ' GLY . 51.6 t30 -27.63 150.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.833 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 41.3 t -125.26 8.18 7.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 110.567 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.631 ' O ' ' ND2' ' A' ' 16' ' ' ASN . . . -170.27 -132.39 1.46 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.216 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.92 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 30.8 p90 -105.76 173.77 3.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.798 0.333 . . . . 0.0 110.888 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.92 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 42.5 Cg_endo -68.15 -29.38 33.1 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.684 2.256 . . . . 0.0 112.457 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.657 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -89.28 -8.61 68.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.527 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.841 HG23 ' CB ' ' A' ' 44' ' ' CYS . 34.8 m -31.56 154.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.869 0.366 . . . . 0.0 111.327 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.999 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 74.5 p -123.99 172.72 5.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.134 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.999 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 28.1 Cg_endo -62.68 -33.08 78.29 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.756 2.304 . . . . 0.0 112.266 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.9 p -86.2 -38.0 18.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.689 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 24.0 mt-30 -69.9 -41.73 74.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.91 -45.89 39.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.792 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -33.07 70.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.058 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.612 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 38.9 t-20 -53.21 -20.67 4.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.817 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.76 -28.51 14.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.52 18.69 9.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.432 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.917 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 70.8 m -102.38 179.62 4.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 0.0 111.036 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.741 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 78.9 m -93.79 155.06 17.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.786 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.551 ' HE2' ' OD2' ' A' ' 36' ' ' ASP . 73.7 t80 -134.24 127.19 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.501 ' OD1' ' OG1' ' A' ' 37' ' ' THR . 26.6 t0 -137.27 92.32 2.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.551 ' OD2' ' HE2' ' A' ' 34' ' ' PHE . 4.6 p30 -89.62 38.02 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.501 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 76.8 p -109.33 -10.46 14.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.576 HG11 HG21 ' A' ' 41' ' ' VAL . 62.6 t -117.61 104.61 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.164 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.723 ' N ' ' HD2' ' A' ' 39' ' ' ARG . 4.3 mpt_? -73.8 155.02 39.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.93 -49.44 1.98 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.438 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.923 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.1 m -92.4 170.55 8.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.753 0.311 . . . . 0.0 111.087 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.923 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 43.9 Cg_endo -68.1 145.64 67.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.604 2.203 . . . . 0.0 112.245 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -89.76 -30.98 17.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.898 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.841 ' CB ' HG23 ' A' ' 22' ' ' VAL . 43.1 t -97.38 128.03 43.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.692 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 33' ' ' CYS . 48.6 p90 -146.12 157.72 43.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.904 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.648 ' CD2' ' O ' ' A' ' 15' ' ' GLN . 83.1 m-85 -70.26 135.63 86.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.917 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 58.3 Cg_endo -72.0 172.81 13.9 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.29 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.877 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 35.3 m-80 -120.56 87.62 2.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.794 ' HG1' ' HG2' ' A' ' 5' ' ' GLU . 91.8 m -85.01 102.44 13.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.058 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.9 mt -104.49 138.89 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.093 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.734 ' CB ' ' HG3' ' A' ' 3' ' ' GLN . 24.7 p-10 -165.1 158.66 16.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.899 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.775 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 33.0 m -156.71 30.51 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.775 ' CD ' ' N ' ' A' ' 52' ' ' VAL . 58.6 Cg_endo -72.01 125.97 11.42 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.751 2.3 . . . . 0.0 112.377 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.18 135.59 29.84 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.784 2.323 . . . . 0.0 112.286 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.692 ' OE1' ' HB2' ' A' ' 58' ' ' CYS . 62.1 mt-10 -93.14 -157.41 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -165.5 -20.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.582 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 17.3 pt-20 -152.21 94.16 1.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.692 ' HB2' ' OE1' ' A' ' 55' ' ' GLU . 52.3 t -139.65 -15.87 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.546 ' OE2' ' CB ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -145.08 16.66 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.546 ' CB ' ' OE2' ' A' ' 59' ' ' GLU . 63.5 t80 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.819 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' GLU . . . . . 0.84 ' HB3' HE22 ' B' ' 3' ' ' GLN . 12.6 mm-40 . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.658 ' N ' ' OE1' ' B' ' 3' ' ' GLN . . . -96.62 37.24 1.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.086 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . 0.946 ' OE1' ' N ' ' B' ' 3' ' ' GLN . 4.6 mp0 -90.14 176.77 6.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.447 ' N ' ' O ' ' B' ' 50' ' ' ILE . 73.4 p -142.22 134.72 28.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.079 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -97.96 134.8 40.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.992 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.733 HG21 ' N ' ' B' ' 7' ' ' CYS . 94.0 m -150.0 170.99 17.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.733 ' N ' HG21 ' B' ' 6' ' ' THR . 74.7 m -103.01 25.0 9.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.434 HG21 ' O ' ' B' ' 8' ' ' THR . 8.8 t -97.77 55.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.992 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.777 HG23 ' HB3' ' B' ' 48' ' ' ASN . 59.9 t -98.95 165.77 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.251 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.864 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -95.24 132.21 28.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.051 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.773 ' HB3' HG23 ' B' ' 41' ' ' VAL . 88.6 Cg_exo -43.84 -29.38 2.46 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.791 2.327 . . . . 0.0 112.49 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -86.71 -29.82 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.859 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' B' ' 10' ' ' ALA . 61.7 mt-10 -94.92 -11.52 28.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.989 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.864 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -61.89 127.14 29.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.971 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . 0.46 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 8.1 tp-100 -92.89 99.74 12.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.776 HD21 ' HB3' ' B' ' 42' ' ' PRO . 27.3 t-20 -33.8 150.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.016 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' B' ' 17' ' ' CYS . 43.3 t -138.02 4.65 2.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.696 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.14 -136.85 2.12 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.379 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.809 ' CZ ' ' HA ' ' B' ' 22' ' ' VAL . 27.5 p90 -105.44 168.9 7.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 0.0 110.99 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.796 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 54.0 Cg_endo -70.13 -12.66 32.6 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.748 2.299 . . . . 0.0 112.408 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.744 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -107.85 5.6 34.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.508 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.809 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 34.0 m -47.94 158.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.166 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.874 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 79.8 p -133.77 178.83 1.58 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.068 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.874 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 56.8 Cg_exo -51.75 -54.79 4.72 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.7 m -72.89 -43.0 63.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.694 ' HG3' ' OG1' ' B' ' 23' ' ' THR . 24.8 mt-30 -57.66 -38.83 75.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.941 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 46.3 t -72.92 -60.58 2.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.81 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.11 -34.75 1.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.973 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -50.02 -35.08 23.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.674 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -93.84 -32.41 13.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.708 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.92 58.35 0.84 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.616 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . 0.671 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 76.8 m -143.07 165.0 28.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.958 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.677 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 73.4 m -70.98 155.11 41.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.89 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.597 ' CE1' ' HA ' ' B' ' 23' ' ' THR . 67.8 t80 -132.32 119.16 20.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.6 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 16.6 t70 -130.1 96.58 4.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.74 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 4.6 p-10 -94.78 46.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 74.9 p -113.73 -31.99 6.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.503 HG11 HG21 ' B' ' 41' ' ' VAL . 63.5 t -107.87 111.43 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.162 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . 0.677 ' NH1' ' HZ2' ' B' ' 43' ' ' TRP . 21.8 mmm180 -68.41 178.21 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.46 -54.82 0.9 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.475 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.773 HG23 ' HB3' ' B' ' 11' ' ' PRO . 33.2 m -82.22 156.32 69.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.814 0.34 . . . . 0.0 111.125 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.776 ' HB3' HD21 ' B' ' 16' ' ' ASN . 47.3 Cg_endo -68.7 140.35 46.61 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.662 2.241 . . . . 0.0 112.317 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.74 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 12.9 m0 -81.56 -47.51 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' CYS . . . . . 0.687 ' CB ' HG23 ' B' ' 22' ' ' VAL . 50.6 t -87.71 119.61 28.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.757 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.76 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 51.3 p90 -152.18 171.29 18.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.502 ' O ' ' HD2' ' B' ' 45' ' ' PHE . 84.9 m-85 -75.62 156.57 84.88 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.848 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 46' ' ' TYR . 54.7 Cg_endo -69.95 -172.42 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.791 2.327 . . . . 0.0 112.305 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.777 ' HB3' HG23 ' B' ' 9' ' ' VAL . 8.2 p30 -123.48 104.09 8.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 76.4 p -67.66 80.54 0.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.067 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.627 HG13 ' OD1' ' B' ' 48' ' ' ASN . 63.1 mt -86.66 152.5 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.746 ' OD2' ' HG3' ' B' ' 3' ' ' GLN . 10.0 m-20 -109.78 134.09 52.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.902 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.908 ' N ' ' CD ' ' B' ' 53' ' ' PRO . 64.3 t -111.91 -11.56 0.11 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.382 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . 0.908 ' CD ' ' N ' ' B' ' 52' ' ' VAL . 56.3 Cg_endo -70.74 99.43 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.66 2.24 . . . . 0.0 112.337 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.795 ' HD3' ' O ' ' B' ' 52' ' ' VAL . 13.4 Cg_exo -69.65 -47.63 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.851 2.367 . . . . 0.0 112.134 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . 0.768 ' HG2' ' H ' ' B' ' 56' ' ' GLU . 41.5 tt0 -150.49 -177.86 6.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.768 ' H ' ' HG2' ' B' ' 55' ' ' GLU . 17.4 pt-20 -73.89 -42.5 60.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' B' ' 57' ' ' GLU . 17.4 pt-20 -114.97 60.81 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.926 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' CYS . . . . . 0.552 ' SG ' ' OE1' ' A' ' 55' ' ' GLU . 51.8 t -165.57 32.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -110.86 161.8 15.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.911 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.842 0.353 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.62 91.46 3.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.047 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.722 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 47.9 mt-30 -140.69 135.2 31.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 3' ' ' GLN . 71.2 p -163.12 176.43 10.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.189 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.923 ' HB3' ' HB2' ' A' ' 47' ' ' PRO . 87.4 mt-10 -81.95 143.47 31.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.832 HG23 ' N ' ' A' ' 7' ' ' CYS . 93.4 m -134.74 178.42 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.832 ' N ' HG23 ' A' ' 6' ' ' THR . 71.7 m -108.69 12.72 25.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.658 HG22 HD13 ' A' ' 50' ' ' ILE . 8.8 t -100.3 63.58 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.149 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.781 HG22 ' ND2' ' A' ' 48' ' ' ASN . 62.5 t -94.0 164.06 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.175 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.878 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -85.88 139.56 35.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.021 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.856 ' HB3' HG12 ' A' ' 38' ' ' VAL . 93.1 Cg_exo -42.07 -36.87 4.16 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.83 2.353 . . . . 0.0 112.481 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 1.057 ' HD3' ' N ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -90.23 -29.36 18.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.758 178.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 1.057 ' N ' ' HD3' ' A' ' 12' ' ' ARG . 85.4 mt-10 -80.85 -12.96 59.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.985 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.878 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 97.6 mtt180 -71.7 113.57 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.073 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.668 ' O ' ' O ' ' A' ' 16' ' ' ASN . 8.0 tp-100 -80.58 95.5 6.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.668 ' O ' ' O ' ' A' ' 15' ' ' GLN . 27.4 t-20 -23.48 150.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.022 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 41.0 t -141.7 4.8 1.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.485 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.1 -139.58 4.86 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.388 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.849 ' CE2' ' N ' ' A' ' 22' ' ' VAL . 40.3 p90 -105.62 167.41 9.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.799 0.333 . . . . 0.0 110.83 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.786 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 38.5 Cg_endo -66.86 -41.91 9.56 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.61 2.207 . . . . 0.0 112.304 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . -61.9 -26.64 67.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.544 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.849 ' N ' ' CE2' ' A' ' 19' ' ' PHE . 34.7 m -31.58 156.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 111.211 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.765 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 80.4 p -124.69 173.46 4.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.707 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 45.0 Cg_exo -56.27 -44.82 42.76 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.731 2.287 . . . . 0.0 112.308 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.537 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 80.1 p -75.73 -39.44 57.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.046 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.639 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 48.2 mt-30 -67.54 -38.1 83.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.1 t -82.23 -51.82 7.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.96 75.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.537 ' HB2' ' O ' ' A' ' 25' ' ' SER . 42.9 t30 -54.66 -16.76 2.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -100.47 -22.6 14.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 -28.73 5.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.585 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.653 ' HB3' ' O ' ' A' ' 45' ' ' PHE . 71.6 m -68.86 179.74 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.882 0.372 . . . . 0.0 111.068 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.3 m -107.22 155.24 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.003 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.765 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 15.5 t80 -115.31 134.15 55.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.484 ' OD1' ' NH1' ' A' ' 14' ' ' ARG . 17.4 t70 -158.77 99.26 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.782 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.4 p-10 -96.68 32.54 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 72.6 p -91.21 -6.68 53.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.856 HG12 ' HB3' ' A' ' 11' ' ' PRO . 61.6 t -132.66 114.91 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.74 ' N ' ' HD3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -78.44 -175.79 4.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.01 -35.19 0.29 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.548 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.728 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.1 m -107.38 164.82 13.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.728 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 59.5 Cg_endo -72.34 127.15 12.31 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.698 2.265 . . . . 0.0 112.282 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.782 ' CD1' ' HA ' ' A' ' 36' ' ' ASP . 35.0 m0 -68.2 -33.72 74.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.861 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.84 ' HB2' HG23 ' A' ' 22' ' ' VAL . 53.4 t -91.31 120.27 32.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.653 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 39.5 p90 -147.36 160.09 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.699 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 86.5 m-85 -67.89 165.0 35.48 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.923 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 39.8 Cg_endo -67.03 172.02 10.43 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.663 2.242 . . . . 0.0 112.306 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.781 ' ND2' HG22 ' A' ' 9' ' ' VAL . 8.2 p30 -136.67 118.82 15.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.688 ' HG1' ' HG2' ' A' ' 5' ' ' GLU . 92.7 m -71.56 93.03 1.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.677 HG13 ' OD1' ' A' ' 48' ' ' ASN . 63.1 mt -89.45 155.25 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.286 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.722 ' CB ' ' HG2' ' A' ' 3' ' ' GLN . 24.4 p-10 -145.98 -172.73 3.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.69 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 33.2 m -82.44 130.19 60.09 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 1.057 ' HD2' ' HD3' ' A' ' 54' ' ' PRO . 16.8 Cg_exo -68.46 -27.75 33.12 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 122.879 2.386 . . . . 0.0 112.598 -178.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 1.057 ' HD3' ' HD2' ' A' ' 53' ' ' PRO . 12.7 Cg_exo -69.51 -6.48 18.58 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.738 2.292 . . . . 0.0 112.158 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.627 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 10.4 tp10 -98.51 49.55 0.98 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.95 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.761 ' HG2' ' O ' ' A' ' 53' ' ' PRO . 12.6 mm-40 -103.56 118.4 36.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' OE2' ' C ' ' A' ' 60' ' ' PHE . 12.5 pt-20 -76.92 -177.43 4.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.939 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.582 ' O ' ' SG ' ' B' ' 58' ' ' CYS . 50.3 t -144.49 -4.2 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.524 ' O ' ' CG ' ' A' ' 60' ' ' PHE . 21.4 mp0 -81.82 -72.7 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.935 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 59' ' ' GLU . 84.9 m-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.867 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' GLU . . . . . 0.583 ' CD ' ' H1 ' ' B' ' 1' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.894 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.45 -129.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . 0.834 ' HB3' HG23 ' B' ' 49' ' ' THR . 51.9 mt-30 -124.12 165.82 16.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.703 ' O ' ' HA ' ' B' ' 49' ' ' THR . 74.8 p -139.77 148.15 41.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.175 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.798 ' HA ' ' O ' ' B' ' 48' ' ' ASN . 0.5 OUTLIER -105.33 152.76 22.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.919 HG21 ' H ' ' B' ' 8' ' ' THR . 87.0 m -146.63 166.83 25.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.663 ' N ' HG21 ' B' ' 6' ' ' THR . 72.8 m -109.29 9.23 25.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.107 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.919 ' H ' HG21 ' B' ' 6' ' ' THR . 9.5 t -82.13 73.24 9.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.821 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.966 HG21 ' ND2' ' B' ' 48' ' ' ASN . 50.1 t -107.19 166.42 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.375 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.829 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -94.21 122.61 61.15 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.92 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.774 ' HB3' HG12 ' B' ' 41' ' ' VAL . 98.9 Cg_exo -42.56 -26.96 0.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.864 2.376 . . . . 0.0 112.523 -178.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.565 ' HG3' ' HG2' ' B' ' 13' ' ' GLU . 16.7 ptm180 -90.05 -29.87 18.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.973 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.565 ' HG2' ' HG3' ' B' ' 12' ' ' ARG . 81.6 mm-40 -99.96 -11.73 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.177 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.934 ' HA ' HG12 ' B' ' 9' ' ' VAL . 96.7 mtt180 -51.54 127.19 19.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.873 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . 1.001 ' HA ' HE21 ' B' ' 15' ' ' GLN . 0.0 OUTLIER -79.91 86.84 5.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.792 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.632 HD21 ' HB3' ' B' ' 42' ' ' PRO . 27.4 t-20 -30.01 133.67 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.105 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' CYS . . . . . 0.759 ' SG ' ' HD2' ' B' ' 30' ' ' LYS . 41.6 t -145.53 2.74 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.616 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.539 ' HA2' ' HB3' ' B' ' 44' ' ' CYS . . . 177.54 122.39 0.73 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.428 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.935 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 53.1 p90 -44.83 172.86 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.804 0.335 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.935 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 33.8 Cg_endo -64.61 -60.72 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.76 2.306 . . . . 0.0 112.226 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -39.3 -17.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.533 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.732 HG21 ' O ' ' B' ' 19' ' ' PHE . 32.1 m -52.13 158.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 111.138 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.787 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 74.5 p -135.27 173.99 5.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.787 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 54.5 Cg_exo -51.84 -42.63 56.54 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.779 2.319 . . . . 0.0 112.321 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.2 m -72.69 -48.61 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.982 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.541 ' O ' ' HB3' ' B' ' 29' ' ' ASN . 26.3 mt-30 -60.57 -54.4 45.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.3 t -54.27 -55.59 26.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.734 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.35 -40.21 11.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.957 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 38.3 t-20 -49.97 -41.51 46.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.759 ' HD2' ' SG ' ' B' ' 17' ' ' CYS . 39.6 ttmt -82.22 -36.22 27.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.55 63.57 0.86 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.704 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . 0.754 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 93.1 m -149.99 178.56 8.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 0.0 111.019 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.799 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 72.2 m -79.02 155.2 28.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.02 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.721 ' CE2' ' HA ' ' B' ' 23' ' ' THR . 42.6 t80 -123.4 111.06 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.661 ' O ' ' HA ' ' B' ' 43' ' ' TRP . 32.7 t0 -135.91 108.38 7.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.827 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 4.6 p-10 -111.9 31.28 6.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 81.1 p -84.09 -24.86 30.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.513 ' HB ' ' CG2' ' B' ' 41' ' ' VAL . 62.4 t -111.6 135.34 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.176 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -85.95 152.24 23.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.31 -43.6 3.16 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.542 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.774 HG12 ' HB3' ' B' ' 11' ' ' PRO . 32.8 m -81.59 154.58 71.2 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.905 0.383 . . . . 0.0 111.148 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.632 ' HB3' HD21 ' B' ' 16' ' ' ASN . 50.0 Cg_endo -69.21 136.84 35.55 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.783 2.322 . . . . 0.0 112.313 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.827 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 51.0 m0 -84.58 -54.37 4.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.002 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' CYS . . . . . 0.799 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 53.8 t -83.19 100.0 10.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.76 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.754 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 44.3 p90 -128.37 167.56 16.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.097 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.609 ' CD1' ' HB2' ' B' ' 17' ' ' CYS . 90.7 m-85 -74.46 147.46 84.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 0.515 ' HB2' ' HB3' ' B' ' 5' ' ' GLU . 65.5 Cg_endo -74.01 -172.23 1.07 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.758 2.305 . . . . 0.0 112.335 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.966 ' ND2' HG21 ' B' ' 9' ' ' VAL . 34.6 m-80 -134.17 122.72 23.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.987 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.834 HG23 ' HB3' ' B' ' 3' ' ' GLN . 92.9 m -93.13 99.03 11.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.199 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.729 HG21 ' N ' ' B' ' 51' ' ' ASP . 62.4 mt -104.37 170.07 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.131 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.729 ' N ' HG21 ' B' ' 50' ' ' ILE . 10.1 m-20 -106.18 160.06 15.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.726 HG21 ' O ' ' B' ' 52' ' ' VAL . 33.3 m -158.46 76.0 3.54 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.094 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.99 114.06 3.78 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.728 2.285 . . . . 0.0 112.354 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.57 88.87 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.917 2.411 . . . . 0.0 112.103 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . 0.764 ' HG2' ' N ' ' B' ' 56' ' ' GLU . 64.1 tt0 -104.56 -119.56 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.932 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.764 ' N ' ' HG2' ' B' ' 55' ' ' GLU . 12.5 mm-40 -83.89 -38.27 21.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.799 ' HG3' ' H ' ' B' ' 58' ' ' CYS . 10.3 tp10 -125.35 -121.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.956 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' CYS . . . . . 0.799 ' H ' ' HG3' ' B' ' 57' ' ' GLU . 26.7 p -123.72 -78.8 0.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.919 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.568 ' N ' ' SG ' ' B' ' 58' ' ' CYS . 12.5 pt-20 -139.79 -176.59 4.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.876 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.612 ' OE1' ' OE1' ' A' ' 3' ' ' GLN . 17.4 pt-20 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.811 0.339 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -164.13 79.14 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.151 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.718 ' HG2' ' OD1' ' A' ' 51' ' ' ASP . 52.3 mt-30 -118.72 168.06 11.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.839 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' A' ' 49' ' ' THR . 77.9 p -162.39 160.02 25.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.173 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.628 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 6.2 mm-40 -96.17 146.63 24.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.893 ' HG1' HG23 ' A' ' 8' ' ' THR . 9.0 t -149.83 161.35 42.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.182 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.593 ' O ' ' HZ ' ' A' ' 45' ' ' PHE . 71.6 m -117.85 -8.24 10.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.952 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.893 HG23 ' HG1' ' A' ' 6' ' ' THR . 9.2 t -69.96 92.14 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.126 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.804 HG23 HD22 ' A' ' 48' ' ' ASN . 63.0 t -127.49 173.96 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.838 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -95.2 126.01 48.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.02 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.857 ' HB3' HG22 ' A' ' 41' ' ' VAL . 81.2 Cg_exo -44.91 -20.54 0.39 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.835 2.356 . . . . 0.0 112.443 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -89.1 -31.53 17.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' ALA . 62.3 mt-10 -109.77 45.6 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.838 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.1 mtt180 -111.02 142.92 42.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.652 ' O ' ' O ' ' A' ' 16' ' ' ASN . 17.0 mp0 -110.39 89.75 3.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.704 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 37.0 t-20 -23.02 147.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.716 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.746 ' SG ' ' CE1' ' A' ' 46' ' ' TYR . 43.5 t -137.64 2.83 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.126 0.488 . . . . 0.0 110.554 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -159.01 -137.91 2.35 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.242 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.933 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 41.1 p90 -105.86 172.82 3.64 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.746 0.308 . . . . 0.0 110.884 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.933 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 46.3 Cg_endo -68.95 -46.33 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.694 2.263 . . . . 0.0 112.366 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.622 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -75.25 6.56 28.43 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.587 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.799 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 26.7 m -50.39 122.9 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 111.309 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.922 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 82.2 p -107.66 -178.51 0.59 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.961 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.922 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 74.5 Cg_exo -49.56 -46.89 24.85 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.425 ' O ' ' CB ' ' A' ' 29' ' ' ASN . 53.8 m -84.29 -34.48 23.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 1.031 ' HA ' HE21 ' A' ' 26' ' ' GLN . 0.0 OUTLIER -65.55 -32.5 74.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.527 ' SG ' ' O ' ' A' ' 33' ' ' CYS . 49.1 t -84.19 -53.43 5.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.789 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.27 -23.99 64.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 25' ' ' SER . 6.9 t30 -76.68 -12.26 59.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.938 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 1.022 ' HZ3' ' HB3' ' A' ' 30' ' ' LYS . 2.7 mmmp? -108.98 -13.92 14.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.913 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.35 34.29 7.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.517 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.977 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 82.7 m -122.65 164.47 18.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.748 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 74.2 m -81.44 153.43 26.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.619 ' HE1' ' O ' ' A' ' 22' ' ' VAL . 72.1 t80 -128.55 136.93 51.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.959 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.65 ' OD2' ' NH2' ' A' ' 14' ' ' ARG . 26.6 t0 -159.79 79.94 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -80.46 46.0 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.88 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.431 ' HG1' HG22 ' A' ' 38' ' ' VAL . 73.9 p -104.49 -4.81 22.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.202 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.84 HG23 ' HG2' ' A' ' 11' ' ' PRO . 67.8 t -145.93 118.59 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.29 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.645 ' C ' ' H ' ' A' ' 41' ' ' VAL . 78.0 mtm180 -76.78 -170.05 1.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.831 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.32 -30.24 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.446 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.857 HG22 ' HB3' ' A' ' 11' ' ' PRO . 32.9 m -111.26 161.91 23.14 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 111.077 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.635 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 40.9 Cg_endo -67.49 132.58 27.62 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.197 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -77.85 -35.26 51.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.002 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.977 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 44.7 t -103.88 105.83 16.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.647 ' CD2' ' HD3' ' A' ' 14' ' ' ARG . 5.6 p90 -124.7 -169.95 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.055 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.746 ' CE1' ' SG ' ' A' ' 17' ' ' CYS . 90.5 m-85 -92.38 160.96 33.9 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.543 ' HD2' ' HB3' ' A' ' 46' ' ' TYR . 57.4 Cg_endo -71.17 -158.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.313 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.804 HD22 HG23 ' A' ' 9' ' ' VAL . 34.5 m-80 -163.03 102.48 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 4' ' ' THR . 94.2 m -63.59 103.5 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.116 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.586 HD11 HG22 ' A' ' 6' ' ' THR . 62.3 mt -113.17 158.7 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.151 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.774 ' C ' ' HD3' ' A' ' 53' ' ' PRO . 70.9 m-20 -90.32 170.34 10.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.958 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 33.1 m -121.49 33.63 0.22 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.166 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.958 ' HD3' ' N ' ' A' ' 52' ' ' VAL . 13.4 Cg_exo -69.62 177.08 5.83 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.952 2.434 . . . . 0.0 112.134 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.636 ' HB2' ' CG ' ' A' ' 57' ' ' GLU . 57.7 Cg_endo -71.39 129.75 16.34 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.688 2.259 . . . . 0.0 112.282 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -111.27 -17.49 13.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 5.0 tp10 -127.37 67.06 1.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.72 ' HA ' ' CE2' ' A' ' 60' ' ' PHE . 1.4 pp20? -144.2 -0.61 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.881 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 79.3 m -72.33 22.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.687 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 44.3 tp10 -135.29 35.92 2.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.943 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.72 ' CE2' ' HA ' ' A' ' 57' ' ' GLU . 92.1 m-85 . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.901 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' GLU . . . . . 0.605 ' OE1' ' HA ' ' B' ' 1' ' ' GLU . 6.3 mm-40 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 1.016 ' HB2' ' HD3' ' B' ' 53' ' ' PRO . . . -114.11 124.02 51.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.106 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . 0.949 ' H ' ' HB ' ' B' ' 50' ' ' ILE . 93.6 mt-30 -160.58 167.63 26.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.248 0.547 . . . . 0.0 111.217 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 1.017 ' HA ' ' H ' ' B' ' 50' ' ' ILE . 17.3 p -68.73 -162.47 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.281 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.887 ' HB3' ' HB2' ' B' ' 47' ' ' PRO . 87.0 mt-10 -48.95 123.68 7.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 110.927 -172.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.775 HG23 ' N ' ' B' ' 7' ' ' CYS . 93.8 m -150.46 174.64 12.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.889 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.775 ' N ' HG23 ' B' ' 6' ' ' THR . 82.5 m -99.55 3.11 45.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.989 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.744 ' H ' HG23 ' B' ' 6' ' ' THR . 8.9 t -93.67 71.83 4.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.849 HG23 ' ND2' ' B' ' 48' ' ' ASN . 59.5 t -109.53 172.5 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.936 ' HB3' ' CZ ' ' B' ' 12' ' ' ARG . . . -85.86 129.05 55.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.015 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.659 ' HB3' HG22 ' B' ' 41' ' ' VAL . 78.0 Cg_exo -39.69 -34.45 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.827 2.351 . . . . 0.0 112.426 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.937 ' HD3' ' H ' ' B' ' 12' ' ' ARG . 0.0 OUTLIER -90.12 -29.78 18.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.895 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.674 ' HB2' ' HB2' ' B' ' 10' ' ' ALA . 6.4 mm-40 -96.24 -5.22 40.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.174 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.889 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -63.06 133.9 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.674 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . 1.018 ' HA ' HE21 ' B' ' 15' ' ' GLN . 0.0 OUTLIER -79.94 79.97 6.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.957 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 1.038 HD21 ' N ' ' B' ' 17' ' ' CYS . 0.2 OUTLIER -34.36 139.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.721 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' CYS . . . . . 1.038 ' N ' HD21 ' B' ' 16' ' ' ASN . 44.6 t -126.98 1.57 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.019 0.437 . . . . 0.0 110.593 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 1.009 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -179.36 -132.72 1.82 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.218 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.855 ' CE2' ' N ' ' B' ' 22' ' ' VAL . 21.3 p90 -105.8 165.61 12.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.349 . . . . 0.0 110.915 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.702 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 43.1 Cg_endo -67.96 -11.57 32.48 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.751 2.301 . . . . 0.0 112.288 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.646 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -98.53 -19.92 21.3 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.855 ' N ' ' CE2' ' B' ' 19' ' ' PHE . 34.5 m -27.7 139.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.0 111.141 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.796 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 75.9 p -109.7 176.25 1.62 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.091 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.796 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 51.6 Cg_exo -52.91 -49.83 16.19 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.75 2.3 . . . . 0.0 112.361 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 48.1 t -68.76 -41.09 79.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.004 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.501 ' HG3' ' HG1' ' B' ' 23' ' ' THR . 52.8 mt-30 -65.69 -40.45 92.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.02 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' B' ' 33' ' ' CYS . 42.3 t -74.58 -41.71 60.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.802 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.8 -33.46 73.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.078 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -49.77 -35.0 20.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.76 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 1.048 ' HE2' ' HA ' ' B' ' 30' ' ' LYS . 0.5 OUTLIER -95.53 -38.05 10.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.521 177.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.07 57.01 0.61 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.522 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . 0.738 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 78.1 m -129.84 177.07 7.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.938 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.9 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 74.1 m -80.03 155.33 27.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.953 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.602 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 41.3 t80 -128.5 114.56 16.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.863 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 16.7 t70 -135.2 94.33 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.992 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.667 ' HA ' ' CG ' ' B' ' 43' ' ' TRP . 25.2 p30 -91.88 22.45 4.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.974 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -97.26 -8.44 29.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.219 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.806 HG23 ' NH2' ' B' ' 14' ' ' ARG . 63.2 t -122.27 106.18 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.089 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . 0.453 ' C ' ' H ' ' B' ' 41' ' ' VAL . 95.3 mtt180 -77.45 -178.46 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.953 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.43 -43.29 0.56 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.405 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.88 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.2 m -105.85 169.25 7.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 110.986 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.88 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 51.6 Cg_endo -69.33 147.58 65.95 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.67 2.247 . . . . 0.0 112.312 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.667 ' CG ' ' HA ' ' B' ' 36' ' ' ASP . 46.5 m0 -91.42 -38.19 12.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.813 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' CYS . . . . . 0.9 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 53.6 t -94.67 121.62 36.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.733 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.571 ' HZ ' ' O ' ' B' ' 7' ' ' CYS . 45.0 p90 -150.99 169.74 21.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.698 ' HD2' ' HG3' ' B' ' 15' ' ' GLN . 89.3 m-85 -83.46 155.52 66.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.818 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 0.887 ' HB2' ' HB3' ' B' ' 5' ' ' GLU . 55.7 Cg_endo -70.49 164.27 35.87 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.705 2.27 . . . . 0.0 112.296 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.849 ' ND2' HG23 ' B' ' 9' ' ' VAL . 8.1 p30 -119.93 136.7 54.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.876 HG23 ' HG3' ' B' ' 5' ' ' GLU . 67.5 p -95.57 132.19 40.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.101 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 1.017 ' H ' ' HA ' ' B' ' 4' ' ' THR . 54.2 mt -160.03 160.99 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.178 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.739 ' O ' ' HB2' ' B' ' 2' ' ' ALA . 9.9 m-20 -116.79 147.21 42.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.068 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.594 HG21 ' O ' ' B' ' 52' ' ' VAL . 32.9 m -73.37 113.58 23.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.214 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . 1.016 ' HD3' ' HB2' ' B' ' 2' ' ' ALA . 73.7 Cg_endo -75.82 160.65 37.25 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.791 2.327 . . . . 0.0 112.427 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.84 144.87 39.62 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.81 2.34 . . . . 0.0 112.297 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . 0.702 ' HB2' ' OE1' ' B' ' 56' ' ' GLU . 87.2 mt-10 -116.12 -58.48 2.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.702 ' OE1' ' HB2' ' B' ' 55' ' ' GLU . 2.9 pm0 -123.22 -9.68 8.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.794 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -131.72 -160.83 1.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' CYS . . . . . 0.537 ' O ' ' CD ' ' B' ' 59' ' ' GLU . 26.9 p -104.67 -49.96 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.537 ' CD ' ' O ' ' B' ' 58' ' ' CYS . 81.6 mm-40 -162.06 -46.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.747 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.688 ' CD2' ' OXT' ' B' ' 60' ' ' PHE . 48.6 p90 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.951 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.647 ' H3 ' ' CD ' ' A' ' 1' ' ' GLU . 20.8 mp0 . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.789 0.328 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.882 ' HB3' HG21 ' A' ' 52' ' ' VAL . . . -151.75 30.58 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -145.26 114.39 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.9 p -143.94 132.4 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.183 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.533 ' HG2' ' OG1' ' A' ' 49' ' ' THR . 61.6 mt-10 -107.61 124.89 50.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.835 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.809 HG21 HG21 ' A' ' 8' ' ' THR . 91.9 m -122.33 133.69 54.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.4 m -112.18 23.95 13.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.987 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.809 HG21 HG21 ' A' ' 6' ' ' THR . 10.0 t -74.27 64.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.079 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.808 HG12 ' HA ' ' A' ' 14' ' ' ARG . 57.2 t -97.47 124.69 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.184 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.969 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . . . -50.26 136.23 22.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.82 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.477 ' HA ' ' NE ' ' A' ' 14' ' ' ARG . 84.7 Cg_exo -41.19 -55.59 2.08 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.906 2.404 . . . . 0.0 112.805 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.833 ' HG3' ' OE2' ' A' ' 13' ' ' GLU . 15.8 ptp180 -81.03 -29.61 35.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.07 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.969 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 22.3 mp0 -80.77 7.85 9.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.039 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.917 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.2 mtt180 -74.94 120.9 21.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.839 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.669 ' O ' ' O ' ' A' ' 16' ' ' ASN . 10.4 mm100 -82.26 80.16 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.919 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.669 ' O ' ' O ' ' A' ' 15' ' ' GLN . 35.9 t-20 -22.51 148.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.037 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.657 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 42.5 t -134.96 0.23 2.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.639 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -166.86 -136.05 1.96 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.268 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.856 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 22.2 p90 -105.55 170.12 6.26 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.811 0.339 . . . . 0.0 110.95 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.856 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 53.4 Cg_endo -69.82 -12.55 33.0 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.749 2.299 . . . . 0.0 112.368 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.661 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -98.44 -21.29 17.46 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.461 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.848 ' N ' ' CE2' ' A' ' 19' ' ' PHE . 34.3 m -24.93 150.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.815 0.341 . . . . 0.0 111.255 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.713 ' HG1' HE21 ' A' ' 26' ' ' GLN . 68.8 p -120.34 165.25 18.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.093 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.693 ' HD3' ' CZ ' ' A' ' 34' ' ' PHE . 53.2 Cg_exo -52.5 -36.52 70.7 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.718 2.279 . . . . 0.0 112.304 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.6 t -79.14 -48.28 14.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.713 HE21 ' HG1' ' A' ' 23' ' ' THR . 48.4 mt-30 -60.37 -44.27 95.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.944 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.6 t -75.02 -58.86 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -53.54 -15.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -92.48 -14.3 28.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 22.8 tptm -98.84 -1.46 40.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.94 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.55 45.79 5.69 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.602 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.779 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 79.9 m -149.96 152.17 34.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 110.993 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.885 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 78.5 m -67.39 155.29 39.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.858 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.693 ' CZ ' ' HD3' ' A' ' 24' ' ' PRO . 59.8 t80 -129.79 109.8 11.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.817 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.607 ' OD1' ' OG1' ' A' ' 37' ' ' THR . 32.9 t0 -138.41 90.48 2.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.704 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.4 p-10 -88.92 -3.12 58.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.607 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 79.1 p -48.71 -7.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.598 ' H ' ' C ' ' A' ' 36' ' ' ASP . 62.2 t -141.26 103.46 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.749 ' HA ' ' HE1' ' A' ' 43' ' ' TRP . 15.9 ptp180 -69.27 -165.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.763 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.22 -34.87 0.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.359 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.816 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.6 m -108.39 167.74 8.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.944 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.816 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 42.9 Cg_endo -68.08 119.97 6.96 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.187 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.749 ' HE1' ' HA ' ' A' ' 39' ' ' ARG . 50.1 m0 -70.11 -37.67 75.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.82 ' HB2' HG23 ' A' ' 22' ' ' VAL . 50.5 t -96.84 128.57 43.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.829 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.576 ' CE2' ' CG2' ' A' ' 9' ' ' VAL . 52.4 p90 -152.81 161.75 42.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -67.02 137.19 94.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.004 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.885 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 99.0 Cg_endo -80.67 -177.05 3.49 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.933 2.422 . . . . 0.0 112.484 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.511 HD22 HG21 ' A' ' 9' ' ' VAL . 36.3 m-80 -129.0 79.96 1.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.781 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.533 ' OG1' ' HG2' ' A' ' 5' ' ' GLU . 95.2 m -90.03 138.02 31.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 60.3 mt -133.01 139.4 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.04 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.586 ' HA ' ' O ' ' A' ' 2' ' ' ALA . 24.5 p-10 -161.97 -169.51 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.882 HG21 ' HB3' ' A' ' 2' ' ' ALA . 29.9 m -140.56 122.57 9.57 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.878 ' HG3' ' HB2' ' B' ' 55' ' ' GLU . 57.2 Cg_endo -71.22 108.77 2.42 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.666 2.244 . . . . 0.0 112.319 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 52' ' ' VAL . 58.3 Cg_endo -71.64 -45.68 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.726 2.284 . . . . 0.0 112.254 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.77 ' HG3' ' H ' ' A' ' 56' ' ' GLU . 4.8 tp10 -143.05 -177.59 5.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.77 ' H ' ' HG3' ' A' ' 55' ' ' GLU . 6.3 mm-40 -70.77 33.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.562 ' H ' ' C ' ' A' ' 55' ' ' GLU . 87.4 mt-10 -162.15 137.96 7.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.965 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.625 ' SG ' ' N ' ' A' ' 59' ' ' GLU . 29.8 p -98.99 -106.93 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.813 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.625 ' N ' ' SG ' ' A' ' 58' ' ' CYS . 45.2 mt-10 -141.77 -145.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.603 ' CG ' ' O ' ' A' ' 59' ' ' GLU . 90.5 m-85 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.909 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' B' ' 1' ' ' GLU . 22.9 pt-20 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.798 0.332 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.805 ' CB ' HG23 ' B' ' 52' ' ' VAL . . . -71.14 5.46 2.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.055 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . 0.874 ' HA ' ' OD1' ' B' ' 51' ' ' ASP . 27.3 mm-40 -91.5 115.23 27.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.692 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.553 ' C ' ' OE2' ' B' ' 5' ' ' GLU . 72.4 p -160.05 132.05 6.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.85 0.357 . . . . 0.0 111.443 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.958 ' HG3' HG23 ' B' ' 49' ' ' THR . 0.6 OUTLIER -110.08 146.81 34.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.754 178.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.683 HG21 ' H ' ' B' ' 8' ' ' THR . 94.4 m -144.1 163.51 33.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.237 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.606 ' N ' HG21 ' B' ' 6' ' ' THR . 73.8 m -121.13 32.29 6.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.683 ' H ' HG21 ' B' ' 6' ' ' THR . 9.1 t -98.05 72.72 2.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.087 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.851 ' CG2' HD22 ' B' ' 48' ' ' ASN . 73.8 t -119.34 -179.53 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.851 ' N ' HG13 ' B' ' 9' ' ' VAL . . . -95.97 159.91 31.23 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.008 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.436 ' HB3' HG13 ' B' ' 41' ' ' VAL . 76.8 Cg_exo -50.08 -39.18 51.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.748 2.298 . . . . 0.0 112.462 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.431 ' C ' ' H ' ' B' ' 14' ' ' ARG . 39.4 ptt180 -89.97 -29.92 18.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.751 ' O ' HG12 ' B' ' 9' ' ' VAL . 45.2 mt-10 -77.0 17.46 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.077 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.813 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.2 mtt180 -98.56 114.39 26.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . 0.447 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 8.1 tp-100 -80.48 98.85 7.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.659 ' ND2' ' H ' ' B' ' 18' ' ' GLY . 2.6 t-20 -32.95 150.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' CYS . . . . . 0.557 ' H ' ' ND2' ' B' ' 16' ' ' ASN . 41.5 t -143.26 5.17 1.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.73 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.659 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -170.85 -138.61 2.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.422 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.827 ' CE1' HG13 ' B' ' 22' ' ' VAL . 42.8 p90 -105.58 166.83 10.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 0.0 110.929 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.755 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 47.1 Cg_endo -68.9 -33.74 19.37 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.751 2.3 . . . . 0.0 112.313 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.663 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -84.05 13.47 49.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.54 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.827 HG13 ' CE1' ' B' ' 19' ' ' PHE . 34.0 m -65.07 164.43 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 111.207 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.753 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 75.2 p -133.75 173.15 6.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.054 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.753 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 55.7 Cg_exo -51.63 -32.75 45.97 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.727 2.285 . . . . 0.0 112.363 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 47.3 t -84.81 -66.74 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.476 ' NE2' ' HZ ' ' B' ' 19' ' ' PHE . 52.6 mt-30 -39.34 -34.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.863 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.6 t -80.58 -60.97 2.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.16 -34.14 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -49.84 -37.09 29.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.42 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -86.76 -30.85 21.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.518 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.01 24.03 9.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.709 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . 0.648 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 81.6 m -102.42 155.54 18.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 110.897 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' B' ' 47' ' ' PRO . 83.0 m -63.56 149.45 46.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.807 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.625 ' CZ ' ' HA ' ' B' ' 23' ' ' THR . 59.6 t80 -133.13 120.24 20.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.535 ' OD2' ' NH1' ' B' ' 14' ' ' ARG . 16.5 t70 -129.3 87.75 2.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.655 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 24.3 p-10 -91.83 51.53 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 75.8 p -117.8 -11.92 10.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.192 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.486 ' O ' HG21 ' B' ' 41' ' ' VAL . 62.2 t -136.01 115.54 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . 0.481 ' C ' ' H ' ' B' ' 41' ' ' VAL . 80.7 mtp180 -67.98 -178.17 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.22 -41.27 0.48 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.557 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.486 HG21 ' O ' ' B' ' 38' ' ' VAL . 33.0 m -92.49 153.07 42.62 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 0.0 111.107 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.29 122.2 9.0 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.749 2.299 . . . . 0.0 112.207 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.655 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 23.1 m0 -67.34 -47.45 70.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.009 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' CYS . . . . . 0.693 ' CB ' HG23 ' B' ' 22' ' ' VAL . 46.8 t -92.03 119.84 32.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.897 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.778 ' CE2' ' HD3' ' B' ' 14' ' ' ARG . 53.3 p90 -149.23 159.41 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.827 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.439 ' CE1' ' O ' ' B' ' 16' ' ' ASN . 91.6 m-85 -58.68 146.92 72.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 0.565 ' HA ' ' SG ' ' B' ' 33' ' ' CYS . 59.0 Cg_endo -72.32 -169.87 0.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.763 2.308 . . . . 0.0 112.371 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.851 HD22 ' CG2' ' B' ' 9' ' ' VAL . 33.0 m-80 -119.71 84.42 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.78 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.958 HG23 ' HG3' ' B' ' 5' ' ' GLU . 81.6 p -75.65 108.68 8.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.086 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 57.3 mt -103.04 136.73 34.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.044 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.874 ' OD1' ' HA ' ' B' ' 3' ' ' GLN . 7.3 m-20 -160.23 160.37 32.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.915 -176.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 1.064 ' N ' ' HD3' ' B' ' 53' ' ' PRO . 30.2 m -131.33 17.7 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.316 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . 1.064 ' HD3' ' N ' ' B' ' 52' ' ' VAL . 12.2 Cg_exo -69.81 118.85 5.92 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.745 2.297 . . . . 0.0 112.154 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.71 -174.24 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.658 2.239 . . . . 0.0 112.204 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . 0.878 ' HB2' ' HG3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -95.59 -98.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.566 ' OE1' ' C ' ' B' ' 56' ' ' GLU . 1.4 pp20? -141.3 155.84 45.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.808 ' HG2' ' H ' ' B' ' 58' ' ' CYS . 41.5 tt0 -123.47 -120.39 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' CYS . . . . . 0.808 ' H ' ' HG2' ' B' ' 57' ' ' GLU . 81.4 m -93.6 173.95 7.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.047 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -169.98 -18.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 61.9 t80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.84 179.859 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.699 ' O ' ' HA ' ' A' ' 51' ' ' ASP . . . -81.7 67.73 7.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.067 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 1.097 HE21 ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -137.45 128.14 26.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.801 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.9 p -137.95 139.31 39.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.174 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.781 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 21.4 mp0 -101.52 126.7 48.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.887 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.957 HG21 ' H ' ' A' ' 8' ' ' THR . 86.0 m -130.26 173.98 10.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.044 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.768 ' N ' HG21 ' A' ' 6' ' ' THR . 71.9 m -131.29 2.43 4.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.24 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.957 ' H ' HG21 ' A' ' 6' ' ' THR . 10.1 t -75.21 63.16 1.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.084 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.904 HG23 HD22 ' A' ' 48' ' ' ASN . 58.0 t -96.65 155.55 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.892 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -69.66 136.3 88.07 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.786 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.557 ' HG3' HG23 ' A' ' 38' ' ' VAL . 88.9 Cg_exo -41.83 -66.69 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.793 2.329 . . . . 0.0 112.593 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -65.12 -30.0 70.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.992 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.89 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 81.0 mm-40 -88.96 27.69 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.097 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.892 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.2 mtt180 -97.83 129.31 44.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.865 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.438 ' O ' ' HB2' ' A' ' 45' ' ' PHE . 29.5 mm-40 -82.63 104.19 12.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.636 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 2.6 t-20 -35.29 122.02 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.905 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 46.4 t -138.8 -0.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.196 0.522 . . . . 0.0 110.229 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.764 ' N ' ' O ' ' A' ' 44' ' ' CYS . . . 174.77 122.34 0.68 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.313 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.776 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 53.2 p90 -44.78 167.87 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.751 0.31 . . . . 0.0 110.973 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.776 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 47.2 Cg_endo -68.9 -52.97 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.659 2.239 . . . . 0.0 112.263 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -40.46 -27.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.382 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.85 HG23 ' HB2' ' A' ' 44' ' ' CYS . 29.1 m -49.93 171.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.342 . . . . 0.0 111.122 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.865 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 74.1 p -137.25 178.71 1.6 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.865 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 58.0 Cg_exo -51.48 -36.58 59.68 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.627 2.218 . . . . 0.0 112.27 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 53.1 m -90.18 -40.01 12.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.792 ' HB2' ' H ' ' A' ' 23' ' ' THR . 24.9 mt-30 -65.23 -27.31 68.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.868 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.947 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 53.0 t -91.56 -52.9 4.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.789 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.84 -21.0 40.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.004 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.517 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 37.8 t-20 -72.01 -27.47 62.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.849 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.11 -24.52 18.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.937 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.32 29.35 5.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.4 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.947 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 61.9 m -108.52 -176.8 3.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.827 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.717 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 73.7 m -109.22 132.62 53.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.636 176.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.772 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 26.9 t80 -104.41 108.5 19.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.896 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.484 ' OD1' ' OG1' ' A' ' 37' ' ' THR . 32.5 t0 -128.98 90.31 3.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.541 ' OD2' ' HE1' ' A' ' 34' ' ' PHE . 25.0 p30 -89.1 60.55 5.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.484 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 75.3 p -114.8 -33.65 5.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.09 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.62 ' O ' HG21 ' A' ' 41' ' ' VAL . 63.5 t -119.48 120.38 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.074 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.617 ' C ' ' H ' ' A' ' 41' ' ' VAL . 98.8 mtt180 -74.24 179.33 4.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.06 -28.5 0.15 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.62 HG21 ' O ' ' A' ' 38' ' ' VAL . 33.0 m -98.84 158.84 31.68 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.8 0.333 . . . . 0.0 111.081 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 50.4 Cg_endo -69.18 120.2 7.09 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 0.0 112.302 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -73.51 -27.4 61.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.932 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 44.6 t -113.27 95.96 5.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.71 ' C ' ' HB3' ' A' ' 17' ' ' CYS . 52.8 p90 -122.71 -169.93 2.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.636 ' CE2' ' O ' ' A' ' 16' ' ' ASN . 96.3 m-85 -88.29 143.39 32.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.976 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 56.6 Cg_endo -70.87 -156.53 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.842 2.362 . . . . 0.0 112.408 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.904 HD22 HG23 ' A' ' 9' ' ' VAL . 76.2 m-20 -135.39 146.9 48.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.5 p -119.48 82.46 1.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.98 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.589 HG21 ' N ' ' A' ' 51' ' ' ASP . 60.4 mt -98.82 161.96 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.269 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.699 ' HA ' ' O ' ' A' ' 2' ' ' ALA . 10.0 m-20 -87.48 160.63 18.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.777 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.917 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 60.7 t -159.43 67.75 3.05 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.134 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -89.37 79.26 0.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.194 2.596 . . . . 0.0 112.686 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.917 ' HD3' ' O ' ' A' ' 52' ' ' VAL . 59.5 Cg_endo -71.88 70.64 2.84 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.642 2.228 . . . . 0.0 112.305 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.629 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 6.2 mm-40 -134.43 -81.01 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.56 ' CD ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -111.85 32.81 5.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -89.62 70.83 7.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.964 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 59' ' ' GLU . 43.9 t -92.86 176.59 6.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.946 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.587 ' N ' ' SG ' ' A' ' 58' ' ' CYS . 12.4 mm-40 -120.84 3.25 10.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.432 ' HB2' ' SG ' ' B' ' 58' ' ' CYS . 89.1 m-85 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.841 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' GLU . . . . . 0.767 ' HG3' ' H ' ' B' ' 2' ' ' ALA . 22.9 pt-20 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.797 0.332 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.795 ' N ' HE22 ' B' ' 3' ' ' GLN . . . -144.52 73.28 1.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.108 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . 0.93 ' HA ' ' HB2' ' B' ' 51' ' ' ASP . 1.5 mp0 -138.32 171.46 14.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.962 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.811 ' O ' ' HA ' ' B' ' 49' ' ' THR . 66.6 p -117.24 -159.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.136 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -109.4 145.47 36.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.962 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.884 ' CG2' HG23 ' B' ' 8' ' ' THR . 87.4 m -149.94 156.47 41.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.034 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.444 ' N ' HG23 ' B' ' 6' ' ' THR . 71.2 m -122.61 -8.26 8.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.286 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.884 HG23 ' CG2' ' B' ' 6' ' ' THR . 9.4 t -74.52 82.95 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 111.099 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.861 HG23 ' ND2' ' B' ' 48' ' ' ASN . 76.4 t -128.59 176.23 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.071 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.824 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -84.17 128.15 63.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.898 ' HD2' ' NH1' ' B' ' 12' ' ' ARG . 97.6 Cg_exo -42.45 -66.25 0.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.795 2.33 . . . . 0.0 112.416 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.898 ' NH1' ' HD2' ' B' ' 11' ' ' PRO . 0.1 OUTLIER -54.16 -29.9 47.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.823 179.076 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.706 ' HB2' ' HB1' ' B' ' 10' ' ' ALA . 87.3 mt-10 -93.82 22.71 5.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.824 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 98.8 mtt180 -98.91 141.54 31.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . 0.549 ' O ' ' HD1' ' B' ' 46' ' ' TYR . 84.9 mm-40 -88.18 80.04 7.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 1.026 HD21 ' N ' ' B' ' 17' ' ' CYS . 0.1 OUTLIER -24.36 138.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.585 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' CYS . . . . . 1.026 ' N ' HD21 ' B' ' 16' ' ' ASN . 40.9 t -133.09 2.82 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 110.559 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.862 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -156.83 -136.5 2.13 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.286 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.901 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 12.3 p90 -105.74 171.54 4.77 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.342 . . . . 0.0 111.007 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.901 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 30.4 Cg_endo -64.05 -10.01 21.5 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.821 2.348 . . . . 0.0 112.386 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.768 ' HA3' ' CZ3' ' B' ' 43' ' ' TRP . . . -128.93 29.07 4.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.606 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.854 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 35.7 m -49.66 161.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.391 . . . . 0.0 111.264 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 1.055 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 66.7 p -135.95 176.41 2.85 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.767 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 1.055 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 10.8 Cg_endo -54.03 -42.22 68.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.597 2.198 . . . . 0.0 112.088 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -81.07 -46.42 15.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.728 ' HG2' ' OG1' ' B' ' 23' ' ' THR . 15.2 mm100 -57.04 -38.63 73.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -73.76 -54.77 7.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.759 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.1 -35.7 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.83 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -54.03 -28.33 37.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.798 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.968 ' HZ3' ' HB3' ' B' ' 30' ' ' LYS . 2.7 mmmp? -100.17 -26.95 13.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.731 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.5 60.58 1.79 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.592 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . 0.51 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 78.6 m -142.88 176.41 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.91 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.649 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.0 m -74.27 148.66 41.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.765 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.624 ' CE1' HG22 ' B' ' 22' ' ' VAL . 75.6 t80 -126.76 130.8 51.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.885 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.571 ' OD2' ' NH2' ' B' ' 14' ' ' ARG . 27.5 t0 -148.19 80.02 1.46 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.873 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.722 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 24.4 p-10 -84.44 53.45 2.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -120.04 -4.84 10.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.554 HG11 HG21 ' B' ' 41' ' ' VAL . 61.8 t -132.7 106.87 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . 0.686 ' C ' ' H ' ' B' ' 41' ' ' VAL . 79.7 mtm180 -71.28 -171.81 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.66 -10.88 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.385 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.88 HG23 ' HB3' ' B' ' 11' ' ' PRO . 34.9 m -131.49 164.98 38.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 0.0 111.1 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.745 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 57.7 Cg_endo -71.31 144.17 45.33 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.751 2.301 . . . . 0.0 112.309 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.768 ' CZ3' ' HA3' ' B' ' 21' ' ' GLY . 27.1 m0 -93.25 -50.7 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.794 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' CYS . . . . . 0.768 ' H ' HG23 ' B' ' 22' ' ' VAL . 52.9 t -87.66 122.85 31.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.727 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.778 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 47.8 p90 -148.19 149.58 32.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.549 ' HD1' ' O ' ' B' ' 15' ' ' GLN . 81.0 m-85 -46.81 150.57 1.25 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.851 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.77 174.08 12.4 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.747 2.298 . . . . 0.0 112.37 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.861 ' ND2' HG23 ' B' ' 9' ' ' VAL . 34.6 m-80 -128.29 144.26 51.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.846 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.811 ' HA ' ' O ' ' B' ' 4' ' ' THR . 93.9 m -101.23 129.76 47.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.155 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.503 HG21 ' N ' ' B' ' 51' ' ' ASP . 63.2 mt -156.64 156.94 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.327 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.93 ' HB2' ' HA ' ' B' ' 3' ' ' GLN . 16.5 t70 -159.72 -171.8 3.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.739 ' H ' ' CG ' ' B' ' 51' ' ' ASP . 61.0 t -106.57 114.12 62.3 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.208 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . 0.444 ' HG3' ' HB3' ' B' ' 59' ' ' GLU . 56.7 Cg_endo -70.98 173.17 12.47 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.726 2.284 . . . . 0.0 112.273 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.57 -51.51 0.4 Allowed 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.908 2.405 . . . . 0.0 112.175 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -124.73 -164.99 1.33 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.961 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -104.22 19.66 19.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' B' ' 57' ' ' GLU . 41.6 tt0 -126.84 1.49 6.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.858 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 60' ' ' PHE . 73.0 m -126.85 67.43 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.806 ' HG3' ' CD2' ' B' ' 60' ' ' PHE . 12.6 pt-20 -152.01 -33.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.85 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.806 ' CD2' ' HG3' ' B' ' 59' ' ' GLU . 94.6 m-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.836 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 1' ' ' GLU . 12.5 pt-20 . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.819 0.342 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.709 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -160.02 121.55 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.799 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 1.3 mp0 -142.8 100.39 3.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.771 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 1.0 ' N ' HG21 ' A' ' 50' ' ' ILE . 71.6 p -169.87 138.55 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.091 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 1.016 ' N ' HG12 ' A' ' 50' ' ' ILE . 37.3 mt-10 -61.5 -174.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.607 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.929 ' C ' HD21 ' A' ' 48' ' ' ASN . 95.7 m -128.13 164.93 21.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.803 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.609 ' N ' HG21 ' A' ' 6' ' ' THR . 70.9 m -130.31 -22.88 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.842 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.515 HG21 ' CG2' ' A' ' 6' ' ' THR . 8.9 t -74.37 51.33 0.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.853 ' CG2' HD22 ' A' ' 48' ' ' ASN . 62.8 t -90.06 177.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.886 ' HB2' ' HB2' ' A' ' 13' ' ' GLU . . . -76.05 132.11 74.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.939 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.667 ' O ' ' HG3' ' A' ' 14' ' ' ARG . 88.6 Cg_exo -46.92 -74.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.746 2.297 . . . . 0.0 112.425 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.699 ' HB2' ' OE2' ' A' ' 13' ' ' GLU . 37.2 mmt180 -52.6 -30.65 32.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.975 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.886 ' HB2' ' HB2' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -89.66 35.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.781 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.0 mtt180 -107.89 124.04 49.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.976 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.572 ' CB ' ' HD2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER -79.93 92.71 5.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 15' ' ' GLN . 27.4 t-20 -30.31 150.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.642 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 43.5 t -135.96 4.67 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.336 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.19 -138.28 2.73 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.336 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.938 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 30.4 p90 -105.75 172.38 4.04 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.778 0.323 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.938 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 46.1 Cg_endo -68.79 -31.59 24.97 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.715 2.277 . . . . 0.0 112.325 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.625 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . -74.27 -27.98 64.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.527 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.842 HG23 ' HB2' ' A' ' 44' ' ' CYS . 34.4 m -26.21 152.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.266 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.684 ' OG1' ' HG3' ' A' ' 26' ' ' GLN . 74.8 p -122.33 164.53 25.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.074 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.756 ' HG3' ' CE1' ' A' ' 34' ' ' PHE . 50.2 Cg_exo -53.48 -32.48 63.16 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.709 2.273 . . . . 0.0 112.349 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 47.8 t -84.83 -46.45 11.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.684 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 26.3 mt-30 -59.71 -46.59 88.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.8 t -76.48 -48.34 19.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' PRO . . . -63.74 -15.29 58.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.086 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 25' ' ' SER . 42.9 t30 -83.4 -14.84 51.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -92.25 -35.96 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.74 11.79 1.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.568 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.746 ' HB3' ' O ' ' A' ' 45' ' ' PHE . 71.7 m -113.81 170.62 8.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 110.941 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 76.8 m -88.17 155.07 19.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.756 ' CE1' ' HG3' ' A' ' 24' ' ' PRO . 45.2 t80 -133.14 119.42 19.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.438 ' CG ' ' HG1' ' A' ' 37' ' ' THR . 16.4 t70 -130.64 79.99 1.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.782 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.3 p-10 -78.18 21.54 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.438 ' HG1' ' CG ' ' A' ' 35' ' ' ASP . 75.0 p -90.84 -16.77 27.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.763 HG13 HG21 ' A' ' 41' ' ' VAL . 62.8 t -108.66 126.71 65.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.093 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.551 ' C ' ' H ' ' A' ' 41' ' ' VAL . 82.9 mtm180 -91.09 176.41 6.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.95 -33.46 0.29 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.466 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.904 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.3 m -106.27 170.64 5.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.72 0.295 . . . . 0.0 111.119 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.904 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 60.0 Cg_endo -72.63 153.65 54.47 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.673 2.248 . . . . 0.0 112.223 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.782 ' CD1' ' HA ' ' A' ' 36' ' ' ASP . 34.1 m0 -97.81 -30.29 12.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.842 ' HB2' HG23 ' A' ' 22' ' ' VAL . 47.4 t -100.04 117.38 34.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.778 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.746 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 52.2 p90 -143.57 170.05 16.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.572 ' HD2' ' CB ' ' A' ' 15' ' ' GLN . 25.6 m-85 -76.97 134.94 67.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.746 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 18.0 Cg_endo -61.02 -150.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.52 -0.195 0 C-N-CA 122.976 2.45 . . . . 0.0 112.606 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.929 HD21 ' C ' ' A' ' 6' ' ' THR . 41.9 m-80 -119.01 -178.55 3.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.357 177.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.794 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 9.9 t -68.68 171.04 8.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.336 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 1.016 HG12 ' N ' ' A' ' 5' ' ' GLU . 76.4 mt -141.06 165.78 19.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.198 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.799 ' HB2' ' HG3' ' A' ' 3' ' ' GLN . 1.7 m-20 -99.92 -164.95 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.718 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.628 ' N ' ' HG3' ' A' ' 3' ' ' GLN . 60.5 t -132.72 119.92 16.31 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.227 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.588 ' HD3' ' HG2' ' A' ' 3' ' ' GLN . 55.5 Cg_endo -70.07 147.67 61.37 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.733 2.289 . . . . 0.0 112.304 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 14.1 Cg_exo -69.49 -7.02 19.87 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.975 2.45 . . . . 0.0 112.251 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 0.5 OUTLIER -79.23 70.19 5.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 55' ' ' GLU . 87.0 mt-10 -163.44 -2.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -141.23 -136.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.794 ' O ' ' HB2' ' B' ' 58' ' ' CYS . 50.1 t -94.5 -70.56 0.7 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.78 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.611 ' HB3' ' HB3' ' B' ' 58' ' ' CYS . 17.3 pt-20 -143.67 14.11 1.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.3 t80 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.915 -179.703 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' GLU . . . . . 0.529 ' O ' ' HG2' ' B' ' 1' ' ' GLU . 64.3 tt0 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.76 136.6 25.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.064 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -157.27 134.98 10.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 74.9 p -156.67 135.92 12.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' B' ' 48' ' ' ASN . 0.5 OUTLIER -92.07 156.88 17.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.82 HG21 ' H ' ' B' ' 8' ' ' THR . 93.6 m -149.21 165.58 31.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.08 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.649 ' N ' HG21 ' B' ' 6' ' ' THR . 76.1 m -112.05 18.41 18.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.82 ' H ' HG21 ' B' ' 6' ' ' THR . 9.0 t -86.9 84.96 7.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.024 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.883 HG12 ' HA ' ' B' ' 14' ' ' ARG . 58.8 t -125.31 165.28 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.208 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.849 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -93.5 131.53 32.29 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.986 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.87 ' HB3' HG22 ' B' ' 41' ' ' VAL . 79.0 Cg_exo -40.07 -32.05 0.59 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.793 2.329 . . . . 0.0 112.516 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.885 ' NH2' HG11 ' B' ' 41' ' ' VAL . 2.0 mmp_? -90.25 -29.89 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' B' ' 10' ' ' ALA . 12.2 mm-40 -93.05 -5.93 49.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.085 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.883 ' HA ' HG12 ' B' ' 9' ' ' VAL . 99.4 mtt180 -69.29 122.2 18.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.823 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . 1.007 ' HA ' HE21 ' B' ' 15' ' ' GLN . 0.0 OUTLIER -79.9 91.18 5.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.869 -178.28 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 1.056 HD21 ' N ' ' B' ' 17' ' ' CYS . 0.1 OUTLIER -32.64 140.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.753 179.029 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' CYS . . . . . 1.056 ' N ' HD21 ' B' ' 16' ' ' ASN . 43.1 t -127.8 1.69 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.526 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 1.031 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -172.39 -134.45 1.8 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.084 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.863 ' CE1' HG13 ' B' ' 22' ' ' VAL . 37.8 p90 -106.15 156.58 36.59 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.732 0.301 . . . . 0.0 110.895 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.562 ' O ' ' CE3' ' B' ' 43' ' ' TRP . 36.4 Cg_endo -65.51 -18.91 60.56 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.681 2.254 . . . . 0.0 112.229 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.639 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -94.14 8.13 72.76 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.47 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.863 HG13 ' CE1' ' B' ' 19' ' ' PHE . 34.6 m -61.67 155.55 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.0 111.129 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.819 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 78.3 p -121.06 174.71 2.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.12 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.819 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 76.8 Cg_exo -50.26 -56.08 3.46 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 0.0 112.309 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 79.5 p -58.35 -55.05 39.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.836 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.812 HE21 ' H ' ' B' ' 23' ' ' THR . 24.6 mt-30 -50.04 -72.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' CYS . . . . . 0.612 ' N ' ' HZ2' ' B' ' 30' ' ' LYS . 49.6 t -32.02 -53.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.73 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.33 -35.79 51.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' B' ' 26' ' ' GLN . 42.1 t30 -49.64 -32.58 13.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.755 ' NZ ' ' C ' ' B' ' 26' ' ' GLN . 2.2 mppt? -95.63 -15.5 22.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.795 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.94 38.31 16.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.532 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . 0.722 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 79.6 m -119.46 161.8 19.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 110.979 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.565 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.2 m -65.43 155.19 36.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.851 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.585 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 57.8 t80 -129.56 118.06 21.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.564 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 16.6 t70 -128.55 100.04 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -91.75 24.7 3.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' THR . . . . . 0.564 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 69.0 p -89.11 -62.39 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.822 HG22 ' HG3' ' B' ' 11' ' ' PRO . 61.1 t -80.52 120.79 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . 0.546 ' C ' ' H ' ' B' ' 41' ' ' VAL . 83.6 mtm180 -89.15 -177.55 5.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.99 -35.52 0.29 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.894 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 27.5 m -100.44 170.43 6.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.745 0.307 . . . . 0.0 111.137 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.894 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 41.1 Cg_endo -67.41 127.99 17.49 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.183 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.562 ' CE3' ' O ' ' B' ' 20' ' ' PRO . 49.7 m0 -78.9 -47.54 16.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.882 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' CYS . . . . . 0.64 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 50.2 t -91.16 123.79 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.777 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.722 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 50.0 p90 -142.67 168.94 18.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.997 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.527 ' O ' ' HD1' ' B' ' 45' ' ' PHE . 88.2 m-85 -75.73 154.08 85.26 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.94 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 0.532 ' HB2' ' HB3' ' B' ' 5' ' ' GLU . 56.7 Cg_endo -70.69 -177.75 2.34 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.798 2.332 . . . . 0.0 112.415 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.847 HD22 ' CG2' ' B' ' 9' ' ' VAL . 33.8 m-80 -132.93 105.63 7.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.522 ' OG1' ' HG3' ' B' ' 5' ' ' GLU . 94.3 m -84.57 100.29 11.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.113 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 62.0 mt -99.43 143.55 13.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.495 ' CG ' ' HD3' ' B' ' 53' ' ' PRO . 24.3 p-10 -134.55 172.0 13.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.579 HG22 ' O ' ' B' ' 52' ' ' VAL . 33.2 m -129.34 58.48 37.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . 0.495 ' HD3' ' CG ' ' B' ' 51' ' ' ASP . 56.2 Cg_endo -70.45 155.63 63.25 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.66 2.24 . . . . 0.0 112.307 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.615 ' O ' ' HG3' ' B' ' 55' ' ' GLU . 56.3 Cg_endo -70.35 -84.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.806 2.337 . . . . 0.0 112.326 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . 0.749 ' OE2' ' HB2' ' A' ' 58' ' ' CYS . 44.4 mt-10 -165.34 -167.21 1.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.817 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -102.79 -141.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -88.08 110.67 20.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' CYS . . . . . 0.794 ' HB2' ' O ' ' A' ' 58' ' ' CYS . 77.0 m -99.05 106.74 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.988 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -139.14 102.62 4.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 t80 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.827 -179.888 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.875 ' H1 ' ' HB3' ' A' ' 53' ' ' PRO . 64.3 tt0 . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.441 ' N ' ' OE1' ' A' ' 3' ' ' GLN . . . -118.07 46.79 1.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.811 HE22 ' HA ' ' A' ' 1' ' ' GLU . 1.2 mp0 -87.92 144.24 26.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.581 HG21 ' O ' ' A' ' 3' ' ' GLN . 82.8 p -163.59 145.3 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.17 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.699 ' HG2' HG23 ' A' ' 49' ' ' THR . 62.3 mt-10 -95.87 128.59 42.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.841 ' HB ' ' HB2' ' A' ' 48' ' ' ASN . 93.9 m -102.1 165.29 11.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.123 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.629 ' N ' HG23 ' A' ' 6' ' ' THR . 72.0 m -146.5 19.38 1.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.979 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.783 HG23 ' CG2' ' A' ' 6' ' ' THR . 9.5 t -100.22 63.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.11 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.797 HG23 HD22 ' A' ' 48' ' ' ASN . 61.2 t -103.44 168.08 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.182 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.841 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -78.47 120.94 82.92 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.104 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.761 ' HA ' ' CD ' ' A' ' 14' ' ' ARG . 88.5 Cg_exo -46.58 -37.75 20.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.691 2.26 . . . . 0.0 112.456 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.705 ' HG3' ' HG3' ' A' ' 13' ' ' GLU . 14.5 ptm180 -71.17 -29.91 65.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.925 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.705 ' HG3' ' HG3' ' A' ' 12' ' ' ARG . 87.2 mt-10 -111.09 42.44 1.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.965 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.841 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.3 mtt180 -107.23 117.85 35.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.944 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.645 ' O ' ' O ' ' A' ' 16' ' ' ASN . 84.6 mm-40 -87.55 100.14 12.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.665 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.4 t-20 -24.92 150.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.814 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.802 ' HB2' ' N ' ' A' ' 46' ' ' TYR . 53.0 t -140.79 2.17 1.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.54 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -148.44 -138.99 3.1 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.294 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 1.104 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 43.9 p90 -105.82 -177.9 0.55 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.595 0.236 . . . . 0.0 110.745 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 1.104 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 38.3 Cg_endo -67.49 -62.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.49 2.127 . . . . 0.0 112.38 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.659 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -78.03 29.91 1.85 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.55 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.939 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 27.5 m -56.95 133.05 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.359 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.819 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 79.2 p -117.01 178.24 1.04 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.954 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.819 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 50.6 Cg_exo -53.81 -40.05 81.73 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.677 2.252 . . . . 0.0 112.271 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.618 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 47.8 t -88.35 -31.56 18.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.737 ' HB2' ' H ' ' A' ' 23' ' ' THR . 52.9 mt-30 -73.46 -33.8 65.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.896 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.912 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.2 t -87.48 -50.2 6.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.32 70.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.003 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.618 ' HB2' ' O ' ' A' ' 25' ' ' SER . 38.1 t-20 -57.04 -21.0 27.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -102.45 -28.85 11.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.946 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.48 -6.36 14.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.405 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.912 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 85.4 m -70.67 -170.07 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 110.904 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.83 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 72.3 m -116.11 155.06 28.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.662 ' CZ ' ' HB3' ' A' ' 36' ' ' ASP . 66.3 t80 -131.35 118.25 20.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.594 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 16.9 t70 -131.03 79.89 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.662 ' HB3' ' CZ ' ' A' ' 34' ' ' PHE . 24.7 p-10 -72.94 13.47 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.576 ' OG1' ' OD2' ' A' ' 35' ' ' ASP . 76.4 p -79.56 -16.41 55.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.081 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.694 HG23 ' CG ' ' A' ' 11' ' ' PRO . 63.2 t -131.39 109.63 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.095 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.809 ' HG2' ' H ' ' A' ' 40' ' ' GLY . 59.9 ttt180 -79.01 -176.93 5.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.809 ' H ' ' HG2' ' A' ' 39' ' ' ARG . . . 73.07 -38.45 0.79 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.383 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.828 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.0 m -98.44 168.03 10.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 111.049 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.828 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 48.1 Cg_endo -68.75 120.9 7.78 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 0.0 112.207 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.8 m0 -67.43 -45.24 76.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.83 ' HA ' ' O ' ' A' ' 33' ' ' CYS . 42.5 t -91.87 116.13 28.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.741 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.574 ' C ' ' CB ' ' A' ' 17' ' ' CYS . 52.1 p90 -139.17 168.91 18.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.965 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.802 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 83.6 m-85 -68.71 135.08 90.24 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.701 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 61.3 Cg_endo -73.35 -156.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.758 2.305 . . . . 0.0 112.318 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.841 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 77.3 m-20 -139.55 93.53 2.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.699 HG23 ' HG2' ' A' ' 5' ' ' GLU . 67.3 p -77.77 118.42 20.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.156 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 61.7 mt -128.36 147.21 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.027 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.751 ' HB3' ' HG3' ' A' ' 3' ' ' GLN . 4.5 p30 -160.43 153.74 21.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.008 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 52' ' ' VAL . 57.7 t -135.8 34.08 0.24 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.011 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.875 ' HB3' ' H1 ' ' A' ' 1' ' ' GLU . 56.8 Cg_endo -71.15 157.73 56.72 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.722 2.282 . . . . 0.0 112.328 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.99 69.62 2.31 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.767 2.311 . . . . 0.0 112.311 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.503 ' OE1' ' HG2' ' A' ' 53' ' ' PRO . 12.4 pt-20 -132.32 -38.33 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -97.35 -75.34 0.55 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.824 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.621 ' OE1' ' HA ' ' A' ' 57' ' ' GLU . 6.2 mm-40 -94.24 140.76 29.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.876 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' B' ' 59' ' ' GLU . 51.5 t -116.6 -51.48 2.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -84.45 -87.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 62.0 t80 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.925 -179.882 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' GLU . . . . . 0.623 ' O ' ' HG3' ' B' ' 1' ' ' GLU . 10.3 tp10 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . 0.442 ' O ' ' NE2' ' B' ' 3' ' ' GLN . . . -108.09 154.18 22.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.033 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . 0.753 ' HB3' ' CG2' ' B' ' 49' ' ' THR . 85.0 mm-40 -155.34 154.88 32.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.683 ' O ' ' HA ' ' B' ' 49' ' ' THR . 75.0 p -148.27 139.37 23.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.054 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.725 ' HA ' ' O ' ' B' ' 48' ' ' ASN . 21.1 mp0 -101.56 130.03 47.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.909 HG21 ' H ' ' B' ' 8' ' ' THR . 86.7 m -138.84 171.53 14.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.057 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.75 ' N ' HG21 ' B' ' 6' ' ' THR . 75.7 m -109.9 3.91 21.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.008 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.909 ' H ' HG21 ' B' ' 6' ' ' THR . 9.1 t -73.8 92.24 2.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.871 HG12 ' HA ' ' B' ' 14' ' ' ARG . 59.1 t -128.98 157.14 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.159 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.889 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -74.06 114.08 29.51 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.96 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.737 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 88.4 Cg_exo -40.31 -28.67 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.813 2.342 . . . . 0.0 112.461 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . 0.617 ' HG3' ' HG3' ' B' ' 13' ' ' GLU . 16.6 ptp180 -90.13 -29.82 18.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.71 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 44.6 mt-10 -104.58 9.59 35.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.076 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.889 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -69.89 145.93 51.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.921 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 17.6 mp0 -89.99 97.42 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.662 ' OD1' ' N ' ' B' ' 17' ' ' CYS . 36.5 t-20 -48.0 149.12 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.018 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' CYS . . . . . 0.894 ' SG ' ' HD3' ' B' ' 30' ' ' LYS . 44.7 t -135.26 1.02 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 110.764 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.611 ' N ' ' OD1' ' B' ' 16' ' ' ASN . . . -170.96 -134.42 1.76 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.289 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 0.843 ' CZ ' ' HA ' ' B' ' 22' ' ' VAL . 35.4 p90 -105.35 167.65 9.47 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 111.041 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.776 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 42.3 Cg_endo -68.15 -25.15 37.57 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.762 2.308 . . . . 0.0 112.436 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.711 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -95.56 6.44 67.87 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.535 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.843 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 35.0 m -49.55 137.05 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 111.275 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 0.902 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 80.2 p -110.95 -179.64 0.68 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.971 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.902 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 75.9 Cg_exo -49.79 -50.09 14.17 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.594 2.196 . . . . 0.0 112.393 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.0 m -74.7 -27.68 60.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.924 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.74 ' HB2' ' H ' ' B' ' 23' ' ' THR . 10.2 mm-40 -73.84 -32.09 63.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' CYS . . . . . 0.684 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 42.1 t -83.65 -53.87 5.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.817 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.95 67.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.988 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -49.94 -32.24 14.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.894 ' HD3' ' SG ' ' B' ' 17' ' ' CYS . 63.0 tttp -98.79 -25.8 14.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.88 66.82 1.13 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.665 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . 0.798 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 76.4 m -149.99 160.6 43.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 82.2 m -60.58 154.78 20.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.791 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.614 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 52.0 t80 -132.71 117.65 18.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.915 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.586 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 32.3 t0 -138.16 83.81 2.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -83.87 58.33 4.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' THR . . . . . 0.586 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 78.3 p -113.23 -25.29 8.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.108 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -122.77 118.83 56.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.149 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . 0.779 ' HG2' ' H ' ' B' ' 40' ' ' GLY . 37.4 ttm180 -75.31 -178.18 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . 0.779 ' H ' ' HG2' ' B' ' 39' ' ' ARG . . . 70.64 -37.08 0.47 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.44 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.735 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.1 m -99.5 165.19 15.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.822 0.344 . . . . 0.0 111.08 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.735 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 43.9 Cg_endo -68.18 130.94 22.39 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.763 2.309 . . . . 0.0 112.167 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.556 ' HE3' ' O ' ' B' ' 22' ' ' VAL . 50.2 m0 -78.31 -18.86 54.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' CYS . . . . . 0.798 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 51.4 t -121.3 124.32 44.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.68 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 36.9 p90 -142.56 170.5 15.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -80.3 154.86 74.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.87 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.4 -170.58 0.38 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.216 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.783 ' ND2' ' CG2' ' B' ' 9' ' ' VAL . 34.5 m-80 -149.64 140.84 23.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.957 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.753 ' CG2' ' HB3' ' B' ' 3' ' ' GLN . 93.8 m -115.62 104.91 12.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 62.4 mt -86.91 148.1 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.105 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.659 ' O ' ' HD3' ' B' ' 53' ' ' PRO . 24.4 p-10 -117.67 128.01 54.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.741 HG22 ' O ' ' B' ' 52' ' ' VAL . 33.3 m -96.87 86.01 0.36 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.198 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . 0.659 ' HD3' ' O ' ' B' ' 51' ' ' ASP . 56.0 Cg_endo -70.2 161.18 46.95 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.713 2.275 . . . . 0.0 112.279 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.562 ' O ' ' CD ' ' B' ' 55' ' ' GLU . 54.8 Cg_endo -70.09 -110.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.682 2.255 . . . . 0.0 112.247 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . 0.607 ' OE1' ' HA ' ' B' ' 55' ' ' GLU . 6.4 mm-40 -164.22 -152.37 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' B' ' 56' ' ' GLU . 23.0 pt-20 -98.04 99.21 10.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.915 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.969 ' OE1' ' N ' ' B' ' 57' ' ' GLU . 7.4 pm0 -143.47 -14.18 0.67 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.896 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' CYS . . . . . 0.656 ' SG ' ' HD1' ' B' ' 60' ' ' PHE . 50.2 t -88.75 -137.54 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.908 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . 0.643 ' N ' ' SG ' ' B' ' 58' ' ' CYS . 41.7 tt0 -134.45 -8.95 2.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . 0.656 ' HD1' ' SG ' ' B' ' 58' ' ' CYS . 50.0 m-85 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.886 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.905 ' OE1' ' N ' ' A' ' 1' ' ' GLU . 10.8 mp0 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.861 0.363 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.602 ' O ' ' CD ' ' A' ' 3' ' ' GLN . . . -76.77 106.3 8.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.981 ' HB3' ' HA ' ' A' ' 51' ' ' ASP . 12.4 mm100 -152.16 101.55 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.751 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.769 HG22 ' O ' ' A' ' 3' ' ' GLN . 70.7 p -170.44 -159.91 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -176.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.954 ' HG2' HG21 ' A' ' 49' ' ' THR . 53.2 mt-10 -99.78 124.84 45.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.666 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.784 ' CG2' HG23 ' A' ' 8' ' ' THR . 95.0 m -111.68 162.36 15.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.382 -178.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.577 ' N ' HG21 ' A' ' 6' ' ' THR . 72.5 m -143.19 -2.3 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.033 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.784 HG23 ' CG2' ' A' ' 6' ' ' THR . 9.8 t -71.91 62.26 0.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.147 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.817 ' CG2' HD22 ' A' ' 48' ' ' ASN . 58.4 t -106.56 165.62 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.825 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -91.6 123.62 63.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.862 ' HB3' HG22 ' A' ' 41' ' ' VAL . 80.7 Cg_exo -44.91 -39.4 14.15 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.728 2.285 . . . . 0.0 112.395 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -66.63 -29.98 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.796 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -112.41 39.26 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.061 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.825 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 96.6 mtt180 -108.26 152.91 23.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.715 ' NE2' ' C ' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -108.24 93.79 4.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.066 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.683 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.5 t-20 -27.7 150.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.683 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 42.1 t -138.02 0.82 2.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.518 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.564 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -177.54 -139.28 3.29 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.36 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.845 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 39.7 p90 -105.71 170.93 5.33 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.867 0.365 . . . . 0.0 110.986 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.845 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 58.4 Cg_endo -71.84 -36.5 6.12 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.767 2.312 . . . . 0.0 112.415 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . -58.63 -38.98 92.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.525 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.824 ' N ' ' CE2' ' A' ' 19' ' ' PHE . 34.2 m -30.34 155.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.805 0.336 . . . . 0.0 111.224 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.829 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 75.3 p -122.74 176.22 2.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.096 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.829 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 53.1 Cg_exo -52.43 -49.09 18.62 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -77.33 -42.33 37.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.719 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 26.4 mt-30 -59.43 -37.9 79.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 34' ' ' PHE . 53.9 t -72.53 -59.24 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.92 -26.87 38.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -67.98 -11.66 59.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.828 ' HD3' ' C ' ' A' ' 30' ' ' LYS . 7.8 tmtt? -100.37 -51.98 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.44 37.69 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.484 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.884 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 71.2 m -149.56 163.07 38.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.832 0.348 . . . . 0.0 111.069 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.855 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 72.6 m -76.15 155.12 34.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.695 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.724 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 77.3 t80 -122.47 136.82 54.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.645 ' CB ' HH12 ' A' ' 14' ' ' ARG . 26.6 t0 -155.72 79.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.697 ' HA ' ' CG ' ' A' ' 43' ' ' TRP . 24.5 p-10 -88.18 40.5 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.455 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 76.5 p -113.45 -13.9 12.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.695 HG11 HG23 ' A' ' 41' ' ' VAL . 62.7 t -113.89 104.09 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.119 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.56 ' C ' ' H ' ' A' ' 41' ' ' VAL . 98.5 mtt180 -70.47 175.52 4.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.86 -20.19 0.4 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.397 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.862 HG22 ' HB3' ' A' ' 11' ' ' PRO . 33.0 m -119.87 163.1 29.69 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.784 0.325 . . . . 0.0 111.162 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.675 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 55.5 Cg_endo -70.08 127.29 14.14 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.696 2.264 . . . . 0.0 112.266 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.697 ' CG ' ' HA ' ' A' ' 36' ' ' ASP . 49.9 m0 -72.16 -50.21 29.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.801 ' CB ' HG23 ' A' ' 22' ' ' VAL . 47.3 t -93.81 112.27 24.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.738 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.788 ' CE1' ' HD3' ' A' ' 14' ' ' ARG . 40.0 p90 -136.44 163.72 29.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.545 ' HD2' ' CB ' ' A' ' 15' ' ' GLN . 35.2 m-85 -57.81 134.72 83.14 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.666 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.884 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 96.8 Cg_endo -80.85 -156.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.842 2.361 . . . . 0.0 112.578 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.817 HD22 ' CG2' ' A' ' 9' ' ' VAL . 78.0 m-20 -139.53 81.34 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.851 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.954 HG21 ' HG2' ' A' ' 5' ' ' GLU . 68.5 p -91.78 103.42 15.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.076 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 4' ' ' THR . 33.3 mt -135.95 131.17 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.943 0.401 . . . . 0.0 111.12 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.981 ' HA ' ' HB3' ' A' ' 3' ' ' GLN . 24.7 p-10 -161.82 151.09 15.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.94 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 1.035 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 31.7 m -113.01 8.89 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.548 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 1.035 ' HD3' ' N ' ' A' ' 52' ' ' VAL . 13.5 Cg_exo -69.32 177.26 5.45 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.682 2.254 . . . . 0.0 112.142 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.613 ' HB2' ' OE1' ' A' ' 55' ' ' GLU . 57.0 Cg_endo -71.01 -121.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.769 2.313 . . . . 0.0 112.301 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.974 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 7.2 pm0 -151.61 -138.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.501 ' N ' ' HG2' ' A' ' 55' ' ' GLU . 12.6 pt-20 -90.61 9.21 30.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.542 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 45.1 mt-10 -136.35 102.49 4.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 80.1 m -117.46 -34.06 4.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.833 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -116.08 40.2 2.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.929 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.927 -179.781 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.816 0.341 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.5 120.02 5.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLN . . . . . 0.658 ' CG ' ' OD1' ' B' ' 51' ' ' ASP . 1.2 mp0 -82.82 167.21 18.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.854 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.705 ' O ' ' HA ' ' B' ' 49' ' ' THR . 68.3 p -163.73 143.86 8.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.21 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . 0.878 ' HB3' ' HB2' ' B' ' 47' ' ' PRO . 62.6 mt-10 -86.53 124.93 33.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.875 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.688 ' CG2' HG23 ' B' ' 8' ' ' THR . 93.7 m -116.71 167.53 11.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . 0.662 ' N ' HG23 ' B' ' 6' ' ' THR . 71.6 m -118.26 -25.2 6.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.997 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' THR . . . . . 0.688 HG23 ' CG2' ' B' ' 6' ' ' THR . 9.0 t -76.7 80.16 3.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.059 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.83 HG23 ' CG ' ' B' ' 48' ' ' ASN . 66.6 t -129.22 177.4 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.247 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.828 ' N ' HG11 ' B' ' 9' ' ' VAL . . . -85.38 151.87 57.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.894 ' HG3' HG13 ' B' ' 38' ' ' VAL . 43.2 Cg_exo -56.36 -16.57 18.3 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.787 2.325 . . . . 0.0 112.321 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -82.92 -29.92 28.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.063 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLU . . . . . 0.739 ' HB2' ' CG1' ' B' ' 9' ' ' VAL . 45.1 mt-10 -94.8 -20.07 19.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' ARG . . . . . 0.672 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 96.5 mtt180 -63.29 94.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLN . . . . . 0.651 ' O ' ' O ' ' B' ' 16' ' ' ASN . 8.3 tt0 -79.66 98.75 7.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . 0.695 ' ND2' ' H ' ' B' ' 18' ' ' GLY . 2.6 t-20 -23.61 149.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.257 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' CYS . . . . . 0.544 ' O ' ' HD3' ' B' ' 30' ' ' LYS . 42.6 t -141.89 4.45 1.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.535 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.695 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -166.96 -137.68 2.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.395 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' PHE . . . . . 1.014 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 29.1 p90 -105.32 175.42 2.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.327 . . . . 0.0 110.84 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 1.014 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 38.4 Cg_endo -67.11 -32.74 33.5 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.604 2.203 . . . . 0.0 112.482 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.733 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -93.84 5.2 72.7 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.602 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.865 HG11 ' O ' ' B' ' 19' ' ' PHE . 27.0 m -37.86 153.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 111.316 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' THR . . . . . 1.022 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 76.1 p -128.35 173.89 5.05 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.816 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 1.022 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 15.3 Cg_endo -57.46 -32.0 92.92 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.58 2.187 . . . . 0.0 112.221 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -85.14 -50.06 7.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' GLN . . . . . 0.408 ' OE1' ' HZ ' ' B' ' 19' ' ' PHE . 52.7 mt-30 -61.01 -32.73 72.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.4 t -78.92 -55.4 5.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.787 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' B' ' 31' ' ' GLY . . . -48.35 -33.87 9.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -49.8 -29.44 7.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.424 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' LYS . . . . . 0.544 ' HD3' ' O ' ' B' ' 17' ' ' CYS . 27.9 mtpp -97.82 -13.53 21.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.544 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' B' ' 28' ' ' ALA . . . 78.27 49.47 6.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.555 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' CYS . . . . . 0.735 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 71.0 m -126.33 166.98 16.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 110.947 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 77.8 m -75.08 149.52 39.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' PHE . . . . . 0.547 ' HE1' ' O ' ' B' ' 22' ' ' VAL . 73.4 t80 -126.95 126.92 44.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.628 ' OD1' HG22 ' B' ' 38' ' ' VAL . 16.6 t70 -149.83 80.47 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.961 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.795 ' HA ' ' CG ' ' B' ' 43' ' ' TRP . 24.5 p-10 -72.14 4.6 3.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 72.3 p -75.3 -7.07 52.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.052 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.894 HG13 ' HG3' ' B' ' 11' ' ' PRO . 68.1 t -115.75 112.46 39.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.181 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -89.01 149.18 23.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.32 -37.3 3.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.412 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . 0.896 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.3 m -112.43 169.76 6.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.35 . . . . 0.0 111.108 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' PRO . . . . . 0.896 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 51.7 Cg_endo -69.35 121.0 7.77 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.744 2.296 . . . . 0.0 112.229 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' TRP . . . . . 0.795 ' CG ' ' HA ' ' B' ' 36' ' ' ASP . 36.7 m0 -62.13 -45.02 95.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' CYS . . . . . 0.777 ' CB ' HG23 ' B' ' 22' ' ' VAL . 51.0 t -86.31 120.91 28.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.803 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . 0.735 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 52.5 p90 -148.81 162.14 40.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' TYR . . . . . 0.45 ' O ' ' HD1' ' B' ' 45' ' ' PHE . 92.6 m-85 -68.94 155.92 92.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' PRO . . . . . 0.878 ' HB2' ' HB3' ' B' ' 5' ' ' GLU . 28.2 Cg_endo -62.8 -173.48 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.774 2.316 . . . . 0.0 112.179 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ASN . . . . . 0.83 ' CG ' HG23 ' B' ' 9' ' ' VAL . 35.0 m-80 -134.33 81.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.109 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' THR . . . . . 0.826 ' HB ' ' HG2' ' B' ' 5' ' ' GLU . 8.0 t -85.96 90.18 8.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.853 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ILE . . . . . 0.716 HG21 ' N ' ' B' ' 51' ' ' ASP . 61.7 mt -107.96 170.07 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.392 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ASP . . . . . 0.716 ' N ' HG21 ' B' ' 50' ' ' ILE . 1.4 m-20 -108.79 177.33 4.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.758 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . 0.856 ' H ' ' HD3' ' B' ' 53' ' ' PRO . 57.3 t -155.21 23.88 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' PRO . . . . . 0.856 ' HD3' ' H ' ' B' ' 52' ' ' VAL . 71.5 Cg_endo -74.82 134.3 17.97 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.677 2.251 . . . . 0.0 112.374 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' B' ' 53' ' ' PRO . 13.8 Cg_exo -69.59 160.37 49.99 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.882 2.388 . . . . 0.0 112.184 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -119.98 -164.42 1.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' GLU . . . . . 0.491 ' N ' ' OE1' ' B' ' 56' ' ' GLU . 21.2 mp0 -94.73 -139.77 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.433 ' CD ' ' N ' ' B' ' 57' ' ' GLU . 0.5 OUTLIER -82.97 168.47 16.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' CYS . . . . . . . . . . . . . 26.7 p -133.64 103.39 5.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -105.15 -71.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.902 179.738 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.912 HG21 HG22 ' A' ' 8' ' ' THR . 86.2 m . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.706 0.288 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.813 ' N ' HG22 ' A' ' 6' ' ' THR . 77.1 m -123.71 -15.7 6.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.176 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.912 HG22 HG21 ' A' ' 6' ' ' THR . 10.2 t -70.88 69.28 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.794 HG22 HD22 ' A' ' 48' ' ' ASN . 60.1 t -114.89 171.81 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.154 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.834 ' C ' ' HG3' ' A' ' 14' ' ' ARG . . . -86.77 121.19 71.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.962 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.79 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 82.8 Cg_exo -45.22 -59.46 1.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.825 2.35 . . . . 0.0 112.44 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.639 ' HG3' ' HG3' ' A' ' 13' ' ' GLU . 37.9 ptt180 -46.42 -29.81 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.639 ' HG3' ' HG3' ' A' ' 12' ' ' ARG . 45.1 mt-10 -104.68 -17.83 14.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.834 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 99.4 mtt180 -51.96 139.4 22.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.758 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.52 ' O ' ' HD1' ' A' ' 46' ' ' TYR . 70.8 mm-40 -90.85 98.48 11.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.786 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.568 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.6 t-20 -41.96 143.0 0.61 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.568 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 44.1 t -145.49 3.48 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.563 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 170.16 124.02 0.72 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.39 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.822 ' O ' HG22 ' A' ' 22' ' ' VAL . 52.6 p90 -44.88 163.88 0.19 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.812 0.339 . . . . 0.0 110.768 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.666 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 36.2 Cg_endo -65.5 -43.9 9.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.289 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.14 -13.67 1.07 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 19' ' ' PHE . 27.4 m -63.52 154.35 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 111.183 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.765 ' OG1' ' HG3' ' A' ' 26' ' ' GLN . 79.4 p -101.68 160.26 27.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.099 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 62.4 Cg_exo -51.21 -35.99 54.53 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.777 2.318 . . . . 0.0 112.306 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 80.2 p -75.74 -37.26 59.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.965 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.765 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 78.6 mt-30 -67.44 -55.67 12.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -55.67 -52.7 62.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.54 -22.54 66.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.015 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.59 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 27.4 t-20 -60.69 -19.09 57.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.834 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -102.21 -26.44 13.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.46 34.61 3.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.544 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.2 m -120.64 176.17 5.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.382 . . . . 0.0 111.037 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.9 m -86.02 155.27 20.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.958 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.683 ' HE2' HG23 ' A' ' 22' ' ' VAL . 19.5 t80 -135.55 108.1 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -125.58 103.24 7.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -96.24 24.23 5.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.0 p -90.71 -31.93 16.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.202 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 41' ' ' VAL . 63.9 t -100.5 121.23 51.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -91.69 155.15 18.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.57 -42.3 2.7 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.431 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.873 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.7 m -93.65 170.04 9.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 111.101 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.873 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 45.7 Cg_endo -68.47 121.05 7.96 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.73 2.286 . . . . 0.0 112.238 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.636 ' CE3' ' O ' ' A' ' 20' ' ' PRO . 49.9 m0 -68.59 -44.73 73.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.807 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 51.3 t -97.36 118.87 34.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.712 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.667 ' CE2' ' HD3' ' A' ' 14' ' ' ARG . 51.3 p90 -147.34 157.59 43.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.959 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.52 ' HD1' ' O ' ' A' ' 15' ' ' GLN . 84.7 m-85 -63.75 157.48 66.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.94 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 46' ' ' TYR . 57.9 Cg_endo -71.68 -161.63 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.737 2.292 . . . . 0.0 112.309 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.794 HD22 HG22 ' A' ' 9' ' ' VAL . 35.4 p30 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.76 ' O ' ' CE2' ' B' ' 45' ' ' PHE . 62.2 m . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.909 0.385 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.578 ' O ' HG23 ' B' ' 8' ' ' THR . 9.1 t -87.01 69.92 10.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.987 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.655 HG12 ' N ' ' B' ' 10' ' ' ALA . 59.5 t -89.83 166.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.044 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.909 ' HB3' ' HB2' ' B' ' 13' ' ' GLU . . . -47.54 113.48 2.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.776 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 80.0 Cg_exo -44.83 -46.03 13.14 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.829 2.352 . . . . 0.0 112.467 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -73.96 -29.97 62.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.909 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 45.1 mt-10 -92.83 -5.47 50.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.03 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.846 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.3 mtt180 -58.98 125.66 24.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.82 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.457 ' O ' ' HD1' ' B' ' 46' ' ' TYR . 56.4 tp60 -80.29 98.29 7.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.469 ' ND2' ' H ' ' B' ' 18' ' ' GLY . 6.8 t30 -35.38 150.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.983 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' CYS . . . . . 0.435 ' SG ' ' O ' ' B' ' 17' ' ' CYS . 41.5 t -134.07 4.2 3.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.469 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . 179.88 -133.72 2.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.437 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.856 ' CE1' HG12 ' B' ' 22' ' ' VAL . 35.6 p90 -105.13 164.29 15.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.907 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.708 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 37.5 Cg_endo -66.33 -31.02 44.34 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.721 2.281 . . . . 0.0 112.304 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.61 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -82.64 -2.64 90.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.458 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.876 HG21 ' CB ' ' B' ' 44' ' ' CYS . 29.1 m -47.11 147.79 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.915 0.388 . . . . 0.0 111.295 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' THR . . . . . 1.032 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 67.1 p -123.0 175.34 2.76 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 1.032 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 10.6 Cg_endo -53.6 -43.56 56.7 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.651 2.234 . . . . 0.0 112.091 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.5 p -76.88 -46.79 23.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.698 ' HB2' ' H ' ' B' ' 23' ' ' THR . 85.2 mm-40 -57.29 -50.48 72.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 46.4 t -60.05 -57.1 14.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.728 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.01 -35.58 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.773 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.638 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 38.4 t-20 -49.94 -36.85 29.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.791 ' HZ2' ' HB3' ' B' ' 30' ' ' LYS . 2.6 mmmp? -88.14 -41.35 13.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.537 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.89 58.39 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.734 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' CYS . . . . . 0.805 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 82.6 m -140.89 174.69 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.359 . . . . 0.0 110.971 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 1.019 ' SG ' ' HG3' ' B' ' 47' ' ' PRO . 73.6 m -92.82 134.2 35.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.904 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.787 ' CZ ' ' HB3' ' B' ' 36' ' ' ASP . 59.4 t80 -91.39 153.06 20.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.122 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.437 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 32.4 t0 -170.2 79.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.834 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 25.3 p30 -90.02 30.41 1.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' THR . . . . . 0.437 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 71.5 p -83.5 -4.9 58.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.083 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 61.0 t -138.3 128.03 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.309 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.833 ' NH1' ' CZ2' ' B' ' 43' ' ' TRP . 22.1 mmm180 -80.92 -178.58 6.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.53 -32.44 0.22 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.563 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.557 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.2 m -104.29 158.95 30.86 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.883 0.373 . . . . 0.0 111.068 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 55.3 Cg_endo -69.9 136.78 33.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.733 2.288 . . . . 0.0 112.277 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.834 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 48.7 m0 -79.73 -32.43 41.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' CYS . . . . . 0.876 ' CB ' HG21 ' B' ' 22' ' ' VAL . 50.6 t -95.01 115.25 27.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.522 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.805 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 6.0 p90 -145.73 172.98 12.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.816 -176.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' B' ' 15' ' ' GLN . 92.7 m-85 -85.33 133.71 41.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.621 176.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' PRO . . . . . 1.019 ' HG3' ' SG ' ' B' ' 33' ' ' CYS . 56.2 Cg_endo . . . . . 0 N--CA 1.457 -0.66 0 C-N-CA 123.343 2.695 . . . . 0.0 112.629 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.962 HG22 ' H ' ' A' ' 8' ' ' THR . 86.1 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.762 0.315 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.808 ' N ' HG22 ' A' ' 6' ' ' THR . 71.4 m -133.93 -2.0 2.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.266 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.962 ' H ' HG22 ' A' ' 6' ' ' THR . 9.6 t -75.69 75.2 2.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.137 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.743 HG11 ' HA ' ' A' ' 14' ' ' ARG . 62.1 t -116.4 161.67 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.89 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -81.33 132.15 56.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.943 ' HB3' HG21 ' A' ' 41' ' ' VAL . 85.5 Cg_exo -40.62 -32.1 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.823 2.349 . . . . 0.0 112.507 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -90.04 -29.74 18.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 10' ' ' ALA . 81.6 mm-40 -92.43 -6.0 50.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.001 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.89 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.4 mtt180 -69.37 118.04 11.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.614 ' O ' ' O ' ' A' ' 16' ' ' ASN . 57.5 tp60 -79.96 93.12 5.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.696 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 42.8 t30 -24.98 148.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.77 ' HB2' ' N ' ' A' ' 46' ' ' TYR . 50.5 t -143.68 3.0 1.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.116 0.484 . . . . 0.0 110.188 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.55 -142.85 3.51 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.113 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.929 ' CZ ' ' HA ' ' A' ' 22' ' ' VAL . 27.4 p90 -105.75 168.91 7.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.793 0.33 . . . . 0.0 111.064 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.833 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 40.7 Cg_endo -67.78 -20.08 46.35 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.258 . . . . 0.0 112.436 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.716 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -102.64 4.96 50.79 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.545 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.929 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 27.7 m -39.9 163.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.008 0.433 . . . . 0.0 111.39 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.012 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 76.4 p -143.94 175.75 2.65 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.762 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.012 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 17.2 Cg_endo -57.74 -35.46 98.79 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.654 2.236 . . . . 0.0 112.196 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 29' ' ' ASN . 51.2 m -89.41 -41.26 12.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.056 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.517 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 52.7 mt-30 -69.06 -29.86 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.039 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.951 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.8 t -93.85 -36.58 12.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.921 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -79.25 -12.15 59.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 25' ' ' SER . 43.2 t30 -91.75 -16.97 26.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -101.34 -33.2 10.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.939 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.54 43.7 0.63 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.951 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 76.1 m -126.94 161.89 27.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.932 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.76 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 77.1 m -85.83 134.77 33.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.644 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.526 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 50.1 t80 -113.59 122.04 46.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.882 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.661 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 16.5 t70 -145.81 99.08 3.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -91.74 54.71 2.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.901 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.478 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 74.3 p -94.99 -31.88 13.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 41' ' ' VAL . 63.3 t -133.97 120.92 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.229 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.577 ' C ' ' H ' ' A' ' 41' ' ' VAL . 35.3 ptt180 -73.47 -175.61 2.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.83 -28.84 0.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.434 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.943 HG21 ' HB3' ' A' ' 11' ' ' PRO . 33.9 m -101.23 166.71 11.88 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.0 111.156 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 60.1 Cg_endo -72.5 120.01 6.47 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.826 2.35 . . . . 0.0 112.225 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.461 ' HE1' ' HA ' ' A' ' 39' ' ' ARG . 51.8 m0 -78.21 -34.07 49.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.898 ' CB ' HG21 ' A' ' 22' ' ' VAL . 51.3 t -101.77 110.29 22.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.789 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.76 ' CE1' ' HD3' ' A' ' 14' ' ' ARG . 51.7 p90 -134.04 175.83 9.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.77 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 92.4 m-85 -76.0 154.14 84.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.857 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' THR . 57.4 Cg_endo -71.35 -156.78 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.694 2.263 . . . . 0.0 112.431 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.528 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 12.8 m120 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 86.0 m . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.805 0.336 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -117.73 49.19 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.106 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.69 HG12 ' N ' ' B' ' 10' ' ' ALA . 61.3 t -103.9 168.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.112 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.882 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -74.45 121.09 84.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.038 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.774 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 87.8 Cg_exo -46.17 -24.77 2.6 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.807 2.338 . . . . 0.0 112.542 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.64 ' HG3' ' HG2' ' B' ' 13' ' ' GLU . 13.8 ptp180 -87.69 -29.96 20.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.64 ' HG2' ' HG3' ' B' ' 12' ' ' ARG . 6.3 mm-40 -108.3 34.61 3.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.015 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.882 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.1 mtt180 -95.49 149.35 21.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.758 ' HB2' ' HB2' ' B' ' 46' ' ' TYR . 17.1 mp0 -82.11 95.23 7.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.61 ' O ' ' CE2' ' B' ' 46' ' ' TYR . 7.0 t30 -41.91 131.95 3.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' CYS . . . . . 0.663 ' HB2' ' CD2' ' B' ' 46' ' ' TYR . 44.3 t -145.82 3.99 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.792 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.59 123.02 0.65 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.504 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.752 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 52.5 p90 -45.02 166.71 0.12 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 120.835 0.35 . . . . 0.0 110.94 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.752 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 44.3 Cg_endo -68.28 -29.52 32.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.759 2.306 . . . . 0.0 112.323 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.705 ' H ' ' HD2' ' B' ' 19' ' ' PHE . . . -61.33 -10.65 23.27 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.449 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.697 HG22 ' O ' ' B' ' 19' ' ' PHE . 33.1 m -66.5 165.97 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.76 0.314 . . . . 0.0 111.159 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' THR . . . . . 0.834 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 72.8 p -126.29 175.03 3.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.834 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 56.8 Cg_exo -51.75 -44.19 46.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.722 2.281 . . . . 0.0 112.297 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 54.6 m -74.89 -47.74 28.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.619 ' HB2' ' H ' ' B' ' 23' ' ' THR . 52.9 mt-30 -54.62 -46.56 73.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.894 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' B' ' 30' ' ' LYS . 42.6 t -65.32 -67.21 0.46 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.804 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.07 -42.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.805 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 7.0 t30 -50.18 -37.17 33.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.574 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' B' ' 27' ' ' CYS . 34.5 mmtp -84.02 -37.37 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.595 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.34 59.88 0.83 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.635 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' CYS . . . . . 0.407 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 74.1 m -150.2 170.38 19.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 110.939 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.848 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.5 m -66.71 150.15 49.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.816 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -128.03 120.08 26.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.789 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' B' ' 43' ' ' TRP . 26.4 t0 -134.96 98.17 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.746 ' HA ' ' CD2' ' B' ' 43' ' ' TRP . 24.5 p-10 -96.81 46.16 1.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 74.9 p -119.77 -39.93 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.106 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.793 HG12 HG22 ' B' ' 41' ' ' VAL . 59.5 t -90.02 139.27 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.152 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.637 ' NH1' ' HZ2' ' B' ' 43' ' ' TRP . 38.6 mmt180 -94.41 162.31 13.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.43 -47.71 1.15 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.793 HG22 HG12 ' B' ' 38' ' ' VAL . 32.8 m -77.12 151.43 81.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.46 120.03 6.91 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.705 2.27 . . . . 0.0 112.259 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.746 ' CD2' ' HA ' ' B' ' 36' ' ' ASP . 35.5 m0 -64.06 -46.39 84.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.878 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' CYS . . . . . 0.848 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 44.2 t -96.0 104.09 16.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.717 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.821 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 44.8 p90 -131.91 150.09 52.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.046 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.758 ' HB2' ' HB2' ' B' ' 15' ' ' GLN . 92.3 m-85 -54.08 144.72 37.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--N 1.341 0.154 0 C-N-CA 122.707 2.271 . . . . 0.0 112.311 179.717 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.892 ' HB ' ' HB2' ' A' ' 48' ' ' ASN . 96.4 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.808 0.337 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' N ' HG22 ' A' ' 6' ' ' THR . 72.0 m -133.83 6.55 3.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.779 HG22 ' CG2' ' A' ' 6' ' ' THR . 9.1 t -89.43 66.71 7.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.181 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.743 HG12 ' N ' ' A' ' 10' ' ' ALA . 61.4 t -97.19 171.44 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.833 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -88.52 112.59 51.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.072 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.82 ' HB3' HG21 ' A' ' 41' ' ' VAL . 83.7 Cg_exo -44.03 -20.02 0.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.795 2.33 . . . . 0.0 112.486 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 10' ' ' ALA . 37.6 mmt180 -90.11 -30.01 17.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 10' ' ' ALA . 44.5 mt-10 -108.12 -4.37 17.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.069 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.833 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.4 mtt180 -54.26 134.26 44.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.648 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 10.1 mm-40 -93.02 79.94 4.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.818 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.633 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 51.6 t30 -27.63 150.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.831 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 41.3 t -125.26 8.18 7.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 110.567 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.631 ' O ' ' ND2' ' A' ' 16' ' ' ASN . . . -170.27 -132.39 1.46 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.216 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.938 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 30.8 p90 -105.76 173.77 3.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.798 0.333 . . . . 0.0 110.888 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.938 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 42.5 Cg_endo -68.15 -29.38 33.1 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.684 2.256 . . . . 0.0 112.457 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.657 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -89.28 -8.61 68.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.527 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.876 HG21 ' CB ' ' A' ' 44' ' ' CYS . 34.8 m -31.56 154.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.869 0.366 . . . . 0.0 111.327 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.013 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 74.5 p -123.99 172.72 5.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.134 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 1.013 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 28.1 Cg_endo -62.68 -33.08 78.29 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.756 2.304 . . . . 0.0 112.266 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.9 p -86.2 -38.0 18.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.672 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 96.4 mt-30 -69.9 -41.73 74.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.91 -45.89 39.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.792 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -33.07 70.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.058 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.612 ' OD1' ' O ' ' A' ' 29' ' ' ASN . 38.9 t-20 -53.21 -20.67 4.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.817 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.76 -28.51 14.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.52 18.69 9.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.432 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.93 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 70.8 m -102.38 179.62 4.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 0.0 111.036 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.751 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 78.9 m -93.79 155.06 17.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.786 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.551 ' HE2' ' OD2' ' A' ' 36' ' ' ASP . 73.7 t80 -134.24 127.19 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.427 ' OD1' ' OG1' ' A' ' 37' ' ' THR . 26.6 t0 -137.27 92.32 2.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.551 ' OD2' ' HE2' ' A' ' 34' ' ' PHE . 4.6 p30 -89.62 38.02 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.427 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 76.8 p -109.33 -10.46 14.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.596 HG12 HG22 ' A' ' 41' ' ' VAL . 62.6 t -117.61 104.61 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.164 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.734 ' HD2' ' N ' ' A' ' 39' ' ' ARG . 4.3 mpt_? -73.8 155.02 39.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.93 -49.44 1.98 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.438 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.928 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.1 m -92.4 170.55 8.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.753 0.311 . . . . 0.0 111.087 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.928 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 43.9 Cg_endo -68.1 145.64 67.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.604 2.203 . . . . 0.0 112.245 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -89.76 -30.98 17.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.898 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.876 ' CB ' HG21 ' A' ' 22' ' ' VAL . 43.1 t -97.38 128.03 43.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.692 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.751 ' CE2' ' HB2' ' A' ' 33' ' ' CYS . 48.6 p90 -146.12 157.72 43.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.904 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.648 ' CD2' ' O ' ' A' ' 15' ' ' GLN . 83.1 m-85 -70.26 135.63 86.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.93 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 58.3 Cg_endo -72.0 172.81 13.9 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.29 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.892 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 17.5 m120 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.734 0.302 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.44 ' O ' HG23 ' B' ' 8' ' ' THR . 8.8 t -97.77 55.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.992 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.649 HG12 ' N ' ' B' ' 10' ' ' ALA . 59.9 t -98.95 165.77 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.251 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.87 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -95.24 132.21 28.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.051 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.778 ' HB3' HG21 ' B' ' 41' ' ' VAL . 88.6 Cg_exo -43.84 -29.38 2.46 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.791 2.327 . . . . 0.0 112.49 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -86.71 -29.82 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.859 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' B' ' 10' ' ' ALA . 61.7 mt-10 -94.92 -11.52 28.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.989 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.87 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -61.89 127.14 29.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.971 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 57.1 tp60 -92.89 99.74 12.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' B' ' 15' ' ' GLN . 6.8 t30 -33.8 150.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.016 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' B' ' 17' ' ' CYS . 43.3 t -138.02 4.65 2.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.696 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.14 -136.85 2.12 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.379 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.831 ' CZ ' ' HA ' ' B' ' 22' ' ' VAL . 27.5 p90 -105.44 168.9 7.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 0.0 110.99 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.821 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 54.0 Cg_endo -70.13 -12.66 32.6 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.748 2.299 . . . . 0.0 112.408 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.744 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -107.85 5.6 34.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.508 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.831 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 34.0 m -47.94 158.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.166 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' THR . . . . . 0.912 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 79.8 p -133.77 178.83 1.58 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.068 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.912 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 56.8 Cg_exo -51.75 -54.79 4.72 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.7 m -72.89 -43.0 63.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.715 ' HB2' ' H ' ' B' ' 23' ' ' THR . 96.4 mt-30 -57.66 -38.83 75.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.941 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 46.3 t -72.92 -60.58 2.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.81 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.11 -34.75 1.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.973 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -50.02 -35.08 23.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.674 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -93.84 -32.41 13.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.708 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.92 58.35 0.84 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.616 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' CYS . . . . . 0.678 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 76.8 m -143.07 165.0 28.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.958 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.69 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 73.4 m -70.98 155.11 41.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.89 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.613 ' CE1' ' HA ' ' B' ' 23' ' ' THR . 67.8 t80 -132.32 119.16 20.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.6 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 16.6 t70 -130.1 96.58 4.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.749 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 4.6 p-10 -94.78 46.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 74.9 p -113.73 -31.99 6.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.518 HG12 HG22 ' B' ' 41' ' ' VAL . 63.5 t -107.87 111.43 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.162 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.667 ' NH1' ' HZ2' ' B' ' 43' ' ' TRP . 21.8 mmm180 -68.41 178.21 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.46 -54.82 0.9 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.475 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.778 HG21 ' HB3' ' B' ' 11' ' ' PRO . 33.2 m -82.22 156.32 69.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.814 0.34 . . . . 0.0 111.125 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 47.3 Cg_endo -68.7 140.35 46.61 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.662 2.241 . . . . 0.0 112.317 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.749 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 12.9 m0 -81.56 -47.51 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' CYS . . . . . 0.703 ' CB ' HG21 ' B' ' 22' ' ' VAL . 50.6 t -87.71 119.61 28.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.757 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.761 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 51.3 p90 -152.18 171.29 18.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.504 ' O ' ' HD2' ' B' ' 45' ' ' PHE . 84.9 m-85 -75.62 156.57 84.88 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.848 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 46' ' ' TYR . 54.7 Cg_endo . . . . . 0 C--N 1.341 0.161 0 C-N-CA 122.791 2.327 . . . . 0.0 112.305 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.845 HG22 ' N ' ' A' ' 7' ' ' CYS . 93.4 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.824 0.345 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.845 ' N ' HG22 ' A' ' 6' ' ' THR . 71.7 m -108.69 12.72 25.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.631 HG22 ' CG2' ' A' ' 6' ' ' THR . 8.8 t -100.3 63.58 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.149 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.728 HG22 ' HB3' ' A' ' 48' ' ' ASN . 62.5 t -94.0 164.06 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.175 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.887 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -85.88 139.56 35.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.021 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.874 ' HG3' HG21 ' A' ' 38' ' ' VAL . 93.1 Cg_exo -42.07 -36.87 4.16 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.83 2.353 . . . . 0.0 112.481 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 1.065 ' HD3' ' N ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -90.23 -29.36 18.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.758 178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 1.065 ' N ' ' HD3' ' A' ' 12' ' ' ARG . 85.4 mt-10 -80.85 -12.96 59.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.985 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.887 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 97.6 mtt180 -71.7 113.57 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.073 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.668 ' O ' ' O ' ' A' ' 16' ' ' ASN . 57.1 tp60 -80.58 95.5 6.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.668 ' O ' ' O ' ' A' ' 15' ' ' GLN . 6.8 t30 -23.48 150.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.022 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.406 ' SG ' ' O ' ' A' ' 17' ' ' CYS . 41.0 t -141.7 4.8 1.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.485 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.1 -139.58 4.86 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.388 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.849 ' CE2' ' N ' ' A' ' 22' ' ' VAL . 40.3 p90 -105.62 167.41 9.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.799 0.333 . . . . 0.0 110.83 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.806 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 38.5 Cg_endo -66.86 -41.91 9.56 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.61 2.207 . . . . 0.0 112.304 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . -61.9 -26.64 67.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.544 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.909 HG21 ' HB2' ' A' ' 44' ' ' CYS . 34.7 m -31.58 156.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 111.211 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.778 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 80.4 p -124.69 173.46 4.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.743 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 45.0 Cg_exo -56.27 -44.82 42.76 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.731 2.287 . . . . 0.0 112.308 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.562 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 80.1 p -75.73 -39.44 57.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.046 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.63 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 52.4 mt-30 -67.54 -38.1 83.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.1 t -82.23 -51.82 7.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.96 75.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 25' ' ' SER . 42.9 t30 -54.66 -16.76 2.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -100.47 -22.6 14.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 -28.73 5.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.585 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.659 ' HB3' ' O ' ' A' ' 45' ' ' PHE . 71.6 m -68.86 179.74 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.882 0.372 . . . . 0.0 111.068 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.3 m -107.22 155.24 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.003 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.778 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 15.5 t80 -115.31 134.15 55.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.484 ' OD1' ' NH1' ' A' ' 14' ' ' ARG . 17.4 t70 -158.77 99.26 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.794 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.4 p-10 -96.68 32.54 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.415 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 72.6 p -91.21 -6.68 53.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.874 HG21 ' HG3' ' A' ' 11' ' ' PRO . 61.6 t -132.66 114.91 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.728 ' N ' ' HD3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -78.44 -175.79 4.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.01 -35.19 0.29 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.548 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.733 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.1 m -107.38 164.82 13.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.733 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 59.5 Cg_endo -72.34 127.15 12.31 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.698 2.265 . . . . 0.0 112.282 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.794 ' CD1' ' HA ' ' A' ' 36' ' ' ASP . 35.0 m0 -68.2 -33.72 74.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.861 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.909 ' HB2' HG21 ' A' ' 22' ' ' VAL . 53.4 t -91.31 120.27 32.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.659 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 39.5 p90 -147.36 160.09 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.694 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 86.5 m-85 -67.89 165.0 35.48 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.694 ' HD2' ' HB3' ' A' ' 46' ' ' TYR . 39.8 Cg_endo -67.03 172.02 10.43 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.663 2.242 . . . . 0.0 112.306 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.728 ' HB3' HG22 ' A' ' 9' ' ' VAL . 3.5 p-10 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.813 0.339 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.623 ' O ' HG23 ' B' ' 8' ' ' THR . 9.5 t -82.13 73.24 9.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.821 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.952 HG11 ' HA ' ' B' ' 14' ' ' ARG . 50.1 t -107.19 166.42 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.375 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.838 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -94.21 122.61 61.15 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.92 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.786 ' HB3' HG11 ' B' ' 41' ' ' VAL . 98.9 Cg_exo -42.56 -26.96 0.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.864 2.376 . . . . 0.0 112.523 -178.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.584 ' HG3' ' HG2' ' B' ' 13' ' ' GLU . 16.7 ptm180 -90.05 -29.87 18.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.973 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.584 ' HG2' ' HG3' ' B' ' 12' ' ' ARG . 81.6 mm-40 -99.96 -11.73 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.177 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.952 ' HA ' HG11 ' B' ' 9' ' ' VAL . 96.7 mtt180 -51.54 127.19 19.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.873 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.603 ' O ' ' HD1' ' B' ' 46' ' ' TYR . 7.3 tp60 -79.91 86.84 5.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.792 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' B' ' 15' ' ' GLN . 6.9 t30 -30.01 133.67 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.105 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' CYS . . . . . 0.782 ' SG ' ' HD2' ' B' ' 30' ' ' LYS . 41.6 t -145.53 2.74 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.616 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' B' ' 44' ' ' CYS . . . 177.54 122.39 0.73 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.428 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.954 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 53.1 p90 -44.83 172.86 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.804 0.335 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.954 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 33.8 Cg_endo -64.61 -60.72 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.76 2.306 . . . . 0.0 112.226 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -39.3 -17.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.533 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.745 HG22 ' O ' ' B' ' 19' ' ' PHE . 32.1 m -52.13 158.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 111.138 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' THR . . . . . 0.825 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 74.5 p -135.27 173.99 5.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.825 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 54.5 Cg_exo -51.84 -42.63 56.54 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.779 2.319 . . . . 0.0 112.321 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.2 m -72.69 -48.61 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.982 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.563 ' O ' ' HB3' ' B' ' 29' ' ' ASN . 78.4 mt-30 -60.57 -54.4 45.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.3 t -54.27 -55.59 26.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.734 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.35 -40.21 11.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.957 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.563 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 38.3 t-20 -49.97 -41.51 46.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.782 ' HD2' ' SG ' ' B' ' 17' ' ' CYS . 39.6 ttmt -82.22 -36.22 27.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.55 63.57 0.86 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.704 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' CYS . . . . . 0.765 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 93.1 m -149.99 178.56 8.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 0.0 111.019 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.811 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 72.2 m -79.02 155.2 28.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.02 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.736 ' CE2' ' HA ' ' B' ' 23' ' ' THR . 42.6 t80 -123.4 111.06 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.663 ' O ' ' HA ' ' B' ' 43' ' ' TRP . 32.7 t0 -135.91 108.38 7.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.835 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 4.6 p-10 -111.9 31.28 6.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 81.1 p -84.09 -24.86 30.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.518 ' HB ' ' CG2' ' B' ' 41' ' ' VAL . 62.4 t -111.6 135.34 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.176 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -85.95 152.24 23.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.31 -43.6 3.16 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.542 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' B' ' 11' ' ' PRO . 32.8 m -81.59 154.58 71.2 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.905 0.383 . . . . 0.0 111.148 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 50.0 Cg_endo -69.21 136.84 35.55 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.783 2.322 . . . . 0.0 112.313 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.835 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 51.0 m0 -84.58 -54.37 4.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.002 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' CYS . . . . . 0.811 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 53.8 t -83.19 100.0 10.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.76 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.765 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 44.3 p90 -128.37 167.56 16.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.097 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.617 ' CD1' ' HB2' ' B' ' 17' ' ' CYS . 90.7 m-85 -74.46 147.46 84.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 0 C--N 1.341 0.181 0 C-N-CA 122.758 2.305 . . . . 0.0 112.335 179.635 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 48' ' ' ASN . 9.0 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.824 0.345 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.593 ' O ' ' HZ ' ' A' ' 45' ' ' PHE . 71.6 m -117.85 -8.24 10.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.952 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.743 HG22 ' OG1' ' A' ' 6' ' ' THR . 9.2 t -69.96 92.14 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.126 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.788 HG12 ' N ' ' A' ' 10' ' ' ALA . 63.0 t -127.49 173.96 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.858 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -95.2 126.01 48.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.02 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.874 ' HG2' HG21 ' A' ' 38' ' ' VAL . 81.2 Cg_exo -44.91 -20.54 0.39 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.835 2.356 . . . . 0.0 112.443 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -89.1 -31.53 17.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' ALA . 62.3 mt-10 -109.77 45.6 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.858 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.1 mtt180 -111.02 142.92 42.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.652 ' O ' ' O ' ' A' ' 16' ' ' ASN . 17.0 mp0 -110.39 89.75 3.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.704 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 37.0 t-20 -23.02 147.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.716 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.746 ' SG ' ' CE1' ' A' ' 46' ' ' TYR . 43.5 t -137.64 2.83 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.126 0.488 . . . . 0.0 110.554 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -159.01 -137.91 2.35 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.242 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.957 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 41.1 p90 -105.86 172.82 3.64 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.746 0.308 . . . . 0.0 110.884 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.957 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 46.3 Cg_endo -68.95 -46.33 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.694 2.263 . . . . 0.0 112.366 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.622 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -75.25 6.56 28.43 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.587 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 19' ' ' PHE . 26.7 m -50.39 122.9 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 111.309 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.963 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 82.2 p -107.66 -178.51 0.59 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.961 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.963 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 74.5 Cg_exo -49.56 -46.89 24.85 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 53.8 m -84.29 -34.48 23.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.909 ' HB2' ' H ' ' A' ' 23' ' ' THR . 15.2 mm-40 -65.55 -32.5 74.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 49.1 t -84.19 -53.43 5.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.789 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.27 -23.99 64.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 25' ' ' SER . 6.9 t30 -76.68 -12.26 59.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.938 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.909 ' HB3' ' HZ2' ' A' ' 30' ' ' LYS . 2.7 mmmp? -108.98 -13.92 14.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.913 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.35 34.29 7.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.517 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.996 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 82.7 m -122.65 164.47 18.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.761 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 74.2 m -81.44 153.43 26.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.62 ' HE1' ' O ' ' A' ' 22' ' ' VAL . 72.1 t80 -128.55 136.93 51.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.959 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.65 ' OD2' ' NH2' ' A' ' 14' ' ' ARG . 26.6 t0 -159.79 79.94 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -80.46 46.0 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.88 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -104.49 -4.81 22.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.202 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.874 HG21 ' HG2' ' A' ' 11' ' ' PRO . 67.8 t -145.93 118.59 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.29 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.607 ' C ' ' H ' ' A' ' 41' ' ' VAL . 78.0 mtm180 -76.78 -170.05 1.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.831 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.32 -30.24 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.446 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.854 HG21 ' HB3' ' A' ' 11' ' ' PRO . 32.9 m -111.26 161.91 23.14 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 111.077 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 40.9 Cg_endo -67.49 132.58 27.62 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.197 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -77.85 -35.26 51.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.002 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.996 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 44.7 t -103.88 105.83 16.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.648 ' HD1' ' O ' ' A' ' 46' ' ' TYR . 5.6 p90 -124.7 -169.95 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.055 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.746 ' CE1' ' SG ' ' A' ' 17' ' ' CYS . 90.5 m-85 -92.38 160.96 33.9 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 46' ' ' TYR . 57.4 Cg_endo -71.17 -158.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.313 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.758 ' O ' HG22 ' A' ' 6' ' ' THR . 17.2 m120 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.573 ' O ' ' HZ ' ' B' ' 45' ' ' PHE . 82.5 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.808 0.337 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.585 ' O ' HG23 ' B' ' 8' ' ' THR . 8.9 t -93.67 71.83 4.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.869 HG11 ' HA ' ' B' ' 14' ' ' ARG . 59.5 t -109.53 172.5 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.94 ' HB1' ' CZ ' ' B' ' 12' ' ' ARG . . . -85.86 129.05 55.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.015 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.643 ' HB3' HG21 ' B' ' 41' ' ' VAL . 78.0 Cg_exo -39.69 -34.45 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.827 2.351 . . . . 0.0 112.426 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 1.032 ' HD3' ' H ' ' B' ' 12' ' ' ARG . 0.0 OUTLIER -90.12 -29.78 18.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.895 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.681 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 6.4 mm-40 -96.24 -5.22 40.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.174 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.901 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -63.06 133.9 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.674 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.715 ' HG3' ' HD2' ' B' ' 46' ' ' TYR . 7.3 tp60 -79.94 79.97 6.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.957 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' B' ' 18' ' ' GLY . 48.6 t-20 -34.36 139.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.721 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' B' ' 16' ' ' ASN . 44.6 t -126.98 1.57 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.019 0.437 . . . . 0.0 110.593 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' B' ' 16' ' ' ASN . . . -179.36 -132.72 1.82 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.218 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.855 ' CE2' ' N ' ' B' ' 22' ' ' VAL . 21.3 p90 -105.8 165.61 12.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.349 . . . . 0.0 110.915 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.723 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 43.1 Cg_endo -67.96 -11.57 32.48 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.751 2.301 . . . . 0.0 112.288 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.646 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -98.53 -19.92 21.3 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.855 ' N ' ' CE2' ' B' ' 19' ' ' PHE . 34.5 m -27.7 139.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.0 111.141 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' THR . . . . . 0.833 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 75.9 p -109.7 176.25 1.62 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.091 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.833 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 51.6 Cg_exo -52.91 -49.83 16.19 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.75 2.3 . . . . 0.0 112.361 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 48.1 t -68.76 -41.09 79.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.004 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.45 ' HB2' ' H ' ' B' ' 23' ' ' THR . 52.8 mt-30 -65.69 -40.45 92.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.02 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' B' ' 33' ' ' CYS . 42.3 t -74.58 -41.71 60.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.802 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.8 -33.46 73.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.078 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -49.77 -35.0 20.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.76 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 1.057 ' HE2' ' HA ' ' B' ' 30' ' ' LYS . 0.5 OUTLIER -95.53 -38.05 10.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.521 177.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.07 57.01 0.61 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.522 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' CYS . . . . . 0.756 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 78.1 m -129.84 177.07 7.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.938 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.912 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 74.1 m -80.03 155.33 27.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.953 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.603 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 41.3 t80 -128.5 114.56 16.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.863 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 16.7 t70 -135.2 94.33 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.992 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.673 ' HA ' ' CG ' ' B' ' 43' ' ' TRP . 25.2 p30 -91.88 22.45 4.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.974 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -97.26 -8.44 29.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.219 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.816 HG21 ' NH2' ' B' ' 14' ' ' ARG . 63.2 t -122.27 106.18 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.089 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.423 ' C ' ' H ' ' B' ' 41' ' ' VAL . 95.3 mtt180 -77.45 -178.46 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.953 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.43 -43.29 0.56 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.405 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.885 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.2 m -105.85 169.25 7.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 110.986 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.885 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 51.6 Cg_endo -69.33 147.58 65.95 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.67 2.247 . . . . 0.0 112.312 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.673 ' CG ' ' HA ' ' B' ' 36' ' ' ASP . 46.5 m0 -91.42 -38.19 12.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.813 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' CYS . . . . . 0.912 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 53.6 t -94.67 121.62 36.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.733 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.573 ' HZ ' ' O ' ' B' ' 7' ' ' CYS . 45.0 p90 -150.99 169.74 21.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.715 ' HD2' ' HG3' ' B' ' 15' ' ' GLN . 89.3 m-85 -83.46 155.52 66.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.818 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--N 1.342 0.196 0 C-N-CA 122.705 2.27 . . . . 0.0 112.296 -179.794 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.838 HG22 HG22 ' A' ' 8' ' ' THR . 91.9 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.857 0.36 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.4 m -112.18 23.95 13.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.987 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.838 HG22 HG22 ' A' ' 6' ' ' THR . 10.0 t -74.27 64.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.079 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.823 HG11 ' HA ' ' A' ' 14' ' ' ARG . 57.2 t -97.47 124.69 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.184 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.983 ' HB3' ' HB2' ' A' ' 13' ' ' GLU . . . -50.26 136.23 22.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.82 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.501 ' HA ' ' NE ' ' A' ' 14' ' ' ARG . 84.7 Cg_exo -41.19 -55.59 2.08 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.906 2.404 . . . . 0.0 112.805 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.847 ' HG3' ' OE2' ' A' ' 13' ' ' GLU . 15.8 ptp180 -81.03 -29.61 35.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.07 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.983 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 22.3 mp0 -80.77 7.85 9.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.039 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.94 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.2 mtt180 -74.94 120.9 21.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.839 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.669 ' O ' ' O ' ' A' ' 16' ' ' ASN . 10.4 mm100 -82.26 80.16 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.919 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.669 ' O ' ' O ' ' A' ' 15' ' ' GLN . 35.9 t-20 -22.51 148.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.037 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.657 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 42.5 t -134.96 0.23 2.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.639 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -166.86 -136.05 1.96 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.268 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.87 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 22.2 p90 -105.55 170.12 6.26 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.811 0.339 . . . . 0.0 110.95 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.87 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 53.4 Cg_endo -69.82 -12.55 33.0 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.749 2.299 . . . . 0.0 112.368 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.661 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -98.44 -21.29 17.46 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.461 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.891 HG21 ' HB2' ' A' ' 44' ' ' CYS . 34.3 m -24.93 150.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.815 0.341 . . . . 0.0 111.255 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.568 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 68.8 p -120.34 165.25 18.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.093 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.673 ' HD3' ' CZ ' ' A' ' 34' ' ' PHE . 53.2 Cg_exo -52.5 -36.52 70.7 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.718 2.279 . . . . 0.0 112.304 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.6 t -79.14 -48.28 14.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.556 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 52.8 mt-30 -60.37 -44.27 95.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.944 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.6 t -75.02 -58.86 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -53.54 -15.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -92.48 -14.3 28.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 22.8 tptm -98.84 -1.46 40.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.94 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.55 45.79 5.69 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.602 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.798 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 79.9 m -149.96 152.17 34.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 110.993 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.882 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 78.5 m -67.39 155.29 39.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.858 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.673 ' CZ ' ' HD3' ' A' ' 24' ' ' PRO . 59.8 t80 -129.79 109.8 11.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.817 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.575 ' OD1' ' OG1' ' A' ' 37' ' ' THR . 32.9 t0 -138.41 90.48 2.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.714 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.4 p-10 -88.92 -3.12 58.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.575 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 79.1 p -48.71 -7.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.572 ' H ' ' C ' ' A' ' 36' ' ' ASP . 62.2 t -141.26 103.46 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.797 ' HA ' ' HE1' ' A' ' 43' ' ' TRP . 15.9 ptp180 -69.27 -165.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.763 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.22 -34.87 0.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.359 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.839 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.6 m -108.39 167.74 8.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.944 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.839 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 42.9 Cg_endo -68.08 119.97 6.96 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.187 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.797 ' HE1' ' HA ' ' A' ' 39' ' ' ARG . 50.1 m0 -70.11 -37.67 75.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.891 ' HB2' HG21 ' A' ' 22' ' ' VAL . 50.5 t -96.84 128.57 43.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.829 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.576 ' CE2' ' CG2' ' A' ' 9' ' ' VAL . 52.4 p90 -152.81 161.75 42.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -67.02 137.19 94.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.004 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.882 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 99.0 Cg_endo -80.67 -177.05 3.49 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.933 2.422 . . . . 0.0 112.484 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.8 m120 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.781 178.783 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.827 0.346 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.605 ' O ' HG23 ' B' ' 8' ' ' THR . 9.1 t -98.05 72.72 2.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.087 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.874 HG12 ' N ' ' B' ' 10' ' ' ALA . 73.8 t -119.34 -179.53 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.874 ' N ' HG12 ' B' ' 9' ' ' VAL . . . -95.97 159.91 31.23 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.008 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.452 ' HB3' HG11 ' B' ' 41' ' ' VAL . 76.8 Cg_exo -50.08 -39.18 51.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.748 2.298 . . . . 0.0 112.462 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.4 ' C ' ' H ' ' B' ' 14' ' ' ARG . 39.4 ptt180 -89.97 -29.92 18.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.764 ' O ' HG11 ' B' ' 9' ' ' VAL . 45.2 mt-10 -77.0 17.46 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.077 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.829 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.2 mtt180 -98.56 114.39 26.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 56.5 tp60 -80.48 98.85 7.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.439 ' O ' ' CE1' ' B' ' 46' ' ' TYR . 43.1 t30 -32.95 150.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' B' ' 17' ' ' CYS . 41.5 t -143.26 5.17 1.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.73 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.85 -138.61 2.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.422 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.859 ' CE1' HG12 ' B' ' 22' ' ' VAL . 42.8 p90 -105.58 166.83 10.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 0.0 110.929 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.776 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 47.1 Cg_endo -68.9 -33.74 19.37 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.751 2.3 . . . . 0.0 112.313 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.663 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -84.05 13.47 49.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.54 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.859 HG12 ' CE1' ' B' ' 19' ' ' PHE . 34.0 m -65.07 164.43 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 111.207 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' THR . . . . . 0.777 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 75.2 p -133.75 173.15 6.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.054 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.777 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 55.7 Cg_exo -51.63 -32.75 45.97 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.727 2.285 . . . . 0.0 112.363 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 47.3 t -84.81 -66.74 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.476 ' NE2' ' HZ ' ' B' ' 19' ' ' PHE . 52.6 mt-30 -39.34 -34.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.863 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' B' ' 30' ' ' LYS . 42.6 t -80.58 -60.97 2.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.16 -34.14 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -49.84 -37.09 29.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.42 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' B' ' 27' ' ' CYS . 46.6 mmtm -86.76 -30.85 21.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.518 176.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.01 24.03 9.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.709 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' CYS . . . . . 0.656 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 81.6 m -102.42 155.54 18.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 110.897 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' B' ' 47' ' ' PRO . 83.0 m -63.56 149.45 46.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.807 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.635 ' CZ ' ' HA ' ' B' ' 23' ' ' THR . 59.6 t80 -133.13 120.24 20.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.535 ' OD2' ' NH1' ' B' ' 14' ' ' ARG . 16.5 t70 -129.3 87.75 2.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.662 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 24.3 p-10 -91.83 51.53 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 75.8 p -117.8 -11.92 10.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.192 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.492 ' O ' HG22 ' B' ' 41' ' ' VAL . 62.2 t -136.01 115.54 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' B' ' 41' ' ' VAL . 80.7 mtp180 -67.98 -178.17 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.22 -41.27 0.48 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.557 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.492 HG22 ' O ' ' B' ' 38' ' ' VAL . 33.0 m -92.49 153.07 42.62 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 0.0 111.107 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.29 122.2 9.0 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.749 2.299 . . . . 0.0 112.207 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.662 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 23.1 m0 -67.34 -47.45 70.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.009 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' CYS . . . . . 0.705 ' CB ' HG21 ' B' ' 22' ' ' VAL . 46.8 t -92.03 119.84 32.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.897 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.763 ' CE2' ' HD3' ' B' ' 14' ' ' ARG . 53.3 p90 -149.23 159.41 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.827 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.439 ' CE1' ' O ' ' B' ' 16' ' ' ASN . 91.6 m-85 -58.68 146.92 72.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' PRO . . . . . 0.507 ' HA ' ' SG ' ' B' ' 33' ' ' CYS . 59.0 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 C-N-CA 122.763 2.308 . . . . 0.0 112.371 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.985 HG22 ' H ' ' A' ' 8' ' ' THR . 86.0 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.731 0.301 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.77 ' N ' HG22 ' A' ' 6' ' ' THR . 71.9 m -131.29 2.43 4.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.24 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.985 ' H ' HG22 ' A' ' 6' ' ' THR . 10.1 t -75.21 63.16 1.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.084 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.517 HG22 ' OD1' ' A' ' 48' ' ' ASN . 58.0 t -96.65 155.55 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.912 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -69.66 136.3 88.07 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.786 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HG3' HG21 ' A' ' 38' ' ' VAL . 88.9 Cg_exo -41.83 -66.69 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.793 2.329 . . . . 0.0 112.593 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -65.12 -30.0 70.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.992 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.897 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 81.0 mm-40 -88.96 27.69 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.097 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.912 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.2 mtt180 -97.83 129.31 44.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.865 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 45' ' ' PHE . 29.5 mm-40 -82.63 104.19 12.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.636 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 43.7 t30 -35.29 122.02 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.905 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 46.4 t -138.8 -0.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.196 0.522 . . . . 0.0 110.229 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.764 ' N ' ' O ' ' A' ' 44' ' ' CYS . . . 174.77 122.34 0.68 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.313 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.818 ' O ' HG22 ' A' ' 22' ' ' VAL . 53.2 p90 -44.78 167.87 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.751 0.31 . . . . 0.0 110.973 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.786 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 47.2 Cg_endo -68.9 -52.97 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.659 2.239 . . . . 0.0 112.263 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -40.46 -27.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.382 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.904 HG21 ' HB2' ' A' ' 44' ' ' CYS . 29.1 m -49.93 171.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.342 . . . . 0.0 111.122 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.891 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 74.1 p -137.25 178.71 1.6 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.891 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 58.0 Cg_exo -51.48 -36.58 59.68 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.627 2.218 . . . . 0.0 112.27 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 53.1 m -90.18 -40.01 12.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.821 ' HB2' ' H ' ' A' ' 23' ' ' THR . 96.1 mt-30 -65.23 -27.31 68.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.868 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.975 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 53.0 t -91.56 -52.9 4.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.789 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.84 -21.0 40.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.004 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.517 ' OD1' ' O ' ' A' ' 29' ' ' ASN . 37.8 t-20 -72.01 -27.47 62.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.849 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.11 -24.52 18.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.937 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.32 29.35 5.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.4 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.975 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 61.9 m -108.52 -176.8 3.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.827 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.73 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 73.7 m -109.22 132.62 53.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.636 176.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.781 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 26.9 t80 -104.41 108.5 19.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.896 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' A' ' 35' ' ' ASP . 32.5 t0 -128.98 90.31 3.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.541 ' OD2' ' HE1' ' A' ' 34' ' ' PHE . 25.0 p30 -89.1 60.55 5.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.3 p -114.8 -33.65 5.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.09 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.624 ' O ' HG22 ' A' ' 41' ' ' VAL . 63.5 t -119.48 120.38 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.074 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.588 ' C ' ' H ' ' A' ' 41' ' ' VAL . 98.8 mtt180 -74.24 179.33 4.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.06 -28.5 0.15 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 38' ' ' VAL . 33.0 m -98.84 158.84 31.68 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.8 0.333 . . . . 0.0 111.081 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 50.4 Cg_endo -69.18 120.2 7.09 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 0.0 112.302 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -73.51 -27.4 61.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.942 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 44.6 t -113.27 95.96 5.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.723 ' C ' ' HB3' ' A' ' 17' ' ' CYS . 52.8 p90 -122.71 -169.93 2.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.636 ' CE2' ' O ' ' A' ' 16' ' ' ASN . 96.3 m-85 -88.29 143.39 32.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.976 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 56.6 Cg_endo -70.87 -156.53 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.842 2.362 . . . . 0.0 112.408 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.517 ' OD1' HG22 ' A' ' 9' ' ' VAL . 12.6 m120 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 71.2 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.677 0.275 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.685 ' O ' HG23 ' B' ' 8' ' ' THR . 9.4 t -74.52 82.95 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 111.099 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.816 HG12 ' N ' ' B' ' 10' ' ' ALA . 76.4 t -128.59 176.23 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.071 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.844 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -84.17 128.15 63.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.924 ' HB3' HG21 ' B' ' 41' ' ' VAL . 97.6 Cg_exo -42.45 -66.25 0.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.795 2.33 . . . . 0.0 112.416 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.89 ' NH1' ' HD2' ' B' ' 11' ' ' PRO . 0.1 OUTLIER -54.16 -29.9 47.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.823 179.076 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.707 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 87.3 mt-10 -93.82 22.71 5.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.844 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 98.8 mtt180 -98.91 141.54 31.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.552 ' O ' ' HD1' ' B' ' 46' ' ' TYR . 84.9 mm-40 -88.18 80.04 7.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' B' ' 15' ' ' GLN . 44.6 t-20 -24.36 138.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.585 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' B' ' 16' ' ' ASN . 40.9 t -133.09 2.82 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 110.559 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' B' ' 16' ' ' ASN . . . -156.83 -136.5 2.13 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.286 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.907 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 12.3 p90 -105.74 171.54 4.77 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.342 . . . . 0.0 111.007 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.907 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 30.4 Cg_endo -64.05 -10.01 21.5 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.821 2.348 . . . . 0.0 112.386 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.772 ' HA2' ' CZ3' ' B' ' 43' ' ' TRP . . . -128.93 29.07 4.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.606 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.879 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 35.7 m -49.66 161.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.391 . . . . 0.0 111.264 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' THR . . . . . 1.082 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 66.7 p -135.95 176.41 2.85 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.767 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 1.082 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 10.8 Cg_endo -54.03 -42.22 68.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.597 2.198 . . . . 0.0 112.088 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -81.07 -46.42 15.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.747 ' HG2' ' OG1' ' B' ' 23' ' ' THR . 85.1 mm-40 -57.04 -38.63 73.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -73.76 -54.77 7.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.759 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.1 -35.7 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.83 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -54.03 -28.33 37.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.798 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.81 ' HZ2' ' HB3' ' B' ' 30' ' ' LYS . 2.7 mmmp? -100.17 -26.95 13.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.731 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.5 60.58 1.79 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.592 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' CYS . . . . . 0.527 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 78.6 m -142.88 176.41 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.91 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.661 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.0 m -74.27 148.66 41.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.765 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.635 ' CE1' HG23 ' B' ' 22' ' ' VAL . 75.6 t80 -126.76 130.8 51.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.885 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.571 ' OD2' ' NH2' ' B' ' 14' ' ' ARG . 27.5 t0 -148.19 80.02 1.46 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.873 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.733 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 24.4 p-10 -84.44 53.45 2.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -120.04 -4.84 10.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.621 HG12 HG22 ' B' ' 41' ' ' VAL . 61.8 t -132.7 106.87 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.668 ' C ' ' H ' ' B' ' 41' ' ' VAL . 79.7 mtm180 -71.28 -171.81 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.66 -10.88 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.385 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.924 HG21 ' HB3' ' B' ' 11' ' ' PRO . 34.9 m -131.49 164.98 38.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 0.0 111.1 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.755 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 57.7 Cg_endo -71.31 144.17 45.33 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.751 2.301 . . . . 0.0 112.309 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.772 ' CZ3' ' HA2' ' B' ' 21' ' ' GLY . 27.1 m0 -93.25 -50.7 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.794 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' CYS . . . . . 0.825 ' H ' HG21 ' B' ' 22' ' ' VAL . 52.9 t -87.66 122.85 31.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.727 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.779 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 47.8 p90 -148.19 149.58 32.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.552 ' HD1' ' O ' ' B' ' 15' ' ' GLN . 81.0 m-85 -46.81 150.57 1.25 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.851 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.465 -0.199 0 C-N-CA 122.747 2.298 . . . . 0.0 112.37 -179.385 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.836 ' N ' ' HB2' ' A' ' 48' ' ' ASN . 95.7 m . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.746 0.308 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.609 ' N ' HG22 ' A' ' 6' ' ' THR . 70.9 m -130.31 -22.88 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.842 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.521 HG22 ' CG2' ' A' ' 6' ' ' THR . 8.9 t -74.37 51.33 0.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.825 HG12 ' N ' ' A' ' 10' ' ' ALA . 62.8 t -90.06 177.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.875 ' HB3' ' HB2' ' A' ' 13' ' ' GLU . . . -76.05 132.11 74.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.939 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.657 ' HA ' ' NE ' ' A' ' 14' ' ' ARG . 88.6 Cg_exo -46.92 -74.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.746 2.297 . . . . 0.0 112.425 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.718 ' HB2' ' OE2' ' A' ' 13' ' ' GLU . 37.2 mmt180 -52.6 -30.65 32.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.975 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.875 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -89.66 35.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.808 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.0 mtt180 -107.89 124.04 49.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.976 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.571 ' CB ' ' HD2' ' A' ' 46' ' ' TYR . 1.3 mp0 -79.93 92.71 5.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 15' ' ' GLN . 27.4 t-20 -30.31 150.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.637 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 43.5 t -135.96 4.67 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.336 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.19 -138.28 2.73 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.336 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.956 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 30.4 p90 -105.75 172.38 4.04 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.778 0.323 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.956 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 46.1 Cg_endo -68.79 -31.59 24.97 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.715 2.277 . . . . 0.0 112.325 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.644 ' H ' ' HD2' ' A' ' 19' ' ' PHE . . . -74.27 -27.98 64.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.527 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.932 HG21 ' HB2' ' A' ' 44' ' ' CYS . 34.4 m -26.21 152.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.266 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.67 ' OG1' ' HG3' ' A' ' 26' ' ' GLN . 74.8 p -122.33 164.53 25.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.074 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.747 ' HG3' ' CE1' ' A' ' 34' ' ' PHE . 50.2 Cg_exo -53.48 -32.48 63.16 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.709 2.273 . . . . 0.0 112.349 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 47.8 t -84.83 -46.45 11.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.67 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 78.4 mt-30 -59.71 -46.59 88.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.8 t -76.48 -48.34 19.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -63.74 -15.29 58.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.086 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 25' ' ' SER . 42.9 t30 -83.4 -14.84 51.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -92.25 -35.96 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.74 11.79 1.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.568 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.775 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 71.7 m -113.81 170.62 8.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 110.941 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 76.8 m -88.17 155.07 19.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.747 ' CE1' ' HG3' ' A' ' 24' ' ' PRO . 45.2 t80 -133.14 119.42 19.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 37' ' ' THR . 16.4 t70 -130.64 79.99 1.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.794 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.3 p-10 -78.18 21.54 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 35' ' ' ASP . 75.0 p -90.84 -16.77 27.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.772 HG12 HG22 ' A' ' 41' ' ' VAL . 62.8 t -108.66 126.71 65.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.093 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.521 ' C ' ' H ' ' A' ' 41' ' ' VAL . 82.9 mtm180 -91.09 176.41 6.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.95 -33.46 0.29 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.466 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.915 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.3 m -106.27 170.64 5.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.72 0.295 . . . . 0.0 111.119 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.915 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 60.0 Cg_endo -72.63 153.65 54.47 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.673 2.248 . . . . 0.0 112.223 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.794 ' CD1' ' HA ' ' A' ' 36' ' ' ASP . 34.1 m0 -97.81 -30.29 12.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.932 ' HB2' HG21 ' A' ' 22' ' ' VAL . 47.4 t -100.04 117.38 34.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.778 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.751 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 52.2 p90 -143.57 170.05 16.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.571 ' HD2' ' CB ' ' A' ' 15' ' ' GLN . 25.6 m-85 -76.97 134.94 67.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.775 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 18.0 Cg_endo -61.02 -150.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.52 -0.195 0 C-N-CA 122.976 2.45 . . . . 0.0 112.606 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.836 ' HB2' ' N ' ' A' ' 6' ' ' THR . 18.1 m120 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.357 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.738 0.304 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.657 ' O ' HG23 ' B' ' 8' ' ' THR . 9.0 t -86.9 84.96 7.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.024 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.91 HG11 ' HA ' ' B' ' 14' ' ' ARG . 58.8 t -125.31 165.28 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.208 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.852 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -93.5 131.53 32.29 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.986 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.892 ' HB3' HG21 ' B' ' 41' ' ' VAL . 79.0 Cg_exo -40.07 -32.05 0.59 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.793 2.329 . . . . 0.0 112.516 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.906 ' NH2' HG12 ' B' ' 41' ' ' VAL . 2.0 mmp_? -90.25 -29.89 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' B' ' 10' ' ' ALA . 12.2 mm-40 -93.05 -5.93 49.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.085 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.91 ' HA ' HG11 ' B' ' 9' ' ' VAL . 99.4 mtt180 -69.29 122.2 18.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.823 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.539 ' HA ' ' OE1' ' B' ' 15' ' ' GLN . 7.3 tp60 -79.9 91.18 5.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.869 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.562 ' OD1' ' N ' ' B' ' 18' ' ' GLY . 45.0 t-20 -32.64 140.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.753 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' CYS . . . . . 0.538 ' N ' ' OD1' ' B' ' 16' ' ' ASN . 43.1 t -127.8 1.69 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.526 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.562 ' N ' ' OD1' ' B' ' 16' ' ' ASN . . . -172.39 -134.45 1.8 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.084 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.897 ' CE1' HG12 ' B' ' 22' ' ' VAL . 37.8 p90 -106.15 156.58 36.59 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.732 0.301 . . . . 0.0 110.895 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.562 ' O ' ' CE3' ' B' ' 43' ' ' TRP . 36.4 Cg_endo -65.51 -18.91 60.56 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.681 2.254 . . . . 0.0 112.229 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.639 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -94.14 8.13 72.76 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.47 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.897 HG12 ' CE1' ' B' ' 19' ' ' PHE . 34.6 m -61.67 155.55 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.0 111.129 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' THR . . . . . 0.846 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 78.3 p -121.06 174.71 2.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.12 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.846 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 76.8 Cg_exo -50.26 -56.08 3.46 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 0.0 112.309 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 79.5 p -58.35 -55.05 39.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.836 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.787 ' C ' ' HZ3' ' B' ' 30' ' ' LYS . 96.2 mt-30 -50.04 -72.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' CYS . . . . . 0.598 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 49.6 t -32.02 -53.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.73 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.33 -35.79 51.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' B' ' 26' ' ' GLN . 42.1 t30 -49.64 -32.58 13.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.787 ' HZ3' ' C ' ' B' ' 26' ' ' GLN . 2.2 mppt? -95.63 -15.5 22.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.795 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.94 38.31 16.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.532 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' CYS . . . . . 0.724 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 79.6 m -119.46 161.8 19.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 110.979 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.2 m -65.43 155.19 36.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.851 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.585 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 57.8 t80 -129.56 118.06 21.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.564 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 16.6 t70 -128.55 100.04 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -91.75 24.7 3.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' THR . . . . . 0.564 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 69.0 p -89.11 -62.39 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.857 HG21 ' HG3' ' B' ' 11' ' ' PRO . 61.1 t -80.52 120.79 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' B' ' 41' ' ' VAL . 83.6 mtm180 -89.15 -177.55 5.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.99 -35.52 0.29 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.906 HG12 ' NH2' ' B' ' 12' ' ' ARG . 27.5 m -100.44 170.43 6.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.745 0.307 . . . . 0.0 111.137 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.894 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 41.1 Cg_endo -67.41 127.99 17.49 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.183 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.562 ' CE3' ' O ' ' B' ' 20' ' ' PRO . 49.7 m0 -78.9 -47.54 16.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.882 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 50.2 t -91.16 123.79 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.777 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.724 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 50.0 p90 -142.67 168.94 18.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.997 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.529 ' O ' ' HD1' ' B' ' 45' ' ' PHE . 88.2 m-85 -75.73 154.08 85.26 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.94 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--O 1.232 0.186 0 C-N-CA 122.798 2.332 . . . . 0.0 112.415 179.838 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.844 ' HB ' ' HB2' ' A' ' 48' ' ' ASN . 93.9 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.803 0.335 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.635 ' N ' HG22 ' A' ' 6' ' ' THR . 72.0 m -146.5 19.38 1.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.979 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.794 HG22 ' CG2' ' A' ' 6' ' ' THR . 9.5 t -100.22 63.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.11 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.685 HG12 ' N ' ' A' ' 10' ' ' ALA . 61.2 t -103.44 168.08 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.182 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.859 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -78.47 120.94 82.92 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.104 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.78 ' HA ' ' CD ' ' A' ' 14' ' ' ARG . 88.5 Cg_exo -46.58 -37.75 20.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.691 2.26 . . . . 0.0 112.456 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.735 ' HG3' ' HG3' ' A' ' 13' ' ' GLU . 14.5 ptm180 -71.17 -29.91 65.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.925 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.735 ' HG3' ' HG3' ' A' ' 12' ' ' ARG . 87.2 mt-10 -111.09 42.44 1.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.965 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.859 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.3 mtt180 -107.23 117.85 35.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.944 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.645 ' O ' ' O ' ' A' ' 16' ' ' ASN . 84.6 mm-40 -87.55 100.14 12.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.665 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.4 t-20 -24.92 150.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.814 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.817 ' HB2' ' N ' ' A' ' 46' ' ' TYR . 53.0 t -140.79 2.17 1.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.54 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -148.44 -138.99 3.1 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.294 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 1.097 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 43.9 p90 -105.82 -177.9 0.55 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.595 0.236 . . . . 0.0 110.745 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 1.097 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 38.3 Cg_endo -67.49 -62.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.49 2.127 . . . . 0.0 112.38 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.659 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -78.03 29.91 1.85 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.55 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.999 HG13 ' O ' ' A' ' 19' ' ' PHE . 27.5 m -56.95 133.05 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.359 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.855 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 79.2 p -117.01 178.24 1.04 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.954 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.855 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 50.6 Cg_exo -53.81 -40.05 81.73 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.677 2.252 . . . . 0.0 112.271 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.643 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 47.8 t -88.35 -31.56 18.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.799 ' HB2' ' H ' ' A' ' 23' ' ' THR . 52.9 mt-30 -73.46 -33.8 65.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.896 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.938 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.2 t -87.48 -50.2 6.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.32 70.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.003 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.643 ' HB2' ' O ' ' A' ' 25' ' ' SER . 38.1 t-20 -57.04 -21.0 27.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -102.45 -28.85 11.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.946 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.48 -6.36 14.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.405 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.938 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 85.4 m -70.67 -170.07 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 110.904 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.842 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 72.3 m -116.11 155.06 28.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 36' ' ' ASP . 66.3 t80 -131.35 118.25 20.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.594 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 16.9 t70 -131.03 79.89 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 34' ' ' PHE . 24.7 p-10 -72.94 13.47 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.576 ' OG1' ' OD2' ' A' ' 35' ' ' ASP . 76.4 p -79.56 -16.41 55.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.081 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.703 HG21 ' CG ' ' A' ' 11' ' ' PRO . 63.2 t -131.39 109.63 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.095 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.813 ' HG2' ' H ' ' A' ' 40' ' ' GLY . 59.9 ttt180 -79.01 -176.93 5.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.813 ' H ' ' HG2' ' A' ' 39' ' ' ARG . . . 73.07 -38.45 0.79 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.383 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.852 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.0 m -98.44 168.03 10.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 111.049 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.852 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 48.1 Cg_endo -68.75 120.9 7.78 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 0.0 112.207 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.8 m0 -67.43 -45.24 76.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.842 ' CB ' HG21 ' A' ' 22' ' ' VAL . 42.5 t -91.87 116.13 28.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.741 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.574 ' C ' ' CB ' ' A' ' 17' ' ' CYS . 52.1 p90 -139.17 168.91 18.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.965 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.817 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 83.6 m-85 -68.71 135.08 90.24 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.687 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 61.3 Cg_endo -73.35 -156.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.758 2.305 . . . . 0.0 112.318 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.844 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 13.1 m120 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' CYS . . . . . 0.504 ' O ' ' HZ ' ' B' ' 45' ' ' PHE . 75.7 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.75 0.31 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.653 ' O ' HG23 ' B' ' 8' ' ' THR . 9.1 t -73.8 92.24 2.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.893 HG11 ' HA ' ' B' ' 14' ' ' ARG . 59.1 t -128.98 157.14 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.159 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.907 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -74.06 114.08 29.51 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.96 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.741 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 88.4 Cg_exo -40.31 -28.67 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.813 2.342 . . . . 0.0 112.461 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ARG . . . . . 0.652 ' HG3' ' HG3' ' B' ' 13' ' ' GLU . 16.6 ptp180 -90.13 -29.82 18.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.726 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 44.6 mt-10 -104.58 9.59 35.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.076 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.907 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -69.89 145.93 51.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.921 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 17.6 mp0 -89.99 97.42 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.662 ' OD1' ' N ' ' B' ' 17' ' ' CYS . 36.5 t-20 -48.0 149.12 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.018 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' CYS . . . . . 0.883 ' SG ' ' HD3' ' B' ' 30' ' ' LYS . 44.7 t -135.26 1.02 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 110.764 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.611 ' N ' ' OD1' ' B' ' 16' ' ' ASN . . . -170.96 -134.42 1.76 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.289 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 0.863 ' CZ ' ' HA ' ' B' ' 22' ' ' VAL . 35.4 p90 -105.35 167.65 9.47 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 111.041 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.797 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 42.3 Cg_endo -68.15 -25.15 37.57 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.762 2.308 . . . . 0.0 112.436 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.711 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -95.56 6.44 67.87 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.535 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.863 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 35.0 m -49.55 137.05 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 111.275 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' THR . . . . . 0.944 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 80.2 p -110.95 -179.64 0.68 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.971 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.944 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 75.9 Cg_exo -49.79 -50.09 14.17 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.594 2.196 . . . . 0.0 112.393 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.0 m -74.7 -27.68 60.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.924 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.771 ' HB2' ' H ' ' B' ' 23' ' ' THR . 10.2 mm-40 -73.84 -32.09 63.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' CYS . . . . . 0.684 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 42.1 t -83.65 -53.87 5.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.817 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.95 67.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.988 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -49.94 -32.24 14.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.883 ' HD3' ' SG ' ' B' ' 17' ' ' CYS . 63.0 tttp -98.79 -25.8 14.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.88 66.82 1.13 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.665 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' CYS . . . . . 0.82 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 76.4 m -149.99 160.6 43.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 82.2 m -60.58 154.78 20.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.791 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.615 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 52.0 t80 -132.71 117.65 18.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.915 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.421 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 32.3 t0 -138.16 83.81 2.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -83.87 58.33 4.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' THR . . . . . 0.421 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 78.3 p -113.23 -25.29 8.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.108 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -122.77 118.83 56.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.149 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ARG . . . . . 0.81 ' HG2' ' H ' ' B' ' 40' ' ' GLY . 37.4 ttm180 -75.31 -178.18 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' GLY . . . . . 0.81 ' H ' ' HG2' ' B' ' 39' ' ' ARG . . . 70.64 -37.08 0.47 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.44 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.753 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.1 m -99.5 165.19 15.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.822 0.344 . . . . 0.0 111.08 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.753 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 43.9 Cg_endo -68.18 130.94 22.39 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.763 2.309 . . . . 0.0 112.167 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.555 ' HE3' ' O ' ' B' ' 22' ' ' VAL . 50.2 m0 -78.31 -18.86 54.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' CYS . . . . . 0.82 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 51.4 t -121.3 124.32 44.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.681 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 36.9 p90 -142.56 170.5 15.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -80.3 154.86 74.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.87 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 C--O 1.232 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.216 179.473 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.795 ' CG2' HG22 ' A' ' 8' ' ' THR . 95.0 m . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.851 0.357 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.574 ' N ' HG22 ' A' ' 6' ' ' THR . 72.5 m -143.19 -2.3 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.033 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.795 HG22 ' CG2' ' A' ' 6' ' ' THR . 9.8 t -71.91 62.26 0.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.147 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.642 HG12 ' N ' ' A' ' 10' ' ' ALA . 58.4 t -106.56 165.62 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.846 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -91.6 123.62 63.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.898 ' HB3' HG21 ' A' ' 41' ' ' VAL . 80.7 Cg_exo -44.91 -39.4 14.15 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.728 2.285 . . . . 0.0 112.395 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -66.63 -29.98 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.796 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -112.41 39.26 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.061 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.846 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 96.6 mtt180 -108.26 152.91 23.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.566 ' O ' ' O ' ' A' ' 16' ' ' ASN . 1.3 mp0 -108.24 93.79 4.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.066 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.683 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.5 t-20 -27.7 150.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.683 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 42.1 t -138.02 0.82 2.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.518 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.564 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -177.54 -139.28 3.29 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.36 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.865 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 39.7 p90 -105.71 170.93 5.33 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.867 0.365 . . . . 0.0 110.986 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.865 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 58.4 Cg_endo -71.84 -36.5 6.12 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.767 2.312 . . . . 0.0 112.415 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . -58.63 -38.98 92.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.525 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.828 HG21 ' CB ' ' A' ' 44' ' ' CYS . 34.2 m -30.34 155.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.805 0.336 . . . . 0.0 111.224 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.866 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 75.3 p -122.74 176.22 2.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.096 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.866 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 53.1 Cg_exo -52.43 -49.09 18.62 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -77.33 -42.33 37.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.708 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 78.4 mt-30 -59.43 -37.9 79.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 34' ' ' PHE . 53.9 t -72.53 -59.24 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.92 -26.87 38.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -67.98 -11.66 59.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.84 ' C ' ' HD3' ' A' ' 30' ' ' LYS . 7.8 tmtt? -100.37 -51.98 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.44 37.69 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.484 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.894 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 71.2 m -149.56 163.07 38.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.832 0.348 . . . . 0.0 111.069 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.858 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 72.6 m -76.15 155.12 34.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.695 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.72 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 77.3 t80 -122.47 136.82 54.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.663 ' CB ' HH12 ' A' ' 14' ' ' ARG . 26.6 t0 -155.72 79.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.702 ' HA ' ' CG ' ' A' ' 43' ' ' TRP . 24.5 p-10 -88.18 40.5 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.5 p -113.45 -13.9 12.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.708 HG12 HG22 ' A' ' 41' ' ' VAL . 62.7 t -113.89 104.09 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.119 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 41' ' ' VAL . 98.5 mtt180 -70.47 175.52 4.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.86 -20.19 0.4 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.397 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.898 HG21 ' HB3' ' A' ' 11' ' ' PRO . 33.0 m -119.87 163.1 29.69 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.784 0.325 . . . . 0.0 111.162 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.693 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 55.5 Cg_endo -70.08 127.29 14.14 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.696 2.264 . . . . 0.0 112.266 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.702 ' CG ' ' HA ' ' A' ' 36' ' ' ASP . 49.9 m0 -72.16 -50.21 29.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.828 ' CB ' HG21 ' A' ' 22' ' ' VAL . 47.3 t -93.81 112.27 24.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.738 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.8 ' CE1' ' HD3' ' A' ' 14' ' ' ARG . 40.0 p90 -136.44 163.72 29.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.547 ' HD2' ' CB ' ' A' ' 15' ' ' GLN . 35.2 m-85 -57.81 134.72 83.14 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.666 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.894 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 96.8 Cg_endo -80.85 -156.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.842 2.361 . . . . 0.0 112.578 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.517 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 13.1 m120 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.851 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.869 0.366 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 8' ' ' THR . . . . . 0.646 ' O ' HG23 ' B' ' 8' ' ' THR . 9.0 t -76.7 80.16 3.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.059 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.83 HG12 ' N ' ' B' ' 10' ' ' ALA . 66.6 t -129.22 177.4 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.247 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.83 ' N ' HG12 ' B' ' 9' ' ' VAL . . . -85.38 151.87 57.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.927 ' HG3' HG11 ' B' ' 38' ' ' VAL . 43.2 Cg_exo -56.36 -16.57 18.3 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.787 2.325 . . . . 0.0 112.321 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -82.92 -29.92 28.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.063 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLU . . . . . 0.755 ' HB2' ' CG1' ' B' ' 9' ' ' VAL . 45.1 mt-10 -94.8 -20.07 19.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' ARG . . . . . 0.677 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 96.5 mtt180 -63.29 94.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLN . . . . . 0.651 ' O ' ' O ' ' B' ' 16' ' ' ASN . 53.3 tt0 -79.66 98.75 7.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ASN . . . . . 0.651 ' O ' ' O ' ' B' ' 15' ' ' GLN . 43.4 t30 -23.61 149.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.257 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' CYS . . . . . 0.549 ' O ' ' HD3' ' B' ' 30' ' ' LYS . 42.6 t -141.89 4.45 1.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.535 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.96 -137.68 2.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.395 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' PHE . . . . . 1.033 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 29.1 p90 -105.32 175.42 2.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.327 . . . . 0.0 110.84 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 1.033 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 38.4 Cg_endo -67.11 -32.74 33.5 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.604 2.203 . . . . 0.0 112.482 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.733 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -93.84 5.2 72.7 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.602 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.946 HG13 ' O ' ' B' ' 19' ' ' PHE . 27.0 m -37.86 153.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 111.316 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' THR . . . . . 1.044 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 76.1 p -128.35 173.89 5.05 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.816 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 1.044 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 15.3 Cg_endo -57.46 -32.0 92.92 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.58 2.187 . . . . 0.0 112.221 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -85.14 -50.06 7.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' GLN . . . . . 0.435 ' HB2' ' H ' ' B' ' 23' ' ' THR . 52.7 mt-30 -61.01 -32.73 72.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.4 t -78.92 -55.4 5.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.787 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' B' ' 31' ' ' GLY . . . -48.35 -33.87 9.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -49.8 -29.44 7.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.424 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' LYS . . . . . 0.549 ' HD3' ' O ' ' B' ' 17' ' ' CYS . 27.9 mtpp -97.82 -13.53 21.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.544 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' B' ' 28' ' ' ALA . . . 78.27 49.47 6.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.555 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' CYS . . . . . 0.745 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 71.0 m -126.33 166.98 16.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 110.947 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 77.8 m -75.08 149.52 39.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' PHE . . . . . 0.548 ' HE1' ' O ' ' B' ' 22' ' ' VAL . 73.4 t80 -126.95 126.92 44.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.635 ' OD1' HG23 ' B' ' 38' ' ' VAL . 16.6 t70 -149.83 80.47 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.961 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ASP . . . . . 0.803 ' HA ' ' CG ' ' B' ' 43' ' ' TRP . 24.5 p-10 -72.14 4.6 3.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 72.3 p -75.3 -7.07 52.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.052 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.927 HG11 ' HG3' ' B' ' 11' ' ' PRO . 68.1 t -115.75 112.46 39.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.181 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -89.01 149.18 23.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.32 -37.3 3.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.412 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' VAL . . . . . 0.911 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.3 m -112.43 169.76 6.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.35 . . . . 0.0 111.108 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' PRO . . . . . 0.911 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 51.7 Cg_endo -69.35 121.0 7.77 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.744 2.296 . . . . 0.0 112.229 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' TRP . . . . . 0.803 ' CG ' ' HA ' ' B' ' 36' ' ' ASP . 36.7 m0 -62.13 -45.02 95.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' CYS . . . . . 0.812 ' CB ' HG21 ' B' ' 22' ' ' VAL . 51.0 t -86.31 120.91 28.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.803 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' PHE . . . . . 0.745 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 52.5 p90 -148.81 162.14 40.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' TYR . . . . . 0.452 ' O ' ' HD1' ' B' ' 45' ' ' PHE . 92.6 m-85 -68.94 155.92 92.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 C--O 1.232 0.178 0 C-N-CA 122.774 2.316 . . . . 0.0 112.179 179.848 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.827 0.346 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.35 77.44 1.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.122 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.759 ' NE2' ' H ' ' A' ' 3' ' ' GLN . 1.4 mp0 -94.91 159.16 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.0 p -149.21 151.89 35.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 47' ' ' PRO . 45.0 mt-10 -102.3 127.61 49.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.912 HG21 HG22 ' A' ' 8' ' ' THR . 86.2 m -117.58 176.85 4.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.813 ' N ' HG22 ' A' ' 6' ' ' THR . 77.1 m -123.71 -15.7 6.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.176 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.912 HG22 HG21 ' A' ' 6' ' ' THR . 10.2 t -70.88 69.28 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.794 HG22 HD22 ' A' ' 48' ' ' ASN . 60.1 t -114.89 171.81 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.154 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.834 ' C ' ' HG3' ' A' ' 14' ' ' ARG . . . -86.77 121.19 71.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.962 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.79 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 82.8 Cg_exo -45.22 -59.46 1.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.825 2.35 . . . . 0.0 112.44 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.639 ' HG3' ' HG3' ' A' ' 13' ' ' GLU . 37.9 ptt180 -46.42 -29.81 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.639 ' HG3' ' HG3' ' A' ' 12' ' ' ARG . 45.1 mt-10 -104.68 -17.83 14.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.834 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 99.4 mtt180 -51.96 139.4 22.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.758 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.52 ' O ' ' HD1' ' A' ' 46' ' ' TYR . 70.8 mm-40 -90.85 98.48 11.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.786 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.568 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.6 t-20 -41.96 143.0 0.61 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.568 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 44.1 t -145.49 3.48 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.563 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 170.16 124.02 0.72 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.39 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.822 ' O ' HG22 ' A' ' 22' ' ' VAL . 52.6 p90 -44.88 163.88 0.19 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.812 0.339 . . . . 0.0 110.768 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.666 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 36.2 Cg_endo -65.5 -43.9 9.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.289 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.14 -13.67 1.07 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 19' ' ' PHE . 27.4 m -63.52 154.35 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 111.183 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.765 ' OG1' ' HG3' ' A' ' 26' ' ' GLN . 79.4 p -101.68 160.26 27.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.099 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 62.4 Cg_exo -51.21 -35.99 54.53 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.777 2.318 . . . . 0.0 112.306 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 80.2 p -75.74 -37.26 59.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.965 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.765 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 78.6 mt-30 -67.44 -55.67 12.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -55.67 -52.7 62.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.54 -22.54 66.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.015 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.59 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 27.4 t-20 -60.69 -19.09 57.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.834 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -102.21 -26.44 13.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.46 34.61 3.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.544 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.2 m -120.64 176.17 5.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.382 . . . . 0.0 111.037 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.9 m -86.02 155.27 20.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.958 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.683 ' HE2' HG23 ' A' ' 22' ' ' VAL . 19.5 t80 -135.55 108.1 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -125.58 103.24 7.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -96.24 24.23 5.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.0 p -90.71 -31.93 16.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.202 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 41' ' ' VAL . 63.9 t -100.5 121.23 51.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -91.69 155.15 18.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.57 -42.3 2.7 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.431 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.873 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.7 m -93.65 170.04 9.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 111.101 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.873 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 45.7 Cg_endo -68.47 121.05 7.96 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.73 2.286 . . . . 0.0 112.238 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.636 ' CE3' ' O ' ' A' ' 20' ' ' PRO . 49.9 m0 -68.59 -44.73 73.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.807 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 51.3 t -97.36 118.87 34.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.712 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.667 ' CE2' ' HD3' ' A' ' 14' ' ' ARG . 51.3 p90 -147.34 157.59 43.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.959 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.52 ' HD1' ' O ' ' A' ' 15' ' ' GLN . 84.7 m-85 -63.75 157.48 66.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.94 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.603 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 57.9 Cg_endo -71.68 -161.63 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.737 2.292 . . . . 0.0 112.309 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.794 HD22 HG22 ' A' ' 9' ' ' VAL . 35.4 p30 -139.1 139.29 37.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.5 p -92.7 122.05 34.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.6 mt -137.29 149.05 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 52' ' ' VAL . 16.5 t70 -124.84 177.88 5.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.875 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.741 ' O ' HG23 ' A' ' 52' ' ' VAL . 33.3 m -138.71 84.84 17.7 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 57.8 Cg_endo -71.5 123.16 9.26 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.676 2.251 . . . . 0.0 112.341 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 13.9 Cg_exo -69.54 179.25 3.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.915 2.41 . . . . 0.0 112.11 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.756 ' O ' ' OE1' ' A' ' 56' ' ' GLU . 17.4 pt-20 -169.95 -19.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.756 ' OE1' ' O ' ' A' ' 55' ' ' GLU . 14.2 mm-40 -165.66 -29.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.673 ' N ' ' HE1' ' A' ' 60' ' ' PHE . 45.1 mt-10 -150.78 -139.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.947 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 46.2 t -137.99 0.8 2.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -94.35 29.23 2.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.819 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.673 ' HE1' ' N ' ' A' ' 57' ' ' GLU . 86.9 m-85 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' GLU . . . . . 0.61 ' O ' HG23 ' B' ' 52' ' ' VAL . 12.8 mm-40 . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.859 ' O ' ' HA ' ' B' ' 51' ' ' ASP . . . -115.48 -132.84 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.034 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.617 ' OE1' ' HB3' ' B' ' 51' ' ' ASP . 12.2 mm-40 -79.96 136.86 36.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.41 . . . . 0.0 110.855 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.955 ' OG1' ' HB ' ' B' ' 50' ' ' ILE . 64.1 p -138.34 -158.42 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.178 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.97 ' O ' HG23 ' B' ' 49' ' ' THR . 87.2 mt-10 -48.3 -174.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.365 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' THR . . . . . 1.014 ' HA ' ' OG1' ' B' ' 49' ' ' THR . 56.8 m -150.29 -178.17 6.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.485 -167.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.898 ' H ' HG22 ' B' ' 6' ' ' THR . 62.2 m -78.6 -6.41 55.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.505 176.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.679 HG22 ' HB ' ' B' ' 6' ' ' THR . 9.1 t -87.01 69.92 10.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.987 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.674 HG22 HD22 ' B' ' 48' ' ' ASN . 59.5 t -89.83 166.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.044 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.909 ' HB3' ' HB2' ' B' ' 13' ' ' GLU . . . -47.54 113.48 2.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.776 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 80.0 Cg_exo -44.83 -46.03 13.14 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.829 2.352 . . . . 0.0 112.467 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -73.96 -29.97 62.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.909 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 45.1 mt-10 -92.83 -5.47 50.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.03 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.846 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.3 mtt180 -58.98 125.66 24.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.82 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.457 ' O ' ' HD1' ' B' ' 46' ' ' TYR . 56.4 tp60 -80.29 98.29 7.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.469 ' ND2' ' H ' ' B' ' 18' ' ' GLY . 6.8 t30 -35.38 150.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.983 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' CYS . . . . . 0.435 ' O ' ' SG ' ' B' ' 17' ' ' CYS . 41.5 t -134.07 4.2 3.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.469 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . 179.88 -133.72 2.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.437 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.856 ' CE1' HG12 ' B' ' 22' ' ' VAL . 35.6 p90 -105.13 164.29 15.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.907 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.708 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 37.5 Cg_endo -66.33 -31.02 44.34 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.721 2.281 . . . . 0.0 112.304 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.61 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -82.64 -2.64 90.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.458 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.876 HG21 ' CB ' ' B' ' 44' ' ' CYS . 29.1 m -47.11 147.79 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.915 0.388 . . . . 0.0 111.295 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' THR . . . . . 1.032 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 67.1 p -123.0 175.34 2.76 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 1.032 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 10.6 Cg_endo -53.6 -43.56 56.7 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.651 2.234 . . . . 0.0 112.091 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.5 p -76.88 -46.79 23.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.698 ' HB2' ' H ' ' B' ' 23' ' ' THR . 85.2 mm-40 -57.29 -50.48 72.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 46.4 t -60.05 -57.1 14.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.728 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.01 -35.58 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.773 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.638 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 38.4 t-20 -49.94 -36.85 29.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.791 ' HZ2' ' HB3' ' B' ' 30' ' ' LYS . 2.6 mmmp? -88.14 -41.35 13.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.537 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.89 58.39 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.734 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' CYS . . . . . 0.805 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 82.6 m -140.89 174.69 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.359 . . . . 0.0 110.971 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 1.019 ' SG ' ' HG3' ' B' ' 47' ' ' PRO . 73.6 m -92.82 134.2 35.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.904 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.787 ' CZ ' ' HB3' ' B' ' 36' ' ' ASP . 59.4 t80 -91.39 153.06 20.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.122 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.437 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 32.4 t0 -170.2 79.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.834 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 25.3 p30 -90.02 30.41 1.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' THR . . . . . 0.437 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 71.5 p -83.5 -4.9 58.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.083 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 61.0 t -138.3 128.03 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.309 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.833 ' NH1' ' CZ2' ' B' ' 43' ' ' TRP . 22.1 mmm180 -80.92 -178.58 6.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.53 -32.44 0.22 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.563 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.557 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.2 m -104.29 158.95 30.86 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.883 0.373 . . . . 0.0 111.068 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 55.3 Cg_endo -69.9 136.78 33.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.733 2.288 . . . . 0.0 112.277 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.834 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 48.7 m0 -79.73 -32.43 41.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' CYS . . . . . 0.876 ' CB ' HG21 ' B' ' 22' ' ' VAL . 50.6 t -95.01 115.25 27.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.522 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.805 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 6.0 p90 -145.73 172.98 12.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.816 -176.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' B' ' 15' ' ' GLN . 92.7 m-85 -85.33 133.71 41.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.621 176.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 1.019 ' HG3' ' SG ' ' B' ' 33' ' ' CYS . 56.2 Cg_endo -93.18 177.5 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.343 2.695 . . . . 0.0 112.629 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.776 ' OD1' ' O ' ' B' ' 6' ' ' THR . 26.4 p30 -150.24 78.52 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.004 0.43 . . . . 0.0 110.831 171.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' THR . . . . . 1.014 ' OG1' ' HA ' ' B' ' 6' ' ' THR . 1.2 m -120.69 125.03 46.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.27 176.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.955 ' HB ' ' OG1' ' B' ' 4' ' ' THR . 5.3 mt -126.37 129.67 71.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.851 0.358 . . . . 0.0 111.099 -173.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.859 ' HA ' ' O ' ' B' ' 2' ' ' ALA . 24.7 p-10 -164.96 167.27 18.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -177.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.932 ' N ' ' HD2' ' B' ' 53' ' ' PRO . 64.2 t -108.07 -11.05 0.12 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.372 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' PRO . . . . . 1.024 ' HB2' ' HD2' ' B' ' 54' ' ' PRO . 50.4 Cg_endo -69.8 -169.17 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.782 2.322 . . . . 0.0 112.29 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 1.024 ' HD2' ' HB2' ' B' ' 53' ' ' PRO . 51.2 Cg_endo -69.54 170.13 17.03 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.655 2.237 . . . . 0.0 112.311 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -112.0 37.5 2.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.168 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.59 ' O ' ' OE2' ' B' ' 57' ' ' GLU . 62.8 tt0 -169.98 126.65 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.747 ' O ' ' SG ' ' B' ' 58' ' ' CYS . 12.7 mm-40 -132.56 -123.45 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' CYS . . . . . 0.747 ' SG ' ' O ' ' B' ' 57' ' ' GLU . 77.7 m -167.06 143.05 4.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.022 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -149.16 71.75 1.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.82 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.898 -179.938 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.425 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.1 -128.51 0.26 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.849 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 1.2 mp0 -85.23 179.12 7.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.5 p -142.08 130.11 21.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.722 ' HG2' ' OG1' ' A' ' 49' ' ' THR . 44.8 mt-10 -97.54 148.88 22.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.041 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.962 HG22 ' H ' ' A' ' 8' ' ' THR . 86.1 m -139.38 176.66 8.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.011 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.808 ' N ' HG22 ' A' ' 6' ' ' THR . 71.4 m -133.93 -2.0 2.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.266 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.962 ' H ' HG22 ' A' ' 6' ' ' THR . 9.6 t -75.69 75.2 2.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.137 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.743 HG11 ' HA ' ' A' ' 14' ' ' ARG . 62.1 t -116.4 161.67 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.89 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -81.33 132.15 56.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.943 ' HB3' HG21 ' A' ' 41' ' ' VAL . 85.5 Cg_exo -40.62 -32.1 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.823 2.349 . . . . 0.0 112.507 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -90.04 -29.74 18.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 10' ' ' ALA . 81.6 mm-40 -92.43 -6.0 50.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.001 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.89 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.4 mtt180 -69.37 118.04 11.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.614 ' O ' ' O ' ' A' ' 16' ' ' ASN . 57.5 tp60 -79.96 93.12 5.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.696 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 42.8 t30 -24.98 148.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.77 ' HB2' ' N ' ' A' ' 46' ' ' TYR . 50.5 t -143.68 3.0 1.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.116 0.484 . . . . 0.0 110.188 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -156.55 -142.85 3.51 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.113 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.929 ' CZ ' ' HA ' ' A' ' 22' ' ' VAL . 27.4 p90 -105.75 168.91 7.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.793 0.33 . . . . 0.0 111.064 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.833 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 40.7 Cg_endo -67.78 -20.08 46.35 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.258 . . . . 0.0 112.436 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.716 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -102.64 4.96 50.79 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.545 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.929 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 27.7 m -39.9 163.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.008 0.433 . . . . 0.0 111.39 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.012 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 76.4 p -143.94 175.75 2.65 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.762 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.012 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 17.2 Cg_endo -57.74 -35.46 98.79 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.654 2.236 . . . . 0.0 112.196 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 29' ' ' ASN . 51.2 m -89.41 -41.26 12.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.056 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.517 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 52.7 mt-30 -69.06 -29.86 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.039 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.951 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.8 t -93.85 -36.58 12.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.921 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -79.25 -12.15 59.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 25' ' ' SER . 43.2 t30 -91.75 -16.97 26.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -101.34 -33.2 10.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.939 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.54 43.7 0.63 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.951 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 76.1 m -126.94 161.89 27.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.932 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.76 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 77.1 m -85.83 134.77 33.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.644 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.526 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 50.1 t80 -113.59 122.04 46.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.882 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.661 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 16.5 t70 -145.81 99.08 3.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -91.74 54.71 2.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.901 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.478 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 74.3 p -94.99 -31.88 13.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 41' ' ' VAL . 63.3 t -133.97 120.92 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.229 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.577 ' C ' ' H ' ' A' ' 41' ' ' VAL . 35.3 ptt180 -73.47 -175.61 2.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.83 -28.84 0.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.434 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.943 HG21 ' HB3' ' A' ' 11' ' ' PRO . 33.9 m -101.23 166.71 11.88 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.0 111.156 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 60.1 Cg_endo -72.5 120.01 6.47 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.826 2.35 . . . . 0.0 112.225 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.461 ' HE1' ' HA ' ' A' ' 39' ' ' ARG . 51.8 m0 -78.21 -34.07 49.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.898 ' CB ' HG21 ' A' ' 22' ' ' VAL . 51.3 t -101.77 110.29 22.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.789 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.76 ' CE1' ' HD3' ' A' ' 14' ' ' ARG . 51.7 p90 -134.04 175.83 9.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.77 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 92.4 m-85 -76.0 154.14 84.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.857 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' THR . 57.4 Cg_endo -71.35 -156.78 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.694 2.263 . . . . 0.0 112.431 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.719 ' H ' ' H ' ' A' ' 6' ' ' THR . 12.8 m120 -138.81 89.13 2.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.722 ' OG1' ' HG2' ' A' ' 5' ' ' GLU . 88.6 m -80.3 88.96 5.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.9 mt -99.56 150.62 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.948 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.849 ' HB2' ' HG3' ' A' ' 3' ' ' GLN . 16.4 t70 -164.3 112.46 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.155 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.031 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 64.1 t -117.32 2.63 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.475 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 1.031 ' HD3' ' N ' ' A' ' 52' ' ' VAL . 13.0 Cg_exo -69.52 167.35 24.38 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.659 2.239 . . . . 0.0 112.231 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.53 ' HG2' ' H ' ' A' ' 55' ' ' GLU . 74.4 Cg_endo -74.8 -84.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.806 2.337 . . . . 0.0 112.387 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.812 ' HG2' ' H ' ' A' ' 56' ' ' GLU . 62.6 tt0 -157.63 -177.16 6.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.849 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.812 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 17.0 pt-20 -82.2 -164.46 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.875 ' HG2' ' H ' ' A' ' 58' ' ' CYS . 62.7 tt0 -101.75 -123.5 0.18 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.875 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 52.8 t -114.39 -70.31 0.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.831 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -95.36 -110.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.698 ' OXT' ' CD2' ' A' ' 60' ' ' PHE . 51.3 p90 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.905 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' B' ' 1' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.763 0.316 . . . . 0.0 110.914 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.75 -152.25 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.669 ' HG2' ' HB3' ' B' ' 51' ' ' ASP . 52.7 mt-30 -142.63 150.21 39.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 75.1 p -143.36 151.27 40.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.647 ' HB3' ' HB2' ' B' ' 47' ' ' PRO . 87.1 mt-10 -91.16 156.08 18.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.779 ' HB ' ' OD1' ' B' ' 48' ' ' ASN . 92.5 m -146.25 167.89 22.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.676 ' N ' HG22 ' B' ' 6' ' ' THR . 86.0 m -129.48 40.41 3.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.748 HG22 ' CG2' ' B' ' 6' ' ' THR . 9.8 t -117.73 49.19 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.106 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.69 HG12 ' N ' ' B' ' 10' ' ' ALA . 61.3 t -103.9 168.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.112 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.882 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -74.45 121.09 84.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.038 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.774 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 87.8 Cg_exo -46.17 -24.77 2.6 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.807 2.338 . . . . 0.0 112.542 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.64 ' HG3' ' HG2' ' B' ' 13' ' ' GLU . 13.8 ptp180 -87.69 -29.96 20.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.64 ' HG2' ' HG3' ' B' ' 12' ' ' ARG . 6.3 mm-40 -108.3 34.61 3.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.015 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.882 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.1 mtt180 -95.49 149.35 21.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.758 ' HB2' ' HB2' ' B' ' 46' ' ' TYR . 17.1 mp0 -82.11 95.23 7.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.61 ' O ' ' CE2' ' B' ' 46' ' ' TYR . 7.0 t30 -41.91 131.95 3.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' CYS . . . . . 0.663 ' HB2' ' CD2' ' B' ' 46' ' ' TYR . 44.3 t -145.82 3.99 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.792 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.59 123.02 0.65 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.504 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.752 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 52.5 p90 -45.02 166.71 0.12 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 120.835 0.35 . . . . 0.0 110.94 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.752 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 44.3 Cg_endo -68.28 -29.52 32.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.759 2.306 . . . . 0.0 112.323 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.705 ' H ' ' HD2' ' B' ' 19' ' ' PHE . . . -61.33 -10.65 23.27 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.449 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.697 HG22 ' O ' ' B' ' 19' ' ' PHE . 33.1 m -66.5 165.97 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.76 0.314 . . . . 0.0 111.159 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.834 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 72.8 p -126.29 175.03 3.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.834 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 56.8 Cg_exo -51.75 -44.19 46.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.722 2.281 . . . . 0.0 112.297 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 54.6 m -74.89 -47.74 28.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.619 ' HB2' ' H ' ' B' ' 23' ' ' THR . 52.9 mt-30 -54.62 -46.56 73.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.894 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' B' ' 30' ' ' LYS . 42.6 t -65.32 -67.21 0.46 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.804 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.07 -42.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.805 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 7.0 t30 -50.18 -37.17 33.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.574 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' B' ' 27' ' ' CYS . 34.5 mmtp -84.02 -37.37 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.595 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.34 59.88 0.83 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.635 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' CYS . . . . . 0.407 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 74.1 m -150.2 170.38 19.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 110.939 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.848 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.5 m -66.71 150.15 49.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.816 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -128.03 120.08 26.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.789 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' B' ' 43' ' ' TRP . 26.4 t0 -134.96 98.17 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.746 ' HA ' ' CD2' ' B' ' 43' ' ' TRP . 24.5 p-10 -96.81 46.16 1.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 74.9 p -119.77 -39.93 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.106 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.793 HG12 HG22 ' B' ' 41' ' ' VAL . 59.5 t -90.02 139.27 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.152 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.637 ' NH1' ' HZ2' ' B' ' 43' ' ' TRP . 38.6 mmt180 -94.41 162.31 13.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.43 -47.71 1.15 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.793 HG22 HG12 ' B' ' 38' ' ' VAL . 32.8 m -77.12 151.43 81.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.46 120.03 6.91 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.705 2.27 . . . . 0.0 112.259 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.746 ' CD2' ' HA ' ' B' ' 36' ' ' ASP . 35.5 m0 -64.06 -46.39 84.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.878 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' CYS . . . . . 0.848 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 44.2 t -96.0 104.09 16.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.717 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.821 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 44.8 p90 -131.91 150.09 52.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.046 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.758 ' HB2' ' HB2' ' B' ' 15' ' ' GLN . 92.3 m-85 -54.08 144.72 37.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.647 ' HB2' ' HB3' ' B' ' 5' ' ' GLU . 58.2 Cg_endo -71.67 -173.71 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.707 2.271 . . . . 0.0 112.311 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.779 ' OD1' ' HB ' ' B' ' 6' ' ' THR . 34.5 p30 -122.73 131.51 53.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 70.1 p -94.76 125.13 39.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.107 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.506 HG22 ' N ' ' B' ' 51' ' ' ASP . 62.4 mt -131.61 158.41 43.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.669 ' HB3' ' HG2' ' B' ' 3' ' ' GLN . 24.9 p30 -152.67 178.23 9.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.69 110.22 59.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.048 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.7 111.34 2.77 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.874 2.383 . . . . 0.0 112.131 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.861 ' HG3' ' HB3' ' B' ' 58' ' ' CYS . 55.5 Cg_endo -70.01 -135.77 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.671 2.247 . . . . 0.0 112.251 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' GLU . . . . . 0.468 ' H ' ' HB2' ' B' ' 54' ' ' PRO . 17.4 pt-20 -150.32 -43.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.951 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.921 ' HG3' ' H ' ' B' ' 57' ' ' GLU . 22.8 pt-20 -121.7 -69.76 0.82 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.051 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.921 ' H ' ' HG3' ' B' ' 56' ' ' GLU . 45.1 mt-10 -115.02 113.29 23.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.946 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' CYS . . . . . 0.861 ' HB3' ' HG3' ' B' ' 54' ' ' PRO . 28.9 p -83.23 43.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.557 ' OE1' ' N ' ' B' ' 60' ' ' PHE . 0.0 OUTLIER -160.3 111.63 1.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.913 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.61 ' CE2' ' O ' ' B' ' 57' ' ' GLU . 93.8 m-85 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.81 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.661 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 86.9 mt-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.783 0.325 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.426 ' N ' ' OE1' ' A' ' 3' ' ' GLN . . . -107.68 70.76 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.153 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.736 ' HG3' ' CB ' ' A' ' 51' ' ' ASP . 1.2 mp0 -86.64 106.16 17.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.875 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.0 p -154.3 146.34 23.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.13 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.585 ' HG2' ' OG1' ' A' ' 49' ' ' THR . 85.0 mt-10 -93.93 133.63 37.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.744 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.892 ' HB ' ' HB2' ' A' ' 48' ' ' ASN . 96.4 m -107.89 152.91 23.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.168 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' N ' HG22 ' A' ' 6' ' ' THR . 72.0 m -133.83 6.55 3.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.779 HG22 ' CG2' ' A' ' 6' ' ' THR . 9.1 t -89.43 66.71 7.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.181 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.743 HG12 ' N ' ' A' ' 10' ' ' ALA . 61.4 t -97.19 171.44 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.833 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -88.52 112.59 51.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.072 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.82 ' HB3' HG21 ' A' ' 41' ' ' VAL . 83.7 Cg_exo -44.03 -20.02 0.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.795 2.33 . . . . 0.0 112.486 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 10' ' ' ALA . 37.6 mmt180 -90.11 -30.01 17.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 10' ' ' ALA . 44.5 mt-10 -108.12 -4.37 17.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.069 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.833 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.4 mtt180 -54.26 134.26 44.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.648 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 10.1 mm-40 -93.02 79.94 4.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.818 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.633 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 51.6 t30 -27.63 150.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.831 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 41.3 t -125.26 8.18 7.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 110.567 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.631 ' O ' ' ND2' ' A' ' 16' ' ' ASN . . . -170.27 -132.39 1.46 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.216 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.938 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 30.8 p90 -105.76 173.77 3.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.798 0.333 . . . . 0.0 110.888 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.938 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 42.5 Cg_endo -68.15 -29.38 33.1 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.684 2.256 . . . . 0.0 112.457 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.657 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -89.28 -8.61 68.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.527 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.876 HG21 ' CB ' ' A' ' 44' ' ' CYS . 34.8 m -31.56 154.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.869 0.366 . . . . 0.0 111.327 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.013 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 74.5 p -123.99 172.72 5.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.134 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 1.013 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 28.1 Cg_endo -62.68 -33.08 78.29 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.756 2.304 . . . . 0.0 112.266 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.9 p -86.2 -38.0 18.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.672 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 96.4 mt-30 -69.9 -41.73 74.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.91 -45.89 39.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.792 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -33.07 70.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.058 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.612 ' OD1' ' O ' ' A' ' 29' ' ' ASN . 38.9 t-20 -53.21 -20.67 4.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.817 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.76 -28.51 14.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.52 18.69 9.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.432 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.93 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 70.8 m -102.38 179.62 4.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 0.0 111.036 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.751 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 78.9 m -93.79 155.06 17.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.786 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.551 ' HE2' ' OD2' ' A' ' 36' ' ' ASP . 73.7 t80 -134.24 127.19 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.427 ' OD1' ' OG1' ' A' ' 37' ' ' THR . 26.6 t0 -137.27 92.32 2.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.551 ' OD2' ' HE2' ' A' ' 34' ' ' PHE . 4.6 p30 -89.62 38.02 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.427 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 76.8 p -109.33 -10.46 14.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.596 HG12 HG22 ' A' ' 41' ' ' VAL . 62.6 t -117.61 104.61 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.164 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.734 ' HD2' ' N ' ' A' ' 39' ' ' ARG . 4.3 mpt_? -73.8 155.02 39.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.93 -49.44 1.98 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.438 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.928 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.1 m -92.4 170.55 8.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.753 0.311 . . . . 0.0 111.087 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.928 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 43.9 Cg_endo -68.1 145.64 67.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.604 2.203 . . . . 0.0 112.245 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -89.76 -30.98 17.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.898 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.876 ' CB ' HG21 ' A' ' 22' ' ' VAL . 43.1 t -97.38 128.03 43.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.692 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.751 ' CE2' ' HB2' ' A' ' 33' ' ' CYS . 48.6 p90 -146.12 157.72 43.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.904 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.648 ' CD2' ' O ' ' A' ' 15' ' ' GLN . 83.1 m-85 -70.26 135.63 86.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.93 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 58.3 Cg_endo -72.0 172.81 13.9 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.29 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.892 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 17.5 m120 -120.56 87.62 2.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.585 ' OG1' ' HG2' ' A' ' 5' ' ' GLU . 91.8 m -85.01 102.44 13.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.058 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.9 mt -104.49 138.89 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.093 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.736 ' CB ' ' HG3' ' A' ' 3' ' ' GLN . 24.7 p-10 -165.1 158.66 16.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.899 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.775 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 33.0 m -156.71 30.51 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.775 ' CD ' ' N ' ' A' ' 52' ' ' VAL . 58.6 Cg_endo -72.01 125.97 11.42 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.751 2.3 . . . . 0.0 112.377 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.18 135.59 29.84 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.784 2.323 . . . . 0.0 112.286 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.698 ' OE1' ' HB2' ' A' ' 58' ' ' CYS . 62.1 mt-10 -93.14 -157.41 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.404 ' H ' ' H ' ' A' ' 57' ' ' GLU . 22.8 pt-20 -165.5 -20.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.589 ' HG3' ' O ' ' A' ' 57' ' ' GLU . 17.3 pt-20 -152.21 94.16 1.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.698 ' HB2' ' OE1' ' A' ' 55' ' ' GLU . 52.3 t -139.65 -15.87 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.546 ' OE2' ' CB ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -145.08 16.66 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.546 ' CB ' ' OE2' ' A' ' 59' ' ' GLU . 63.5 t80 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.819 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' GLU . . . . . 0.825 ' HB3' ' NE2' ' B' ' 3' ' ' GLN . 12.6 mm-40 . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.658 ' N ' ' OE1' ' B' ' 3' ' ' GLN . . . -96.62 37.24 1.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.086 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.946 ' N ' ' OE1' ' B' ' 3' ' ' GLN . 4.6 mp0 -90.14 176.77 6.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.447 ' N ' ' O ' ' B' ' 50' ' ' ILE . 73.4 p -142.22 134.72 28.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.079 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -97.96 134.8 40.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.992 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.736 HG22 ' N ' ' B' ' 7' ' ' CYS . 94.0 m -150.0 170.99 17.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.736 ' N ' HG22 ' B' ' 6' ' ' THR . 74.7 m -103.01 25.0 9.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.44 ' O ' HG23 ' B' ' 8' ' ' THR . 8.8 t -97.77 55.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.992 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.785 HG22 ' HB3' ' B' ' 48' ' ' ASN . 59.9 t -98.95 165.77 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.251 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.87 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -95.24 132.21 28.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.051 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.778 ' HB3' HG21 ' B' ' 41' ' ' VAL . 88.6 Cg_exo -43.84 -29.38 2.46 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.791 2.327 . . . . 0.0 112.49 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -86.71 -29.82 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.859 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' B' ' 10' ' ' ALA . 61.7 mt-10 -94.92 -11.52 28.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.989 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.87 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -61.89 127.14 29.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.971 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 57.1 tp60 -92.89 99.74 12.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' B' ' 15' ' ' GLN . 6.8 t30 -33.8 150.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.016 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' CYS . . . . . 0.431 ' SG ' ' O ' ' B' ' 17' ' ' CYS . 43.3 t -138.02 4.65 2.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.696 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.14 -136.85 2.12 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.379 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.831 ' CZ ' ' HA ' ' B' ' 22' ' ' VAL . 27.5 p90 -105.44 168.9 7.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 0.0 110.99 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.821 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 54.0 Cg_endo -70.13 -12.66 32.6 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.748 2.299 . . . . 0.0 112.408 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.744 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -107.85 5.6 34.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.508 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.831 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 34.0 m -47.94 158.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.166 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.912 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 79.8 p -133.77 178.83 1.58 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.068 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.912 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 56.8 Cg_exo -51.75 -54.79 4.72 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.7 m -72.89 -43.0 63.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.715 ' HB2' ' H ' ' B' ' 23' ' ' THR . 96.4 mt-30 -57.66 -38.83 75.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.941 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 46.3 t -72.92 -60.58 2.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.81 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.11 -34.75 1.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.973 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -50.02 -35.08 23.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.674 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -93.84 -32.41 13.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.708 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.92 58.35 0.84 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.616 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' CYS . . . . . 0.678 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 76.8 m -143.07 165.0 28.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.958 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.69 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 73.4 m -70.98 155.11 41.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.89 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.613 ' CE1' ' HA ' ' B' ' 23' ' ' THR . 67.8 t80 -132.32 119.16 20.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.6 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 16.6 t70 -130.1 96.58 4.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.749 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 4.6 p-10 -94.78 46.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 74.9 p -113.73 -31.99 6.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.518 HG12 HG22 ' B' ' 41' ' ' VAL . 63.5 t -107.87 111.43 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.162 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.667 ' NH1' ' HZ2' ' B' ' 43' ' ' TRP . 21.8 mmm180 -68.41 178.21 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.46 -54.82 0.9 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.475 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.778 HG21 ' HB3' ' B' ' 11' ' ' PRO . 33.2 m -82.22 156.32 69.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.814 0.34 . . . . 0.0 111.125 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 47.3 Cg_endo -68.7 140.35 46.61 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.662 2.241 . . . . 0.0 112.317 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.749 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 12.9 m0 -81.56 -47.51 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' CYS . . . . . 0.703 ' CB ' HG21 ' B' ' 22' ' ' VAL . 50.6 t -87.71 119.61 28.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.757 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.761 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 51.3 p90 -152.18 171.29 18.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.504 ' O ' ' HD2' ' B' ' 45' ' ' PHE . 84.9 m-85 -75.62 156.57 84.88 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.848 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 46' ' ' TYR . 54.7 Cg_endo -69.95 -172.42 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.791 2.327 . . . . 0.0 112.305 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.785 ' HB3' HG22 ' B' ' 9' ' ' VAL . 8.2 p30 -123.48 104.09 8.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 76.4 p -67.66 80.54 0.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.067 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.615 HG13 ' OD1' ' B' ' 48' ' ' ASN . 63.1 mt -86.66 152.5 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.737 ' OD2' ' HG3' ' B' ' 3' ' ' GLN . 10.0 m-20 -109.78 134.09 52.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.902 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.908 ' N ' ' CD ' ' B' ' 53' ' ' PRO . 64.3 t -111.91 -11.56 0.11 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.382 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' PRO . . . . . 0.908 ' CD ' ' N ' ' B' ' 52' ' ' VAL . 56.3 Cg_endo -70.74 99.43 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.66 2.24 . . . . 0.0 112.337 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.774 ' HD3' ' O ' ' B' ' 52' ' ' VAL . 13.4 Cg_exo -69.65 -47.63 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.851 2.367 . . . . 0.0 112.134 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' GLU . . . . . 0.791 ' HG2' ' H ' ' B' ' 56' ' ' GLU . 41.5 tt0 -150.49 -177.86 6.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.791 ' H ' ' HG2' ' B' ' 55' ' ' GLU . 17.4 pt-20 -73.89 -42.5 60.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' B' ' 57' ' ' GLU . 17.4 pt-20 -114.97 60.81 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.926 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' CYS . . . . . 0.552 ' SG ' ' OE1' ' A' ' 55' ' ' GLU . 51.8 t -165.57 32.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -110.86 161.8 15.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.911 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.842 0.353 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.62 91.46 3.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.047 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.719 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 47.9 mt-30 -140.69 135.2 31.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 3' ' ' GLN . 71.2 p -163.12 176.43 10.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.189 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.941 ' HB3' ' HB2' ' A' ' 47' ' ' PRO . 87.4 mt-10 -81.95 143.47 31.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.845 HG22 ' N ' ' A' ' 7' ' ' CYS . 93.4 m -134.74 178.42 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.845 ' N ' HG22 ' A' ' 6' ' ' THR . 71.7 m -108.69 12.72 25.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.673 HG23 HD11 ' A' ' 50' ' ' ILE . 8.8 t -100.3 63.58 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.149 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.786 HG23 ' ND2' ' A' ' 48' ' ' ASN . 62.5 t -94.0 164.06 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.175 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.887 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -85.88 139.56 35.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.021 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.874 ' HG3' HG21 ' A' ' 38' ' ' VAL . 93.1 Cg_exo -42.07 -36.87 4.16 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.83 2.353 . . . . 0.0 112.481 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 1.065 ' HD3' ' N ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -90.23 -29.36 18.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.758 178.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 1.065 ' N ' ' HD3' ' A' ' 12' ' ' ARG . 85.4 mt-10 -80.85 -12.96 59.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.985 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.887 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 97.6 mtt180 -71.7 113.57 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.073 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.668 ' O ' ' O ' ' A' ' 16' ' ' ASN . 57.1 tp60 -80.58 95.5 6.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.668 ' O ' ' O ' ' A' ' 15' ' ' GLN . 6.8 t30 -23.48 150.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.022 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 41.0 t -141.7 4.8 1.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.485 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.1 -139.58 4.86 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.388 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.849 ' CE2' ' N ' ' A' ' 22' ' ' VAL . 40.3 p90 -105.62 167.41 9.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.799 0.333 . . . . 0.0 110.83 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.806 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 38.5 Cg_endo -66.86 -41.91 9.56 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.61 2.207 . . . . 0.0 112.304 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . -61.9 -26.64 67.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.544 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.909 HG21 ' HB2' ' A' ' 44' ' ' CYS . 34.7 m -31.58 156.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 111.211 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.778 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 80.4 p -124.69 173.46 4.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.743 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 45.0 Cg_exo -56.27 -44.82 42.76 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.731 2.287 . . . . 0.0 112.308 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.562 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 80.1 p -75.73 -39.44 57.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.046 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.63 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 52.4 mt-30 -67.54 -38.1 83.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.1 t -82.23 -51.82 7.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.96 75.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 25' ' ' SER . 42.9 t30 -54.66 -16.76 2.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -100.47 -22.6 14.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 -28.73 5.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.585 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.659 ' HB3' ' O ' ' A' ' 45' ' ' PHE . 71.6 m -68.86 179.74 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.882 0.372 . . . . 0.0 111.068 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.3 m -107.22 155.24 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.003 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.778 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 15.5 t80 -115.31 134.15 55.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.484 ' OD1' ' NH1' ' A' ' 14' ' ' ARG . 17.4 t70 -158.77 99.26 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.794 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.4 p-10 -96.68 32.54 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.415 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 72.6 p -91.21 -6.68 53.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.874 HG21 ' HG3' ' A' ' 11' ' ' PRO . 61.6 t -132.66 114.91 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.728 ' HD3' ' N ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -78.44 -175.79 4.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.01 -35.19 0.29 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.548 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.733 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.1 m -107.38 164.82 13.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.733 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 59.5 Cg_endo -72.34 127.15 12.31 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.698 2.265 . . . . 0.0 112.282 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.794 ' CD1' ' HA ' ' A' ' 36' ' ' ASP . 35.0 m0 -68.2 -33.72 74.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.861 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.909 ' HB2' HG21 ' A' ' 22' ' ' VAL . 53.4 t -91.31 120.27 32.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.659 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 39.5 p90 -147.36 160.09 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.694 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 86.5 m-85 -67.89 165.0 35.48 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.941 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 39.8 Cg_endo -67.03 172.02 10.43 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.663 2.242 . . . . 0.0 112.306 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.786 ' ND2' HG23 ' A' ' 9' ' ' VAL . 8.2 p30 -136.67 118.82 15.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 92.7 m -71.56 93.03 1.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.677 HG13 ' OD1' ' A' ' 48' ' ' ASN . 63.1 mt -89.45 155.25 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.286 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.719 ' CB ' ' HG2' ' A' ' 3' ' ' GLN . 24.4 p-10 -145.98 -172.73 3.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.714 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 33.2 m -82.44 130.19 60.09 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 1.073 ' HD2' ' HD3' ' A' ' 54' ' ' PRO . 16.8 Cg_exo -68.46 -27.75 33.12 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 122.879 2.386 . . . . 0.0 112.598 -178.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 1.073 ' HD3' ' HD2' ' A' ' 53' ' ' PRO . 12.7 Cg_exo -69.51 -6.48 18.58 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.738 2.292 . . . . 0.0 112.158 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.621 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 10.4 tp10 -98.51 49.55 0.98 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.95 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.78 ' HG2' ' O ' ' A' ' 53' ' ' PRO . 12.6 mm-40 -103.56 118.4 36.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' OE2' ' C ' ' A' ' 60' ' ' PHE . 12.5 pt-20 -76.92 -177.43 4.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.939 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.582 ' O ' ' SG ' ' B' ' 58' ' ' CYS . 50.3 t -144.49 -4.2 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.524 ' O ' ' CG ' ' A' ' 60' ' ' PHE . 21.4 mp0 -81.82 -72.7 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.935 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 59' ' ' GLU . 84.9 m-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.867 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' GLU . . . . . 0.425 ' N ' ' CD ' ' B' ' 1' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.894 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.45 -129.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.847 ' HB3' HG22 ' B' ' 49' ' ' THR . 51.9 mt-30 -124.12 165.82 16.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.704 ' O ' ' HA ' ' B' ' 49' ' ' THR . 74.8 p -139.77 148.15 41.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.175 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.809 ' HA ' ' O ' ' B' ' 48' ' ' ASN . 0.5 OUTLIER -105.33 152.76 22.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.938 HG22 ' H ' ' B' ' 8' ' ' THR . 87.0 m -146.63 166.83 25.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.655 ' N ' HG22 ' B' ' 6' ' ' THR . 72.8 m -109.29 9.23 25.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.107 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.938 ' H ' HG22 ' B' ' 6' ' ' THR . 9.5 t -82.13 73.24 9.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.821 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.952 HG11 ' HA ' ' B' ' 14' ' ' ARG . 50.1 t -107.19 166.42 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.375 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.838 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -94.21 122.61 61.15 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.92 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.786 ' HB3' HG11 ' B' ' 41' ' ' VAL . 98.9 Cg_exo -42.56 -26.96 0.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.864 2.376 . . . . 0.0 112.523 -178.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.584 ' HG3' ' HG2' ' B' ' 13' ' ' GLU . 16.7 ptm180 -90.05 -29.87 18.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.973 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.584 ' HG2' ' HG3' ' B' ' 12' ' ' ARG . 81.6 mm-40 -99.96 -11.73 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.177 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.952 ' HA ' HG11 ' B' ' 9' ' ' VAL . 96.7 mtt180 -51.54 127.19 19.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.873 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.603 ' O ' ' HD1' ' B' ' 46' ' ' TYR . 7.3 tp60 -79.91 86.84 5.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.792 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' B' ' 15' ' ' GLN . 6.9 t30 -30.01 133.67 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.105 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' CYS . . . . . 0.782 ' SG ' ' HD2' ' B' ' 30' ' ' LYS . 41.6 t -145.53 2.74 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.616 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' B' ' 44' ' ' CYS . . . 177.54 122.39 0.73 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.428 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.954 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 53.1 p90 -44.83 172.86 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.804 0.335 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.954 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 33.8 Cg_endo -64.61 -60.72 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.76 2.306 . . . . 0.0 112.226 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -39.3 -17.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.533 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.745 HG22 ' O ' ' B' ' 19' ' ' PHE . 32.1 m -52.13 158.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 111.138 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.825 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 74.5 p -135.27 173.99 5.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.825 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 54.5 Cg_exo -51.84 -42.63 56.54 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.779 2.319 . . . . 0.0 112.321 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.2 m -72.69 -48.61 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.982 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.563 ' O ' ' HB3' ' B' ' 29' ' ' ASN . 78.4 mt-30 -60.57 -54.4 45.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.3 t -54.27 -55.59 26.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.734 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.35 -40.21 11.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.957 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.563 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 38.3 t-20 -49.97 -41.51 46.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.782 ' HD2' ' SG ' ' B' ' 17' ' ' CYS . 39.6 ttmt -82.22 -36.22 27.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.55 63.57 0.86 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.704 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' CYS . . . . . 0.765 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 93.1 m -149.99 178.56 8.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 0.0 111.019 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.811 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 72.2 m -79.02 155.2 28.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.02 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.736 ' CE2' ' HA ' ' B' ' 23' ' ' THR . 42.6 t80 -123.4 111.06 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.663 ' O ' ' HA ' ' B' ' 43' ' ' TRP . 32.7 t0 -135.91 108.38 7.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.835 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 4.6 p-10 -111.9 31.28 6.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 81.1 p -84.09 -24.86 30.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.518 ' HB ' ' CG2' ' B' ' 41' ' ' VAL . 62.4 t -111.6 135.34 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.176 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -85.95 152.24 23.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.31 -43.6 3.16 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.542 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' B' ' 11' ' ' PRO . 32.8 m -81.59 154.58 71.2 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.905 0.383 . . . . 0.0 111.148 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 50.0 Cg_endo -69.21 136.84 35.55 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.783 2.322 . . . . 0.0 112.313 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.835 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 51.0 m0 -84.58 -54.37 4.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.002 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' CYS . . . . . 0.811 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 53.8 t -83.19 100.0 10.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.76 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.765 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 44.3 p90 -128.37 167.56 16.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.097 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.617 ' CD1' ' HB2' ' B' ' 17' ' ' CYS . 90.7 m-85 -74.46 147.46 84.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.547 ' HB2' ' HB3' ' B' ' 5' ' ' GLU . 65.5 Cg_endo -74.01 -172.23 1.07 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.758 2.305 . . . . 0.0 112.335 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.847 ' OD1' HG22 ' B' ' 9' ' ' VAL . 17.1 m120 -134.17 122.72 23.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.987 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.847 HG22 ' HB3' ' B' ' 3' ' ' GLN . 92.9 m -93.13 99.03 11.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.199 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.734 HG22 ' N ' ' B' ' 51' ' ' ASP . 62.4 mt -104.37 170.07 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.131 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.734 ' N ' HG22 ' B' ' 50' ' ' ILE . 10.1 m-20 -106.18 160.06 15.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.73 HG23 ' O ' ' B' ' 52' ' ' VAL . 33.3 m -158.46 76.0 3.54 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.094 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' B' ' 54' ' ' PRO . 56.5 Cg_endo -70.99 114.06 3.78 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.728 2.285 . . . . 0.0 112.354 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' ' 53' ' ' PRO . 13.4 Cg_exo -69.57 88.87 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.917 2.411 . . . . 0.0 112.103 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' GLU . . . . . 0.765 ' HG2' ' N ' ' B' ' 56' ' ' GLU . 64.1 tt0 -104.56 -119.56 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.932 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.765 ' N ' ' HG2' ' B' ' 55' ' ' GLU . 12.5 mm-40 -83.89 -38.27 21.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.795 ' HG3' ' H ' ' B' ' 58' ' ' CYS . 10.3 tp10 -125.35 -121.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.956 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' CYS . . . . . 0.795 ' H ' ' HG3' ' B' ' 57' ' ' GLU . 26.7 p -123.72 -78.8 0.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.919 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.599 ' N ' ' SG ' ' B' ' 58' ' ' CYS . 12.5 pt-20 -139.79 -176.59 4.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.876 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.612 ' OE1' ' OE1' ' A' ' 3' ' ' GLN . 17.4 pt-20 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.811 0.339 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.428 ' HB1' HG22 ' A' ' 52' ' ' VAL . . . -164.13 79.14 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.151 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.733 ' HG2' ' OD1' ' A' ' 51' ' ' ASP . 52.3 mt-30 -118.72 168.06 11.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.839 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.657 ' O ' ' HA ' ' A' ' 49' ' ' THR . 77.9 p -162.39 160.02 25.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.173 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.63 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 6.2 mm-40 -96.17 146.63 24.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 48' ' ' ASN . 9.0 t -149.83 161.35 42.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.182 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.593 ' O ' ' HZ ' ' A' ' 45' ' ' PHE . 71.6 m -117.85 -8.24 10.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.952 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.743 HG22 ' OG1' ' A' ' 6' ' ' THR . 9.2 t -69.96 92.14 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.126 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.788 HG12 ' N ' ' A' ' 10' ' ' ALA . 63.0 t -127.49 173.96 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.858 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -95.2 126.01 48.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.02 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.874 ' HG2' HG21 ' A' ' 38' ' ' VAL . 81.2 Cg_exo -44.91 -20.54 0.39 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.835 2.356 . . . . 0.0 112.443 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -89.1 -31.53 17.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' ALA . 62.3 mt-10 -109.77 45.6 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.858 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.1 mtt180 -111.02 142.92 42.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.652 ' O ' ' O ' ' A' ' 16' ' ' ASN . 17.0 mp0 -110.39 89.75 3.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.704 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 37.0 t-20 -23.02 147.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.716 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.746 ' SG ' ' CE1' ' A' ' 46' ' ' TYR . 43.5 t -137.64 2.83 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.126 0.488 . . . . 0.0 110.554 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -159.01 -137.91 2.35 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.242 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.957 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 41.1 p90 -105.86 172.82 3.64 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.746 0.308 . . . . 0.0 110.884 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.957 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 46.3 Cg_endo -68.95 -46.33 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.694 2.263 . . . . 0.0 112.366 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.622 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -75.25 6.56 28.43 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.587 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 19' ' ' PHE . 26.7 m -50.39 122.9 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 111.309 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.963 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 82.2 p -107.66 -178.51 0.59 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.961 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.963 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 74.5 Cg_exo -49.56 -46.89 24.85 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 53.8 m -84.29 -34.48 23.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.909 ' HB2' ' H ' ' A' ' 23' ' ' THR . 15.2 mm-40 -65.55 -32.5 74.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 49.1 t -84.19 -53.43 5.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.789 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.27 -23.99 64.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 25' ' ' SER . 6.9 t30 -76.68 -12.26 59.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.938 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.909 ' HZ2' ' HB3' ' A' ' 30' ' ' LYS . 2.7 mmmp? -108.98 -13.92 14.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.913 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.35 34.29 7.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.517 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.996 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 82.7 m -122.65 164.47 18.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.761 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 74.2 m -81.44 153.43 26.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.62 ' HE1' ' O ' ' A' ' 22' ' ' VAL . 72.1 t80 -128.55 136.93 51.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.959 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.65 ' OD2' ' NH2' ' A' ' 14' ' ' ARG . 26.6 t0 -159.79 79.94 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -80.46 46.0 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.88 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -104.49 -4.81 22.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.202 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.874 HG21 ' HG2' ' A' ' 11' ' ' PRO . 67.8 t -145.93 118.59 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.29 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.607 ' C ' ' H ' ' A' ' 41' ' ' VAL . 78.0 mtm180 -76.78 -170.05 1.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.831 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.32 -30.24 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.446 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.854 HG21 ' HB3' ' A' ' 11' ' ' PRO . 32.9 m -111.26 161.91 23.14 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 111.077 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 40.9 Cg_endo -67.49 132.58 27.62 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.197 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -77.85 -35.26 51.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.002 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.996 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 44.7 t -103.88 105.83 16.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.648 ' HD1' ' O ' ' A' ' 46' ' ' TYR . 5.6 p90 -124.7 -169.95 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.055 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.746 ' CE1' ' SG ' ' A' ' 17' ' ' CYS . 90.5 m-85 -92.38 160.96 33.9 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 46' ' ' TYR . 57.4 Cg_endo -71.17 -158.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.313 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.758 ' O ' HG22 ' A' ' 6' ' ' THR . 17.2 m120 -163.03 102.48 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 4' ' ' THR . 94.2 m -63.59 103.5 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.116 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.603 HD12 HG21 ' A' ' 6' ' ' THR . 62.3 mt -113.17 158.7 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.151 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.803 ' C ' ' HD3' ' A' ' 53' ' ' PRO . 70.9 m-20 -90.32 170.34 10.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.962 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 33.1 m -121.49 33.63 0.22 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.166 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.962 ' HD3' ' N ' ' A' ' 52' ' ' VAL . 13.4 Cg_exo -69.62 177.08 5.83 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.952 2.434 . . . . 0.0 112.134 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.656 ' HB2' ' CG ' ' A' ' 57' ' ' GLU . 57.7 Cg_endo -71.39 129.75 16.34 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.688 2.259 . . . . 0.0 112.282 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -111.27 -17.49 13.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.587 ' OE1' ' HA ' ' A' ' 56' ' ' GLU . 5.0 tp10 -127.37 67.06 1.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.733 ' HA ' ' CE2' ' A' ' 60' ' ' PHE . 1.4 pp20? -144.2 -0.61 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.881 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 79.3 m -72.33 22.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.678 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 44.3 tp10 -135.29 35.92 2.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.943 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.733 ' CE2' ' HA ' ' A' ' 57' ' ' GLU . 92.1 m-85 . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.901 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' GLU . . . . . 0.607 ' OE1' ' HA ' ' B' ' 1' ' ' GLU . 6.3 mm-40 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 1.02 ' HB3' ' HD3' ' B' ' 53' ' ' PRO . . . -114.11 124.02 51.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.106 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.967 ' H ' ' HB ' ' B' ' 50' ' ' ILE . 93.6 mt-30 -160.58 167.63 26.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.248 0.547 . . . . 0.0 111.217 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' THR . . . . . 1.038 ' HA ' ' H ' ' B' ' 50' ' ' ILE . 17.3 p -68.73 -162.47 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.281 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.911 ' HB3' ' HB2' ' B' ' 47' ' ' PRO . 87.0 mt-10 -48.95 123.68 7.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 110.927 -172.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.778 HG22 ' N ' ' B' ' 7' ' ' CYS . 93.8 m -150.46 174.64 12.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.889 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.778 ' N ' HG22 ' B' ' 6' ' ' THR . 82.5 m -99.55 3.11 45.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.989 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.767 ' H ' HG22 ' B' ' 6' ' ' THR . 8.9 t -93.67 71.83 4.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.869 HG11 ' HA ' ' B' ' 14' ' ' ARG . 59.5 t -109.53 172.5 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.94 ' HB1' ' CZ ' ' B' ' 12' ' ' ARG . . . -85.86 129.05 55.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.015 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.643 ' HB3' HG21 ' B' ' 41' ' ' VAL . 78.0 Cg_exo -39.69 -34.45 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.827 2.351 . . . . 0.0 112.426 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 1.032 ' H ' ' HD3' ' B' ' 12' ' ' ARG . 0.0 OUTLIER -90.12 -29.78 18.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.895 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.681 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 6.4 mm-40 -96.24 -5.22 40.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.174 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.901 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -63.06 133.9 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.674 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.715 ' HG3' ' HD2' ' B' ' 46' ' ' TYR . 7.3 tp60 -79.94 79.97 6.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.957 -178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' B' ' 18' ' ' GLY . 48.6 t-20 -34.36 139.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.721 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' B' ' 16' ' ' ASN . 44.6 t -126.98 1.57 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.019 0.437 . . . . 0.0 110.593 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.523 ' N ' ' OD1' ' B' ' 16' ' ' ASN . . . -179.36 -132.72 1.82 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.218 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.855 ' CE2' ' N ' ' B' ' 22' ' ' VAL . 21.3 p90 -105.8 165.61 12.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.349 . . . . 0.0 110.915 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.723 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 43.1 Cg_endo -67.96 -11.57 32.48 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.751 2.301 . . . . 0.0 112.288 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.646 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -98.53 -19.92 21.3 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.855 ' N ' ' CE2' ' B' ' 19' ' ' PHE . 34.5 m -27.7 139.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.0 111.141 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.833 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 75.9 p -109.7 176.25 1.62 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.091 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.833 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 51.6 Cg_exo -52.91 -49.83 16.19 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.75 2.3 . . . . 0.0 112.361 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 48.1 t -68.76 -41.09 79.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.004 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.45 ' HB2' ' H ' ' B' ' 23' ' ' THR . 52.8 mt-30 -65.69 -40.45 92.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.02 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' B' ' 33' ' ' CYS . 42.3 t -74.58 -41.71 60.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.802 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.8 -33.46 73.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.078 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -49.77 -35.0 20.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.76 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 1.057 ' HE2' ' HA ' ' B' ' 30' ' ' LYS . 0.5 OUTLIER -95.53 -38.05 10.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.521 177.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.07 57.01 0.61 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.522 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' CYS . . . . . 0.756 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 78.1 m -129.84 177.07 7.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.938 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.912 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 74.1 m -80.03 155.33 27.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.953 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.603 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 41.3 t80 -128.5 114.56 16.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.863 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 16.7 t70 -135.2 94.33 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.992 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.673 ' HA ' ' CG ' ' B' ' 43' ' ' TRP . 25.2 p30 -91.88 22.45 4.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.974 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -97.26 -8.44 29.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.219 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.816 HG21 ' NH2' ' B' ' 14' ' ' ARG . 63.2 t -122.27 106.18 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.089 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.423 ' C ' ' H ' ' B' ' 41' ' ' VAL . 95.3 mtt180 -77.45 -178.46 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.953 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.43 -43.29 0.56 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.405 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.885 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.2 m -105.85 169.25 7.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 110.986 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.885 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 51.6 Cg_endo -69.33 147.58 65.95 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.67 2.247 . . . . 0.0 112.312 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.673 ' CG ' ' HA ' ' B' ' 36' ' ' ASP . 46.5 m0 -91.42 -38.19 12.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.813 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' CYS . . . . . 0.912 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 53.6 t -94.67 121.62 36.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.733 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.573 ' HZ ' ' O ' ' B' ' 7' ' ' CYS . 45.0 p90 -150.99 169.74 21.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.715 ' HD2' ' HG3' ' B' ' 15' ' ' GLN . 89.3 m-85 -83.46 155.52 66.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.818 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.911 ' HB2' ' HB3' ' B' ' 5' ' ' GLU . 55.7 Cg_endo -70.49 164.27 35.87 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.705 2.27 . . . . 0.0 112.296 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.794 ' O ' ' O ' ' B' ' 4' ' ' THR . 3.8 p-10 -119.93 136.7 54.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.898 HG22 ' HG3' ' B' ' 5' ' ' GLU . 67.5 p -95.57 132.19 40.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.101 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 1.038 ' H ' ' HA ' ' B' ' 4' ' ' THR . 54.2 mt -160.03 160.99 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.178 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.651 ' O ' ' HB3' ' B' ' 2' ' ' ALA . 9.9 m-20 -116.79 147.21 42.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.068 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 52' ' ' VAL . 32.9 m -73.37 113.58 23.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.214 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' PRO . . . . . 1.02 ' HD3' ' HB3' ' B' ' 2' ' ' ALA . 73.7 Cg_endo -75.82 160.65 37.25 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.791 2.327 . . . . 0.0 112.427 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.84 144.87 39.62 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.81 2.34 . . . . 0.0 112.297 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' GLU . . . . . 0.724 ' HB2' ' OE1' ' B' ' 56' ' ' GLU . 87.2 mt-10 -116.12 -58.48 2.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.724 ' OE1' ' HB2' ' B' ' 55' ' ' GLU . 2.9 pm0 -123.22 -9.68 8.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.794 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -131.72 -160.83 1.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' CYS . . . . . 0.537 ' O ' ' CD ' ' B' ' 59' ' ' GLU . 26.9 p -104.67 -49.96 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.537 ' CD ' ' O ' ' B' ' 58' ' ' CYS . 81.6 mm-40 -162.06 -46.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.747 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.688 ' OXT' ' CD2' ' B' ' 60' ' ' PHE . 48.6 p90 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.951 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.461 ' OE1' ' N ' ' A' ' 1' ' ' GLU . 20.8 mp0 . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.789 0.328 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.942 ' HB1' HG22 ' A' ' 52' ' ' VAL . . . -151.75 30.58 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -145.26 114.39 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.9 p -143.94 132.4 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.183 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.531 ' HG2' ' OG1' ' A' ' 49' ' ' THR . 61.6 mt-10 -107.61 124.89 50.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.835 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.838 HG22 HG22 ' A' ' 8' ' ' THR . 91.9 m -122.33 133.69 54.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.4 m -112.18 23.95 13.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.987 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.838 HG22 HG22 ' A' ' 6' ' ' THR . 10.0 t -74.27 64.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.079 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.823 HG11 ' HA ' ' A' ' 14' ' ' ARG . 57.2 t -97.47 124.69 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.184 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.983 ' HB3' ' HB2' ' A' ' 13' ' ' GLU . . . -50.26 136.23 22.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.82 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.501 ' HA ' ' NE ' ' A' ' 14' ' ' ARG . 84.7 Cg_exo -41.19 -55.59 2.08 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.906 2.404 . . . . 0.0 112.805 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.847 ' HG3' ' OE2' ' A' ' 13' ' ' GLU . 15.8 ptp180 -81.03 -29.61 35.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.07 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.983 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 22.3 mp0 -80.77 7.85 9.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.039 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.94 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.2 mtt180 -74.94 120.9 21.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.839 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.669 ' O ' ' O ' ' A' ' 16' ' ' ASN . 10.4 mm100 -82.26 80.16 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.919 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.669 ' O ' ' O ' ' A' ' 15' ' ' GLN . 35.9 t-20 -22.51 148.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.037 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.657 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 42.5 t -134.96 0.23 2.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.639 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -166.86 -136.05 1.96 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.268 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.87 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 22.2 p90 -105.55 170.12 6.26 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.811 0.339 . . . . 0.0 110.95 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.87 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 53.4 Cg_endo -69.82 -12.55 33.0 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.749 2.299 . . . . 0.0 112.368 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.661 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -98.44 -21.29 17.46 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.461 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.891 HG21 ' HB2' ' A' ' 44' ' ' CYS . 34.3 m -24.93 150.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.815 0.341 . . . . 0.0 111.255 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.568 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 68.8 p -120.34 165.25 18.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.093 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.673 ' HD3' ' CZ ' ' A' ' 34' ' ' PHE . 53.2 Cg_exo -52.5 -36.52 70.7 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.718 2.279 . . . . 0.0 112.304 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.6 t -79.14 -48.28 14.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.556 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 52.8 mt-30 -60.37 -44.27 95.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.944 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.6 t -75.02 -58.86 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -53.54 -15.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -92.48 -14.3 28.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 22.8 tptm -98.84 -1.46 40.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.94 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.55 45.79 5.69 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.602 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.798 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 79.9 m -149.96 152.17 34.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 110.993 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.882 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 78.5 m -67.39 155.29 39.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.858 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.673 ' CZ ' ' HD3' ' A' ' 24' ' ' PRO . 59.8 t80 -129.79 109.8 11.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.817 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.575 ' OD1' ' OG1' ' A' ' 37' ' ' THR . 32.9 t0 -138.41 90.48 2.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.714 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.4 p-10 -88.92 -3.12 58.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.575 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 79.1 p -48.71 -7.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.572 ' H ' ' C ' ' A' ' 36' ' ' ASP . 62.2 t -141.26 103.46 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.797 ' HA ' ' HE1' ' A' ' 43' ' ' TRP . 15.9 ptp180 -69.27 -165.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.763 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.22 -34.87 0.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.359 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.839 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.6 m -108.39 167.74 8.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.944 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.839 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 42.9 Cg_endo -68.08 119.97 6.96 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.187 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.797 ' HE1' ' HA ' ' A' ' 39' ' ' ARG . 50.1 m0 -70.11 -37.67 75.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.891 ' HB2' HG21 ' A' ' 22' ' ' VAL . 50.5 t -96.84 128.57 43.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.829 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.576 ' CE2' ' CG2' ' A' ' 9' ' ' VAL . 52.4 p90 -152.81 161.75 42.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -67.02 137.19 94.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.004 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.882 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 99.0 Cg_endo -80.67 -177.05 3.49 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.933 2.422 . . . . 0.0 112.484 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -129.0 79.96 1.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.781 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.531 ' OG1' ' HG2' ' A' ' 5' ' ' GLU . 95.2 m -90.03 138.02 31.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 60.3 mt -133.01 139.4 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.04 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 2' ' ' ALA . 24.5 p-10 -161.97 -169.51 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.942 HG22 ' HB1' ' A' ' 2' ' ' ALA . 29.9 m -140.56 122.57 9.57 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.896 ' HG3' ' HB2' ' B' ' 55' ' ' GLU . 57.2 Cg_endo -71.22 108.77 2.42 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.666 2.244 . . . . 0.0 112.319 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 52' ' ' VAL . 58.3 Cg_endo -71.64 -45.68 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.726 2.284 . . . . 0.0 112.254 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.742 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 4.8 tp10 -143.05 -177.59 5.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.742 ' N ' ' HG3' ' A' ' 55' ' ' GLU . 6.3 mm-40 -70.77 33.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' H ' ' C ' ' A' ' 55' ' ' GLU . 87.4 mt-10 -162.15 137.96 7.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.965 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 59' ' ' GLU . 29.8 p -98.99 -106.93 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.813 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.634 ' N ' ' SG ' ' A' ' 58' ' ' CYS . 45.2 mt-10 -141.77 -145.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.603 ' CG ' ' O ' ' A' ' 59' ' ' GLU . 90.5 m-85 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.909 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' B' ' 1' ' ' GLU . 22.9 pt-20 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.798 0.332 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.818 ' CB ' HG22 ' B' ' 52' ' ' VAL . . . -71.14 5.46 2.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.055 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.884 ' HA ' ' OD1' ' B' ' 51' ' ' ASP . 12.5 mm100 -91.5 115.23 27.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.692 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.553 ' C ' ' OE2' ' B' ' 5' ' ' GLU . 72.4 p -160.05 132.05 6.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.85 0.357 . . . . 0.0 111.443 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 1.002 ' HG3' HG22 ' B' ' 49' ' ' THR . 0.6 OUTLIER -110.08 146.81 34.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.754 178.157 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.701 HG22 ' H ' ' B' ' 8' ' ' THR . 94.4 m -144.1 163.51 33.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.237 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.606 ' N ' HG22 ' B' ' 6' ' ' THR . 73.8 m -121.13 32.29 6.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.701 ' H ' HG22 ' B' ' 6' ' ' THR . 9.1 t -98.05 72.72 2.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.087 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.874 HG12 ' N ' ' B' ' 10' ' ' ALA . 73.8 t -119.34 -179.53 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.874 ' N ' HG12 ' B' ' 9' ' ' VAL . . . -95.97 159.91 31.23 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.008 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.452 ' HB3' HG11 ' B' ' 41' ' ' VAL . 76.8 Cg_exo -50.08 -39.18 51.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.748 2.298 . . . . 0.0 112.462 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.4 ' C ' ' H ' ' B' ' 14' ' ' ARG . 39.4 ptt180 -89.97 -29.92 18.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.764 ' O ' HG11 ' B' ' 9' ' ' VAL . 45.2 mt-10 -77.0 17.46 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.077 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.829 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.2 mtt180 -98.56 114.39 26.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 56.5 tp60 -80.48 98.85 7.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.439 ' O ' ' CE1' ' B' ' 46' ' ' TYR . 43.1 t30 -32.95 150.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' CYS . . . . . 0.442 ' O ' ' SG ' ' B' ' 17' ' ' CYS . 41.5 t -143.26 5.17 1.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.73 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.85 -138.61 2.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.422 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.859 ' CE1' HG12 ' B' ' 22' ' ' VAL . 42.8 p90 -105.58 166.83 10.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 0.0 110.929 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.776 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 47.1 Cg_endo -68.9 -33.74 19.37 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.751 2.3 . . . . 0.0 112.313 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.663 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -84.05 13.47 49.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.54 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.859 HG12 ' CE1' ' B' ' 19' ' ' PHE . 34.0 m -65.07 164.43 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 111.207 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.777 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 75.2 p -133.75 173.15 6.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.054 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.777 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 55.7 Cg_exo -51.63 -32.75 45.97 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.727 2.285 . . . . 0.0 112.363 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 47.3 t -84.81 -66.74 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.476 ' NE2' ' HZ ' ' B' ' 19' ' ' PHE . 52.6 mt-30 -39.34 -34.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.863 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' B' ' 30' ' ' LYS . 42.6 t -80.58 -60.97 2.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.16 -34.14 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -49.84 -37.09 29.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.42 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' B' ' 27' ' ' CYS . 46.6 mmtm -86.76 -30.85 21.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.518 176.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.01 24.03 9.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.709 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' CYS . . . . . 0.656 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 81.6 m -102.42 155.54 18.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 110.897 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' B' ' 47' ' ' PRO . 83.0 m -63.56 149.45 46.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.807 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.635 ' CZ ' ' HA ' ' B' ' 23' ' ' THR . 59.6 t80 -133.13 120.24 20.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.535 ' OD2' ' NH1' ' B' ' 14' ' ' ARG . 16.5 t70 -129.3 87.75 2.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.662 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 24.3 p-10 -91.83 51.53 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 75.8 p -117.8 -11.92 10.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.192 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.492 ' O ' HG22 ' B' ' 41' ' ' VAL . 62.2 t -136.01 115.54 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' B' ' 41' ' ' VAL . 80.7 mtp180 -67.98 -178.17 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.22 -41.27 0.48 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.557 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.492 HG22 ' O ' ' B' ' 38' ' ' VAL . 33.0 m -92.49 153.07 42.62 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 0.0 111.107 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.29 122.2 9.0 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.749 2.299 . . . . 0.0 112.207 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.662 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 23.1 m0 -67.34 -47.45 70.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.009 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' CYS . . . . . 0.705 ' CB ' HG21 ' B' ' 22' ' ' VAL . 46.8 t -92.03 119.84 32.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.897 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.763 ' CE2' ' HD3' ' B' ' 14' ' ' ARG . 53.3 p90 -149.23 159.41 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.827 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.439 ' CE1' ' O ' ' B' ' 16' ' ' ASN . 91.6 m-85 -58.68 146.92 72.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.507 ' HA ' ' SG ' ' B' ' 33' ' ' CYS . 59.0 Cg_endo -72.32 -169.87 0.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.763 2.308 . . . . 0.0 112.371 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.853 HD21 ' CG2' ' B' ' 9' ' ' VAL . 33.0 m-80 -119.71 84.42 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.78 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' THR . . . . . 1.002 HG22 ' HG3' ' B' ' 5' ' ' GLU . 81.6 p -75.65 108.68 8.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.086 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 57.3 mt -103.04 136.73 34.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.044 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.884 ' OD1' ' HA ' ' B' ' 3' ' ' GLN . 7.3 m-20 -160.23 160.37 32.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.915 -176.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 1.077 ' N ' ' HD3' ' B' ' 53' ' ' PRO . 30.2 m -131.33 17.7 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.316 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' PRO . . . . . 1.077 ' HD3' ' N ' ' B' ' 52' ' ' VAL . 12.2 Cg_exo -69.81 118.85 5.92 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.745 2.297 . . . . 0.0 112.154 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.71 -174.24 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.658 2.239 . . . . 0.0 112.204 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' GLU . . . . . 0.896 ' HB2' ' HG3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -95.59 -98.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.566 ' C ' ' OE1' ' B' ' 56' ' ' GLU . 1.4 pp20? -141.3 155.84 45.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.781 ' HG2' ' H ' ' B' ' 58' ' ' CYS . 41.5 tt0 -123.47 -120.39 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' CYS . . . . . 0.781 ' H ' ' HG2' ' B' ' 57' ' ' GLU . 81.4 m -93.6 173.95 7.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.047 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -169.98 -18.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 61.9 t80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.84 179.859 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.71 ' O ' ' HA ' ' A' ' 51' ' ' ASP . . . -81.7 67.73 7.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.067 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.546 ' OE1' ' HA ' ' A' ' 3' ' ' GLN . 14.4 mm-40 -137.45 128.14 26.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.801 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.9 p -137.95 139.31 39.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.174 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.793 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 21.4 mp0 -101.52 126.7 48.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.887 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.985 HG22 ' H ' ' A' ' 8' ' ' THR . 86.0 m -130.26 173.98 10.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.044 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.77 ' N ' HG22 ' A' ' 6' ' ' THR . 71.9 m -131.29 2.43 4.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.24 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.985 ' H ' HG22 ' A' ' 6' ' ' THR . 10.1 t -75.21 63.16 1.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.084 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.517 HG22 ' OD1' ' A' ' 48' ' ' ASN . 58.0 t -96.65 155.55 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.912 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -69.66 136.3 88.07 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.786 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HG3' HG21 ' A' ' 38' ' ' VAL . 88.9 Cg_exo -41.83 -66.69 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.793 2.329 . . . . 0.0 112.593 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -65.12 -30.0 70.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.992 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.897 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 81.0 mm-40 -88.96 27.69 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.097 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.912 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.2 mtt180 -97.83 129.31 44.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.865 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 45' ' ' PHE . 29.5 mm-40 -82.63 104.19 12.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.636 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 43.7 t30 -35.29 122.02 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.905 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 46.4 t -138.8 -0.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.196 0.522 . . . . 0.0 110.229 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.764 ' N ' ' O ' ' A' ' 44' ' ' CYS . . . 174.77 122.34 0.68 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.313 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.818 ' O ' HG22 ' A' ' 22' ' ' VAL . 53.2 p90 -44.78 167.87 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.751 0.31 . . . . 0.0 110.973 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.786 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 47.2 Cg_endo -68.9 -52.97 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.659 2.239 . . . . 0.0 112.263 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -40.46 -27.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.382 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.904 HG21 ' HB2' ' A' ' 44' ' ' CYS . 29.1 m -49.93 171.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.342 . . . . 0.0 111.122 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.891 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 74.1 p -137.25 178.71 1.6 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.891 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 58.0 Cg_exo -51.48 -36.58 59.68 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.627 2.218 . . . . 0.0 112.27 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 53.1 m -90.18 -40.01 12.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.821 ' HB2' ' H ' ' A' ' 23' ' ' THR . 96.1 mt-30 -65.23 -27.31 68.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.868 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.975 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 53.0 t -91.56 -52.9 4.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.789 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.84 -21.0 40.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.004 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.517 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 37.8 t-20 -72.01 -27.47 62.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.849 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.11 -24.52 18.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.937 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.32 29.35 5.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.4 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.975 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 61.9 m -108.52 -176.8 3.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.827 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.73 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 73.7 m -109.22 132.62 53.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.636 176.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.781 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 26.9 t80 -104.41 108.5 19.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.896 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 35' ' ' ASP . 32.5 t0 -128.98 90.31 3.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.541 ' OD2' ' HE1' ' A' ' 34' ' ' PHE . 25.0 p30 -89.1 60.55 5.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.3 p -114.8 -33.65 5.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.09 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.624 ' O ' HG22 ' A' ' 41' ' ' VAL . 63.5 t -119.48 120.38 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.074 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.588 ' C ' ' H ' ' A' ' 41' ' ' VAL . 98.8 mtt180 -74.24 179.33 4.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.06 -28.5 0.15 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 38' ' ' VAL . 33.0 m -98.84 158.84 31.68 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.8 0.333 . . . . 0.0 111.081 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 50.4 Cg_endo -69.18 120.2 7.09 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 0.0 112.302 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -73.51 -27.4 61.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.942 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 44.6 t -113.27 95.96 5.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.723 ' C ' ' HB3' ' A' ' 17' ' ' CYS . 52.8 p90 -122.71 -169.93 2.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.636 ' CE2' ' O ' ' A' ' 16' ' ' ASN . 96.3 m-85 -88.29 143.39 32.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.976 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 56.6 Cg_endo -70.87 -156.53 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.842 2.362 . . . . 0.0 112.408 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.793 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 12.6 m120 -135.39 146.9 48.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.5 p -119.48 82.46 1.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.98 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 51' ' ' ASP . 60.4 mt -98.82 161.96 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.269 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.71 ' HA ' ' O ' ' A' ' 2' ' ' ALA . 10.0 m-20 -87.48 160.63 18.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.777 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.95 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 60.7 t -159.43 67.75 3.05 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.134 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -89.37 79.26 0.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.194 2.596 . . . . 0.0 112.686 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.95 ' HD3' ' O ' ' A' ' 52' ' ' VAL . 59.5 Cg_endo -71.88 70.64 2.84 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.642 2.228 . . . . 0.0 112.305 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.63 ' OE1' ' HA ' ' A' ' 55' ' ' GLU . 6.2 mm-40 -134.43 -81.01 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.56 ' O ' ' CD ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -111.85 32.81 5.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -89.62 70.83 7.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.964 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 59' ' ' GLU . 43.9 t -92.86 176.59 6.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.946 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.587 ' N ' ' SG ' ' A' ' 58' ' ' CYS . 12.4 mm-40 -120.84 3.25 10.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.443 ' HB2' ' SG ' ' B' ' 58' ' ' CYS . 89.1 m-85 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.841 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' GLU . . . . . 0.815 ' HG3' ' H ' ' B' ' 2' ' ' ALA . 22.9 pt-20 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.797 0.332 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.815 ' H ' ' HG3' ' B' ' 1' ' ' GLU . . . -144.52 73.28 1.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.108 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.942 ' HA ' ' HB2' ' B' ' 51' ' ' ASP . 17.6 mp0 -138.32 171.46 14.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.962 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.808 ' O ' ' HA ' ' B' ' 49' ' ' THR . 66.6 p -117.24 -159.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.136 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -109.4 145.47 36.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.962 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.907 ' CG2' HG22 ' B' ' 8' ' ' THR . 87.4 m -149.94 156.47 41.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.034 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.458 ' N ' HG22 ' B' ' 6' ' ' THR . 71.2 m -122.61 -8.26 8.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.286 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.907 HG22 ' CG2' ' B' ' 6' ' ' THR . 9.4 t -74.52 82.95 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 111.099 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.816 HG12 ' N ' ' B' ' 10' ' ' ALA . 76.4 t -128.59 176.23 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.071 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.844 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -84.17 128.15 63.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.924 ' HB3' HG21 ' B' ' 41' ' ' VAL . 97.6 Cg_exo -42.45 -66.25 0.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.795 2.33 . . . . 0.0 112.416 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.89 ' NH1' ' HD2' ' B' ' 11' ' ' PRO . 0.1 OUTLIER -54.16 -29.9 47.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.823 179.076 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.707 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 87.3 mt-10 -93.82 22.71 5.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.844 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 98.8 mtt180 -98.91 141.54 31.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.552 ' O ' ' HD1' ' B' ' 46' ' ' TYR . 84.9 mm-40 -88.18 80.04 7.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.538 ' C ' ' O ' ' B' ' 15' ' ' GLN . 44.6 t-20 -24.36 138.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.585 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' B' ' 16' ' ' ASN . 40.9 t -133.09 2.82 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 110.559 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.402 ' N ' ' OD1' ' B' ' 16' ' ' ASN . . . -156.83 -136.5 2.13 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.286 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.907 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 12.3 p90 -105.74 171.54 4.77 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.342 . . . . 0.0 111.007 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.907 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 30.4 Cg_endo -64.05 -10.01 21.5 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.821 2.348 . . . . 0.0 112.386 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.772 ' HA2' ' CZ3' ' B' ' 43' ' ' TRP . . . -128.93 29.07 4.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.606 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.879 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 35.7 m -49.66 161.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.391 . . . . 0.0 111.264 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' THR . . . . . 1.082 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 66.7 p -135.95 176.41 2.85 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.767 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 1.082 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 10.8 Cg_endo -54.03 -42.22 68.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.597 2.198 . . . . 0.0 112.088 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -81.07 -46.42 15.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.747 ' HG2' ' OG1' ' B' ' 23' ' ' THR . 85.1 mm-40 -57.04 -38.63 73.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -73.76 -54.77 7.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.759 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.1 -35.7 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.83 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -54.03 -28.33 37.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.798 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.81 ' HZ2' ' HB3' ' B' ' 30' ' ' LYS . 2.7 mmmp? -100.17 -26.95 13.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.731 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.5 60.58 1.79 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.592 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' CYS . . . . . 0.527 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 78.6 m -142.88 176.41 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.91 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.661 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.0 m -74.27 148.66 41.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.765 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.635 ' CE1' HG23 ' B' ' 22' ' ' VAL . 75.6 t80 -126.76 130.8 51.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.885 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.571 ' OD2' ' NH2' ' B' ' 14' ' ' ARG . 27.5 t0 -148.19 80.02 1.46 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.873 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.733 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 24.4 p-10 -84.44 53.45 2.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -120.04 -4.84 10.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.621 HG12 HG22 ' B' ' 41' ' ' VAL . 61.8 t -132.7 106.87 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.668 ' C ' ' H ' ' B' ' 41' ' ' VAL . 79.7 mtm180 -71.28 -171.81 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.66 -10.88 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.385 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.924 HG21 ' HB3' ' B' ' 11' ' ' PRO . 34.9 m -131.49 164.98 38.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 0.0 111.1 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.755 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 57.7 Cg_endo -71.31 144.17 45.33 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.751 2.301 . . . . 0.0 112.309 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.772 ' CZ3' ' HA2' ' B' ' 21' ' ' GLY . 27.1 m0 -93.25 -50.7 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.794 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' CYS . . . . . 0.825 ' H ' HG21 ' B' ' 22' ' ' VAL . 52.9 t -87.66 122.85 31.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.727 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.779 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 47.8 p90 -148.19 149.58 32.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.552 ' HD1' ' O ' ' B' ' 15' ' ' GLN . 81.0 m-85 -46.81 150.57 1.25 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.851 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.77 174.08 12.4 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.747 2.298 . . . . 0.0 112.37 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.735 ' OD1' HG21 ' B' ' 9' ' ' VAL . 17.3 m120 -128.29 144.26 51.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.846 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.808 ' HA ' ' O ' ' B' ' 4' ' ' THR . 93.9 m -101.23 129.76 47.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.155 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.505 HG22 ' N ' ' B' ' 51' ' ' ASP . 63.2 mt -156.64 156.94 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.327 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.942 ' HB2' ' HA ' ' B' ' 3' ' ' GLN . 16.5 t70 -159.72 -171.8 3.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.711 ' H ' ' CG ' ' B' ' 51' ' ' ASP . 61.0 t -106.57 114.12 62.3 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.208 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' PRO . . . . . 0.473 ' HG3' ' HB3' ' B' ' 59' ' ' GLU . 56.7 Cg_endo -70.98 173.17 12.47 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.726 2.284 . . . . 0.0 112.273 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.57 -51.51 0.4 Allowed 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.908 2.405 . . . . 0.0 112.175 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -124.73 -164.99 1.33 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.961 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -104.22 19.66 19.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.511 ' HG2' ' O ' ' B' ' 57' ' ' GLU . 41.6 tt0 -126.84 1.49 6.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.858 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 60' ' ' PHE . 73.0 m -126.85 67.43 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.819 ' HG3' ' CD2' ' B' ' 60' ' ' PHE . 12.6 pt-20 -152.01 -33.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.85 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.819 ' CD2' ' HG3' ' B' ' 59' ' ' GLU . 94.6 m-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.836 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 1' ' ' GLU . 12.5 pt-20 . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.819 0.342 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.718 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -160.02 121.55 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.81 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 1.3 mp0 -142.8 100.39 3.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.771 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 1.008 ' N ' HG23 ' A' ' 50' ' ' ILE . 71.6 p -169.87 138.55 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.091 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 1.045 ' HG3' HD11 ' A' ' 50' ' ' ILE . 37.3 mt-10 -61.5 -174.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.607 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.836 ' N ' ' HB2' ' A' ' 48' ' ' ASN . 95.7 m -128.13 164.93 21.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.803 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.609 ' N ' HG22 ' A' ' 6' ' ' THR . 70.9 m -130.31 -22.88 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.842 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.521 HG22 ' CG2' ' A' ' 6' ' ' THR . 8.9 t -74.37 51.33 0.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.825 HG12 ' N ' ' A' ' 10' ' ' ALA . 62.8 t -90.06 177.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.875 ' HB3' ' HB2' ' A' ' 13' ' ' GLU . . . -76.05 132.11 74.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.939 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.657 ' HA ' ' NE ' ' A' ' 14' ' ' ARG . 88.6 Cg_exo -46.92 -74.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.746 2.297 . . . . 0.0 112.425 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.718 ' HB2' ' OE2' ' A' ' 13' ' ' GLU . 37.2 mmt180 -52.6 -30.65 32.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.975 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.875 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -89.66 35.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.808 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.0 mtt180 -107.89 124.04 49.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.976 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.571 ' CB ' ' HD2' ' A' ' 46' ' ' TYR . 1.3 mp0 -79.93 92.71 5.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 15' ' ' GLN . 27.4 t-20 -30.31 150.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.637 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 43.5 t -135.96 4.67 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.336 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.19 -138.28 2.73 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.336 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.956 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 30.4 p90 -105.75 172.38 4.04 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.778 0.323 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.956 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 46.1 Cg_endo -68.79 -31.59 24.97 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.715 2.277 . . . . 0.0 112.325 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.644 ' H ' ' HD2' ' A' ' 19' ' ' PHE . . . -74.27 -27.98 64.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.527 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.932 HG21 ' HB2' ' A' ' 44' ' ' CYS . 34.4 m -26.21 152.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.266 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.67 ' OG1' ' HG3' ' A' ' 26' ' ' GLN . 74.8 p -122.33 164.53 25.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.074 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.747 ' HG3' ' CE1' ' A' ' 34' ' ' PHE . 50.2 Cg_exo -53.48 -32.48 63.16 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.709 2.273 . . . . 0.0 112.349 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 47.8 t -84.83 -46.45 11.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.67 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 78.4 mt-30 -59.71 -46.59 88.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.8 t -76.48 -48.34 19.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -63.74 -15.29 58.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.086 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 25' ' ' SER . 42.9 t30 -83.4 -14.84 51.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -92.25 -35.96 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.74 11.79 1.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.568 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.775 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 71.7 m -113.81 170.62 8.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 110.941 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 76.8 m -88.17 155.07 19.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.747 ' CE1' ' HG3' ' A' ' 24' ' ' PRO . 45.2 t80 -133.14 119.42 19.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 37' ' ' THR . 16.4 t70 -130.64 79.99 1.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.794 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.3 p-10 -78.18 21.54 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 35' ' ' ASP . 75.0 p -90.84 -16.77 27.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.772 HG12 HG22 ' A' ' 41' ' ' VAL . 62.8 t -108.66 126.71 65.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.093 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.521 ' C ' ' H ' ' A' ' 41' ' ' VAL . 82.9 mtm180 -91.09 176.41 6.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.95 -33.46 0.29 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.466 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.915 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.3 m -106.27 170.64 5.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.72 0.295 . . . . 0.0 111.119 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.915 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 60.0 Cg_endo -72.63 153.65 54.47 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.673 2.248 . . . . 0.0 112.223 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.794 ' CD1' ' HA ' ' A' ' 36' ' ' ASP . 34.1 m0 -97.81 -30.29 12.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.932 ' HB2' HG21 ' A' ' 22' ' ' VAL . 47.4 t -100.04 117.38 34.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.778 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.751 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 52.2 p90 -143.57 170.05 16.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.571 ' HD2' ' CB ' ' A' ' 15' ' ' GLN . 25.6 m-85 -76.97 134.94 67.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.775 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 18.0 Cg_endo -61.02 -150.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.52 -0.195 0 C-N-CA 122.976 2.45 . . . . 0.0 112.606 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.836 ' HB2' ' N ' ' A' ' 6' ' ' THR . 18.1 m120 -119.01 -178.55 3.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.357 177.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.801 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 9.9 t -68.68 171.04 8.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.336 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 1.045 HD11 ' HG3' ' A' ' 5' ' ' GLU . 76.4 mt -141.06 165.78 19.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.198 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.81 ' HB2' ' HG3' ' A' ' 3' ' ' GLN . 1.7 m-20 -99.92 -164.95 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.718 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.653 ' N ' ' HG3' ' A' ' 3' ' ' GLN . 60.5 t -132.72 119.92 16.31 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.227 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.582 ' HD3' ' HG2' ' A' ' 3' ' ' GLN . 55.5 Cg_endo -70.07 147.67 61.37 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.733 2.289 . . . . 0.0 112.304 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 14.1 Cg_exo -69.49 -7.02 19.87 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.975 2.45 . . . . 0.0 112.251 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 0.5 OUTLIER -79.23 70.19 5.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 55' ' ' GLU . 87.0 mt-10 -163.44 -2.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -141.23 -136.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.786 ' O ' ' HB2' ' B' ' 58' ' ' CYS . 50.1 t -94.5 -70.56 0.7 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.78 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.633 ' HB3' ' HB3' ' B' ' 58' ' ' CYS . 17.3 pt-20 -143.67 14.11 1.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.3 t80 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.915 -179.703 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' B' ' 1' ' ' GLU . 64.3 tt0 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.76 136.6 25.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.064 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -157.27 134.98 10.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 74.9 p -156.67 135.92 12.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' B' ' 47' ' ' PRO . 0.5 OUTLIER -92.07 156.88 17.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.87 HG22 ' H ' ' B' ' 8' ' ' THR . 93.6 m -149.21 165.58 31.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.08 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.644 ' N ' HG22 ' B' ' 6' ' ' THR . 76.1 m -112.05 18.41 18.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.87 ' H ' HG22 ' B' ' 6' ' ' THR . 9.0 t -86.9 84.96 7.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.024 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.91 HG11 ' HA ' ' B' ' 14' ' ' ARG . 58.8 t -125.31 165.28 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.208 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.852 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -93.5 131.53 32.29 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.986 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.892 ' HB3' HG21 ' B' ' 41' ' ' VAL . 79.0 Cg_exo -40.07 -32.05 0.59 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.793 2.329 . . . . 0.0 112.516 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.906 ' NH2' HG12 ' B' ' 41' ' ' VAL . 2.0 mmp_? -90.25 -29.89 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' B' ' 10' ' ' ALA . 12.2 mm-40 -93.05 -5.93 49.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.085 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.91 ' HA ' HG11 ' B' ' 9' ' ' VAL . 99.4 mtt180 -69.29 122.2 18.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.823 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.539 ' OE1' ' HA ' ' B' ' 15' ' ' GLN . 7.3 tp60 -79.9 91.18 5.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.869 -178.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.562 ' OD1' ' N ' ' B' ' 18' ' ' GLY . 45.0 t-20 -32.64 140.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.753 179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' CYS . . . . . 0.538 ' N ' ' OD1' ' B' ' 16' ' ' ASN . 43.1 t -127.8 1.69 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.526 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.562 ' N ' ' OD1' ' B' ' 16' ' ' ASN . . . -172.39 -134.45 1.8 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.084 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.897 ' CE1' HG12 ' B' ' 22' ' ' VAL . 37.8 p90 -106.15 156.58 36.59 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.732 0.301 . . . . 0.0 110.895 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.562 ' O ' ' CE3' ' B' ' 43' ' ' TRP . 36.4 Cg_endo -65.51 -18.91 60.56 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.681 2.254 . . . . 0.0 112.229 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.639 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -94.14 8.13 72.76 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.47 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.897 HG12 ' CE1' ' B' ' 19' ' ' PHE . 34.6 m -61.67 155.55 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.0 111.129 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.846 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 78.3 p -121.06 174.71 2.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.12 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.846 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 76.8 Cg_exo -50.26 -56.08 3.46 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 0.0 112.309 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 79.5 p -58.35 -55.05 39.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.836 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.787 ' C ' ' HZ3' ' B' ' 30' ' ' LYS . 96.2 mt-30 -50.04 -72.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' CYS . . . . . 0.598 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 49.6 t -32.02 -53.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.73 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.33 -35.79 51.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' B' ' 26' ' ' GLN . 42.1 t30 -49.64 -32.58 13.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.787 ' HZ3' ' C ' ' B' ' 26' ' ' GLN . 2.2 mppt? -95.63 -15.5 22.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.795 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.94 38.31 16.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.532 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' CYS . . . . . 0.724 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 79.6 m -119.46 161.8 19.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 110.979 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.2 m -65.43 155.19 36.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.851 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.585 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 57.8 t80 -129.56 118.06 21.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.564 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 16.6 t70 -128.55 100.04 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -91.75 24.7 3.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' THR . . . . . 0.564 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 69.0 p -89.11 -62.39 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.857 HG21 ' HG3' ' B' ' 11' ' ' PRO . 61.1 t -80.52 120.79 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' B' ' 41' ' ' VAL . 83.6 mtm180 -89.15 -177.55 5.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.99 -35.52 0.29 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.906 HG12 ' NH2' ' B' ' 12' ' ' ARG . 27.5 m -100.44 170.43 6.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.745 0.307 . . . . 0.0 111.137 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.894 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 41.1 Cg_endo -67.41 127.99 17.49 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.183 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.562 ' CE3' ' O ' ' B' ' 20' ' ' PRO . 49.7 m0 -78.9 -47.54 16.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.882 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 50.2 t -91.16 123.79 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.777 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.724 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 50.0 p90 -142.67 168.94 18.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.997 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.529 ' O ' ' HD1' ' B' ' 45' ' ' PHE . 88.2 m-85 -75.73 154.08 85.26 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.94 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' B' ' 5' ' ' GLU . 56.7 Cg_endo -70.69 -177.75 2.34 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.798 2.332 . . . . 0.0 112.415 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.555 ' O ' ' HA ' ' B' ' 5' ' ' GLU . 16.9 m120 -132.93 105.63 7.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.531 ' OG1' ' HG3' ' B' ' 5' ' ' GLU . 94.3 m -84.57 100.29 11.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.113 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 62.0 mt -99.43 143.55 13.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.514 ' CG ' ' HD3' ' B' ' 53' ' ' PRO . 24.3 p-10 -134.55 172.0 13.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.584 HG23 ' O ' ' B' ' 52' ' ' VAL . 33.2 m -129.34 58.48 37.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' PRO . . . . . 0.514 ' HD3' ' CG ' ' B' ' 51' ' ' ASP . 56.2 Cg_endo -70.45 155.63 63.25 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.66 2.24 . . . . 0.0 112.307 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.633 ' O ' ' HG3' ' B' ' 55' ' ' GLU . 56.3 Cg_endo -70.35 -84.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.806 2.337 . . . . 0.0 112.326 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' GLU . . . . . 0.76 ' OE2' ' HB2' ' A' ' 58' ' ' CYS . 44.4 mt-10 -165.34 -167.21 1.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.817 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -102.79 -141.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -88.08 110.67 20.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' CYS . . . . . 0.786 ' HB2' ' O ' ' A' ' 58' ' ' CYS . 77.0 m -99.05 106.74 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.988 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -139.14 102.62 4.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 t80 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.827 -179.888 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.852 ' HA ' HE22 ' A' ' 3' ' ' GLN . 64.3 tt0 . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.441 ' N ' ' OE1' ' A' ' 3' ' ' GLN . . . -118.07 46.79 1.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.852 HE22 ' HA ' ' A' ' 1' ' ' GLU . 1.2 mp0 -87.92 144.24 26.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 3' ' ' GLN . 82.8 p -163.59 145.3 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.17 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.722 ' HG2' HG22 ' A' ' 49' ' ' THR . 62.3 mt-10 -95.87 128.59 42.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.844 ' HB ' ' HB2' ' A' ' 48' ' ' ASN . 93.9 m -102.1 165.29 11.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.123 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.635 ' N ' HG22 ' A' ' 6' ' ' THR . 72.0 m -146.5 19.38 1.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.979 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.794 HG22 ' CG2' ' A' ' 6' ' ' THR . 9.5 t -100.22 63.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.11 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.685 HG12 ' N ' ' A' ' 10' ' ' ALA . 61.2 t -103.44 168.08 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.182 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.859 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -78.47 120.94 82.92 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.104 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.78 ' HA ' ' CD ' ' A' ' 14' ' ' ARG . 88.5 Cg_exo -46.58 -37.75 20.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.691 2.26 . . . . 0.0 112.456 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.735 ' HG3' ' HG3' ' A' ' 13' ' ' GLU . 14.5 ptm180 -71.17 -29.91 65.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.925 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.735 ' HG3' ' HG3' ' A' ' 12' ' ' ARG . 87.2 mt-10 -111.09 42.44 1.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.965 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.859 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.3 mtt180 -107.23 117.85 35.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.944 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.645 ' O ' ' O ' ' A' ' 16' ' ' ASN . 84.6 mm-40 -87.55 100.14 12.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.665 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.4 t-20 -24.92 150.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.814 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.817 ' HB2' ' N ' ' A' ' 46' ' ' TYR . 53.0 t -140.79 2.17 1.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.54 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -148.44 -138.99 3.1 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.294 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 1.097 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 43.9 p90 -105.82 -177.9 0.55 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.595 0.236 . . . . 0.0 110.745 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 1.097 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 38.3 Cg_endo -67.49 -62.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.49 2.127 . . . . 0.0 112.38 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.659 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -78.03 29.91 1.85 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.55 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.999 HG13 ' O ' ' A' ' 19' ' ' PHE . 27.5 m -56.95 133.05 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.359 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.855 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 79.2 p -117.01 178.24 1.04 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.954 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.855 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 50.6 Cg_exo -53.81 -40.05 81.73 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.677 2.252 . . . . 0.0 112.271 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.643 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 47.8 t -88.35 -31.56 18.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.799 ' HB2' ' H ' ' A' ' 23' ' ' THR . 52.9 mt-30 -73.46 -33.8 65.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.896 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.938 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.2 t -87.48 -50.2 6.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.32 70.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.003 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.643 ' HB2' ' O ' ' A' ' 25' ' ' SER . 38.1 t-20 -57.04 -21.0 27.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -102.45 -28.85 11.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.946 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.48 -6.36 14.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.405 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.938 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 85.4 m -70.67 -170.07 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 110.904 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.842 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 72.3 m -116.11 155.06 28.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 36' ' ' ASP . 66.3 t80 -131.35 118.25 20.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.594 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 16.9 t70 -131.03 79.89 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 34' ' ' PHE . 24.7 p-10 -72.94 13.47 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.576 ' OG1' ' OD2' ' A' ' 35' ' ' ASP . 76.4 p -79.56 -16.41 55.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.081 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.703 HG21 ' CG ' ' A' ' 11' ' ' PRO . 63.2 t -131.39 109.63 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.095 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.813 ' HG2' ' H ' ' A' ' 40' ' ' GLY . 59.9 ttt180 -79.01 -176.93 5.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.813 ' H ' ' HG2' ' A' ' 39' ' ' ARG . . . 73.07 -38.45 0.79 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.383 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.852 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.0 m -98.44 168.03 10.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 111.049 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.852 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 48.1 Cg_endo -68.75 120.9 7.78 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 0.0 112.207 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.8 m0 -67.43 -45.24 76.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.842 ' CB ' HG21 ' A' ' 22' ' ' VAL . 42.5 t -91.87 116.13 28.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.741 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.574 ' C ' ' CB ' ' A' ' 17' ' ' CYS . 52.1 p90 -139.17 168.91 18.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.965 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.817 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 83.6 m-85 -68.71 135.08 90.24 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.687 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 61.3 Cg_endo -73.35 -156.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.758 2.305 . . . . 0.0 112.318 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.844 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 13.1 m120 -139.55 93.53 2.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.722 HG22 ' HG2' ' A' ' 5' ' ' GLU . 67.3 p -77.77 118.42 20.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.156 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 61.7 mt -128.36 147.21 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.027 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.741 ' HB3' ' HG3' ' A' ' 3' ' ' GLN . 4.5 p30 -160.43 153.74 21.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.008 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.791 HG12 ' O ' ' A' ' 52' ' ' VAL . 57.7 t -135.8 34.08 0.24 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.011 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 52' ' ' VAL . 56.8 Cg_endo -71.15 157.73 56.72 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.722 2.282 . . . . 0.0 112.328 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.99 69.62 2.31 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.767 2.311 . . . . 0.0 112.311 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.534 ' OE1' ' HG2' ' A' ' 53' ' ' PRO . 12.4 pt-20 -132.32 -38.33 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -97.35 -75.34 0.55 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.824 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.623 ' OE1' ' HA ' ' A' ' 57' ' ' GLU . 6.2 mm-40 -94.24 140.76 29.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.876 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' B' ' 59' ' ' GLU . 51.5 t -116.6 -51.48 2.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -84.45 -87.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 62.0 t80 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.925 -179.882 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' B' ' 1' ' ' GLU . 10.3 tp10 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ALA . . . . . 0.442 ' O ' ' NE2' ' B' ' 3' ' ' GLN . . . -108.09 154.18 22.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.033 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.758 ' HB3' ' CG2' ' B' ' 49' ' ' THR . 85.0 mm-40 -155.34 154.88 32.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.689 ' O ' ' HA ' ' B' ' 49' ' ' THR . 75.0 p -148.27 139.37 23.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.054 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.738 ' HA ' ' O ' ' B' ' 48' ' ' ASN . 21.1 mp0 -101.56 130.03 47.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.946 HG22 ' H ' ' B' ' 8' ' ' THR . 86.7 m -138.84 171.53 14.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.057 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.731 ' N ' HG22 ' B' ' 6' ' ' THR . 75.7 m -109.9 3.91 21.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.008 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.946 ' H ' HG22 ' B' ' 6' ' ' THR . 9.1 t -73.8 92.24 2.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.893 HG11 ' HA ' ' B' ' 14' ' ' ARG . 59.1 t -128.98 157.14 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.159 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.907 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -74.06 114.08 29.51 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.96 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.741 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 88.4 Cg_exo -40.31 -28.67 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.813 2.342 . . . . 0.0 112.461 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ARG . . . . . 0.652 ' HG3' ' HG3' ' B' ' 13' ' ' GLU . 16.6 ptp180 -90.13 -29.82 18.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.726 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 44.6 mt-10 -104.58 9.59 35.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.076 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.907 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -69.89 145.93 51.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.921 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 17.6 mp0 -89.99 97.42 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.662 ' OD1' ' N ' ' B' ' 17' ' ' CYS . 36.5 t-20 -48.0 149.12 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.018 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' CYS . . . . . 0.883 ' SG ' ' HD3' ' B' ' 30' ' ' LYS . 44.7 t -135.26 1.02 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 110.764 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.611 ' N ' ' OD1' ' B' ' 16' ' ' ASN . . . -170.96 -134.42 1.76 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.289 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 0.863 ' CZ ' ' HA ' ' B' ' 22' ' ' VAL . 35.4 p90 -105.35 167.65 9.47 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 111.041 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.797 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 42.3 Cg_endo -68.15 -25.15 37.57 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.762 2.308 . . . . 0.0 112.436 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.711 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -95.56 6.44 67.87 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.535 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.863 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 35.0 m -49.55 137.05 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 111.275 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' THR . . . . . 0.944 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 80.2 p -110.95 -179.64 0.68 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.971 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.944 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 75.9 Cg_exo -49.79 -50.09 14.17 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.594 2.196 . . . . 0.0 112.393 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.0 m -74.7 -27.68 60.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.924 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.771 ' HB2' ' H ' ' B' ' 23' ' ' THR . 10.2 mm-40 -73.84 -32.09 63.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' CYS . . . . . 0.684 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 42.1 t -83.65 -53.87 5.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.817 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.95 67.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.988 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -49.94 -32.24 14.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.883 ' HD3' ' SG ' ' B' ' 17' ' ' CYS . 63.0 tttp -98.79 -25.8 14.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.88 66.82 1.13 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.665 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' CYS . . . . . 0.82 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 76.4 m -149.99 160.6 43.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 82.2 m -60.58 154.78 20.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.791 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.615 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 52.0 t80 -132.71 117.65 18.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.915 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.421 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 32.3 t0 -138.16 83.81 2.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -83.87 58.33 4.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' THR . . . . . 0.421 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 78.3 p -113.23 -25.29 8.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.108 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -122.77 118.83 56.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.149 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ARG . . . . . 0.81 ' HG2' ' H ' ' B' ' 40' ' ' GLY . 37.4 ttm180 -75.31 -178.18 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' GLY . . . . . 0.81 ' H ' ' HG2' ' B' ' 39' ' ' ARG . . . 70.64 -37.08 0.47 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.44 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.753 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.1 m -99.5 165.19 15.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.822 0.344 . . . . 0.0 111.08 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.753 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 43.9 Cg_endo -68.18 130.94 22.39 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.763 2.309 . . . . 0.0 112.167 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.555 ' HE3' ' O ' ' B' ' 22' ' ' VAL . 50.2 m0 -78.31 -18.86 54.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' CYS . . . . . 0.82 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 51.4 t -121.3 124.32 44.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.681 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 36.9 p90 -142.56 170.5 15.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -80.3 154.86 74.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.87 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.4 -170.58 0.38 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.216 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.738 ' O ' ' HA ' ' B' ' 5' ' ' GLU . 17.1 m120 -149.64 140.84 23.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.957 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.758 ' CG2' ' HB3' ' B' ' 3' ' ' GLN . 93.8 m -115.62 104.91 12.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 62.4 mt -86.91 148.1 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.105 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.697 ' HB3' HE22 ' B' ' 3' ' ' GLN . 24.4 p-10 -117.67 128.01 54.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.752 HG23 ' O ' ' B' ' 52' ' ' VAL . 33.3 m -96.87 86.01 0.36 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.198 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' B' ' 51' ' ' ASP . 56.0 Cg_endo -70.2 161.18 46.95 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.713 2.275 . . . . 0.0 112.279 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.562 ' O ' ' CD ' ' B' ' 55' ' ' GLU . 54.8 Cg_endo -70.09 -110.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.682 2.255 . . . . 0.0 112.247 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' GLU . . . . . 0.608 ' HA ' ' OE1' ' B' ' 55' ' ' GLU . 6.4 mm-40 -164.22 -152.37 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' B' ' 56' ' ' GLU . 23.0 pt-20 -98.04 99.21 10.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.915 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.969 ' N ' ' OE1' ' B' ' 57' ' ' GLU . 7.4 pm0 -143.47 -14.18 0.67 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.896 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' CYS . . . . . 0.659 ' SG ' ' HD1' ' B' ' 60' ' ' PHE . 50.2 t -88.75 -137.54 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.908 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLU . . . . . 0.643 ' N ' ' SG ' ' B' ' 58' ' ' CYS . 41.7 tt0 -134.45 -8.95 2.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' PHE . . . . . 0.659 ' HD1' ' SG ' ' B' ' 58' ' ' CYS . 50.0 m-85 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.886 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.905 ' OE1' ' N ' ' A' ' 1' ' ' GLU . 10.8 mp0 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.861 0.363 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.602 ' O ' ' CD ' ' A' ' 3' ' ' GLN . . . -76.77 106.3 8.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.997 ' HB3' ' HA ' ' A' ' 51' ' ' ASP . 69.8 mm-40 -152.16 101.55 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.751 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 3' ' ' GLN . 70.7 p -170.44 -159.91 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -176.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.948 ' HG2' HG22 ' A' ' 49' ' ' THR . 53.2 mt-10 -99.78 124.84 45.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.666 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.795 ' CG2' HG22 ' A' ' 8' ' ' THR . 95.0 m -111.68 162.36 15.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.382 -178.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.574 ' N ' HG22 ' A' ' 6' ' ' THR . 72.5 m -143.19 -2.3 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.033 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.795 HG22 ' CG2' ' A' ' 6' ' ' THR . 9.8 t -71.91 62.26 0.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.147 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.642 HG12 ' N ' ' A' ' 10' ' ' ALA . 58.4 t -106.56 165.62 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.846 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -91.6 123.62 63.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.898 ' HB3' HG21 ' A' ' 41' ' ' VAL . 80.7 Cg_exo -44.91 -39.4 14.15 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.728 2.285 . . . . 0.0 112.395 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -66.63 -29.98 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.796 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -112.41 39.26 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.061 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.846 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 96.6 mtt180 -108.26 152.91 23.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.566 ' O ' ' O ' ' A' ' 16' ' ' ASN . 1.3 mp0 -108.24 93.79 4.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.066 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.683 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.5 t-20 -27.7 150.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.683 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 42.1 t -138.02 0.82 2.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.518 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.564 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -177.54 -139.28 3.29 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.36 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.865 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 39.7 p90 -105.71 170.93 5.33 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.867 0.365 . . . . 0.0 110.986 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.865 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 58.4 Cg_endo -71.84 -36.5 6.12 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.767 2.312 . . . . 0.0 112.415 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . -58.63 -38.98 92.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.525 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.828 HG21 ' CB ' ' A' ' 44' ' ' CYS . 34.2 m -30.34 155.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.805 0.336 . . . . 0.0 111.224 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.866 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 75.3 p -122.74 176.22 2.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.096 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.866 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 53.1 Cg_exo -52.43 -49.09 18.62 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -77.33 -42.33 37.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.708 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 78.4 mt-30 -59.43 -37.9 79.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 34' ' ' PHE . 53.9 t -72.53 -59.24 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.92 -26.87 38.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -67.98 -11.66 59.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.84 ' HD3' ' C ' ' A' ' 30' ' ' LYS . 7.8 tmtt? -100.37 -51.98 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.44 37.69 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.484 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.894 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 71.2 m -149.56 163.07 38.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.832 0.348 . . . . 0.0 111.069 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.858 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 72.6 m -76.15 155.12 34.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.695 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.72 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 77.3 t80 -122.47 136.82 54.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.663 ' CB ' HH12 ' A' ' 14' ' ' ARG . 26.6 t0 -155.72 79.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.702 ' HA ' ' CG ' ' A' ' 43' ' ' TRP . 24.5 p-10 -88.18 40.5 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.5 p -113.45 -13.9 12.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.708 HG12 HG22 ' A' ' 41' ' ' VAL . 62.7 t -113.89 104.09 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.119 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 41' ' ' VAL . 98.5 mtt180 -70.47 175.52 4.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.86 -20.19 0.4 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.397 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.898 HG21 ' HB3' ' A' ' 11' ' ' PRO . 33.0 m -119.87 163.1 29.69 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.784 0.325 . . . . 0.0 111.162 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.693 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 55.5 Cg_endo -70.08 127.29 14.14 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.696 2.264 . . . . 0.0 112.266 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.702 ' CG ' ' HA ' ' A' ' 36' ' ' ASP . 49.9 m0 -72.16 -50.21 29.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.828 ' CB ' HG21 ' A' ' 22' ' ' VAL . 47.3 t -93.81 112.27 24.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.738 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.8 ' CE1' ' HD3' ' A' ' 14' ' ' ARG . 40.0 p90 -136.44 163.72 29.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.547 ' HD2' ' CB ' ' A' ' 15' ' ' GLN . 35.2 m-85 -57.81 134.72 83.14 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.666 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.894 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 96.8 Cg_endo -80.85 -156.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.842 2.361 . . . . 0.0 112.578 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.517 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 13.1 m120 -139.53 81.34 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.851 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.948 HG22 ' HG2' ' A' ' 5' ' ' GLU . 68.5 p -91.78 103.42 15.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.076 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 4' ' ' THR . 33.3 mt -135.95 131.17 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.943 0.401 . . . . 0.0 111.12 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.997 ' HA ' ' HB3' ' A' ' 3' ' ' GLN . 24.7 p-10 -161.82 151.09 15.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.94 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.047 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 31.7 m -113.01 8.89 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.548 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 1.047 ' HD3' ' N ' ' A' ' 52' ' ' VAL . 13.5 Cg_exo -69.32 177.26 5.45 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.682 2.254 . . . . 0.0 112.142 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.606 ' HB2' ' OE1' ' A' ' 55' ' ' GLU . 57.0 Cg_endo -71.01 -121.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.769 2.313 . . . . 0.0 112.301 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.974 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 7.2 pm0 -151.61 -138.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' N ' ' HG2' ' A' ' 55' ' ' GLU . 12.6 pt-20 -90.61 9.21 30.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.565 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 45.1 mt-10 -136.35 102.49 4.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 80.1 m -117.46 -34.06 4.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.833 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -116.08 40.2 2.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.929 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.927 -179.781 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.816 0.341 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.5 120.02 5.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLN . . . . . 0.658 ' CG ' ' OD1' ' B' ' 51' ' ' ASP . 1.2 mp0 -82.82 167.21 18.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.854 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.717 ' O ' ' HA ' ' B' ' 49' ' ' THR . 68.3 p -163.73 143.86 8.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.21 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.912 ' HB3' ' HB2' ' B' ' 47' ' ' PRO . 62.6 mt-10 -86.53 124.93 33.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.875 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.701 ' CG2' HG22 ' B' ' 8' ' ' THR . 93.7 m -116.71 167.53 11.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' CYS . . . . . 0.67 ' N ' HG22 ' B' ' 6' ' ' THR . 71.6 m -118.26 -25.2 6.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.997 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' THR . . . . . 0.701 HG22 ' CG2' ' B' ' 6' ' ' THR . 9.0 t -76.7 80.16 3.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.059 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.844 HG21 ' CG ' ' B' ' 48' ' ' ASN . 66.6 t -129.22 177.4 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.247 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.83 ' N ' HG12 ' B' ' 9' ' ' VAL . . . -85.38 151.87 57.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.927 ' HG3' HG11 ' B' ' 38' ' ' VAL . 43.2 Cg_exo -56.36 -16.57 18.3 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.787 2.325 . . . . 0.0 112.321 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -82.92 -29.92 28.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.063 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLU . . . . . 0.755 ' HB2' ' CG1' ' B' ' 9' ' ' VAL . 45.1 mt-10 -94.8 -20.07 19.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' ARG . . . . . 0.677 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 96.5 mtt180 -63.29 94.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLN . . . . . 0.651 ' O ' ' O ' ' B' ' 16' ' ' ASN . 53.3 tt0 -79.66 98.75 7.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ASN . . . . . 0.651 ' O ' ' O ' ' B' ' 15' ' ' GLN . 43.4 t30 -23.61 149.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.257 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' CYS . . . . . 0.549 ' O ' ' HD3' ' B' ' 30' ' ' LYS . 42.6 t -141.89 4.45 1.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.535 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.96 -137.68 2.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.395 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' PHE . . . . . 1.033 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 29.1 p90 -105.32 175.42 2.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.327 . . . . 0.0 110.84 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 1.033 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 38.4 Cg_endo -67.11 -32.74 33.5 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.604 2.203 . . . . 0.0 112.482 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.733 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -93.84 5.2 72.7 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.602 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.946 HG13 ' O ' ' B' ' 19' ' ' PHE . 27.0 m -37.86 153.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 111.316 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' THR . . . . . 1.044 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 76.1 p -128.35 173.89 5.05 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.816 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 1.044 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 15.3 Cg_endo -57.46 -32.0 92.92 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.58 2.187 . . . . 0.0 112.221 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -85.14 -50.06 7.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' GLN . . . . . 0.435 ' HB2' ' H ' ' B' ' 23' ' ' THR . 52.7 mt-30 -61.01 -32.73 72.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.4 t -78.92 -55.4 5.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.787 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' B' ' 31' ' ' GLY . . . -48.35 -33.87 9.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -49.8 -29.44 7.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.424 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' LYS . . . . . 0.549 ' HD3' ' O ' ' B' ' 17' ' ' CYS . 27.9 mtpp -97.82 -13.53 21.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.544 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' B' ' 28' ' ' ALA . . . 78.27 49.47 6.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.555 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' CYS . . . . . 0.745 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 71.0 m -126.33 166.98 16.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 110.947 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 77.8 m -75.08 149.52 39.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' PHE . . . . . 0.548 ' HE1' ' O ' ' B' ' 22' ' ' VAL . 73.4 t80 -126.95 126.92 44.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.635 ' OD1' HG23 ' B' ' 38' ' ' VAL . 16.6 t70 -149.83 80.47 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.961 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ASP . . . . . 0.803 ' HA ' ' CG ' ' B' ' 43' ' ' TRP . 24.5 p-10 -72.14 4.6 3.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 72.3 p -75.3 -7.07 52.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.052 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.927 HG11 ' HG3' ' B' ' 11' ' ' PRO . 68.1 t -115.75 112.46 39.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.181 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -89.01 149.18 23.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.32 -37.3 3.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.412 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' VAL . . . . . 0.911 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.3 m -112.43 169.76 6.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.35 . . . . 0.0 111.108 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' PRO . . . . . 0.911 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 51.7 Cg_endo -69.35 121.0 7.77 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.744 2.296 . . . . 0.0 112.229 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' TRP . . . . . 0.803 ' CG ' ' HA ' ' B' ' 36' ' ' ASP . 36.7 m0 -62.13 -45.02 95.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' CYS . . . . . 0.812 ' CB ' HG21 ' B' ' 22' ' ' VAL . 51.0 t -86.31 120.91 28.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.803 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' PHE . . . . . 0.745 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 52.5 p90 -148.81 162.14 40.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' TYR . . . . . 0.452 ' O ' ' HD1' ' B' ' 45' ' ' PHE . 92.6 m-85 -68.94 155.92 92.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' PRO . . . . . 0.912 ' HB2' ' HB3' ' B' ' 5' ' ' GLU . 28.2 Cg_endo -62.8 -173.48 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.774 2.316 . . . . 0.0 112.179 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ASN . . . . . 0.844 ' CG ' HG21 ' B' ' 9' ' ' VAL . 35.0 m-80 -134.33 81.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.109 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' THR . . . . . 0.864 ' HB ' ' HG2' ' B' ' 5' ' ' GLU . 8.0 t -85.96 90.18 8.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.853 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ILE . . . . . 0.719 HG22 ' N ' ' B' ' 51' ' ' ASP . 61.7 mt -107.96 170.07 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.392 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ASP . . . . . 0.719 ' N ' HG22 ' B' ' 50' ' ' ILE . 1.4 m-20 -108.79 177.33 4.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.758 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' VAL . . . . . 0.879 ' H ' ' HD3' ' B' ' 53' ' ' PRO . 57.3 t -155.21 23.88 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' PRO . . . . . 0.879 ' HD3' ' H ' ' B' ' 52' ' ' VAL . 71.5 Cg_endo -74.82 134.3 17.97 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.677 2.251 . . . . 0.0 112.374 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' B' ' 53' ' ' PRO . 13.8 Cg_exo -69.59 160.37 49.99 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.882 2.388 . . . . 0.0 112.184 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -119.98 -164.42 1.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' GLU . . . . . 0.491 ' N ' ' OE1' ' B' ' 56' ' ' GLU . 21.2 mp0 -94.73 -139.77 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.433 ' N ' ' CD ' ' B' ' 57' ' ' GLU . 0.5 OUTLIER -82.97 168.47 16.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 58' ' ' CYS . . . . . . . . . . . . . 26.7 p -133.64 103.39 5.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -105.15 -71.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.902 179.738 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.912 HG21 HG22 ' A' ' 8' ' ' THR . 86.2 m . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.706 0.288 . . . . 0.0 111.033 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.813 ' N ' HG22 ' A' ' 6' ' ' THR . 77.1 m -123.71 -15.7 6.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.176 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.912 HG22 HG21 ' A' ' 6' ' ' THR . 10.2 t -70.88 69.28 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.794 HG22 HD22 ' A' ' 48' ' ' ASN . 60.1 t -114.89 171.81 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.154 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.834 ' C ' ' HG3' ' A' ' 14' ' ' ARG . . . -86.77 121.19 71.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.962 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.79 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 82.8 Cg_exo -45.22 -59.46 1.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.825 2.35 . . . . 0.0 112.44 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.639 ' HG3' ' HG3' ' A' ' 13' ' ' GLU . 37.9 ptt180 -46.42 -29.81 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.639 ' HG3' ' HG3' ' A' ' 12' ' ' ARG . 45.1 mt-10 -104.68 -17.83 14.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.834 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 99.4 mtt180 -51.96 139.4 22.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.758 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.52 ' O ' ' HD1' ' A' ' 46' ' ' TYR . 12.2 mm100 -90.85 98.48 11.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.786 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.568 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.6 t-20 -41.96 143.0 0.61 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.568 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 44.1 t -145.49 3.48 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.563 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 170.16 124.02 0.72 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.39 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.822 ' O ' HG22 ' A' ' 22' ' ' VAL . 52.6 p90 -44.88 163.88 0.19 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.812 0.339 . . . . 0.0 110.768 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.666 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 36.2 Cg_endo -65.5 -43.9 9.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.289 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.14 -13.67 1.07 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 19' ' ' PHE . 27.4 m -63.52 154.35 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 111.183 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.765 ' OG1' ' HG3' ' A' ' 26' ' ' GLN . 79.4 p -101.68 160.26 27.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.099 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 62.4 Cg_exo -51.21 -35.99 54.53 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.777 2.318 . . . . 0.0 112.306 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 80.2 p -75.74 -37.26 59.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.965 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.765 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 26.6 mt-30 -67.44 -55.67 12.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -55.67 -52.7 62.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.54 -22.54 66.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.015 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.59 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 27.4 t-20 -60.69 -19.09 57.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.834 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -102.21 -26.44 13.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.46 34.61 3.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.544 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.2 m -120.64 176.17 5.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.382 . . . . 0.0 111.037 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.9 m -86.02 155.27 20.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.958 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.683 ' HE2' HG23 ' A' ' 22' ' ' VAL . 19.5 t80 -135.55 108.1 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -125.58 103.24 7.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -96.24 24.23 5.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.0 p -90.71 -31.93 16.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.202 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 41' ' ' VAL . 63.9 t -100.5 121.23 51.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -91.69 155.15 18.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.57 -42.3 2.7 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.431 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.873 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.7 m -93.65 170.04 9.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 111.101 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.873 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 45.7 Cg_endo -68.47 121.05 7.96 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.73 2.286 . . . . 0.0 112.238 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.636 ' CE3' ' O ' ' A' ' 20' ' ' PRO . 49.9 m0 -68.59 -44.73 73.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.807 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 51.3 t -97.36 118.87 34.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.712 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.667 ' CE2' ' HD3' ' A' ' 14' ' ' ARG . 51.3 p90 -147.34 157.59 43.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.959 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.52 ' HD1' ' O ' ' A' ' 15' ' ' GLN . 84.7 m-85 -63.75 157.48 66.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.94 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.442 ' HD2' ' HB3' ' A' ' 46' ' ' TYR . 57.9 Cg_endo -71.68 -161.63 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.737 2.292 . . . . 0.0 112.309 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.794 HD22 HG22 ' A' ' 9' ' ' VAL . 35.4 p30 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.76 ' O ' ' CE2' ' B' ' 45' ' ' PHE . 62.2 m . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 120.909 0.385 . . . . 0.0 110.505 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.578 HG23 ' O ' ' B' ' 8' ' ' THR . 9.1 t -87.01 69.92 10.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.987 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.655 HG12 ' N ' ' B' ' 10' ' ' ALA . 59.5 t -89.83 166.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.044 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.909 ' HB3' ' HB2' ' B' ' 13' ' ' GLU . . . -47.54 113.48 2.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.776 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 80.0 Cg_exo -44.83 -46.03 13.14 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.829 2.352 . . . . 0.0 112.467 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -73.96 -29.97 62.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.909 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 45.1 mt-10 -92.83 -5.47 50.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.03 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.846 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.3 mtt180 -58.98 125.66 24.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.82 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.457 ' O ' ' HD1' ' B' ' 46' ' ' TYR . 8.1 tp-100 -80.29 98.29 7.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.748 HD22 ' HB3' ' B' ' 42' ' ' PRO . 27.3 t-20 -35.38 150.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.983 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' CYS . . . . . 0.435 ' O ' ' SG ' ' B' ' 17' ' ' CYS . 41.5 t -134.07 4.2 3.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.88 -133.72 2.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.437 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.856 ' CE1' HG12 ' B' ' 22' ' ' VAL . 35.6 p90 -105.13 164.29 15.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.907 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.708 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 37.5 Cg_endo -66.33 -31.02 44.34 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.721 2.281 . . . . 0.0 112.304 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.61 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -82.64 -2.64 90.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.458 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.876 HG21 ' CB ' ' B' ' 44' ' ' CYS . 29.1 m -47.11 147.79 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.915 0.388 . . . . 0.0 111.295 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' THR . . . . . 1.032 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 67.1 p -123.0 175.34 2.76 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 1.032 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 10.6 Cg_endo -53.6 -43.56 56.7 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.651 2.234 . . . . 0.0 112.091 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.5 p -76.88 -46.79 23.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.698 ' HB2' ' H ' ' B' ' 23' ' ' THR . 15.2 mm100 -57.29 -50.48 72.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 46.4 t -60.05 -57.1 14.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.728 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.01 -35.58 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.773 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.638 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 38.4 t-20 -49.94 -36.85 29.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.791 ' HZ2' ' HB3' ' B' ' 30' ' ' LYS . 2.6 mmmp? -88.14 -41.35 13.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.537 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.89 58.39 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.734 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' CYS . . . . . 0.805 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 82.6 m -140.89 174.69 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.359 . . . . 0.0 110.971 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 1.019 ' SG ' ' HG3' ' B' ' 47' ' ' PRO . 73.6 m -92.82 134.2 35.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.904 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.787 ' CZ ' ' HB3' ' B' ' 36' ' ' ASP . 59.4 t80 -91.39 153.06 20.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.122 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.437 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 32.4 t0 -170.2 79.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.834 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 25.3 p30 -90.02 30.41 1.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . 0.437 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 71.5 p -83.5 -4.9 58.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.083 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 61.0 t -138.3 128.03 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.309 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.833 ' NH1' ' CZ2' ' B' ' 43' ' ' TRP . 22.1 mmm180 -80.92 -178.58 6.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.53 -32.44 0.22 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.563 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.557 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.2 m -104.29 158.95 30.86 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.883 0.373 . . . . 0.0 111.068 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.748 ' HB3' HD22 ' B' ' 16' ' ' ASN . 55.3 Cg_endo -69.9 136.78 33.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.733 2.288 . . . . 0.0 112.277 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.834 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 48.7 m0 -79.73 -32.43 41.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' CYS . . . . . 0.876 ' CB ' HG21 ' B' ' 22' ' ' VAL . 50.6 t -95.01 115.25 27.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.522 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.805 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 6.0 p90 -145.73 172.98 12.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.816 -176.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' B' ' 15' ' ' GLN . 92.7 m-85 -85.33 133.71 41.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.621 176.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . 1.019 ' HG3' ' SG ' ' B' ' 33' ' ' CYS . 56.2 Cg_endo . . . . . 0 N--CA 1.457 -0.66 0 C-N-CA 123.343 2.695 . . . . 0.0 112.629 -177.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.962 HG22 ' H ' ' A' ' 8' ' ' THR . 86.1 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.762 0.315 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.808 ' N ' HG22 ' A' ' 6' ' ' THR . 71.4 m -133.93 -2.0 2.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.266 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.962 ' H ' HG22 ' A' ' 6' ' ' THR . 9.6 t -75.69 75.2 2.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.137 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.759 ' CG2' HD21 ' A' ' 48' ' ' ASN . 62.1 t -116.4 161.67 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.89 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -81.33 132.15 56.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.943 ' HB3' HG21 ' A' ' 41' ' ' VAL . 85.5 Cg_exo -40.62 -32.1 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.823 2.349 . . . . 0.0 112.507 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -90.04 -29.74 18.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 10' ' ' ALA . 81.6 mm-40 -92.43 -6.0 50.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.001 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.89 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.4 mtt180 -69.37 118.04 11.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.614 ' O ' ' O ' ' A' ' 16' ' ' ASN . 8.1 tp-100 -79.96 93.12 5.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.696 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 2.6 t-20 -24.98 148.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.77 ' HB2' ' N ' ' A' ' 46' ' ' TYR . 50.5 t -143.68 3.0 1.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.116 0.484 . . . . 0.0 110.188 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.683 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . -156.55 -142.85 3.51 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.113 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.929 ' CZ ' ' HA ' ' A' ' 22' ' ' VAL . 27.4 p90 -105.75 168.91 7.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.793 0.33 . . . . 0.0 111.064 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.833 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 40.7 Cg_endo -67.78 -20.08 46.35 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.258 . . . . 0.0 112.436 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.716 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -102.64 4.96 50.79 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.545 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.929 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 27.7 m -39.9 163.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.008 0.433 . . . . 0.0 111.39 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.012 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 76.4 p -143.94 175.75 2.65 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.762 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.012 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 17.2 Cg_endo -57.74 -35.46 98.79 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.654 2.236 . . . . 0.0 112.196 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 29' ' ' ASN . 51.2 m -89.41 -41.26 12.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.056 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.701 HE21 ' CG2' ' A' ' 23' ' ' THR . 48.6 mt-30 -69.06 -29.86 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.039 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.951 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.8 t -93.85 -36.58 12.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.921 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -79.25 -12.15 59.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 25' ' ' SER . 43.2 t30 -91.75 -16.97 26.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -101.34 -33.2 10.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.939 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.54 43.7 0.63 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.951 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 76.1 m -126.94 161.89 27.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.932 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.76 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 77.1 m -85.83 134.77 33.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.644 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.526 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 50.1 t80 -113.59 122.04 46.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.882 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.661 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 16.5 t70 -145.81 99.08 3.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -91.74 54.71 2.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.901 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.478 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 74.3 p -94.99 -31.88 13.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 41' ' ' VAL . 63.3 t -133.97 120.92 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.229 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.577 ' C ' ' H ' ' A' ' 41' ' ' VAL . 35.3 ptt180 -73.47 -175.61 2.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.83 -28.84 0.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.434 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.943 HG21 ' HB3' ' A' ' 11' ' ' PRO . 33.9 m -101.23 166.71 11.88 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.0 111.156 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 60.1 Cg_endo -72.5 120.01 6.47 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.826 2.35 . . . . 0.0 112.225 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.461 ' HE1' ' HA ' ' A' ' 39' ' ' ARG . 51.8 m0 -78.21 -34.07 49.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.898 ' CB ' HG21 ' A' ' 22' ' ' VAL . 51.3 t -101.77 110.29 22.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.789 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.76 ' CE1' ' HD3' ' A' ' 14' ' ' ARG . 51.7 p90 -134.04 175.83 9.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.77 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 92.4 m-85 -76.0 154.14 84.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.857 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' THR . 57.4 Cg_endo -71.35 -156.78 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.694 2.263 . . . . 0.0 112.431 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.759 HD21 ' CG2' ' A' ' 9' ' ' VAL . 75.9 m-20 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 86.0 m . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.805 0.336 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . . . . . . . . . 9.8 t -117.73 49.19 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.106 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.69 HG12 ' N ' ' B' ' 10' ' ' ALA . 61.3 t -103.9 168.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.112 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.882 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -74.45 121.09 84.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.038 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.774 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 87.8 Cg_exo -46.17 -24.77 2.6 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.807 2.338 . . . . 0.0 112.542 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.64 ' HG3' ' HG2' ' B' ' 13' ' ' GLU . 13.8 ptp180 -87.69 -29.96 20.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.64 ' HG2' ' HG3' ' B' ' 12' ' ' ARG . 6.3 mm-40 -108.3 34.61 3.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.015 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.882 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.1 mtt180 -95.49 149.35 21.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.758 ' HB2' ' HB2' ' B' ' 46' ' ' TYR . 17.1 mp0 -82.11 95.23 7.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.61 ' O ' ' CE2' ' B' ' 46' ' ' TYR . 27.4 t-20 -41.91 131.95 3.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' CYS . . . . . 0.663 ' HB2' ' CD2' ' B' ' 46' ' ' TYR . 44.3 t -145.82 3.99 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.792 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.59 123.02 0.65 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.504 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.752 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 52.5 p90 -45.02 166.71 0.12 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 120.835 0.35 . . . . 0.0 110.94 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.752 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 44.3 Cg_endo -68.28 -29.52 32.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.759 2.306 . . . . 0.0 112.323 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.705 ' H ' ' HD2' ' B' ' 19' ' ' PHE . . . -61.33 -10.65 23.27 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.449 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.697 HG22 ' O ' ' B' ' 19' ' ' PHE . 33.1 m -66.5 165.97 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.76 0.314 . . . . 0.0 111.159 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' THR . . . . . 0.834 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 72.8 p -126.29 175.03 3.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.834 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 56.8 Cg_exo -51.75 -44.19 46.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.722 2.281 . . . . 0.0 112.297 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 54.6 m -74.89 -47.74 28.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.619 ' HB2' ' H ' ' B' ' 23' ' ' THR . 52.9 mt-30 -54.62 -46.56 73.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.894 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' B' ' 30' ' ' LYS . 42.6 t -65.32 -67.21 0.46 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.804 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.07 -42.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.805 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 7.0 t30 -50.18 -37.17 33.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.574 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' B' ' 27' ' ' CYS . 34.5 mmtp -84.02 -37.37 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.595 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.34 59.88 0.83 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.635 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' CYS . . . . . 0.407 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 74.1 m -150.2 170.38 19.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 110.939 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.848 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.5 m -66.71 150.15 49.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.816 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -128.03 120.08 26.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.789 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' B' ' 43' ' ' TRP . 26.4 t0 -134.96 98.17 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.746 ' HA ' ' CD2' ' B' ' 43' ' ' TRP . 24.5 p-10 -96.81 46.16 1.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 74.9 p -119.77 -39.93 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.106 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.793 HG12 HG22 ' B' ' 41' ' ' VAL . 59.5 t -90.02 139.27 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.152 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.637 ' NH1' ' HZ2' ' B' ' 43' ' ' TRP . 38.6 mmt180 -94.41 162.31 13.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.43 -47.71 1.15 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.793 HG22 HG12 ' B' ' 38' ' ' VAL . 32.8 m -77.12 151.43 81.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.46 120.03 6.91 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.705 2.27 . . . . 0.0 112.259 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.746 ' CD2' ' HA ' ' B' ' 36' ' ' ASP . 35.5 m0 -64.06 -46.39 84.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.878 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' CYS . . . . . 0.848 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 44.2 t -96.0 104.09 16.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.717 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.821 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 44.8 p90 -131.91 150.09 52.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.046 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.758 ' HB2' ' HB2' ' B' ' 15' ' ' GLN . 92.3 m-85 -54.08 144.72 37.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo . . . . . 0 C--N 1.341 0.154 0 C-N-CA 122.707 2.271 . . . . 0.0 112.311 179.717 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.892 ' HB ' ' HB2' ' A' ' 48' ' ' ASN . 96.4 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.808 0.337 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' N ' HG22 ' A' ' 6' ' ' THR . 72.0 m -133.83 6.55 3.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.779 HG22 ' CG2' ' A' ' 6' ' ' THR . 9.1 t -89.43 66.71 7.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.181 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.743 HG12 ' N ' ' A' ' 10' ' ' ALA . 61.4 t -97.19 171.44 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.833 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -88.52 112.59 51.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.072 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.82 ' HB3' HG21 ' A' ' 41' ' ' VAL . 83.7 Cg_exo -44.03 -20.02 0.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.795 2.33 . . . . 0.0 112.486 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 10' ' ' ALA . 37.6 mmt180 -90.11 -30.01 17.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 10' ' ' ALA . 44.5 mt-10 -108.12 -4.37 17.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.069 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.833 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.4 mtt180 -54.26 134.26 44.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.648 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 10.1 mm-40 -93.02 79.94 4.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.818 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.633 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 51.6 t30 -27.63 150.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.831 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 41.3 t -125.26 8.18 7.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 110.567 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.631 ' O ' ' ND2' ' A' ' 16' ' ' ASN . . . -170.27 -132.39 1.46 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.216 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.938 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 30.8 p90 -105.76 173.77 3.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.798 0.333 . . . . 0.0 110.888 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.938 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 42.5 Cg_endo -68.15 -29.38 33.1 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.684 2.256 . . . . 0.0 112.457 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.657 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -89.28 -8.61 68.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.527 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.876 HG21 ' CB ' ' A' ' 44' ' ' CYS . 34.8 m -31.56 154.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.869 0.366 . . . . 0.0 111.327 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.013 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 74.5 p -123.99 172.72 5.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.134 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 1.013 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 28.1 Cg_endo -62.68 -33.08 78.29 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.756 2.304 . . . . 0.0 112.266 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.9 p -86.2 -38.0 18.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.685 ' NE2' ' HZ ' ' A' ' 19' ' ' PHE . 24.0 mt-30 -69.9 -41.73 74.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.91 -45.89 39.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.792 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -33.07 70.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.058 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.612 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 38.9 t-20 -53.21 -20.67 4.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.817 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.76 -28.51 14.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.52 18.69 9.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.432 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.93 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 70.8 m -102.38 179.62 4.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 0.0 111.036 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.751 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 78.9 m -93.79 155.06 17.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.786 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.551 ' HE2' ' OD2' ' A' ' 36' ' ' ASP . 73.7 t80 -134.24 127.19 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.427 ' OD1' ' OG1' ' A' ' 37' ' ' THR . 26.6 t0 -137.27 92.32 2.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.551 ' OD2' ' HE2' ' A' ' 34' ' ' PHE . 4.6 p30 -89.62 38.02 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.427 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 76.8 p -109.33 -10.46 14.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.596 HG12 HG22 ' A' ' 41' ' ' VAL . 62.6 t -117.61 104.61 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.164 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.734 ' HD2' ' N ' ' A' ' 39' ' ' ARG . 4.3 mpt_? -73.8 155.02 39.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.93 -49.44 1.98 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.438 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.928 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.1 m -92.4 170.55 8.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.753 0.311 . . . . 0.0 111.087 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.928 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 43.9 Cg_endo -68.1 145.64 67.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.604 2.203 . . . . 0.0 112.245 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -89.76 -30.98 17.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.898 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.876 ' CB ' HG21 ' A' ' 22' ' ' VAL . 43.1 t -97.38 128.03 43.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.692 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.751 ' CE2' ' HB2' ' A' ' 33' ' ' CYS . 48.6 p90 -146.12 157.72 43.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.904 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.648 ' CD2' ' O ' ' A' ' 15' ' ' GLN . 83.1 m-85 -70.26 135.63 86.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.93 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 58.3 Cg_endo -72.0 172.81 13.9 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.29 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.892 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 35.3 m-80 . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 74.7 m . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.734 0.302 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.44 HG23 ' O ' ' B' ' 8' ' ' THR . 8.8 t -97.77 55.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.992 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.649 HG12 ' N ' ' B' ' 10' ' ' ALA . 59.9 t -98.95 165.77 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.251 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.87 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -95.24 132.21 28.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.051 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.778 ' HB3' HG21 ' B' ' 41' ' ' VAL . 88.6 Cg_exo -43.84 -29.38 2.46 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.791 2.327 . . . . 0.0 112.49 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -86.71 -29.82 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.859 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' B' ' 10' ' ' ALA . 61.7 mt-10 -94.92 -11.52 28.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.989 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.87 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -61.89 127.14 29.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.971 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 8.1 tp-100 -92.89 99.74 12.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.856 HD22 ' HB3' ' B' ' 42' ' ' PRO . 27.3 t-20 -33.8 150.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.016 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' B' ' 17' ' ' CYS . 43.3 t -138.02 4.65 2.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.696 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.14 -136.85 2.12 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.379 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.831 ' CZ ' ' HA ' ' B' ' 22' ' ' VAL . 27.5 p90 -105.44 168.9 7.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 0.0 110.99 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.821 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 54.0 Cg_endo -70.13 -12.66 32.6 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.748 2.299 . . . . 0.0 112.408 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.744 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -107.85 5.6 34.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.508 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.831 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 34.0 m -47.94 158.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.166 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' THR . . . . . 0.912 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 79.8 p -133.77 178.83 1.58 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.068 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.912 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 56.8 Cg_exo -51.75 -54.79 4.72 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.7 m -72.89 -43.0 63.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.715 ' HB2' ' H ' ' B' ' 23' ' ' THR . 24.8 mt-30 -57.66 -38.83 75.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.941 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 46.3 t -72.92 -60.58 2.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.81 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.11 -34.75 1.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.973 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -50.02 -35.08 23.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.674 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -93.84 -32.41 13.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.708 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.92 58.35 0.84 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.616 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' CYS . . . . . 0.678 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 76.8 m -143.07 165.0 28.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.958 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.69 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 73.4 m -70.98 155.11 41.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.89 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.613 ' CE1' ' HA ' ' B' ' 23' ' ' THR . 67.8 t80 -132.32 119.16 20.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.6 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 16.6 t70 -130.1 96.58 4.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.749 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 4.6 p-10 -94.78 46.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 74.9 p -113.73 -31.99 6.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.518 HG12 HG22 ' B' ' 41' ' ' VAL . 63.5 t -107.87 111.43 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.162 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.667 ' NH1' ' HZ2' ' B' ' 43' ' ' TRP . 21.8 mmm180 -68.41 178.21 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.46 -54.82 0.9 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.475 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.778 HG21 ' HB3' ' B' ' 11' ' ' PRO . 33.2 m -82.22 156.32 69.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.814 0.34 . . . . 0.0 111.125 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.856 ' HB3' HD22 ' B' ' 16' ' ' ASN . 47.3 Cg_endo -68.7 140.35 46.61 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.662 2.241 . . . . 0.0 112.317 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.749 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 12.9 m0 -81.56 -47.51 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' CYS . . . . . 0.703 ' CB ' HG21 ' B' ' 22' ' ' VAL . 50.6 t -87.71 119.61 28.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.757 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.761 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 51.3 p90 -152.18 171.29 18.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.504 ' O ' ' HD2' ' B' ' 45' ' ' PHE . 84.9 m-85 -75.62 156.57 84.88 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.848 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 46' ' ' TYR . 54.7 Cg_endo . . . . . 0 C--N 1.341 0.161 0 C-N-CA 122.791 2.327 . . . . 0.0 112.305 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.845 HG22 ' N ' ' A' ' 7' ' ' CYS . 93.4 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.824 0.345 . . . . 0.0 111.117 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.845 ' N ' HG22 ' A' ' 6' ' ' THR . 71.7 m -108.69 12.72 25.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.631 HG22 ' CG2' ' A' ' 6' ' ' THR . 8.8 t -100.3 63.58 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.149 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.786 HG23 ' ND2' ' A' ' 48' ' ' ASN . 62.5 t -94.0 164.06 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.175 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.887 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -85.88 139.56 35.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.021 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.874 ' HG3' HG21 ' A' ' 38' ' ' VAL . 93.1 Cg_exo -42.07 -36.87 4.16 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.83 2.353 . . . . 0.0 112.481 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 1.065 ' HD3' ' N ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -90.23 -29.36 18.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.758 178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 1.065 ' N ' ' HD3' ' A' ' 12' ' ' ARG . 85.4 mt-10 -80.85 -12.96 59.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.985 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.887 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 97.6 mtt180 -71.7 113.57 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.073 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.668 ' O ' ' O ' ' A' ' 16' ' ' ASN . 8.0 tp-100 -80.58 95.5 6.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.678 HD22 ' CB ' ' A' ' 42' ' ' PRO . 27.4 t-20 -23.48 150.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.022 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 41.0 t -141.7 4.8 1.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.485 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.1 -139.58 4.86 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.388 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.849 ' CE2' ' N ' ' A' ' 22' ' ' VAL . 40.3 p90 -105.62 167.41 9.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.799 0.333 . . . . 0.0 110.83 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.806 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 38.5 Cg_endo -66.86 -41.91 9.56 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.61 2.207 . . . . 0.0 112.304 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . -61.9 -26.64 67.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.544 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.909 HG21 ' HB2' ' A' ' 44' ' ' CYS . 34.7 m -31.58 156.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 111.211 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.778 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 80.4 p -124.69 173.46 4.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.743 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 45.0 Cg_exo -56.27 -44.82 42.76 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.731 2.287 . . . . 0.0 112.308 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.562 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 80.1 p -75.73 -39.44 57.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.046 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.663 HE21 ' CG2' ' A' ' 23' ' ' THR . 48.2 mt-30 -67.54 -38.1 83.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.1 t -82.23 -51.82 7.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.96 75.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 25' ' ' SER . 42.9 t30 -54.66 -16.76 2.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -100.47 -22.6 14.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 -28.73 5.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.585 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.659 ' HB3' ' O ' ' A' ' 45' ' ' PHE . 71.6 m -68.86 179.74 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.882 0.372 . . . . 0.0 111.068 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.3 m -107.22 155.24 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.003 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.778 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 15.5 t80 -115.31 134.15 55.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.484 ' OD1' ' NH1' ' A' ' 14' ' ' ARG . 17.4 t70 -158.77 99.26 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.794 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.4 p-10 -96.68 32.54 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.415 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 72.6 p -91.21 -6.68 53.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.874 HG21 ' HG3' ' A' ' 11' ' ' PRO . 61.6 t -132.66 114.91 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.728 ' HD3' ' N ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -78.44 -175.79 4.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.01 -35.19 0.29 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.548 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.733 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.1 m -107.38 164.82 13.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.733 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 59.5 Cg_endo -72.34 127.15 12.31 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.698 2.265 . . . . 0.0 112.282 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.794 ' CD1' ' HA ' ' A' ' 36' ' ' ASP . 35.0 m0 -68.2 -33.72 74.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.861 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.909 ' HB2' HG21 ' A' ' 22' ' ' VAL . 53.4 t -91.31 120.27 32.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.659 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 39.5 p90 -147.36 160.09 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.694 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 86.5 m-85 -67.89 165.0 35.48 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.694 ' HD2' ' HB3' ' A' ' 46' ' ' TYR . 39.8 Cg_endo -67.03 172.02 10.43 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.663 2.242 . . . . 0.0 112.306 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.786 ' ND2' HG23 ' A' ' 9' ' ' VAL . 8.2 p30 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.813 0.339 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.623 HG23 ' O ' ' B' ' 8' ' ' THR . 9.5 t -82.13 73.24 9.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.821 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.952 HG11 ' HA ' ' B' ' 14' ' ' ARG . 50.1 t -107.19 166.42 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.375 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.838 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -94.21 122.61 61.15 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.92 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.786 ' HB3' HG11 ' B' ' 41' ' ' VAL . 98.9 Cg_exo -42.56 -26.96 0.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.864 2.376 . . . . 0.0 112.523 -178.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.584 ' HG3' ' HG2' ' B' ' 13' ' ' GLU . 16.7 ptm180 -90.05 -29.87 18.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.973 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.584 ' HG2' ' HG3' ' B' ' 12' ' ' ARG . 81.6 mm-40 -99.96 -11.73 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.177 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.952 ' HA ' HG11 ' B' ' 9' ' ' VAL . 96.7 mtt180 -51.54 127.19 19.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.873 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 1.015 HE21 ' HA ' ' B' ' 15' ' ' GLN . 0.0 OUTLIER -79.91 86.84 5.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.792 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.706 HD22 ' HB3' ' B' ' 42' ' ' PRO . 27.4 t-20 -30.01 133.67 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.105 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' CYS . . . . . 0.782 ' SG ' ' HD2' ' B' ' 30' ' ' LYS . 41.6 t -145.53 2.74 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.616 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' B' ' 44' ' ' CYS . . . 177.54 122.39 0.73 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.428 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.954 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 53.1 p90 -44.83 172.86 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.804 0.335 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.954 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 33.8 Cg_endo -64.61 -60.72 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.76 2.306 . . . . 0.0 112.226 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -39.3 -17.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.533 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.745 HG22 ' O ' ' B' ' 19' ' ' PHE . 32.1 m -52.13 158.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 111.138 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' THR . . . . . 0.825 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 74.5 p -135.27 173.99 5.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.825 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 54.5 Cg_exo -51.84 -42.63 56.54 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.779 2.319 . . . . 0.0 112.321 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.2 m -72.69 -48.61 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.982 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.563 ' O ' ' HB3' ' B' ' 29' ' ' ASN . 26.3 mt-30 -60.57 -54.4 45.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.3 t -54.27 -55.59 26.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.734 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.35 -40.21 11.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.957 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.563 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 38.3 t-20 -49.97 -41.51 46.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.782 ' HD2' ' SG ' ' B' ' 17' ' ' CYS . 39.6 ttmt -82.22 -36.22 27.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.55 63.57 0.86 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.704 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' CYS . . . . . 0.765 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 93.1 m -149.99 178.56 8.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 0.0 111.019 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.811 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 72.2 m -79.02 155.2 28.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.02 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.736 ' CE2' ' HA ' ' B' ' 23' ' ' THR . 42.6 t80 -123.4 111.06 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.663 ' O ' ' HA ' ' B' ' 43' ' ' TRP . 32.7 t0 -135.91 108.38 7.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.835 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 4.6 p-10 -111.9 31.28 6.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 81.1 p -84.09 -24.86 30.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.518 ' HB ' ' CG2' ' B' ' 41' ' ' VAL . 62.4 t -111.6 135.34 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.176 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -85.95 152.24 23.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.31 -43.6 3.16 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.542 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' B' ' 11' ' ' PRO . 32.8 m -81.59 154.58 71.2 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.905 0.383 . . . . 0.0 111.148 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.706 ' HB3' HD22 ' B' ' 16' ' ' ASN . 50.0 Cg_endo -69.21 136.84 35.55 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.783 2.322 . . . . 0.0 112.313 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.835 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 51.0 m0 -84.58 -54.37 4.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.002 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' CYS . . . . . 0.811 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 53.8 t -83.19 100.0 10.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.76 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.765 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 44.3 p90 -128.37 167.56 16.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.097 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.617 ' CD1' ' HB2' ' B' ' 17' ' ' CYS . 90.7 m-85 -74.46 147.46 84.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 0 C--N 1.341 0.181 0 C-N-CA 122.758 2.305 . . . . 0.0 112.335 179.635 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 48' ' ' ASN . 9.0 t . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.824 0.345 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.593 ' O ' ' HZ ' ' A' ' 45' ' ' PHE . 71.6 m -117.85 -8.24 10.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.952 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.743 HG22 ' OG1' ' A' ' 6' ' ' THR . 9.2 t -69.96 92.14 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.126 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.843 HG21 HD21 ' A' ' 48' ' ' ASN . 63.0 t -127.49 173.96 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.858 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -95.2 126.01 48.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.02 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.874 ' HG2' HG21 ' A' ' 38' ' ' VAL . 81.2 Cg_exo -44.91 -20.54 0.39 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.835 2.356 . . . . 0.0 112.443 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -89.1 -31.53 17.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' ALA . 62.3 mt-10 -109.77 45.6 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.858 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.1 mtt180 -111.02 142.92 42.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.652 ' O ' ' O ' ' A' ' 16' ' ' ASN . 17.0 mp0 -110.39 89.75 3.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.704 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 37.0 t-20 -23.02 147.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.716 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.746 ' SG ' ' CE1' ' A' ' 46' ' ' TYR . 43.5 t -137.64 2.83 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.126 0.488 . . . . 0.0 110.554 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -159.01 -137.91 2.35 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.242 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.957 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 41.1 p90 -105.86 172.82 3.64 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.746 0.308 . . . . 0.0 110.884 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.957 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 46.3 Cg_endo -68.95 -46.33 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.694 2.263 . . . . 0.0 112.366 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.622 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -75.25 6.56 28.43 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.587 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 19' ' ' PHE . 26.7 m -50.39 122.9 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 111.309 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.963 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 82.2 p -107.66 -178.51 0.59 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.961 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.963 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 74.5 Cg_exo -49.56 -46.89 24.85 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 53.8 m -84.29 -34.48 23.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 1.026 HE21 ' HA ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -65.55 -32.5 74.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 49.1 t -84.19 -53.43 5.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.789 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.27 -23.99 64.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 25' ' ' SER . 6.9 t30 -76.68 -12.26 59.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.938 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.909 ' HB3' ' HZ2' ' A' ' 30' ' ' LYS . 2.7 mmmp? -108.98 -13.92 14.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.913 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.35 34.29 7.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.517 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.996 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 82.7 m -122.65 164.47 18.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.761 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 74.2 m -81.44 153.43 26.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.62 ' HE1' ' O ' ' A' ' 22' ' ' VAL . 72.1 t80 -128.55 136.93 51.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.959 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.65 ' OD2' ' NH2' ' A' ' 14' ' ' ARG . 26.6 t0 -159.79 79.94 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -80.46 46.0 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.88 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -104.49 -4.81 22.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.202 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.874 HG21 ' HG2' ' A' ' 11' ' ' PRO . 67.8 t -145.93 118.59 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.29 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.607 ' C ' ' H ' ' A' ' 41' ' ' VAL . 78.0 mtm180 -76.78 -170.05 1.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.831 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.32 -30.24 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.446 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.854 HG21 ' HB3' ' A' ' 11' ' ' PRO . 32.9 m -111.26 161.91 23.14 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 111.077 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 40.9 Cg_endo -67.49 132.58 27.62 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.197 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -77.85 -35.26 51.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.002 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.996 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 44.7 t -103.88 105.83 16.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.648 ' HD1' ' O ' ' A' ' 46' ' ' TYR . 5.6 p90 -124.7 -169.95 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.055 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.746 ' CE1' ' SG ' ' A' ' 17' ' ' CYS . 90.5 m-85 -92.38 160.96 33.9 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 46' ' ' TYR . 57.4 Cg_endo -71.17 -158.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.313 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.843 HD21 HG21 ' A' ' 9' ' ' VAL . 34.5 m-80 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.573 ' O ' ' HZ ' ' B' ' 45' ' ' PHE . 82.5 m . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.808 0.337 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.585 HG23 ' O ' ' B' ' 8' ' ' THR . 8.9 t -93.67 71.83 4.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.869 HG11 ' HA ' ' B' ' 14' ' ' ARG . 59.5 t -109.53 172.5 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.94 ' HB1' ' CZ ' ' B' ' 12' ' ' ARG . . . -85.86 129.05 55.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.015 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.643 ' HB3' HG21 ' B' ' 41' ' ' VAL . 78.0 Cg_exo -39.69 -34.45 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.827 2.351 . . . . 0.0 112.426 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 1.032 ' H ' ' HD3' ' B' ' 12' ' ' ARG . 0.0 OUTLIER -90.12 -29.78 18.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.895 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.681 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 6.4 mm-40 -96.24 -5.22 40.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.174 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.901 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -63.06 133.9 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.674 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 1.028 HE21 ' HA ' ' B' ' 15' ' ' GLN . 0.0 OUTLIER -79.94 79.97 6.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.957 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 1.083 HD22 ' N ' ' B' ' 17' ' ' CYS . 0.2 OUTLIER -34.36 139.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.721 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' CYS . . . . . 1.083 ' N ' HD22 ' B' ' 16' ' ' ASN . 44.6 t -126.98 1.57 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.019 0.437 . . . . 0.0 110.593 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 1.04 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -179.36 -132.72 1.82 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.218 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.855 ' CE2' ' N ' ' B' ' 22' ' ' VAL . 21.3 p90 -105.8 165.61 12.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.349 . . . . 0.0 110.915 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.723 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 43.1 Cg_endo -67.96 -11.57 32.48 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.751 2.301 . . . . 0.0 112.288 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.646 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -98.53 -19.92 21.3 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.855 ' N ' ' CE2' ' B' ' 19' ' ' PHE . 34.5 m -27.7 139.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.0 111.141 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' THR . . . . . 0.833 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 75.9 p -109.7 176.25 1.62 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.091 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.833 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 51.6 Cg_exo -52.91 -49.83 16.19 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.75 2.3 . . . . 0.0 112.361 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 48.1 t -68.76 -41.09 79.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.004 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.45 ' HB2' ' H ' ' B' ' 23' ' ' THR . 52.8 mt-30 -65.69 -40.45 92.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.02 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' B' ' 33' ' ' CYS . 42.3 t -74.58 -41.71 60.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.802 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.8 -33.46 73.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.078 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -49.77 -35.0 20.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.76 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 1.057 ' HE2' ' HA ' ' B' ' 30' ' ' LYS . 0.5 OUTLIER -95.53 -38.05 10.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.521 177.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.07 57.01 0.61 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.522 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' CYS . . . . . 0.756 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 78.1 m -129.84 177.07 7.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.938 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.912 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 74.1 m -80.03 155.33 27.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.953 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.603 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 41.3 t80 -128.5 114.56 16.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.863 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 16.7 t70 -135.2 94.33 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.992 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.673 ' HA ' ' CG ' ' B' ' 43' ' ' TRP . 25.2 p30 -91.88 22.45 4.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.974 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -97.26 -8.44 29.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.219 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.816 HG21 ' NH2' ' B' ' 14' ' ' ARG . 63.2 t -122.27 106.18 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.089 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.423 ' C ' ' H ' ' B' ' 41' ' ' VAL . 95.3 mtt180 -77.45 -178.46 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.953 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.43 -43.29 0.56 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.405 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.885 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.2 m -105.85 169.25 7.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 110.986 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.885 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 51.6 Cg_endo -69.33 147.58 65.95 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.67 2.247 . . . . 0.0 112.312 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.673 ' CG ' ' HA ' ' B' ' 36' ' ' ASP . 46.5 m0 -91.42 -38.19 12.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.813 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' CYS . . . . . 0.912 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 53.6 t -94.67 121.62 36.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.733 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.573 ' HZ ' ' O ' ' B' ' 7' ' ' CYS . 45.0 p90 -150.99 169.74 21.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.715 ' HD2' ' HG3' ' B' ' 15' ' ' GLN . 89.3 m-85 -83.46 155.52 66.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.818 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 C--N 1.342 0.196 0 C-N-CA 122.705 2.27 . . . . 0.0 112.296 -179.794 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.838 HG22 HG22 ' A' ' 8' ' ' THR . 91.9 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.857 0.36 . . . . 0.0 111.11 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.4 m -112.18 23.95 13.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.987 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.838 HG22 HG22 ' A' ' 6' ' ' THR . 10.0 t -74.27 64.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.079 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.823 HG11 ' HA ' ' A' ' 14' ' ' ARG . 57.2 t -97.47 124.69 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.184 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.983 ' HB3' ' HB2' ' A' ' 13' ' ' GLU . . . -50.26 136.23 22.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.82 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.501 ' HA ' ' NE ' ' A' ' 14' ' ' ARG . 84.7 Cg_exo -41.19 -55.59 2.08 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.906 2.404 . . . . 0.0 112.805 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.847 ' HG3' ' OE2' ' A' ' 13' ' ' GLU . 15.8 ptp180 -81.03 -29.61 35.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.07 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.983 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 22.3 mp0 -80.77 7.85 9.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.039 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.94 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.2 mtt180 -74.94 120.9 21.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.839 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.669 ' O ' ' O ' ' A' ' 16' ' ' ASN . 10.4 mm100 -82.26 80.16 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.919 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.669 ' O ' ' O ' ' A' ' 15' ' ' GLN . 35.9 t-20 -22.51 148.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.037 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.657 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 42.5 t -134.96 0.23 2.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.639 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -166.86 -136.05 1.96 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.268 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.87 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 22.2 p90 -105.55 170.12 6.26 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.811 0.339 . . . . 0.0 110.95 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.87 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 53.4 Cg_endo -69.82 -12.55 33.0 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.749 2.299 . . . . 0.0 112.368 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.661 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -98.44 -21.29 17.46 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.461 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.891 HG21 ' HB2' ' A' ' 44' ' ' CYS . 34.3 m -24.93 150.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.815 0.341 . . . . 0.0 111.255 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.568 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 68.8 p -120.34 165.25 18.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.093 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.673 ' HD3' ' CZ ' ' A' ' 34' ' ' PHE . 53.2 Cg_exo -52.5 -36.52 70.7 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.718 2.279 . . . . 0.0 112.304 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.6 t -79.14 -48.28 14.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.556 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 48.4 mt-30 -60.37 -44.27 95.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.944 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.6 t -75.02 -58.86 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -53.54 -15.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -92.48 -14.3 28.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 22.8 tptm -98.84 -1.46 40.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.94 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.55 45.79 5.69 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.602 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.798 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 79.9 m -149.96 152.17 34.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 110.993 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.882 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 78.5 m -67.39 155.29 39.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.858 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.673 ' CZ ' ' HD3' ' A' ' 24' ' ' PRO . 59.8 t80 -129.79 109.8 11.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.817 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.575 ' OD1' ' OG1' ' A' ' 37' ' ' THR . 32.9 t0 -138.41 90.48 2.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.714 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.4 p-10 -88.92 -3.12 58.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.575 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 79.1 p -48.71 -7.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.572 ' H ' ' C ' ' A' ' 36' ' ' ASP . 62.2 t -141.26 103.46 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.797 ' HA ' ' HE1' ' A' ' 43' ' ' TRP . 15.9 ptp180 -69.27 -165.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.763 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.22 -34.87 0.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.359 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.839 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.6 m -108.39 167.74 8.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.944 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.839 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 42.9 Cg_endo -68.08 119.97 6.96 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.187 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.797 ' HE1' ' HA ' ' A' ' 39' ' ' ARG . 50.1 m0 -70.11 -37.67 75.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.891 ' HB2' HG21 ' A' ' 22' ' ' VAL . 50.5 t -96.84 128.57 43.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.829 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.576 ' CE2' ' CG2' ' A' ' 9' ' ' VAL . 52.4 p90 -152.81 161.75 42.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -67.02 137.19 94.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.004 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.882 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 99.0 Cg_endo -80.67 -177.05 3.49 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.933 2.422 . . . . 0.0 112.484 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.565 HD21 HG22 ' A' ' 9' ' ' VAL . 36.3 m-80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.781 178.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 73.8 m . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.827 0.346 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.605 HG23 ' O ' ' B' ' 8' ' ' THR . 9.1 t -98.05 72.72 2.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.087 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.874 HG12 ' N ' ' B' ' 10' ' ' ALA . 73.8 t -119.34 -179.53 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.874 ' N ' HG12 ' B' ' 9' ' ' VAL . . . -95.97 159.91 31.23 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.008 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.452 ' HB3' HG11 ' B' ' 41' ' ' VAL . 76.8 Cg_exo -50.08 -39.18 51.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.748 2.298 . . . . 0.0 112.462 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.4 ' C ' ' H ' ' B' ' 14' ' ' ARG . 39.4 ptt180 -89.97 -29.92 18.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.764 ' O ' HG11 ' B' ' 9' ' ' VAL . 45.2 mt-10 -77.0 17.46 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.077 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.829 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.2 mtt180 -98.56 114.39 26.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 8.1 tp-100 -80.48 98.85 7.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.708 ' ND2' ' H ' ' B' ' 18' ' ' GLY . 2.6 t-20 -32.95 150.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' CYS . . . . . 0.527 ' H ' ' ND2' ' B' ' 16' ' ' ASN . 41.5 t -143.26 5.17 1.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.73 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.708 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -170.85 -138.61 2.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.422 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.859 ' CE1' HG12 ' B' ' 22' ' ' VAL . 42.8 p90 -105.58 166.83 10.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 0.0 110.929 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.776 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 47.1 Cg_endo -68.9 -33.74 19.37 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.751 2.3 . . . . 0.0 112.313 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.663 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -84.05 13.47 49.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.54 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.859 HG12 ' CE1' ' B' ' 19' ' ' PHE . 34.0 m -65.07 164.43 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 111.207 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' THR . . . . . 0.777 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 75.2 p -133.75 173.15 6.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.054 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.777 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 55.7 Cg_exo -51.63 -32.75 45.97 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.727 2.285 . . . . 0.0 112.363 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 47.3 t -84.81 -66.74 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.476 ' NE2' ' HZ ' ' B' ' 19' ' ' PHE . 52.6 mt-30 -39.34 -34.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.863 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' B' ' 30' ' ' LYS . 42.6 t -80.58 -60.97 2.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.16 -34.14 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -49.84 -37.09 29.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.42 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' B' ' 27' ' ' CYS . 46.6 mmtm -86.76 -30.85 21.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.518 176.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.01 24.03 9.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.709 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' CYS . . . . . 0.656 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 81.6 m -102.42 155.54 18.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 110.897 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' B' ' 47' ' ' PRO . 83.0 m -63.56 149.45 46.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.807 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.635 ' CZ ' ' HA ' ' B' ' 23' ' ' THR . 59.6 t80 -133.13 120.24 20.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.535 ' OD2' ' NH1' ' B' ' 14' ' ' ARG . 16.5 t70 -129.3 87.75 2.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.662 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 24.3 p-10 -91.83 51.53 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 75.8 p -117.8 -11.92 10.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.192 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.492 ' O ' HG22 ' B' ' 41' ' ' VAL . 62.2 t -136.01 115.54 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' B' ' 41' ' ' VAL . 80.7 mtp180 -67.98 -178.17 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.22 -41.27 0.48 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.557 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.492 HG22 ' O ' ' B' ' 38' ' ' VAL . 33.0 m -92.49 153.07 42.62 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 0.0 111.107 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.29 122.2 9.0 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.749 2.299 . . . . 0.0 112.207 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.662 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 23.1 m0 -67.34 -47.45 70.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.009 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' CYS . . . . . 0.705 ' CB ' HG21 ' B' ' 22' ' ' VAL . 46.8 t -92.03 119.84 32.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.897 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.763 ' CE2' ' HD3' ' B' ' 14' ' ' ARG . 53.3 p90 -149.23 159.41 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.827 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.439 ' CE1' ' O ' ' B' ' 16' ' ' ASN . 91.6 m-85 -58.68 146.92 72.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . 0.507 ' HA ' ' SG ' ' B' ' 33' ' ' CYS . 59.0 Cg_endo . . . . . 0 N--CA 1.465 -0.159 0 C-N-CA 122.763 2.308 . . . . 0.0 112.371 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.985 HG22 ' H ' ' A' ' 8' ' ' THR . 86.0 m . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.731 0.301 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.77 ' N ' HG22 ' A' ' 6' ' ' THR . 71.9 m -131.29 2.43 4.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.24 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.985 ' H ' HG22 ' A' ' 6' ' ' THR . 10.1 t -75.21 63.16 1.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.084 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.949 HG22 HD21 ' A' ' 48' ' ' ASN . 58.0 t -96.65 155.55 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.912 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -69.66 136.3 88.07 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.786 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HG3' HG21 ' A' ' 38' ' ' VAL . 88.9 Cg_exo -41.83 -66.69 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.793 2.329 . . . . 0.0 112.593 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -65.12 -30.0 70.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.992 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.897 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 81.0 mm-40 -88.96 27.69 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.097 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.912 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.2 mtt180 -97.83 129.31 44.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.865 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 45' ' ' PHE . 29.5 mm-40 -82.63 104.19 12.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.636 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 2.6 t-20 -35.29 122.02 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.905 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 46.4 t -138.8 -0.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.196 0.522 . . . . 0.0 110.229 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.764 ' N ' ' O ' ' A' ' 44' ' ' CYS . . . 174.77 122.34 0.68 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.313 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.818 ' O ' HG22 ' A' ' 22' ' ' VAL . 53.2 p90 -44.78 167.87 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.751 0.31 . . . . 0.0 110.973 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.786 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 47.2 Cg_endo -68.9 -52.97 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.659 2.239 . . . . 0.0 112.263 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -40.46 -27.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.382 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.904 HG21 ' HB2' ' A' ' 44' ' ' CYS . 29.1 m -49.93 171.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.342 . . . . 0.0 111.122 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.891 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 74.1 p -137.25 178.71 1.6 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.891 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 58.0 Cg_exo -51.48 -36.58 59.68 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.627 2.218 . . . . 0.0 112.27 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 53.1 m -90.18 -40.01 12.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.821 ' HB2' ' H ' ' A' ' 23' ' ' THR . 24.9 mt-30 -65.23 -27.31 68.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.868 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.975 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 53.0 t -91.56 -52.9 4.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.789 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.84 -21.0 40.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.004 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.517 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 37.8 t-20 -72.01 -27.47 62.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.849 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.11 -24.52 18.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.937 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.32 29.35 5.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.4 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.975 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 61.9 m -108.52 -176.8 3.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.827 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.73 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 73.7 m -109.22 132.62 53.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.636 176.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.781 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 26.9 t80 -104.41 108.5 19.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.896 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 35' ' ' ASP . 32.5 t0 -128.98 90.31 3.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.541 ' OD2' ' HE1' ' A' ' 34' ' ' PHE . 25.0 p30 -89.1 60.55 5.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.3 p -114.8 -33.65 5.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.09 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.624 ' O ' HG22 ' A' ' 41' ' ' VAL . 63.5 t -119.48 120.38 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.074 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.588 ' C ' ' H ' ' A' ' 41' ' ' VAL . 98.8 mtt180 -74.24 179.33 4.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.06 -28.5 0.15 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 38' ' ' VAL . 33.0 m -98.84 158.84 31.68 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.8 0.333 . . . . 0.0 111.081 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 50.4 Cg_endo -69.18 120.2 7.09 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 0.0 112.302 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -73.51 -27.4 61.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.942 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 44.6 t -113.27 95.96 5.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.723 ' C ' ' HB3' ' A' ' 17' ' ' CYS . 52.8 p90 -122.71 -169.93 2.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.636 ' CE2' ' O ' ' A' ' 16' ' ' ASN . 96.3 m-85 -88.29 143.39 32.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.976 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 56.6 Cg_endo -70.87 -156.53 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.842 2.362 . . . . 0.0 112.408 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.949 HD21 HG22 ' A' ' 9' ' ' VAL . 76.2 m-20 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 71.2 m . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.677 0.275 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.685 HG23 ' O ' ' B' ' 8' ' ' THR . 9.4 t -74.52 82.95 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 111.099 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.816 HG12 ' N ' ' B' ' 10' ' ' ALA . 76.4 t -128.59 176.23 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.071 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.844 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -84.17 128.15 63.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.924 ' HB3' HG21 ' B' ' 41' ' ' VAL . 97.6 Cg_exo -42.45 -66.25 0.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.795 2.33 . . . . 0.0 112.416 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.89 ' NH1' ' HD2' ' B' ' 11' ' ' PRO . 0.1 OUTLIER -54.16 -29.9 47.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.823 179.076 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.707 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 87.3 mt-10 -93.82 22.71 5.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.844 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 98.8 mtt180 -98.91 141.54 31.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.552 ' O ' ' HD1' ' B' ' 46' ' ' TYR . 84.9 mm-40 -88.18 80.04 7.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 1.058 HD22 ' N ' ' B' ' 17' ' ' CYS . 0.1 OUTLIER -24.36 138.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.585 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' CYS . . . . . 1.058 ' N ' HD22 ' B' ' 16' ' ' ASN . 40.9 t -133.09 2.82 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 110.559 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.879 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -156.83 -136.5 2.13 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.286 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.907 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 12.3 p90 -105.74 171.54 4.77 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.342 . . . . 0.0 111.007 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.907 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 30.4 Cg_endo -64.05 -10.01 21.5 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.821 2.348 . . . . 0.0 112.386 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.772 ' HA2' ' CZ3' ' B' ' 43' ' ' TRP . . . -128.93 29.07 4.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.606 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.879 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 35.7 m -49.66 161.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.391 . . . . 0.0 111.264 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' THR . . . . . 1.082 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 66.7 p -135.95 176.41 2.85 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.767 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 1.082 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 10.8 Cg_endo -54.03 -42.22 68.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.597 2.198 . . . . 0.0 112.088 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -81.07 -46.42 15.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.747 ' HG2' ' OG1' ' B' ' 23' ' ' THR . 15.2 mm100 -57.04 -38.63 73.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -73.76 -54.77 7.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.759 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.1 -35.7 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.83 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -54.03 -28.33 37.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.798 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.81 ' HZ2' ' HB3' ' B' ' 30' ' ' LYS . 2.7 mmmp? -100.17 -26.95 13.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.731 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.5 60.58 1.79 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.592 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' CYS . . . . . 0.527 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 78.6 m -142.88 176.41 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.91 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.661 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.0 m -74.27 148.66 41.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.765 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.635 ' CE1' HG23 ' B' ' 22' ' ' VAL . 75.6 t80 -126.76 130.8 51.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.885 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.571 ' OD2' ' NH2' ' B' ' 14' ' ' ARG . 27.5 t0 -148.19 80.02 1.46 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.873 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.733 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 24.4 p-10 -84.44 53.45 2.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -120.04 -4.84 10.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.621 HG12 HG22 ' B' ' 41' ' ' VAL . 61.8 t -132.7 106.87 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.668 ' C ' ' H ' ' B' ' 41' ' ' VAL . 79.7 mtm180 -71.28 -171.81 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.66 -10.88 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.385 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.924 HG21 ' HB3' ' B' ' 11' ' ' PRO . 34.9 m -131.49 164.98 38.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 0.0 111.1 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.755 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 57.7 Cg_endo -71.31 144.17 45.33 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.751 2.301 . . . . 0.0 112.309 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.772 ' CZ3' ' HA2' ' B' ' 21' ' ' GLY . 27.1 m0 -93.25 -50.7 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.794 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' CYS . . . . . 0.825 ' H ' HG21 ' B' ' 22' ' ' VAL . 52.9 t -87.66 122.85 31.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.727 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.779 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 47.8 p90 -148.19 149.58 32.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.552 ' HD1' ' O ' ' B' ' 15' ' ' GLN . 81.0 m-85 -46.81 150.57 1.25 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.851 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.465 -0.199 0 C-N-CA 122.747 2.298 . . . . 0.0 112.37 -179.385 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.976 ' C ' HD22 ' A' ' 48' ' ' ASN . 95.7 m . . . . . 0 N--CA 1.456 -0.13 0 CA-C-O 120.746 0.308 . . . . 0.0 110.803 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.609 ' N ' HG22 ' A' ' 6' ' ' THR . 70.9 m -130.31 -22.88 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.842 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.521 HG22 ' CG2' ' A' ' 6' ' ' THR . 8.9 t -74.37 51.33 0.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.878 ' CG2' HD21 ' A' ' 48' ' ' ASN . 62.8 t -90.06 177.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.875 ' HB3' ' HB2' ' A' ' 13' ' ' GLU . . . -76.05 132.11 74.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.939 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.657 ' HA ' ' NE ' ' A' ' 14' ' ' ARG . 88.6 Cg_exo -46.92 -74.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.746 2.297 . . . . 0.0 112.425 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.718 ' HB2' ' OE2' ' A' ' 13' ' ' GLU . 37.2 mmt180 -52.6 -30.65 32.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.975 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.875 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -89.66 35.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.808 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.0 mtt180 -107.89 124.04 49.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.976 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.571 ' CB ' ' HD2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER -79.93 92.71 5.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 15' ' ' GLN . 27.4 t-20 -30.31 150.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.637 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 43.5 t -135.96 4.67 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.336 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.19 -138.28 2.73 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.336 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.956 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 30.4 p90 -105.75 172.38 4.04 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.778 0.323 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.956 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 46.1 Cg_endo -68.79 -31.59 24.97 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.715 2.277 . . . . 0.0 112.325 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.644 ' H ' ' HD2' ' A' ' 19' ' ' PHE . . . -74.27 -27.98 64.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.527 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.932 HG21 ' HB2' ' A' ' 44' ' ' CYS . 34.4 m -26.21 152.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.266 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.67 ' OG1' ' HG3' ' A' ' 26' ' ' GLN . 74.8 p -122.33 164.53 25.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.074 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.747 ' HG3' ' CE1' ' A' ' 34' ' ' PHE . 50.2 Cg_exo -53.48 -32.48 63.16 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.709 2.273 . . . . 0.0 112.349 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 47.8 t -84.83 -46.45 11.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.67 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 26.3 mt-30 -59.71 -46.59 88.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.8 t -76.48 -48.34 19.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -63.74 -15.29 58.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.086 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 25' ' ' SER . 42.9 t30 -83.4 -14.84 51.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -92.25 -35.96 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.74 11.79 1.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.568 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.775 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 71.7 m -113.81 170.62 8.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 110.941 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 76.8 m -88.17 155.07 19.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.747 ' CE1' ' HG3' ' A' ' 24' ' ' PRO . 45.2 t80 -133.14 119.42 19.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 37' ' ' THR . 16.4 t70 -130.64 79.99 1.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.794 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.3 p-10 -78.18 21.54 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 35' ' ' ASP . 75.0 p -90.84 -16.77 27.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.772 HG12 HG22 ' A' ' 41' ' ' VAL . 62.8 t -108.66 126.71 65.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.093 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.521 ' C ' ' H ' ' A' ' 41' ' ' VAL . 82.9 mtm180 -91.09 176.41 6.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.95 -33.46 0.29 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.466 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.915 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.3 m -106.27 170.64 5.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.72 0.295 . . . . 0.0 111.119 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.915 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 60.0 Cg_endo -72.63 153.65 54.47 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.673 2.248 . . . . 0.0 112.223 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.794 ' CD1' ' HA ' ' A' ' 36' ' ' ASP . 34.1 m0 -97.81 -30.29 12.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.932 ' HB2' HG21 ' A' ' 22' ' ' VAL . 47.4 t -100.04 117.38 34.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.778 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.751 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 52.2 p90 -143.57 170.05 16.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.571 ' HD2' ' CB ' ' A' ' 15' ' ' GLN . 25.6 m-85 -76.97 134.94 67.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.775 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 18.0 Cg_endo -61.02 -150.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.52 -0.195 0 C-N-CA 122.976 2.45 . . . . 0.0 112.606 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.976 HD22 ' C ' ' A' ' 6' ' ' THR . 41.9 m-80 . . . . . 0 C--N 1.326 -0.421 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.357 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 76.1 m . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.738 0.304 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.657 HG23 ' O ' ' B' ' 8' ' ' THR . 9.0 t -86.9 84.96 7.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.024 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.91 HG11 ' HA ' ' B' ' 14' ' ' ARG . 58.8 t -125.31 165.28 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.208 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.852 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -93.5 131.53 32.29 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.986 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.892 ' HB3' HG21 ' B' ' 41' ' ' VAL . 79.0 Cg_exo -40.07 -32.05 0.59 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.793 2.329 . . . . 0.0 112.516 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.906 ' NH2' HG12 ' B' ' 41' ' ' VAL . 2.0 mmp_? -90.25 -29.89 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' B' ' 10' ' ' ALA . 12.2 mm-40 -93.05 -5.93 49.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.085 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.91 ' HA ' HG11 ' B' ' 9' ' ' VAL . 99.4 mtt180 -69.29 122.2 18.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.823 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 1.009 ' HA ' HE21 ' B' ' 15' ' ' GLN . 0.0 OUTLIER -79.9 91.18 5.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.869 -178.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 1.098 HD22 ' N ' ' B' ' 17' ' ' CYS . 0.1 OUTLIER -32.64 140.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.753 179.029 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' CYS . . . . . 1.098 ' N ' HD22 ' B' ' 16' ' ' ASN . 43.1 t -127.8 1.69 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.526 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 1.067 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -172.39 -134.45 1.8 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.084 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.897 ' CE1' HG12 ' B' ' 22' ' ' VAL . 37.8 p90 -106.15 156.58 36.59 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.732 0.301 . . . . 0.0 110.895 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.562 ' O ' ' CE3' ' B' ' 43' ' ' TRP . 36.4 Cg_endo -65.51 -18.91 60.56 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.681 2.254 . . . . 0.0 112.229 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.639 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -94.14 8.13 72.76 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.47 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.897 HG12 ' CE1' ' B' ' 19' ' ' PHE . 34.6 m -61.67 155.55 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.0 111.129 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' THR . . . . . 0.846 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 78.3 p -121.06 174.71 2.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.12 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.846 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 76.8 Cg_exo -50.26 -56.08 3.46 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 0.0 112.309 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 79.5 p -58.35 -55.05 39.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.836 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.828 HE21 ' H ' ' B' ' 23' ' ' THR . 24.6 mt-30 -50.04 -72.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' CYS . . . . . 0.598 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 49.6 t -32.02 -53.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.73 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.33 -35.79 51.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' B' ' 26' ' ' GLN . 42.1 t30 -49.64 -32.58 13.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.787 ' HZ3' ' C ' ' B' ' 26' ' ' GLN . 2.2 mppt? -95.63 -15.5 22.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.795 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.94 38.31 16.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.532 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' CYS . . . . . 0.724 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 79.6 m -119.46 161.8 19.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 110.979 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.2 m -65.43 155.19 36.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.851 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.585 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 57.8 t80 -129.56 118.06 21.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.564 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 16.6 t70 -128.55 100.04 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -91.75 24.7 3.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . 0.564 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 69.0 p -89.11 -62.39 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.857 HG21 ' HG3' ' B' ' 11' ' ' PRO . 61.1 t -80.52 120.79 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' B' ' 41' ' ' VAL . 83.6 mtm180 -89.15 -177.55 5.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.99 -35.52 0.29 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.906 HG12 ' NH2' ' B' ' 12' ' ' ARG . 27.5 m -100.44 170.43 6.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.745 0.307 . . . . 0.0 111.137 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.894 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 41.1 Cg_endo -67.41 127.99 17.49 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.183 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.562 ' CE3' ' O ' ' B' ' 20' ' ' PRO . 49.7 m0 -78.9 -47.54 16.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.882 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 50.2 t -91.16 123.79 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.777 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.724 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 50.0 p90 -142.67 168.94 18.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.997 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.529 ' O ' ' HD1' ' B' ' 45' ' ' PHE . 88.2 m-85 -75.73 154.08 85.26 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.94 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 C--O 1.232 0.186 0 C-N-CA 122.798 2.332 . . . . 0.0 112.415 179.838 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.844 ' HB ' ' HB2' ' A' ' 48' ' ' ASN . 93.9 m . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.803 0.335 . . . . 0.0 111.123 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.635 ' N ' HG22 ' A' ' 6' ' ' THR . 72.0 m -146.5 19.38 1.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.979 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.794 HG22 ' CG2' ' A' ' 6' ' ' THR . 9.5 t -100.22 63.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.11 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.851 HG22 HD21 ' A' ' 48' ' ' ASN . 61.2 t -103.44 168.08 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.182 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.859 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -78.47 120.94 82.92 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.104 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.78 ' HA ' ' CD ' ' A' ' 14' ' ' ARG . 88.5 Cg_exo -46.58 -37.75 20.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.691 2.26 . . . . 0.0 112.456 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.735 ' HG3' ' HG3' ' A' ' 13' ' ' GLU . 14.5 ptm180 -71.17 -29.91 65.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.925 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.735 ' HG3' ' HG3' ' A' ' 12' ' ' ARG . 87.2 mt-10 -111.09 42.44 1.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.965 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.859 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.3 mtt180 -107.23 117.85 35.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.944 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.645 ' O ' ' O ' ' A' ' 16' ' ' ASN . 84.6 mm-40 -87.55 100.14 12.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.665 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.4 t-20 -24.92 150.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.814 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.817 ' HB2' ' N ' ' A' ' 46' ' ' TYR . 53.0 t -140.79 2.17 1.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.54 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -148.44 -138.99 3.1 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.294 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 1.097 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 43.9 p90 -105.82 -177.9 0.55 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.595 0.236 . . . . 0.0 110.745 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 1.097 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 38.3 Cg_endo -67.49 -62.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.49 2.127 . . . . 0.0 112.38 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.659 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -78.03 29.91 1.85 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.55 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.999 HG13 ' O ' ' A' ' 19' ' ' PHE . 27.5 m -56.95 133.05 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.359 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.855 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 79.2 p -117.01 178.24 1.04 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.954 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.855 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 50.6 Cg_exo -53.81 -40.05 81.73 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.677 2.252 . . . . 0.0 112.271 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.643 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 47.8 t -88.35 -31.56 18.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.799 ' HB2' ' H ' ' A' ' 23' ' ' THR . 52.9 mt-30 -73.46 -33.8 65.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.896 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.938 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.2 t -87.48 -50.2 6.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.32 70.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.003 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.643 ' HB2' ' O ' ' A' ' 25' ' ' SER . 38.1 t-20 -57.04 -21.0 27.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -102.45 -28.85 11.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.946 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.48 -6.36 14.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.405 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.938 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 85.4 m -70.67 -170.07 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 110.904 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.842 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 72.3 m -116.11 155.06 28.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 36' ' ' ASP . 66.3 t80 -131.35 118.25 20.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.594 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 16.9 t70 -131.03 79.89 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 34' ' ' PHE . 24.7 p-10 -72.94 13.47 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.576 ' OG1' ' OD2' ' A' ' 35' ' ' ASP . 76.4 p -79.56 -16.41 55.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.081 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.703 HG21 ' CG ' ' A' ' 11' ' ' PRO . 63.2 t -131.39 109.63 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.095 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.813 ' HG2' ' H ' ' A' ' 40' ' ' GLY . 59.9 ttt180 -79.01 -176.93 5.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.813 ' H ' ' HG2' ' A' ' 39' ' ' ARG . . . 73.07 -38.45 0.79 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.383 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.852 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.0 m -98.44 168.03 10.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 111.049 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.852 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 48.1 Cg_endo -68.75 120.9 7.78 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 0.0 112.207 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.8 m0 -67.43 -45.24 76.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.842 ' CB ' HG21 ' A' ' 22' ' ' VAL . 42.5 t -91.87 116.13 28.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.741 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.574 ' C ' ' CB ' ' A' ' 17' ' ' CYS . 52.1 p90 -139.17 168.91 18.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.965 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.817 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 83.6 m-85 -68.71 135.08 90.24 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.687 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 61.3 Cg_endo -73.35 -156.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.758 2.305 . . . . 0.0 112.318 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.851 HD21 HG22 ' A' ' 9' ' ' VAL . 77.3 m-20 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . 0.504 ' O ' ' HZ ' ' B' ' 45' ' ' PHE . 75.7 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.75 0.31 . . . . 0.0 111.008 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.653 HG23 ' O ' ' B' ' 8' ' ' THR . 9.1 t -73.8 92.24 2.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.893 HG11 ' HA ' ' B' ' 14' ' ' ARG . 59.1 t -128.98 157.14 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.159 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.907 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -74.06 114.08 29.51 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.96 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.741 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 88.4 Cg_exo -40.31 -28.67 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.813 2.342 . . . . 0.0 112.461 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . 0.652 ' HG3' ' HG3' ' B' ' 13' ' ' GLU . 16.6 ptp180 -90.13 -29.82 18.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.726 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 44.6 mt-10 -104.58 9.59 35.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.076 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.907 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -69.89 145.93 51.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.921 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 17.6 mp0 -89.99 97.42 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.662 ' OD1' ' N ' ' B' ' 17' ' ' CYS . 36.5 t-20 -48.0 149.12 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.018 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' CYS . . . . . 0.883 ' SG ' ' HD3' ' B' ' 30' ' ' LYS . 44.7 t -135.26 1.02 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 110.764 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.611 ' N ' ' OD1' ' B' ' 16' ' ' ASN . . . -170.96 -134.42 1.76 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.289 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 0.863 ' CZ ' ' HA ' ' B' ' 22' ' ' VAL . 35.4 p90 -105.35 167.65 9.47 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 111.041 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.797 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 42.3 Cg_endo -68.15 -25.15 37.57 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.762 2.308 . . . . 0.0 112.436 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.711 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -95.56 6.44 67.87 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.535 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.863 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 35.0 m -49.55 137.05 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 111.275 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' THR . . . . . 0.944 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 80.2 p -110.95 -179.64 0.68 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.971 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.944 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 75.9 Cg_exo -49.79 -50.09 14.17 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.594 2.196 . . . . 0.0 112.393 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.0 m -74.7 -27.68 60.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.924 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.771 ' HB2' ' H ' ' B' ' 23' ' ' THR . 10.2 mm-40 -73.84 -32.09 63.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' CYS . . . . . 0.684 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 42.1 t -83.65 -53.87 5.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.817 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.95 67.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.988 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -49.94 -32.24 14.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.883 ' HD3' ' SG ' ' B' ' 17' ' ' CYS . 63.0 tttp -98.79 -25.8 14.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.88 66.82 1.13 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.665 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' CYS . . . . . 0.82 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 76.4 m -149.99 160.6 43.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 82.2 m -60.58 154.78 20.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.791 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.615 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 52.0 t80 -132.71 117.65 18.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.915 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.421 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 32.3 t0 -138.16 83.81 2.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -83.87 58.33 4.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . 0.421 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 78.3 p -113.23 -25.29 8.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.108 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -122.77 118.83 56.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.149 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . 0.81 ' HG2' ' H ' ' B' ' 40' ' ' GLY . 37.4 ttm180 -75.31 -178.18 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . 0.81 ' H ' ' HG2' ' B' ' 39' ' ' ARG . . . 70.64 -37.08 0.47 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.44 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.753 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.1 m -99.5 165.19 15.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.822 0.344 . . . . 0.0 111.08 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.753 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 43.9 Cg_endo -68.18 130.94 22.39 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.763 2.309 . . . . 0.0 112.167 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.555 ' HE3' ' O ' ' B' ' 22' ' ' VAL . 50.2 m0 -78.31 -18.86 54.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' CYS . . . . . 0.82 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 51.4 t -121.3 124.32 44.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.681 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 36.9 p90 -142.56 170.5 15.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -80.3 154.86 74.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.87 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo . . . . . 0 C--O 1.232 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.216 179.473 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.795 ' CG2' HG22 ' A' ' 8' ' ' THR . 95.0 m . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.851 0.357 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.574 ' N ' HG22 ' A' ' 6' ' ' THR . 72.5 m -143.19 -2.3 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.033 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.795 HG22 ' CG2' ' A' ' 6' ' ' THR . 9.8 t -71.91 62.26 0.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.147 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.857 ' CG2' HD21 ' A' ' 48' ' ' ASN . 58.4 t -106.56 165.62 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.846 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -91.6 123.62 63.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.898 ' HB3' HG21 ' A' ' 41' ' ' VAL . 80.7 Cg_exo -44.91 -39.4 14.15 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.728 2.285 . . . . 0.0 112.395 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -66.63 -29.98 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.796 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -112.41 39.26 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.061 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.846 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 96.6 mtt180 -108.26 152.91 23.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.715 ' NE2' ' C ' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -108.24 93.79 4.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.066 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.683 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.5 t-20 -27.7 150.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.683 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 42.1 t -138.02 0.82 2.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.518 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.564 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -177.54 -139.28 3.29 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.36 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.865 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 39.7 p90 -105.71 170.93 5.33 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.867 0.365 . . . . 0.0 110.986 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.865 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 58.4 Cg_endo -71.84 -36.5 6.12 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.767 2.312 . . . . 0.0 112.415 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . -58.63 -38.98 92.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.525 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.828 HG21 ' CB ' ' A' ' 44' ' ' CYS . 34.2 m -30.34 155.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.805 0.336 . . . . 0.0 111.224 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.866 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 75.3 p -122.74 176.22 2.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.096 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.866 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 53.1 Cg_exo -52.43 -49.09 18.62 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -77.33 -42.33 37.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.708 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 26.4 mt-30 -59.43 -37.9 79.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 34' ' ' PHE . 53.9 t -72.53 -59.24 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.92 -26.87 38.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -67.98 -11.66 59.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.84 ' C ' ' HD3' ' A' ' 30' ' ' LYS . 7.8 tmtt? -100.37 -51.98 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.44 37.69 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.484 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.894 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 71.2 m -149.56 163.07 38.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.832 0.348 . . . . 0.0 111.069 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.858 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 72.6 m -76.15 155.12 34.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.695 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.72 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 77.3 t80 -122.47 136.82 54.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.663 ' CB ' HH12 ' A' ' 14' ' ' ARG . 26.6 t0 -155.72 79.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.702 ' HA ' ' CG ' ' A' ' 43' ' ' TRP . 24.5 p-10 -88.18 40.5 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.5 p -113.45 -13.9 12.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.708 HG12 HG22 ' A' ' 41' ' ' VAL . 62.7 t -113.89 104.09 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.119 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 41' ' ' VAL . 98.5 mtt180 -70.47 175.52 4.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.86 -20.19 0.4 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.397 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.898 HG21 ' HB3' ' A' ' 11' ' ' PRO . 33.0 m -119.87 163.1 29.69 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.784 0.325 . . . . 0.0 111.162 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.693 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 55.5 Cg_endo -70.08 127.29 14.14 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.696 2.264 . . . . 0.0 112.266 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.702 ' CG ' ' HA ' ' A' ' 36' ' ' ASP . 49.9 m0 -72.16 -50.21 29.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.828 ' CB ' HG21 ' A' ' 22' ' ' VAL . 47.3 t -93.81 112.27 24.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.738 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.8 ' CE1' ' HD3' ' A' ' 14' ' ' ARG . 40.0 p90 -136.44 163.72 29.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.547 ' HD2' ' CB ' ' A' ' 15' ' ' GLN . 35.2 m-85 -57.81 134.72 83.14 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.666 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.894 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 96.8 Cg_endo -80.85 -156.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.842 2.361 . . . . 0.0 112.578 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.857 HD21 ' CG2' ' A' ' 9' ' ' VAL . 78.0 m-20 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.851 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 71.6 m . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.869 0.366 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' THR . . . . . 0.646 HG23 ' O ' ' B' ' 8' ' ' THR . 9.0 t -76.7 80.16 3.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.059 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.83 HG12 ' N ' ' B' ' 10' ' ' ALA . 66.6 t -129.22 177.4 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.247 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.83 ' N ' HG12 ' B' ' 9' ' ' VAL . . . -85.38 151.87 57.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.927 ' HG3' HG11 ' B' ' 38' ' ' VAL . 43.2 Cg_exo -56.36 -16.57 18.3 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.787 2.325 . . . . 0.0 112.321 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -82.92 -29.92 28.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.063 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLU . . . . . 0.755 ' HB2' ' CG1' ' B' ' 9' ' ' VAL . 45.1 mt-10 -94.8 -20.07 19.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' ARG . . . . . 0.677 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 96.5 mtt180 -63.29 94.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLN . . . . . 0.651 ' O ' ' O ' ' B' ' 16' ' ' ASN . 8.3 tt0 -79.66 98.75 7.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . 0.744 ' ND2' ' H ' ' B' ' 18' ' ' GLY . 2.6 t-20 -23.61 149.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.257 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' CYS . . . . . 0.549 ' O ' ' HD3' ' B' ' 30' ' ' LYS . 42.6 t -141.89 4.45 1.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.535 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.744 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -166.96 -137.68 2.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.395 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' PHE . . . . . 1.033 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 29.1 p90 -105.32 175.42 2.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.327 . . . . 0.0 110.84 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 1.033 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 38.4 Cg_endo -67.11 -32.74 33.5 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.604 2.203 . . . . 0.0 112.482 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.733 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -93.84 5.2 72.7 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.602 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.946 HG13 ' O ' ' B' ' 19' ' ' PHE . 27.0 m -37.86 153.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 111.316 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' THR . . . . . 1.044 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 76.1 p -128.35 173.89 5.05 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.816 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 1.044 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 15.3 Cg_endo -57.46 -32.0 92.92 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.58 2.187 . . . . 0.0 112.221 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -85.14 -50.06 7.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' GLN . . . . . 0.435 ' HB2' ' H ' ' B' ' 23' ' ' THR . 52.7 mt-30 -61.01 -32.73 72.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.4 t -78.92 -55.4 5.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.787 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' B' ' 31' ' ' GLY . . . -48.35 -33.87 9.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -49.8 -29.44 7.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.424 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' LYS . . . . . 0.549 ' HD3' ' O ' ' B' ' 17' ' ' CYS . 27.9 mtpp -97.82 -13.53 21.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.544 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' B' ' 28' ' ' ALA . . . 78.27 49.47 6.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.555 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' CYS . . . . . 0.745 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 71.0 m -126.33 166.98 16.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 110.947 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 77.8 m -75.08 149.52 39.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' PHE . . . . . 0.548 ' HE1' ' O ' ' B' ' 22' ' ' VAL . 73.4 t80 -126.95 126.92 44.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.635 ' OD1' HG23 ' B' ' 38' ' ' VAL . 16.6 t70 -149.83 80.47 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.961 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . 0.803 ' HA ' ' CG ' ' B' ' 43' ' ' TRP . 24.5 p-10 -72.14 4.6 3.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 72.3 p -75.3 -7.07 52.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.052 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.927 HG11 ' HG3' ' B' ' 11' ' ' PRO . 68.1 t -115.75 112.46 39.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.181 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -89.01 149.18 23.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.32 -37.3 3.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.412 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' VAL . . . . . 0.911 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.3 m -112.43 169.76 6.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.35 . . . . 0.0 111.108 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' PRO . . . . . 0.911 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 51.7 Cg_endo -69.35 121.0 7.77 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.744 2.296 . . . . 0.0 112.229 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' TRP . . . . . 0.803 ' CG ' ' HA ' ' B' ' 36' ' ' ASP . 36.7 m0 -62.13 -45.02 95.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' CYS . . . . . 0.812 ' CB ' HG21 ' B' ' 22' ' ' VAL . 51.0 t -86.31 120.91 28.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.803 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . 0.745 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 52.5 p90 -148.81 162.14 40.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' TYR . . . . . 0.452 ' O ' ' HD1' ' B' ' 45' ' ' PHE . 92.6 m-85 -68.94 155.92 92.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo . . . . . 0 C--O 1.232 0.178 0 C-N-CA 122.774 2.316 . . . . 0.0 112.179 179.848 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.827 0.346 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.35 77.44 1.58 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.122 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.759 ' H ' ' NE2' ' A' ' 3' ' ' GLN . 1.4 mp0 -94.91 159.16 15.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.903 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.0 p -149.21 151.89 35.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.603 ' HB3' ' HB2' ' A' ' 47' ' ' PRO . 45.0 mt-10 -102.3 127.61 49.21 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.88 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.912 HG21 HG22 ' A' ' 8' ' ' THR . 86.2 m -117.58 176.85 4.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.033 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.813 ' N ' HG22 ' A' ' 6' ' ' THR . 77.1 m -123.71 -15.7 6.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.176 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.912 HG22 HG21 ' A' ' 6' ' ' THR . 10.2 t -70.88 69.28 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 0.0 111.096 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.794 HG22 HD22 ' A' ' 48' ' ' ASN . 60.1 t -114.89 171.81 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.154 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.834 ' C ' ' HG3' ' A' ' 14' ' ' ARG . . . -86.77 121.19 71.99 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.962 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.79 ' HA ' ' HD2' ' A' ' 14' ' ' ARG . 82.8 Cg_exo -45.22 -59.46 1.15 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.825 2.35 . . . . 0.0 112.44 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.639 ' HG3' ' HG3' ' A' ' 13' ' ' GLU . 37.9 ptt180 -46.42 -29.81 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.925 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.639 ' HG3' ' HG3' ' A' ' 12' ' ' ARG . 45.1 mt-10 -104.68 -17.83 14.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.072 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.834 ' HG3' ' C ' ' A' ' 10' ' ' ALA . 99.4 mtt180 -51.96 139.4 22.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.758 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.52 ' O ' ' HD1' ' A' ' 46' ' ' TYR . 12.2 mm100 -90.85 98.48 11.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.786 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.568 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.6 t-20 -41.96 143.0 0.61 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.048 -178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.568 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 44.1 t -145.49 3.48 1.0 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.563 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 44' ' ' CYS . . . 170.16 124.02 0.72 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.854 -0.688 . . . . 0.0 112.39 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.822 ' O ' HG22 ' A' ' 22' ' ' VAL . 52.6 p90 -44.88 163.88 0.19 Allowed Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.812 0.339 . . . . 0.0 110.768 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.666 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 36.2 Cg_endo -65.5 -43.9 9.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.704 2.269 . . . . 0.0 112.289 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.14 -13.67 1.07 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 19' ' ' PHE . 27.4 m -63.52 154.35 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.803 0.335 . . . . 0.0 111.183 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.765 ' OG1' ' HG3' ' A' ' 26' ' ' GLN . 79.4 p -101.68 160.26 27.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.099 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 62.4 Cg_exo -51.21 -35.99 54.53 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.777 2.318 . . . . 0.0 112.306 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 80.2 p -75.74 -37.26 59.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.965 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.765 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 26.6 mt-30 -67.44 -55.67 12.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -55.67 -52.7 62.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.54 -22.54 66.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.015 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.59 ' HB3' ' O ' ' A' ' 26' ' ' GLN . 27.4 t-20 -60.69 -19.09 57.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.834 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.9 tppp? -102.21 -26.44 13.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.46 34.61 3.3 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.544 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.2 m -120.64 176.17 5.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.901 0.382 . . . . 0.0 111.037 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 75.9 m -86.02 155.27 20.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.958 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.683 ' HE2' HG23 ' A' ' 22' ' ' VAL . 19.5 t80 -135.55 108.1 7.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.86 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -125.58 103.24 7.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 -179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -96.24 24.23 5.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.873 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.0 p -90.71 -31.93 16.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.202 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.651 HG12 HG22 ' A' ' 41' ' ' VAL . 63.9 t -100.5 121.23 51.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 -91.69 155.15 18.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.9 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.57 -42.3 2.7 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.431 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.873 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.7 m -93.65 170.04 9.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.836 0.351 . . . . 0.0 111.101 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.873 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 45.7 Cg_endo -68.47 121.05 7.96 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.73 2.286 . . . . 0.0 112.238 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.636 ' CE3' ' O ' ' A' ' 20' ' ' PRO . 49.9 m0 -68.59 -44.73 73.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.807 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 51.3 t -97.36 118.87 34.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.712 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.667 ' CE2' ' HD3' ' A' ' 14' ' ' ARG . 51.3 p90 -147.34 157.59 43.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.959 -178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.52 ' HD1' ' O ' ' A' ' 15' ' ' GLN . 84.7 m-85 -63.75 157.48 66.77 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.94 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.603 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 57.9 Cg_endo -71.68 -161.63 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.737 2.292 . . . . 0.0 112.309 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.794 HD22 HG22 ' A' ' 9' ' ' VAL . 35.4 p30 -139.1 139.29 37.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 73.5 p -92.7 122.05 34.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 62.6 mt -137.29 149.05 25.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.119 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 52' ' ' VAL . 16.5 t70 -124.84 177.88 5.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.875 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.741 HG23 ' O ' ' A' ' 52' ' ' VAL . 33.3 m -138.71 84.84 17.7 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.112 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 57.8 Cg_endo -71.5 123.16 9.26 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.676 2.251 . . . . 0.0 112.341 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 13.9 Cg_exo -69.54 179.25 3.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.915 2.41 . . . . 0.0 112.11 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.756 ' O ' ' OE1' ' A' ' 56' ' ' GLU . 17.4 pt-20 -169.95 -19.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.756 ' OE1' ' O ' ' A' ' 55' ' ' GLU . 14.2 mm-40 -165.66 -29.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.895 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.673 ' N ' ' HE1' ' A' ' 60' ' ' PHE . 45.1 mt-10 -150.78 -139.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.947 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 46.2 t -137.99 0.8 2.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -94.35 29.23 2.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.819 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.673 ' HE1' ' N ' ' A' ' 57' ' ' GLU . 86.9 m-85 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.218 -0.896 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' GLU . . . . . 0.61 ' O ' HG23 ' B' ' 52' ' ' VAL . 12.8 mm-40 . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.859 ' O ' ' HA ' ' B' ' 51' ' ' ASP . . . -115.48 -132.84 0.33 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.034 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.617 ' OE1' ' HB3' ' B' ' 51' ' ' ASP . 12.2 mm-40 -79.96 136.86 36.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.96 0.41 . . . . 0.0 110.855 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.955 ' OG1' ' HB ' ' B' ' 50' ' ' ILE . 64.1 p -138.34 -158.42 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.178 -176.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.97 ' O ' HG23 ' B' ' 49' ' ' THR . 87.2 mt-10 -48.3 -174.23 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.365 -177.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 1.014 ' HA ' ' OG1' ' B' ' 49' ' ' THR . 56.8 m -150.29 -178.17 6.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.485 -167.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.898 ' H ' HG22 ' B' ' 6' ' ' THR . 62.2 m -78.6 -6.41 55.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.505 176.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.679 HG22 ' HB ' ' B' ' 6' ' ' THR . 9.1 t -87.01 69.92 10.26 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.987 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.655 HG12 ' N ' ' B' ' 10' ' ' ALA . 59.5 t -89.83 166.1 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.044 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.909 ' HB3' ' HB2' ' B' ' 13' ' ' GLU . . . -47.54 113.48 2.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.776 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 80.0 Cg_exo -44.83 -46.03 13.14 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.829 2.352 . . . . 0.0 112.467 -178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -73.96 -29.97 62.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.947 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.909 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 45.1 mt-10 -92.83 -5.47 50.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.03 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.846 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.3 mtt180 -58.98 125.66 24.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.82 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.457 ' O ' ' HD1' ' B' ' 46' ' ' TYR . 8.1 tp-100 -80.29 98.29 7.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.748 HD22 ' HB3' ' B' ' 42' ' ' PRO . 27.3 t-20 -35.38 150.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.983 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' CYS . . . . . 0.435 ' O ' ' SG ' ' B' ' 17' ' ' CYS . 41.5 t -134.07 4.2 3.48 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.751 178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.88 -133.72 2.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.437 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.856 ' CE1' HG12 ' B' ' 22' ' ' VAL . 35.6 p90 -105.13 164.29 15.41 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.785 0.326 . . . . 0.0 110.907 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.708 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 37.5 Cg_endo -66.33 -31.02 44.34 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.721 2.281 . . . . 0.0 112.304 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.61 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -82.64 -2.64 90.66 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.458 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.876 HG21 ' CB ' ' B' ' 44' ' ' CYS . 29.1 m -47.11 147.79 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.915 0.388 . . . . 0.0 111.295 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 1.032 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 67.1 p -123.0 175.34 2.76 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.918 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 1.032 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 10.6 Cg_endo -53.6 -43.56 56.7 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.651 2.234 . . . . 0.0 112.091 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.5 p -76.88 -46.79 23.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.698 ' HB2' ' H ' ' B' ' 23' ' ' THR . 15.2 mm100 -57.29 -50.48 72.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.87 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 46.4 t -60.05 -57.1 14.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.728 -179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.01 -35.58 0.92 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.773 177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.638 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 38.4 t-20 -49.94 -36.85 29.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.582 177.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.791 ' HZ2' ' HB3' ' B' ' 30' ' ' LYS . 2.6 mmmp? -88.14 -41.35 13.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.537 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.89 58.39 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.734 178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . 0.805 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 82.6 m -140.89 174.69 10.27 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.853 0.359 . . . . 0.0 110.971 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 1.019 ' SG ' ' HG3' ' B' ' 47' ' ' PRO . 73.6 m -92.82 134.2 35.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.904 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.787 ' CZ ' ' HB3' ' B' ' 36' ' ' ASP . 59.4 t80 -91.39 153.06 20.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.122 -177.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.437 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 32.4 t0 -170.2 79.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.834 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 25.3 p30 -90.02 30.41 1.08 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . 0.437 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 71.5 p -83.5 -4.9 58.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.083 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 61.0 t -138.3 128.03 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.309 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.833 ' NH1' ' CZ2' ' B' ' 43' ' ' TRP . 22.1 mmm180 -80.92 -178.58 6.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 178.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 67.53 -32.44 0.22 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.563 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.557 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.2 m -104.29 158.95 30.86 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.883 0.373 . . . . 0.0 111.068 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.748 ' HB3' HD22 ' B' ' 16' ' ' ASN . 55.3 Cg_endo -69.9 136.78 33.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.733 2.288 . . . . 0.0 112.277 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.834 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 48.7 m0 -79.73 -32.43 41.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.9 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' CYS . . . . . 0.876 ' CB ' HG21 ' B' ' 22' ' ' VAL . 50.6 t -95.01 115.25 27.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.522 177.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.805 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 6.0 p90 -145.73 172.98 12.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.816 -176.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.457 ' HD1' ' O ' ' B' ' 15' ' ' GLN . 92.7 m-85 -85.33 133.71 41.96 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.621 176.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 1.019 ' HG3' ' SG ' ' B' ' 33' ' ' CYS . 56.2 Cg_endo -93.18 177.5 1.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 123.343 2.695 . . . . 0.0 112.629 -177.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.929 ' ND2' ' O ' ' B' ' 6' ' ' THR . 0.2 OUTLIER -150.24 78.52 1.33 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.004 0.43 . . . . 0.0 110.831 171.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 1.014 ' OG1' ' HA ' ' B' ' 6' ' ' THR . 1.2 m -120.69 125.03 46.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.27 176.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.955 ' HB ' ' OG1' ' B' ' 4' ' ' THR . 5.3 mt -126.37 129.67 71.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.851 0.358 . . . . 0.0 111.099 -173.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.859 ' HA ' ' O ' ' B' ' 2' ' ' ALA . 24.7 p-10 -164.96 167.27 18.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -177.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.932 ' N ' ' HD2' ' B' ' 53' ' ' PRO . 64.2 t -108.07 -11.05 0.12 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.372 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . 1.024 ' HB2' ' HD2' ' B' ' 54' ' ' PRO . 50.4 Cg_endo -69.8 -169.17 0.31 Allowed 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.782 2.322 . . . . 0.0 112.29 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 1.024 ' HD2' ' HB2' ' B' ' 53' ' ' PRO . 51.2 Cg_endo -69.54 170.13 17.03 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.655 2.237 . . . . 0.0 112.311 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -112.0 37.5 2.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.168 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.59 ' O ' ' OE2' ' B' ' 57' ' ' GLU . 62.8 tt0 -169.98 126.65 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.007 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.747 ' O ' ' SG ' ' B' ' 58' ' ' CYS . 12.7 mm-40 -132.56 -123.45 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' CYS . . . . . 0.747 ' SG ' ' O ' ' B' ' 57' ' ' GLU . 77.7 m -167.06 143.05 4.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.022 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -149.16 71.75 1.14 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.82 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.898 -179.938 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.425 ' CD ' ' N ' ' A' ' 1' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.877 0.37 . . . . 0.0 110.879 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.1 -128.51 0.26 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.118 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.849 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 1.2 mp0 -85.23 179.12 7.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.5 p -142.08 130.11 21.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.722 ' HG2' ' OG1' ' A' ' 49' ' ' THR . 44.8 mt-10 -97.54 148.88 22.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.041 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.962 HG22 ' H ' ' A' ' 8' ' ' THR . 86.1 m -139.38 176.66 8.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.011 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.808 ' N ' HG22 ' A' ' 6' ' ' THR . 71.4 m -133.93 -2.0 2.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.266 -179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.962 ' H ' HG22 ' A' ' 6' ' ' THR . 9.6 t -75.69 75.2 2.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.137 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.759 ' CG2' HD21 ' A' ' 48' ' ' ASN . 62.1 t -116.4 161.67 14.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.116 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.89 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -81.33 132.15 56.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.068 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.943 ' HB3' HG21 ' A' ' 41' ' ' VAL . 85.5 Cg_exo -40.62 -32.1 0.76 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.823 2.349 . . . . 0.0 112.507 -179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -90.04 -29.74 18.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 10' ' ' ALA . 81.6 mm-40 -92.43 -6.0 50.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.001 -179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.89 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.4 mtt180 -69.37 118.04 11.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.886 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.614 ' O ' ' O ' ' A' ' 16' ' ' ASN . 8.1 tp-100 -79.96 93.12 5.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.696 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 2.6 t-20 -24.98 148.85 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.896 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.77 ' HB2' ' N ' ' A' ' 46' ' ' TYR . 50.5 t -143.68 3.0 1.25 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.116 0.484 . . . . 0.0 110.188 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.683 ' H ' ' ND2' ' A' ' 16' ' ' ASN . . . -156.55 -142.85 3.51 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.113 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.929 ' CZ ' ' HA ' ' A' ' 22' ' ' VAL . 27.4 p90 -105.75 168.91 7.61 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.793 0.33 . . . . 0.0 111.064 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.833 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 40.7 Cg_endo -67.78 -20.08 46.35 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.688 2.258 . . . . 0.0 112.436 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.716 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -102.64 4.96 50.79 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.545 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.929 ' HA ' ' CZ ' ' A' ' 19' ' ' PHE . 27.7 m -39.9 163.24 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.008 0.433 . . . . 0.0 111.39 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.012 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 76.4 p -143.94 175.75 2.65 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.762 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.012 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 17.2 Cg_endo -57.74 -35.46 98.79 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.654 2.236 . . . . 0.0 112.196 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.487 ' O ' ' CB ' ' A' ' 29' ' ' ASN . 51.2 m -89.41 -41.26 12.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.056 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.701 HE21 ' CG2' ' A' ' 23' ' ' THR . 48.6 mt-30 -69.06 -29.86 68.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.039 -178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.951 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.8 t -93.85 -36.58 12.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.921 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -79.25 -12.15 59.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 25' ' ' SER . 43.2 t30 -91.75 -16.97 26.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.918 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -101.34 -33.2 10.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.939 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.54 43.7 0.63 Allowed Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.475 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.951 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 76.1 m -126.94 161.89 27.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.865 0.364 . . . . 0.0 110.932 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.76 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 77.1 m -85.83 134.77 33.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.644 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.526 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 50.1 t80 -113.59 122.04 46.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.882 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.661 ' OD1' ' NH2' ' A' ' 14' ' ' ARG . 16.5 t70 -145.81 99.08 3.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.911 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -91.74 54.71 2.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.901 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.478 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 74.3 p -94.99 -31.88 13.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.162 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.597 ' O ' HG22 ' A' ' 41' ' ' VAL . 63.3 t -133.97 120.92 37.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.229 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.577 ' C ' ' H ' ' A' ' 41' ' ' VAL . 35.3 ptt180 -73.47 -175.61 2.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.893 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.83 -28.84 0.18 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.434 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.943 HG21 ' HB3' ' A' ' 11' ' ' PRO . 33.9 m -101.23 166.71 11.88 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.0 111.156 179.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.793 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 60.1 Cg_endo -72.5 120.01 6.47 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.826 2.35 . . . . 0.0 112.225 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.461 ' HE1' ' HA ' ' A' ' 39' ' ' ARG . 51.8 m0 -78.21 -34.07 49.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.955 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.898 ' CB ' HG21 ' A' ' 22' ' ' VAL . 51.3 t -101.77 110.29 22.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.789 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.76 ' CE1' ' HD3' ' A' ' 14' ' ' ARG . 51.7 p90 -134.04 175.83 9.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.961 -179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.77 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 92.4 m-85 -76.0 154.14 84.75 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.857 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' THR . 57.4 Cg_endo -71.35 -156.78 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.694 2.263 . . . . 0.0 112.431 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.759 HD21 ' CG2' ' A' ' 9' ' ' VAL . 75.9 m-20 -138.81 89.13 2.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.87 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.722 ' OG1' ' HG2' ' A' ' 5' ' ' GLU . 88.6 m -80.3 88.96 5.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.143 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 64.9 mt -99.56 150.62 5.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.948 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.849 ' HB2' ' HG3' ' A' ' 3' ' ' GLN . 16.4 t70 -164.3 112.46 1.12 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.155 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.031 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 64.1 t -117.32 2.63 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.475 178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 1.031 ' HD3' ' N ' ' A' ' 52' ' ' VAL . 13.0 Cg_exo -69.52 167.35 24.38 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.659 2.239 . . . . 0.0 112.231 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.53 ' HG2' ' H ' ' A' ' 55' ' ' GLU . 74.4 Cg_endo -74.8 -84.08 0.0 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.806 2.337 . . . . 0.0 112.387 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.812 ' HG2' ' H ' ' A' ' 56' ' ' GLU . 62.6 tt0 -157.63 -177.16 6.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.849 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.812 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 17.0 pt-20 -82.2 -164.46 0.82 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.923 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.875 ' HG2' ' H ' ' A' ' 58' ' ' CYS . 62.7 tt0 -101.75 -123.5 0.18 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.875 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 52.8 t -114.39 -70.31 0.81 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.831 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -95.36 -110.25 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.698 ' CD2' ' OXT' ' A' ' 60' ' ' PHE . 51.3 p90 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.905 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' GLU . . . . . 0.577 ' O ' ' HG2' ' B' ' 1' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.763 0.316 . . . . 0.0 110.914 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.75 -152.25 0.51 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.669 ' HG2' ' HB3' ' B' ' 51' ' ' ASP . 52.7 mt-30 -142.63 150.21 39.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.861 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 75.1 p -143.36 151.27 40.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.647 ' HB3' ' HB2' ' B' ' 47' ' ' PRO . 87.1 mt-10 -91.16 156.08 18.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.779 ' HB ' ' OD1' ' B' ' 48' ' ' ASN . 92.5 m -146.25 167.89 22.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.082 179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.676 ' N ' HG22 ' B' ' 6' ' ' THR . 86.0 m -129.48 40.41 3.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 -179.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.748 HG22 ' CG2' ' B' ' 6' ' ' THR . 9.8 t -117.73 49.19 1.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.106 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.69 HG12 ' N ' ' B' ' 10' ' ' ALA . 61.3 t -103.9 168.61 2.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.112 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.882 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -74.45 121.09 84.43 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.038 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.774 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 87.8 Cg_exo -46.17 -24.77 2.6 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.807 2.338 . . . . 0.0 112.542 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.64 ' HG3' ' HG2' ' B' ' 13' ' ' GLU . 13.8 ptp180 -87.69 -29.96 20.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.903 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.64 ' HG2' ' HG3' ' B' ' 12' ' ' ARG . 6.3 mm-40 -108.3 34.61 3.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.015 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.882 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.1 mtt180 -95.49 149.35 21.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.758 ' HB2' ' HB2' ' B' ' 46' ' ' TYR . 17.1 mp0 -82.11 95.23 7.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.61 ' O ' ' CE2' ' B' ' 46' ' ' TYR . 27.4 t-20 -41.91 131.95 3.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.947 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' CYS . . . . . 0.663 ' HB2' ' CD2' ' B' ' 46' ' ' TYR . 44.3 t -145.82 3.99 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.792 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . 168.59 123.02 0.65 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.504 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.752 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 52.5 p90 -45.02 166.71 0.12 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 120.835 0.35 . . . . 0.0 110.94 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.752 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 44.3 Cg_endo -68.28 -29.52 32.03 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.759 2.306 . . . . 0.0 112.323 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.705 ' H ' ' HD2' ' B' ' 19' ' ' PHE . . . -61.33 -10.65 23.27 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.449 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.697 HG22 ' O ' ' B' ' 19' ' ' PHE . 33.1 m -66.5 165.97 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.76 0.314 . . . . 0.0 111.159 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.834 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 72.8 p -126.29 175.03 3.5 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.094 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.834 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 56.8 Cg_exo -51.75 -44.19 46.28 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.722 2.281 . . . . 0.0 112.297 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 54.6 m -74.89 -47.74 28.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.937 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.619 ' HB2' ' H ' ' B' ' 23' ' ' THR . 52.9 mt-30 -54.62 -46.56 73.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.894 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' B' ' 30' ' ' LYS . 42.6 t -65.32 -67.21 0.46 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.804 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.07 -42.35 1.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.805 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 7.0 t30 -50.18 -37.17 33.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.574 177.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' B' ' 27' ' ' CYS . 34.5 mmtp -84.02 -37.37 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.595 177.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.34 59.88 0.83 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.635 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . 0.407 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 74.1 m -150.2 170.38 19.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.854 0.359 . . . . 0.0 110.939 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.848 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.5 m -66.71 150.15 49.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.816 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -128.03 120.08 26.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.789 179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.445 ' O ' ' CG ' ' B' ' 43' ' ' TRP . 26.4 t0 -134.96 98.17 3.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.746 ' HA ' ' CD2' ' B' ' 43' ' ' TRP . 24.5 p-10 -96.81 46.16 1.05 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.949 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 74.9 p -119.77 -39.93 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.106 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.793 HG12 HG22 ' B' ' 41' ' ' VAL . 59.5 t -90.02 139.27 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.152 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.637 ' NH1' ' HZ2' ' B' ' 43' ' ' TRP . 38.6 mmt180 -94.41 162.31 13.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.43 -47.71 1.15 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.498 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.793 HG22 HG12 ' B' ' 38' ' ' VAL . 32.8 m -77.12 151.43 81.53 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 111.101 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.46 120.03 6.91 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.705 2.27 . . . . 0.0 112.259 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.746 ' CD2' ' HA ' ' B' ' 36' ' ' ASP . 35.5 m0 -64.06 -46.39 84.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.878 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' CYS . . . . . 0.848 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 44.2 t -96.0 104.09 16.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.717 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.821 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 44.8 p90 -131.91 150.09 52.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.046 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.758 ' HB2' ' HB2' ' B' ' 15' ' ' GLN . 92.3 m-85 -54.08 144.72 37.52 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.868 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.647 ' HB2' ' HB3' ' B' ' 5' ' ' GLU . 58.2 Cg_endo -71.67 -173.71 1.08 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.707 2.271 . . . . 0.0 112.311 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.779 ' OD1' ' HB ' ' B' ' 6' ' ' THR . 34.5 p30 -122.73 131.51 53.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 70.1 p -94.76 125.13 39.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.107 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.506 HG22 ' N ' ' B' ' 51' ' ' ASP . 62.4 mt -131.61 158.41 43.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.133 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.669 ' HB3' ' HG2' ' B' ' 3' ' ' GLN . 24.9 p30 -152.67 178.23 9.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.919 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 61.7 t -100.69 110.22 59.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.048 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -69.7 111.34 2.77 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.874 2.383 . . . . 0.0 112.131 -179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.861 ' HG3' ' HB3' ' B' ' 58' ' ' CYS . 55.5 Cg_endo -70.01 -135.77 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.671 2.247 . . . . 0.0 112.251 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . 0.468 ' H ' ' HB2' ' B' ' 54' ' ' PRO . 17.4 pt-20 -150.32 -43.11 0.13 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.951 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.921 ' HG3' ' H ' ' B' ' 57' ' ' GLU . 22.8 pt-20 -121.7 -69.76 0.82 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.051 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.921 ' H ' ' HG3' ' B' ' 56' ' ' GLU . 45.1 mt-10 -115.02 113.29 23.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.946 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' CYS . . . . . 0.861 ' HB3' ' HG3' ' B' ' 54' ' ' PRO . 28.9 p -83.23 43.62 0.89 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.557 ' OE1' ' N ' ' B' ' 60' ' ' PHE . 0.0 OUTLIER -160.3 111.63 1.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.913 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.61 ' CE2' ' O ' ' B' ' 57' ' ' GLU . 93.8 m-85 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.81 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.661 ' HA ' ' HB3' ' A' ' 53' ' ' PRO . 86.9 mt-10 . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.783 0.325 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.705 ' N ' HE22 ' A' ' 3' ' ' GLN . . . -107.68 70.76 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.153 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.738 ' NE2' ' HD3' ' A' ' 53' ' ' PRO . 0.9 OUTLIER -86.64 106.16 17.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.875 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.0 p -154.3 146.34 23.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.13 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.585 ' HG2' ' OG1' ' A' ' 49' ' ' THR . 85.0 mt-10 -93.93 133.63 37.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.744 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.892 ' HB ' ' HB2' ' A' ' 48' ' ' ASN . 96.4 m -107.89 152.91 23.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.168 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' N ' HG22 ' A' ' 6' ' ' THR . 72.0 m -133.83 6.55 3.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.971 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.779 HG22 ' CG2' ' A' ' 6' ' ' THR . 9.1 t -89.43 66.71 7.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.181 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.743 HG12 ' N ' ' A' ' 10' ' ' ALA . 61.4 t -97.19 171.44 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.092 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.833 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -88.52 112.59 51.03 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.072 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.82 ' HB3' HG21 ' A' ' 41' ' ' VAL . 83.7 Cg_exo -44.03 -20.02 0.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.795 2.33 . . . . 0.0 112.486 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.4 ' N ' ' O ' ' A' ' 10' ' ' ALA . 37.6 mmt180 -90.11 -30.01 17.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.87 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 10' ' ' ALA . 44.5 mt-10 -108.12 -4.37 17.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.069 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.833 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.4 mtt180 -54.26 134.26 44.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.926 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.648 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 10.1 mm-40 -93.02 79.94 4.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.818 179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.633 ' HA ' ' O ' ' A' ' 44' ' ' CYS . 51.6 t30 -27.63 150.37 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.822 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.831 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 41.3 t -125.26 8.18 7.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.0 110.567 -178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.631 ' O ' ' ND2' ' A' ' 16' ' ' ASN . . . -170.27 -132.39 1.46 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.216 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.938 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 30.8 p90 -105.76 173.77 3.03 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.798 0.333 . . . . 0.0 110.888 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.938 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 42.5 Cg_endo -68.15 -29.38 33.1 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.684 2.256 . . . . 0.0 112.457 -178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.657 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -89.28 -8.61 68.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.527 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.876 HG21 ' CB ' ' A' ' 44' ' ' CYS . 34.8 m -31.56 154.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.869 0.366 . . . . 0.0 111.327 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.013 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 74.5 p -123.99 172.72 5.37 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.134 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 1.013 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 28.1 Cg_endo -62.68 -33.08 78.29 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.756 2.304 . . . . 0.0 112.266 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.9 p -86.2 -38.0 18.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.685 ' NE2' ' HZ ' ' A' ' 19' ' ' PHE . 24.0 mt-30 -69.9 -41.73 74.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 53.6 t -74.91 -45.89 39.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.792 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.05 -33.07 70.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.058 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.612 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 38.9 t-20 -53.21 -20.67 4.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.817 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -96.76 -28.51 14.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.52 18.69 9.94 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.432 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.93 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 70.8 m -102.38 179.62 4.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.838 0.351 . . . . 0.0 111.036 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.751 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 78.9 m -93.79 155.06 17.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.786 179.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.551 ' HE2' ' OD2' ' A' ' 36' ' ' ASP . 73.7 t80 -134.24 127.19 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.931 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.427 ' OD1' ' OG1' ' A' ' 37' ' ' THR . 26.6 t0 -137.27 92.32 2.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.91 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.551 ' OD2' ' HE2' ' A' ' 34' ' ' PHE . 4.6 p30 -89.62 38.02 0.89 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.427 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 76.8 p -109.33 -10.46 14.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.129 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.596 HG12 HG22 ' A' ' 41' ' ' VAL . 62.6 t -117.61 104.61 16.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.164 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.734 ' N ' ' HD2' ' A' ' 39' ' ' ARG . 4.3 mpt_? -73.8 155.02 39.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.93 -49.44 1.98 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.438 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.928 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.1 m -92.4 170.55 8.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.753 0.311 . . . . 0.0 111.087 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.928 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 43.9 Cg_endo -68.1 145.64 67.79 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.604 2.203 . . . . 0.0 112.245 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -89.76 -30.98 17.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.898 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.876 ' CB ' HG21 ' A' ' 22' ' ' VAL . 43.1 t -97.38 128.03 43.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.692 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.751 ' CE2' ' HB2' ' A' ' 33' ' ' CYS . 48.6 p90 -146.12 157.72 43.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.904 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.648 ' CD2' ' O ' ' A' ' 15' ' ' GLN . 83.1 m-85 -70.26 135.63 86.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.93 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 58.3 Cg_endo -72.0 172.81 13.9 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.671 2.248 . . . . 0.0 112.29 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.892 ' HB2' ' HB ' ' A' ' 6' ' ' THR . 35.3 m-80 -120.56 87.62 2.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.897 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.585 ' OG1' ' HG2' ' A' ' 5' ' ' GLU . 91.8 m -85.01 102.44 13.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.058 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.9 mt -104.49 138.89 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.093 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.736 ' CB ' ' HG3' ' A' ' 3' ' ' GLN . 24.7 p-10 -165.1 158.66 16.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.899 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.775 ' N ' ' CD ' ' A' ' 53' ' ' PRO . 33.0 m -156.71 30.51 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.117 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.775 ' CD ' ' N ' ' A' ' 52' ' ' VAL . 58.6 Cg_endo -72.01 125.97 11.42 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.751 2.3 . . . . 0.0 112.377 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.18 135.59 29.84 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.784 2.323 . . . . 0.0 112.286 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.698 ' OE1' ' HB2' ' A' ' 58' ' ' CYS . 62.1 mt-10 -93.14 -157.41 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.899 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.404 ' H ' ' H ' ' A' ' 57' ' ' GLU . 22.8 pt-20 -165.5 -20.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.589 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 17.3 pt-20 -152.21 94.16 1.9 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.889 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.698 ' HB2' ' OE1' ' A' ' 55' ' ' GLU . 52.3 t -139.65 -15.87 1.04 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.902 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.546 ' OE2' ' CB ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -145.08 16.66 1.55 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.923 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.546 ' CB ' ' OE2' ' A' ' 59' ' ' GLU . 63.5 t80 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.819 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' GLU . . . . . 0.825 ' HB3' ' NE2' ' B' ' 3' ' ' GLN . 12.6 mm-40 . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.823 0.344 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.658 ' N ' ' OE1' ' B' ' 3' ' ' GLN . . . -96.62 37.24 1.29 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.086 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.946 ' OE1' ' N ' ' B' ' 3' ' ' GLN . 4.6 mp0 -90.14 176.77 6.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.447 ' N ' ' O ' ' B' ' 50' ' ' ILE . 73.4 p -142.22 134.72 28.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.079 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -97.96 134.8 40.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.992 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.736 HG22 ' N ' ' B' ' 7' ' ' CYS . 94.0 m -150.0 170.99 17.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.113 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.736 ' N ' HG22 ' B' ' 6' ' ' THR . 74.7 m -103.01 25.0 9.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.44 HG23 ' O ' ' B' ' 8' ' ' THR . 8.8 t -97.77 55.73 1.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.992 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.785 HG22 ' HB3' ' B' ' 48' ' ' ASN . 59.9 t -98.95 165.77 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.251 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.87 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -95.24 132.21 28.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.051 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.778 ' HB3' HG21 ' B' ' 41' ' ' VAL . 88.6 Cg_exo -43.84 -29.38 2.46 Favored 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 122.791 2.327 . . . . 0.0 112.49 -179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -86.71 -29.82 22.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.859 179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' B' ' 10' ' ' ALA . 61.7 mt-10 -94.92 -11.52 28.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.989 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.87 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -61.89 127.14 29.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.971 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.483 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 8.1 tp-100 -92.89 99.74 12.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.856 HD22 ' HB3' ' B' ' 42' ' ' PRO . 27.3 t-20 -33.8 150.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.016 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' CYS . . . . . 0.431 ' O ' ' SG ' ' B' ' 17' ' ' CYS . 43.3 t -138.02 4.65 2.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.696 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -168.14 -136.85 2.12 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.379 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.831 ' CZ ' ' HA ' ' B' ' 22' ' ' VAL . 27.5 p90 -105.44 168.9 7.67 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 0.0 110.99 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.821 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 54.0 Cg_endo -70.13 -12.66 32.6 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.748 2.299 . . . . 0.0 112.408 -178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.744 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -107.85 5.6 34.71 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.609 -0.805 . . . . 0.0 112.508 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.831 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 34.0 m -47.94 158.83 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 111.166 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.912 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 79.8 p -133.77 178.83 1.58 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.068 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.912 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 56.8 Cg_exo -51.75 -54.79 4.72 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.676 2.251 . . . . 0.0 112.33 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.7 m -72.89 -43.0 63.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.715 ' HB2' ' H ' ' B' ' 23' ' ' THR . 24.8 mt-30 -57.66 -38.83 75.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.941 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 46.3 t -72.92 -60.58 2.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.81 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.11 -34.75 1.13 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.973 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -50.02 -35.08 23.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.674 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -93.84 -32.41 13.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.708 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.92 58.35 0.84 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.616 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . 0.678 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 76.8 m -143.07 165.0 28.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.958 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.69 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 73.4 m -70.98 155.11 41.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.89 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.613 ' CE1' ' HA ' ' B' ' 23' ' ' THR . 67.8 t80 -132.32 119.16 20.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.6 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 16.6 t70 -130.1 96.58 4.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.749 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 4.6 p-10 -94.78 46.79 1.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.849 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 74.9 p -113.73 -31.99 6.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.518 HG12 HG22 ' B' ' 41' ' ' VAL . 63.5 t -107.87 111.43 35.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.162 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.667 ' NH1' ' HZ2' ' B' ' 43' ' ' TRP . 21.8 mmm180 -68.41 178.21 2.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.871 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.46 -54.82 0.9 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.475 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.778 HG21 ' HB3' ' B' ' 11' ' ' PRO . 33.2 m -82.22 156.32 69.16 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.814 0.34 . . . . 0.0 111.125 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.856 ' HB3' HD22 ' B' ' 16' ' ' ASN . 47.3 Cg_endo -68.7 140.35 46.61 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.662 2.241 . . . . 0.0 112.317 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.749 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 12.9 m0 -81.56 -47.51 12.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' CYS . . . . . 0.703 ' CB ' HG21 ' B' ' 22' ' ' VAL . 50.6 t -87.71 119.61 28.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.757 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.761 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 51.3 p90 -152.18 171.29 18.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.504 ' O ' ' HD2' ' B' ' 45' ' ' PHE . 84.9 m-85 -75.62 156.57 84.88 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.848 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 46' ' ' TYR . 54.7 Cg_endo -69.95 -172.42 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.791 2.327 . . . . 0.0 112.305 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.785 ' HB3' HG22 ' B' ' 9' ' ' VAL . 8.2 p30 -123.48 104.09 8.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . . . . . . . . . 76.4 p -67.66 80.54 0.18 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.067 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.615 HG13 ' OD1' ' B' ' 48' ' ' ASN . 63.1 mt -86.66 152.5 3.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.737 ' OD2' ' HG3' ' B' ' 3' ' ' GLN . 10.0 m-20 -109.78 134.09 52.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.902 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.908 ' N ' ' CD ' ' B' ' 53' ' ' PRO . 64.3 t -111.91 -11.56 0.11 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.382 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . 0.908 ' CD ' ' N ' ' B' ' 52' ' ' VAL . 56.3 Cg_endo -70.74 99.43 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.66 2.24 . . . . 0.0 112.337 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.774 ' HD3' ' O ' ' B' ' 52' ' ' VAL . 13.4 Cg_exo -69.65 -47.63 0.92 Allowed 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.851 2.367 . . . . 0.0 112.134 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . 0.791 ' HG2' ' H ' ' B' ' 56' ' ' GLU . 41.5 tt0 -150.49 -177.86 6.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.791 ' H ' ' HG2' ' B' ' 55' ' ' GLU . 17.4 pt-20 -73.89 -42.5 60.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.859 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' B' ' 57' ' ' GLU . 17.4 pt-20 -114.97 60.81 0.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.926 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' CYS . . . . . 0.552 ' SG ' ' OE1' ' A' ' 55' ' ' GLU . 51.8 t -165.57 32.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.854 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -110.86 161.8 15.45 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.939 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.911 179.967 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.842 0.353 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.62 91.46 3.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.047 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.719 ' HG2' ' CB ' ' A' ' 51' ' ' ASP . 47.9 mt-30 -140.69 135.2 31.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 3' ' ' GLN . 71.2 p -163.12 176.43 10.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.189 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.941 ' HB3' ' HB2' ' A' ' 47' ' ' PRO . 87.4 mt-10 -81.95 143.47 31.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.91 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.845 HG22 ' N ' ' A' ' 7' ' ' CYS . 93.4 m -134.74 178.42 7.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.117 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.845 ' N ' HG22 ' A' ' 6' ' ' THR . 71.7 m -108.69 12.72 25.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.944 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.673 HG23 HD11 ' A' ' 50' ' ' ILE . 8.8 t -100.3 63.58 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.149 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.786 HG23 ' ND2' ' A' ' 48' ' ' ASN . 62.5 t -94.0 164.06 2.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.175 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.887 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -85.88 139.56 35.07 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.021 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.874 ' HG3' HG21 ' A' ' 38' ' ' VAL . 93.1 Cg_exo -42.07 -36.87 4.16 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.83 2.353 . . . . 0.0 112.481 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 1.065 ' HD3' ' N ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -90.23 -29.36 18.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.758 178.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 1.065 ' N ' ' HD3' ' A' ' 12' ' ' ARG . 85.4 mt-10 -80.85 -12.96 59.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.985 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.887 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 97.6 mtt180 -71.7 113.57 8.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.073 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.668 ' O ' ' O ' ' A' ' 16' ' ' ASN . 8.0 tp-100 -80.58 95.5 6.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.838 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.678 HD22 ' CB ' ' A' ' 42' ' ' PRO . 27.4 t-20 -23.48 150.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.022 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.406 ' O ' ' SG ' ' A' ' 17' ' ' CYS . 41.0 t -141.7 4.8 1.74 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.485 179.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 175.1 -139.58 4.86 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.388 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.849 ' CE2' ' N ' ' A' ' 22' ' ' VAL . 40.3 p90 -105.62 167.41 9.76 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 120.799 0.333 . . . . 0.0 110.83 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.806 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 38.5 Cg_endo -66.86 -41.91 9.56 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.61 2.207 . . . . 0.0 112.304 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.556 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . -61.9 -26.64 67.42 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.544 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.909 HG21 ' HB2' ' A' ' 44' ' ' CYS . 34.7 m -31.58 156.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.794 0.331 . . . . 0.0 111.211 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.778 ' HA ' ' CE2' ' A' ' 34' ' ' PHE . 80.4 p -124.69 173.46 4.74 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.15 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.743 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 45.0 Cg_exo -56.27 -44.82 42.76 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.731 2.287 . . . . 0.0 112.308 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.562 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 80.1 p -75.73 -39.44 57.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.046 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.663 HE21 ' CG2' ' A' ' 23' ' ' THR . 48.2 mt-30 -67.54 -38.1 83.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.908 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 52.1 t -82.23 -51.82 7.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.75 -36.96 75.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.068 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 25' ' ' SER . 42.9 t30 -54.66 -16.76 2.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.881 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -100.47 -22.6 14.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.03 -28.73 5.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.585 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.659 ' HB3' ' O ' ' A' ' 45' ' ' PHE . 71.6 m -68.86 179.74 1.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.882 0.372 . . . . 0.0 111.068 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.3 m -107.22 155.24 20.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.003 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.778 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 15.5 t80 -115.31 134.15 55.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 178.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.484 ' OD1' ' NH1' ' A' ' 14' ' ' ARG . 17.4 t70 -158.77 99.26 1.55 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.878 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.794 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.4 p-10 -96.68 32.54 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.933 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.415 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 72.6 p -91.21 -6.68 53.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.117 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.874 HG21 ' HG3' ' A' ' 11' ' ' PRO . 61.6 t -132.66 114.91 23.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.13 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.728 ' N ' ' HD3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -78.44 -175.79 4.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.906 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.01 -35.19 0.29 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.548 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.733 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.1 m -107.38 164.82 13.99 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 120.798 0.332 . . . . 0.0 111.123 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.733 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 59.5 Cg_endo -72.34 127.15 12.31 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.698 2.265 . . . . 0.0 112.282 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.794 ' CD1' ' HA ' ' A' ' 36' ' ' ASP . 35.0 m0 -68.2 -33.72 74.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.861 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.909 ' HB2' HG21 ' A' ' 22' ' ' VAL . 53.4 t -91.31 120.27 32.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.778 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.659 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 39.5 p90 -147.36 160.09 42.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.694 ' HB3' ' HD2' ' A' ' 47' ' ' PRO . 86.5 m-85 -67.89 165.0 35.48 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.867 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.941 ' HB2' ' HB3' ' A' ' 5' ' ' GLU . 39.8 Cg_endo -67.03 172.02 10.43 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.663 2.242 . . . . 0.0 112.306 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.786 ' ND2' HG23 ' A' ' 9' ' ' VAL . 8.2 p30 -136.67 118.82 15.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 92.7 m -71.56 93.03 1.18 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.971 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.677 HG13 ' OD1' ' A' ' 48' ' ' ASN . 63.1 mt -89.45 155.25 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.286 -178.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.719 ' CB ' ' HG2' ' A' ' 3' ' ' GLN . 24.4 p-10 -145.98 -172.73 3.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.714 ' HB ' ' HD2' ' A' ' 54' ' ' PRO . 33.2 m -82.44 130.19 60.09 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 1.073 ' HD2' ' HD3' ' A' ' 54' ' ' PRO . 16.8 Cg_exo -68.46 -27.75 33.12 Favored 'Trans proline' 0 CA--C 1.528 0.186 0 C-N-CA 122.879 2.386 . . . . 0.0 112.598 -178.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 1.073 ' HD3' ' HD2' ' A' ' 53' ' ' PRO . 12.7 Cg_exo -69.51 -6.48 18.58 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.738 2.292 . . . . 0.0 112.158 179.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.621 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 10.4 tp10 -98.51 49.55 0.98 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.95 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.78 ' HG2' ' O ' ' A' ' 53' ' ' PRO . 12.6 mm-40 -103.56 118.4 36.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.491 ' OE2' ' C ' ' A' ' 60' ' ' PHE . 12.5 pt-20 -76.92 -177.43 4.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.939 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.582 ' O ' ' SG ' ' B' ' 58' ' ' CYS . 50.3 t -144.49 -4.2 0.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.938 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.524 ' O ' ' CG ' ' A' ' 60' ' ' PHE . 21.4 mp0 -81.82 -72.7 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.935 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.524 ' CG ' ' O ' ' A' ' 59' ' ' GLU . 84.9 m-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.867 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' GLU . . . . . 0.425 ' CD ' ' N ' ' B' ' 1' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.894 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.45 -129.39 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.095 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.847 ' HB3' HG22 ' B' ' 49' ' ' THR . 51.9 mt-30 -124.12 165.82 16.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.704 ' O ' ' HA ' ' B' ' 49' ' ' THR . 74.8 p -139.77 148.15 41.83 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.175 -179.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.809 ' HA ' ' O ' ' B' ' 48' ' ' ASN . 0.5 OUTLIER -105.33 152.76 22.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.938 HG22 ' H ' ' B' ' 8' ' ' THR . 87.0 m -146.63 166.83 25.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.655 ' N ' HG22 ' B' ' 6' ' ' THR . 72.8 m -109.29 9.23 25.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.107 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.938 ' H ' HG22 ' B' ' 6' ' ' THR . 9.5 t -82.13 73.24 9.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.821 178.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 1.007 HG22 ' ND2' ' B' ' 48' ' ' ASN . 50.1 t -107.19 166.42 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.375 -176.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.838 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -94.21 122.61 61.15 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.92 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.786 ' HB3' HG11 ' B' ' 41' ' ' VAL . 98.9 Cg_exo -42.56 -26.96 0.69 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.864 2.376 . . . . 0.0 112.523 -178.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.584 ' HG3' ' HG2' ' B' ' 13' ' ' GLU . 16.7 ptm180 -90.05 -29.87 18.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.973 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.584 ' HG2' ' HG3' ' B' ' 12' ' ' ARG . 81.6 mm-40 -99.96 -11.73 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.177 -178.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.952 ' HA ' HG11 ' B' ' 9' ' ' VAL . 96.7 mtt180 -51.54 127.19 19.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.873 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 1.015 ' HA ' HE21 ' B' ' 15' ' ' GLN . 0.0 OUTLIER -79.91 86.84 5.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.792 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.706 HD22 ' HB3' ' B' ' 42' ' ' PRO . 27.4 t-20 -30.01 133.67 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.105 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' CYS . . . . . 0.782 ' SG ' ' HD2' ' B' ' 30' ' ' LYS . 41.6 t -145.53 2.74 0.97 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.616 177.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' B' ' 44' ' ' CYS . . . 177.54 122.39 0.73 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.428 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.954 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 53.1 p90 -44.83 172.86 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.804 0.335 . . . . 0.0 110.861 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.954 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 33.8 Cg_endo -64.61 -60.72 0.13 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.76 2.306 . . . . 0.0 112.226 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -39.3 -17.72 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.533 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.745 HG22 ' O ' ' B' ' 19' ' ' PHE . 32.1 m -52.13 158.74 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.362 . . . . 0.0 111.138 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.825 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 74.5 p -135.27 173.99 5.11 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.825 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 54.5 Cg_exo -51.84 -42.63 56.54 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.779 2.319 . . . . 0.0 112.321 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.2 m -72.69 -48.61 37.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.982 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.563 ' O ' ' HB3' ' B' ' 29' ' ' ASN . 26.3 mt-30 -60.57 -54.4 45.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.977 -179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.3 t -54.27 -55.59 26.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.734 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.35 -40.21 11.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.957 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.563 ' HB3' ' O ' ' B' ' 26' ' ' GLN . 38.3 t-20 -49.97 -41.51 46.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.622 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.782 ' HD2' ' SG ' ' B' ' 17' ' ' CYS . 39.6 ttmt -82.22 -36.22 27.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.695 177.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.55 63.57 0.86 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.704 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . 0.765 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 93.1 m -149.99 178.56 8.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.875 0.369 . . . . 0.0 111.019 177.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.811 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 72.2 m -79.02 155.2 28.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.02 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.736 ' CE2' ' HA ' ' B' ' 23' ' ' THR . 42.6 t80 -123.4 111.06 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.663 ' O ' ' HA ' ' B' ' 43' ' ' TRP . 32.7 t0 -135.91 108.38 7.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.959 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.835 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 4.6 p-10 -111.9 31.28 6.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.886 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 81.1 p -84.09 -24.86 30.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.154 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.518 ' HB ' ' CG2' ' B' ' 41' ' ' VAL . 62.4 t -111.6 135.34 51.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.176 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -85.95 152.24 23.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.888 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 83.31 -43.6 3.16 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.542 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.786 HG11 ' HB3' ' B' ' 11' ' ' PRO . 32.8 m -81.59 154.58 71.2 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.905 0.383 . . . . 0.0 111.148 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.706 ' HB3' HD22 ' B' ' 16' ' ' ASN . 50.0 Cg_endo -69.21 136.84 35.55 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.783 2.322 . . . . 0.0 112.313 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.835 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 51.0 m0 -84.58 -54.37 4.78 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.002 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' CYS . . . . . 0.811 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 53.8 t -83.19 100.0 10.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.76 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.765 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 44.3 p90 -128.37 167.56 16.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.097 -178.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.617 ' CD1' ' HB2' ' B' ' 17' ' ' CYS . 90.7 m-85 -74.46 147.46 84.97 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.907 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.547 ' HB2' ' HB3' ' B' ' 5' ' ' GLU . 65.5 Cg_endo -74.01 -172.23 1.07 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.758 2.305 . . . . 0.0 112.335 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 1.007 ' ND2' HG22 ' B' ' 9' ' ' VAL . 34.6 m-80 -134.17 122.72 23.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.987 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.847 HG22 ' HB3' ' B' ' 3' ' ' GLN . 92.9 m -93.13 99.03 11.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.199 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.734 HG22 ' N ' ' B' ' 51' ' ' ASP . 62.4 mt -104.37 170.07 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.131 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.734 ' N ' HG22 ' B' ' 50' ' ' ILE . 10.1 m-20 -106.18 160.06 15.62 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.871 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.73 ' O ' HG23 ' B' ' 52' ' ' VAL . 33.3 m -158.46 76.0 3.54 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.094 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . 0.433 ' HA ' ' HD3' ' B' ' 54' ' ' PRO . 56.5 Cg_endo -70.99 114.06 3.78 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.728 2.285 . . . . 0.0 112.354 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' B' ' 53' ' ' PRO . 13.4 Cg_exo -69.57 88.87 0.51 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.917 2.411 . . . . 0.0 112.103 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . 0.765 ' HG2' ' N ' ' B' ' 56' ' ' GLU . 64.1 tt0 -104.56 -119.56 0.21 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.932 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.765 ' N ' ' HG2' ' B' ' 55' ' ' GLU . 12.5 mm-40 -83.89 -38.27 21.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.795 ' HG3' ' H ' ' B' ' 58' ' ' CYS . 10.3 tp10 -125.35 -121.2 0.26 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.956 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' CYS . . . . . 0.795 ' H ' ' HG3' ' B' ' 57' ' ' GLU . 26.7 p -123.72 -78.8 0.6 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.919 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.599 ' N ' ' SG ' ' B' ' 58' ' ' CYS . 12.5 pt-20 -139.79 -176.59 4.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.876 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.612 ' OE1' ' OE1' ' A' ' 3' ' ' GLN . 17.4 pt-20 . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.811 0.339 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.428 ' HB1' HG22 ' A' ' 52' ' ' VAL . . . -164.13 79.14 0.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.151 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.733 ' HG2' ' OD1' ' A' ' 51' ' ' ASP . 52.3 mt-30 -118.72 168.06 11.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.839 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.657 ' O ' ' HA ' ' A' ' 49' ' ' THR . 77.9 p -162.39 160.02 25.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.173 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.63 ' HA ' ' OE1' ' A' ' 5' ' ' GLU . 6.2 mm-40 -96.17 146.63 24.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.851 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.758 HG22 ' O ' ' A' ' 48' ' ' ASN . 9.0 t -149.83 161.35 42.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.182 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.593 ' O ' ' HZ ' ' A' ' 45' ' ' PHE . 71.6 m -117.85 -8.24 10.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.952 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.743 HG22 ' OG1' ' A' ' 6' ' ' THR . 9.2 t -69.96 92.14 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.126 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.843 HG21 HD21 ' A' ' 48' ' ' ASN . 63.0 t -127.49 173.96 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.115 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.858 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -95.2 126.01 48.02 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.02 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.874 ' HG2' HG21 ' A' ' 38' ' ' VAL . 81.2 Cg_exo -44.91 -20.54 0.39 Allowed 'Trans proline' 0 N--CA 1.464 -0.218 0 C-N-CA 122.835 2.356 . . . . 0.0 112.443 -179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 38.2 mmt180 -89.1 -31.53 17.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.904 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' ALA . 62.3 mt-10 -109.77 45.6 1.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.858 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.1 mtt180 -111.02 142.92 42.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.652 ' O ' ' O ' ' A' ' 16' ' ' ASN . 17.0 mp0 -110.39 89.75 3.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.873 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.704 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 37.0 t-20 -23.02 147.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.716 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.746 ' SG ' ' CE1' ' A' ' 46' ' ' TYR . 43.5 t -137.64 2.83 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.126 0.488 . . . . 0.0 110.554 -179.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -159.01 -137.91 2.35 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.649 -0.705 . . . . 0.0 112.242 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.957 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 41.1 p90 -105.86 172.82 3.64 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.746 0.308 . . . . 0.0 110.884 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.957 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 46.3 Cg_endo -68.95 -46.33 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.694 2.263 . . . . 0.0 112.366 -179.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.622 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -75.25 6.56 28.43 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.587 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 19' ' ' PHE . 26.7 m -50.39 122.9 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 111.309 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.963 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 82.2 p -107.66 -178.51 0.59 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.961 179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.963 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 74.5 Cg_exo -49.56 -46.89 24.85 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.655 2.237 . . . . 0.0 112.364 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 53.8 m -84.29 -34.48 23.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.018 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 1.026 ' HA ' HE21 ' A' ' 26' ' ' GLN . 0.0 OUTLIER -65.55 -32.5 74.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.909 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 49.1 t -84.19 -53.43 5.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.789 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.27 -23.99 64.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.947 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 25' ' ' SER . 6.9 t30 -76.68 -12.26 59.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.938 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.909 ' HZ2' ' HB3' ' A' ' 30' ' ' LYS . 2.7 mmmp? -108.98 -13.92 14.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.913 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.35 34.29 7.58 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.517 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.996 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 82.7 m -122.65 164.47 18.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.36 . . . . 0.0 110.872 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.761 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 74.2 m -81.44 153.43 26.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.645 176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.62 ' HE1' ' O ' ' A' ' 22' ' ' VAL . 72.1 t80 -128.55 136.93 51.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.959 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.65 ' OD2' ' NH2' ' A' ' 14' ' ' ARG . 26.6 t0 -159.79 79.94 0.71 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 24.3 p-10 -80.46 46.0 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.88 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -104.49 -4.81 22.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.202 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.874 HG21 ' HG2' ' A' ' 11' ' ' PRO . 67.8 t -145.93 118.59 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.29 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.607 ' C ' ' H ' ' A' ' 41' ' ' VAL . 78.0 mtm180 -76.78 -170.05 1.47 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.831 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 64.32 -30.24 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.446 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.854 HG21 ' HB3' ' A' ' 11' ' ' PRO . 32.9 m -111.26 161.91 23.14 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.854 0.359 . . . . 0.0 111.077 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.648 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 40.9 Cg_endo -67.49 132.58 27.62 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 112.197 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -77.85 -35.26 51.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.002 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.996 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 44.7 t -103.88 105.83 16.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.878 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.648 ' HD1' ' O ' ' A' ' 46' ' ' TYR . 5.6 p90 -124.7 -169.95 2.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.055 -178.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.746 ' CE1' ' SG ' ' A' ' 17' ' ' CYS . 90.5 m-85 -92.38 160.96 33.9 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 46' ' ' TYR . 57.4 Cg_endo -71.17 -158.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.313 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.843 HD21 HG21 ' A' ' 9' ' ' VAL . 34.5 m-80 -163.03 102.48 0.99 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 4' ' ' THR . 94.2 m -63.59 103.5 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.116 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.603 HD12 HG21 ' A' ' 6' ' ' THR . 62.3 mt -113.17 158.7 13.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.151 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.803 ' C ' ' HD3' ' A' ' 53' ' ' PRO . 70.9 m-20 -90.32 170.34 10.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.939 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.962 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 33.1 m -121.49 33.63 0.22 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.166 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.962 ' HD3' ' N ' ' A' ' 52' ' ' VAL . 13.4 Cg_exo -69.62 177.08 5.83 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.952 2.434 . . . . 0.0 112.134 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.656 ' HB2' ' CG ' ' A' ' 57' ' ' GLU . 57.7 Cg_endo -71.39 129.75 16.34 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.688 2.259 . . . . 0.0 112.282 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -111.27 -17.49 13.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.587 ' HA ' ' OE1' ' A' ' 56' ' ' GLU . 5.0 tp10 -127.37 67.06 1.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.901 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.733 ' HA ' ' CE2' ' A' ' 60' ' ' PHE . 1.4 pp20? -144.2 -0.61 0.99 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.881 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 79.3 m -72.33 22.09 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.678 ' O ' ' HG3' ' A' ' 59' ' ' GLU . 44.3 tp10 -135.29 35.92 2.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.943 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.733 ' CE2' ' HA ' ' A' ' 57' ' ' GLU . 92.1 m-85 . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.901 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' GLU . . . . . 0.607 ' OE1' ' HA ' ' B' ' 1' ' ' GLU . 6.3 mm-40 . . . . . 0 N--CA 1.485 1.325 0 CA-C-O 120.869 0.366 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 1.02 ' HB3' ' HD3' ' B' ' 53' ' ' PRO . . . -114.11 124.02 51.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.106 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.967 ' H ' ' HB ' ' B' ' 50' ' ' ILE . 93.6 mt-30 -160.58 167.63 26.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.248 0.547 . . . . 0.0 111.217 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 1.038 ' HA ' ' H ' ' B' ' 50' ' ' ILE . 17.3 p -68.73 -162.47 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.281 -176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.911 ' HB3' ' HB2' ' B' ' 47' ' ' PRO . 87.0 mt-10 -48.95 123.68 7.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.931 0.396 . . . . 0.0 110.927 -172.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.778 HG22 ' N ' ' B' ' 7' ' ' CYS . 93.8 m -150.46 174.64 12.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.889 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.778 ' N ' HG22 ' B' ' 6' ' ' THR . 82.5 m -99.55 3.11 45.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.989 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.767 ' H ' HG22 ' B' ' 6' ' ' THR . 8.9 t -93.67 71.83 4.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.147 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.869 HG11 ' HA ' ' B' ' 14' ' ' ARG . 59.5 t -109.53 172.5 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.174 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.94 ' HB1' ' CZ ' ' B' ' 12' ' ' ARG . . . -85.86 129.05 55.92 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.015 178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.643 ' HB3' HG21 ' B' ' 41' ' ' VAL . 78.0 Cg_exo -39.69 -34.45 0.78 Allowed 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.827 2.351 . . . . 0.0 112.426 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 1.032 ' HD3' ' H ' ' B' ' 12' ' ' ARG . 0.0 OUTLIER -90.12 -29.78 18.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.895 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.681 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 6.4 mm-40 -96.24 -5.22 40.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.174 -178.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.901 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -63.06 133.9 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.853 0.358 . . . . 0.0 110.674 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 1.028 ' HA ' HE21 ' B' ' 15' ' ' GLN . 0.0 OUTLIER -79.94 79.97 6.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.957 -178.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 1.083 HD22 ' N ' ' B' ' 17' ' ' CYS . 0.2 OUTLIER -34.36 139.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.721 179.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' CYS . . . . . 1.083 ' N ' HD22 ' B' ' 16' ' ' ASN . 44.6 t -126.98 1.57 6.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.019 0.437 . . . . 0.0 110.593 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 1.04 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -179.36 -132.72 1.82 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.218 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.855 ' CE2' ' N ' ' B' ' 22' ' ' VAL . 21.3 p90 -105.8 165.61 12.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.832 0.349 . . . . 0.0 110.915 178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.723 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 43.1 Cg_endo -67.96 -11.57 32.48 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.751 2.301 . . . . 0.0 112.288 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.646 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -98.53 -19.92 21.3 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.463 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.855 ' N ' ' CE2' ' B' ' 19' ' ' PHE . 34.5 m -27.7 139.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.761 0.315 . . . . 0.0 111.141 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.833 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 75.9 p -109.7 176.25 1.62 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.091 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.833 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 51.6 Cg_exo -52.91 -49.83 16.19 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.75 2.3 . . . . 0.0 112.361 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 48.1 t -68.76 -41.09 79.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.004 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.45 ' HB2' ' H ' ' B' ' 23' ' ' THR . 52.8 mt-30 -65.69 -40.45 92.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.02 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' CYS . . . . . 0.426 ' SG ' ' O ' ' B' ' 33' ' ' CYS . 42.3 t -74.58 -41.71 60.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.802 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.8 -33.46 73.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.078 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -49.77 -35.0 20.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.76 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 1.057 ' HE2' ' HA ' ' B' ' 30' ' ' LYS . 0.5 OUTLIER -95.53 -38.05 10.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.521 177.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 107.07 57.01 0.61 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.522 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . 0.756 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 78.1 m -129.84 177.07 7.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.885 0.374 . . . . 0.0 110.938 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.912 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 74.1 m -80.03 155.33 27.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.953 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.603 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 41.3 t80 -128.5 114.56 16.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.863 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' B' ' 43' ' ' TRP . 16.7 t70 -135.2 94.33 3.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.992 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.673 ' HA ' ' CG ' ' B' ' 43' ' ' TRP . 25.2 p30 -91.88 22.45 4.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.974 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -97.26 -8.44 29.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.219 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.816 HG21 ' NH2' ' B' ' 14' ' ' ARG . 63.2 t -122.27 106.18 17.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.089 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.423 ' C ' ' H ' ' B' ' 41' ' ' VAL . 95.3 mtt180 -77.45 -178.46 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.953 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.43 -43.29 0.56 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.405 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.885 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.2 m -105.85 169.25 7.18 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 120.837 0.351 . . . . 0.0 110.986 179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.885 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 51.6 Cg_endo -69.33 147.58 65.95 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.67 2.247 . . . . 0.0 112.312 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.673 ' CG ' ' HA ' ' B' ' 36' ' ' ASP . 46.5 m0 -91.42 -38.19 12.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.813 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' CYS . . . . . 0.912 ' HA ' ' O ' ' B' ' 33' ' ' CYS . 53.6 t -94.67 121.62 36.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.733 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.573 ' HZ ' ' O ' ' B' ' 7' ' ' CYS . 45.0 p90 -150.99 169.74 21.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 -179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.715 ' HD2' ' HG3' ' B' ' 15' ' ' GLN . 89.3 m-85 -83.46 155.52 66.0 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.818 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.911 ' HB2' ' HB3' ' B' ' 5' ' ' GLU . 55.7 Cg_endo -70.49 164.27 35.87 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.705 2.27 . . . . 0.0 112.296 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.86 ' ND2' HG22 ' B' ' 9' ' ' VAL . 8.1 p30 -119.93 136.7 54.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.898 HG22 ' HG3' ' B' ' 5' ' ' GLU . 67.5 p -95.57 132.19 40.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.101 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 1.038 ' H ' ' HA ' ' B' ' 4' ' ' THR . 54.2 mt -160.03 160.99 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.178 -179.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.651 ' O ' ' HB3' ' B' ' 2' ' ' ALA . 9.9 m-20 -116.79 147.21 42.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.068 -178.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.595 ' O ' HG23 ' B' ' 52' ' ' VAL . 32.9 m -73.37 113.58 23.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.214 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . 1.02 ' HD3' ' HB3' ' B' ' 2' ' ' ALA . 73.7 Cg_endo -75.82 160.65 37.25 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.791 2.327 . . . . 0.0 112.427 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.84 144.87 39.62 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.81 2.34 . . . . 0.0 112.297 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . 0.724 ' HB2' ' OE1' ' B' ' 56' ' ' GLU . 87.2 mt-10 -116.12 -58.48 2.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.831 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.724 ' OE1' ' HB2' ' B' ' 55' ' ' GLU . 2.9 pm0 -123.22 -9.68 8.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.794 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -131.72 -160.83 1.08 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' CYS . . . . . 0.537 ' O ' ' CD ' ' B' ' 59' ' ' GLU . 26.9 p -104.67 -49.96 3.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.952 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.537 ' CD ' ' O ' ' B' ' 58' ' ' CYS . 81.6 mm-40 -162.06 -46.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.747 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.688 ' CD2' ' OXT' ' B' ' 60' ' ' PHE . 48.6 p90 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.951 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.461 ' OE1' ' N ' ' A' ' 1' ' ' GLU . 20.8 mp0 . . . . . 0 N--CA 1.485 1.308 0 CA-C-O 120.789 0.328 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.942 ' HB1' HG22 ' A' ' 52' ' ' VAL . . . -151.75 30.58 0.58 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -145.26 114.39 7.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.9 p -143.94 132.4 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.183 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.531 ' HG2' ' OG1' ' A' ' 49' ' ' THR . 61.6 mt-10 -107.61 124.89 50.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.835 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.838 HG22 HG22 ' A' ' 8' ' ' THR . 91.9 m -122.33 133.69 54.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.11 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.4 m -112.18 23.95 13.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.987 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.838 HG22 HG22 ' A' ' 6' ' ' THR . 10.0 t -74.27 64.24 1.09 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.079 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.823 HG11 ' HA ' ' A' ' 14' ' ' ARG . 57.2 t -97.47 124.69 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.184 -179.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.983 ' HB3' ' HB2' ' A' ' 13' ' ' GLU . . . -50.26 136.23 22.82 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.82 178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.501 ' HA ' ' NE ' ' A' ' 14' ' ' ARG . 84.7 Cg_exo -41.19 -55.59 2.08 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.906 2.404 . . . . 0.0 112.805 -177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.847 ' HG3' ' OE2' ' A' ' 13' ' ' GLU . 15.8 ptp180 -81.03 -29.61 35.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.07 -178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.983 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 22.3 mp0 -80.77 7.85 9.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.039 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.94 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.2 mtt180 -74.94 120.9 21.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.839 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.669 ' O ' ' O ' ' A' ' 16' ' ' ASN . 10.4 mm100 -82.26 80.16 8.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.919 -177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.669 ' O ' ' O ' ' A' ' 15' ' ' GLN . 35.9 t-20 -22.51 148.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.037 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.657 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 42.5 t -134.96 0.23 2.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.639 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.588 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -166.86 -136.05 1.96 Allowed Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.268 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.87 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 22.2 p90 -105.55 170.12 6.26 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.811 0.339 . . . . 0.0 110.95 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.87 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 53.4 Cg_endo -69.82 -12.55 33.0 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.749 2.299 . . . . 0.0 112.368 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.661 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -98.44 -21.29 17.46 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.697 -0.764 . . . . 0.0 112.461 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.891 HG21 ' HB2' ' A' ' 44' ' ' CYS . 34.3 m -24.93 150.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.815 0.341 . . . . 0.0 111.255 -179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.568 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 68.8 p -120.34 165.25 18.78 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.093 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.673 ' HD3' ' CZ ' ' A' ' 34' ' ' PHE . 53.2 Cg_exo -52.5 -36.52 70.7 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.718 2.279 . . . . 0.0 112.304 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.6 t -79.14 -48.28 14.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.556 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 48.4 mt-30 -60.37 -44.27 95.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.944 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 50.6 t -75.02 -58.86 3.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.899 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -53.54 -15.7 1.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -92.48 -14.3 28.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 22.8 tptm -98.84 -1.46 40.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.94 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.55 45.79 5.69 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.602 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.798 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 79.9 m -149.96 152.17 34.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.898 0.38 . . . . 0.0 110.993 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.882 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 78.5 m -67.39 155.29 39.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.858 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.673 ' CZ ' ' HD3' ' A' ' 24' ' ' PRO . 59.8 t80 -129.79 109.8 11.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.817 179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.575 ' OD1' ' OG1' ' A' ' 37' ' ' THR . 32.9 t0 -138.41 90.48 2.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.714 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.4 p-10 -88.92 -3.12 58.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.912 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.575 ' OG1' ' OD1' ' A' ' 35' ' ' ASP . 79.1 p -48.71 -7.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.067 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.572 ' H ' ' C ' ' A' ' 36' ' ' ASP . 62.2 t -141.26 103.46 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.123 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.797 ' HA ' ' HE1' ' A' ' 43' ' ' TRP . 15.9 ptp180 -69.27 -165.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.763 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.22 -34.87 0.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.359 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.839 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.6 m -108.39 167.74 8.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 0.0 110.944 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.839 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 42.9 Cg_endo -68.08 119.97 6.96 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.706 2.271 . . . . 0.0 112.187 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.797 ' HE1' ' HA ' ' A' ' 39' ' ' ARG . 50.1 m0 -70.11 -37.67 75.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.891 ' HB2' HG21 ' A' ' 22' ' ' VAL . 50.5 t -96.84 128.57 43.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.829 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.576 ' CE2' ' CG2' ' A' ' 9' ' ' VAL . 52.4 p90 -152.81 161.75 42.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.937 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -67.02 137.19 94.49 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.004 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.882 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 99.0 Cg_endo -80.67 -177.05 3.49 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.933 2.422 . . . . 0.0 112.484 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.565 HD21 HG22 ' A' ' 9' ' ' VAL . 36.3 m-80 -129.0 79.96 1.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.781 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.531 ' OG1' ' HG2' ' A' ' 5' ' ' GLU . 95.2 m -90.03 138.02 31.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.132 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 60.3 mt -133.01 139.4 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.04 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.592 ' HA ' ' O ' ' A' ' 2' ' ' ALA . 24.5 p-10 -161.97 -169.51 2.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.942 HG22 ' HB1' ' A' ' 2' ' ' ALA . 29.9 m -140.56 122.57 9.57 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.105 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.896 ' HG3' ' HB2' ' B' ' 55' ' ' GLU . 57.2 Cg_endo -71.22 108.77 2.42 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.666 2.244 . . . . 0.0 112.319 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.437 ' HD3' ' O ' ' A' ' 52' ' ' VAL . 58.3 Cg_endo -71.64 -45.68 0.74 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.726 2.284 . . . . 0.0 112.254 179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.742 ' HG3' ' N ' ' A' ' 56' ' ' GLU . 4.8 tp10 -143.05 -177.59 5.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.742 ' N ' ' HG3' ' A' ' 55' ' ' GLU . 6.3 mm-40 -70.77 33.44 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.523 ' H ' ' C ' ' A' ' 55' ' ' GLU . 87.4 mt-10 -162.15 137.96 7.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.965 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.634 ' SG ' ' N ' ' A' ' 59' ' ' GLU . 29.8 p -98.99 -106.93 0.2 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.813 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.634 ' N ' ' SG ' ' A' ' 58' ' ' CYS . 45.2 mt-10 -141.77 -145.78 0.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.603 ' CG ' ' O ' ' A' ' 59' ' ' GLU . 90.5 m-85 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.268 -0.872 . . . . 0.0 110.909 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' B' ' 1' ' ' GLU . 22.9 pt-20 . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.798 0.332 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.818 ' CB ' HG22 ' B' ' 52' ' ' VAL . . . -71.14 5.46 2.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.055 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.884 ' HA ' ' OD1' ' B' ' 51' ' ' ASP . 27.3 mm-40 -91.5 115.23 27.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.692 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.553 ' C ' ' OE2' ' B' ' 5' ' ' GLU . 72.4 p -160.05 132.05 6.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.85 0.357 . . . . 0.0 111.443 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 1.002 ' HG3' HG22 ' B' ' 49' ' ' THR . 0.6 OUTLIER -110.08 146.81 34.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.754 178.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.701 HG22 ' H ' ' B' ' 8' ' ' THR . 94.4 m -144.1 163.51 33.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.237 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.606 ' N ' HG22 ' B' ' 6' ' ' THR . 73.8 m -121.13 32.29 6.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.701 ' H ' HG22 ' B' ' 6' ' ' THR . 9.1 t -98.05 72.72 2.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.087 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.874 HG12 ' N ' ' B' ' 10' ' ' ALA . 73.8 t -119.34 -179.53 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.204 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.874 ' N ' HG12 ' B' ' 9' ' ' VAL . . . -95.97 159.91 31.23 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.008 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.452 ' HB3' HG11 ' B' ' 41' ' ' VAL . 76.8 Cg_exo -50.08 -39.18 51.06 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.748 2.298 . . . . 0.0 112.462 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.4 ' C ' ' H ' ' B' ' 14' ' ' ARG . 39.4 ptt180 -89.97 -29.92 18.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.764 ' O ' HG11 ' B' ' 9' ' ' VAL . 45.2 mt-10 -77.0 17.46 0.44 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.077 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.829 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.2 mtt180 -98.56 114.39 26.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.97 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 8.1 tp-100 -80.48 98.85 7.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.708 ' ND2' ' H ' ' B' ' 18' ' ' GLY . 2.6 t-20 -32.95 150.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.101 -179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' CYS . . . . . 0.527 ' H ' ' ND2' ' B' ' 16' ' ' ASN . 41.5 t -143.26 5.17 1.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.73 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.708 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -170.85 -138.61 2.55 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.422 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.859 ' CE1' HG12 ' B' ' 22' ' ' VAL . 42.8 p90 -105.58 166.83 10.65 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.813 0.339 . . . . 0.0 110.929 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.776 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 47.1 Cg_endo -68.9 -33.74 19.37 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.751 2.3 . . . . 0.0 112.313 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.663 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -84.05 13.47 49.27 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.54 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.859 HG12 ' CE1' ' B' ' 19' ' ' PHE . 34.0 m -65.07 164.43 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.801 0.334 . . . . 0.0 111.207 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.777 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 75.2 p -133.75 173.15 6.18 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.054 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.777 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 55.7 Cg_exo -51.63 -32.75 45.97 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.727 2.285 . . . . 0.0 112.363 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 47.3 t -84.81 -66.74 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.476 ' NE2' ' HZ ' ' B' ' 19' ' ' PHE . 52.6 mt-30 -39.34 -34.45 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.863 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' B' ' 30' ' ' LYS . 42.6 t -80.58 -60.97 2.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.761 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -41.16 -34.14 0.43 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 177.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -49.84 -37.09 29.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.42 177.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' B' ' 27' ' ' CYS . 46.6 mmtm -86.76 -30.85 21.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.518 176.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.01 24.03 9.36 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.709 178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . 0.656 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 81.6 m -102.42 155.54 18.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 110.897 178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' B' ' 47' ' ' PRO . 83.0 m -63.56 149.45 46.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.807 179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.635 ' CZ ' ' HA ' ' B' ' 23' ' ' THR . 59.6 t80 -133.13 120.24 20.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.89 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.535 ' OD2' ' NH1' ' B' ' 14' ' ' ARG . 16.5 t70 -129.3 87.75 2.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.662 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 24.3 p-10 -91.83 51.53 1.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 75.8 p -117.8 -11.92 10.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.192 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.492 ' O ' HG22 ' B' ' 41' ' ' VAL . 62.2 t -136.01 115.54 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.441 ' C ' ' H ' ' B' ' 41' ' ' VAL . 80.7 mtp180 -67.98 -178.17 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.22 -41.27 0.48 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.557 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.492 HG22 ' O ' ' B' ' 38' ' ' VAL . 33.0 m -92.49 153.07 42.62 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.803 0.335 . . . . 0.0 111.107 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -69.29 122.2 9.0 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.749 2.299 . . . . 0.0 112.207 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.662 ' CD1' ' HA ' ' B' ' 36' ' ' ASP . 23.1 m0 -67.34 -47.45 70.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.009 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' CYS . . . . . 0.705 ' CB ' HG21 ' B' ' 22' ' ' VAL . 46.8 t -92.03 119.84 32.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.897 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.763 ' CE2' ' HD3' ' B' ' 14' ' ' ARG . 53.3 p90 -149.23 159.41 44.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.827 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.439 ' CE1' ' O ' ' B' ' 16' ' ' ASN . 91.6 m-85 -58.68 146.92 72.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.507 ' HA ' ' SG ' ' B' ' 33' ' ' CYS . 59.0 Cg_endo -72.32 -169.87 0.51 Allowed 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.763 2.308 . . . . 0.0 112.371 -179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.853 HD21 ' CG2' ' B' ' 9' ' ' VAL . 33.0 m-80 -119.71 84.42 2.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.78 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 1.002 HG22 ' HG3' ' B' ' 5' ' ' GLU . 81.6 p -75.65 108.68 8.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.086 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 57.3 mt -103.04 136.73 34.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.044 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.884 ' OD1' ' HA ' ' B' ' 3' ' ' GLN . 7.3 m-20 -160.23 160.37 32.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.915 -176.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 1.077 ' N ' ' HD3' ' B' ' 53' ' ' PRO . 30.2 m -131.33 17.7 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.316 177.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . 1.077 ' HD3' ' N ' ' B' ' 52' ' ' VAL . 12.2 Cg_exo -69.81 118.85 5.92 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.745 2.297 . . . . 0.0 112.154 179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.71 -174.24 1.04 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.658 2.239 . . . . 0.0 112.204 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . 0.896 ' HB2' ' HG3' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -95.59 -98.0 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.887 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.566 ' OE1' ' C ' ' B' ' 56' ' ' GLU . 1.4 pp20? -141.3 155.84 45.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.781 ' HG2' ' H ' ' B' ' 58' ' ' CYS . 41.5 tt0 -123.47 -120.39 0.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.876 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' CYS . . . . . 0.781 ' H ' ' HG2' ' B' ' 57' ' ' GLU . 81.4 m -93.6 173.95 7.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.047 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -169.98 -18.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 61.9 t80 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.84 179.859 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.826 0.346 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.71 ' O ' ' HA ' ' A' ' 51' ' ' ASP . . . -81.7 67.73 7.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.067 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 1.113 HE21 ' HA ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -137.45 128.14 26.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.801 179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 75.9 p -137.95 139.31 39.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.174 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.793 ' HA ' ' O ' ' A' ' 48' ' ' ASN . 21.4 mp0 -101.52 126.7 48.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.887 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.985 HG22 ' H ' ' A' ' 8' ' ' THR . 86.0 m -130.26 173.98 10.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.044 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.77 ' N ' HG22 ' A' ' 6' ' ' THR . 71.9 m -131.29 2.43 4.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.24 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.985 ' H ' HG22 ' A' ' 6' ' ' THR . 10.1 t -75.21 63.16 1.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.084 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.949 HG22 HD21 ' A' ' 48' ' ' ASN . 58.0 t -96.65 155.55 3.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.139 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.912 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -69.66 136.3 88.07 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.786 178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.593 ' HG3' HG21 ' A' ' 38' ' ' VAL . 88.9 Cg_exo -41.83 -66.69 0.14 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.793 2.329 . . . . 0.0 112.593 -177.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 61.9 mtp180 -65.12 -30.0 70.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.992 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.897 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 81.0 mm-40 -88.96 27.69 1.3 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.097 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.912 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.2 mtt180 -97.83 129.31 44.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.865 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.458 ' O ' ' HB2' ' A' ' 45' ' ' PHE . 29.5 mm-40 -82.63 104.19 12.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.87 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.636 ' O ' ' CE2' ' A' ' 46' ' ' TYR . 2.6 t-20 -35.29 122.02 0.59 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.905 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 46.4 t -138.8 -0.73 1.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.196 0.522 . . . . 0.0 110.229 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.764 ' N ' ' O ' ' A' ' 44' ' ' CYS . . . 174.77 122.34 0.68 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.313 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.818 ' O ' HG22 ' A' ' 22' ' ' VAL . 53.2 p90 -44.78 167.87 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.397 0 CA-C-O 120.751 0.31 . . . . 0.0 110.973 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.786 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 47.2 Cg_endo -68.9 -52.97 0.35 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.659 2.239 . . . . 0.0 112.263 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -40.46 -27.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.382 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.904 HG21 ' HB2' ' A' ' 44' ' ' CYS . 29.1 m -49.93 171.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.819 0.342 . . . . 0.0 111.122 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.891 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 74.1 p -137.25 178.71 1.6 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.94 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.891 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 58.0 Cg_exo -51.48 -36.58 59.68 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.627 2.218 . . . . 0.0 112.27 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.431 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 53.1 m -90.18 -40.01 12.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.941 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.821 ' HB2' ' H ' ' A' ' 23' ' ' THR . 24.9 mt-30 -65.23 -27.31 68.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.868 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.975 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 53.0 t -91.56 -52.9 4.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.789 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.84 -21.0 40.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.004 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.517 ' O ' ' OD1' ' A' ' 29' ' ' ASN . 37.8 t-20 -72.01 -27.47 62.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.849 179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -93.11 -24.52 18.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.937 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.32 29.35 5.14 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.4 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.975 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 61.9 m -108.52 -176.8 3.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.864 0.364 . . . . 0.0 110.827 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.73 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 73.7 m -109.22 132.62 53.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.636 176.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.781 ' CE2' ' HA ' ' A' ' 23' ' ' THR . 26.9 t80 -104.41 108.5 19.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.896 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.41 ' OD1' ' C ' ' A' ' 35' ' ' ASP . 32.5 t0 -128.98 90.31 3.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.541 ' OD2' ' HE1' ' A' ' 34' ' ' PHE . 25.0 p30 -89.1 60.55 5.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.3 p -114.8 -33.65 5.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.09 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.624 ' O ' HG22 ' A' ' 41' ' ' VAL . 63.5 t -119.48 120.38 63.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.074 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.588 ' C ' ' H ' ' A' ' 41' ' ' VAL . 98.8 mtt180 -74.24 179.33 4.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 66.06 -28.5 0.15 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.455 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.624 HG22 ' O ' ' A' ' 38' ' ' VAL . 33.0 m -98.84 158.84 31.68 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 120.8 0.333 . . . . 0.0 111.081 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.557 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 50.4 Cg_endo -69.18 120.2 7.09 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.67 2.247 . . . . 0.0 112.302 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 38.5 m0 -73.51 -27.4 61.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.942 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 44.6 t -113.27 95.96 5.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.916 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.723 ' C ' ' HB3' ' A' ' 17' ' ' CYS . 52.8 p90 -122.71 -169.93 2.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.636 ' CE2' ' O ' ' A' ' 16' ' ' ASN . 96.3 m-85 -88.29 143.39 32.56 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.976 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.416 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 56.6 Cg_endo -70.87 -156.53 0.04 OUTLIER 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.842 2.362 . . . . 0.0 112.408 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.949 HD21 HG22 ' A' ' 9' ' ' VAL . 76.2 m-20 -135.39 146.9 48.79 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.892 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 66.5 p -119.48 82.46 1.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.98 178.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.593 HG22 ' N ' ' A' ' 51' ' ' ASP . 60.4 mt -98.82 161.96 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.269 -178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.71 ' HA ' ' O ' ' A' ' 2' ' ' ALA . 10.0 m-20 -87.48 160.63 18.2 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.777 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.95 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 60.7 t -159.43 67.75 3.05 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.134 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -89.37 79.26 0.89 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.194 2.596 . . . . 0.0 112.686 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.95 ' HD3' ' O ' ' A' ' 52' ' ' VAL . 59.5 Cg_endo -71.88 70.64 2.84 Favored 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.642 2.228 . . . . 0.0 112.305 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.63 ' HA ' ' OE1' ' A' ' 55' ' ' GLU . 6.2 mm-40 -134.43 -81.01 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.959 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.56 ' CD ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -111.85 32.81 5.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.882 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -89.62 70.83 7.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.964 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.587 ' SG ' ' N ' ' A' ' 59' ' ' GLU . 43.9 t -92.86 176.59 6.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.946 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.587 ' N ' ' SG ' ' A' ' 58' ' ' CYS . 12.4 mm-40 -120.84 3.25 10.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.443 ' HB2' ' SG ' ' B' ' 58' ' ' CYS . 89.1 m-85 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.841 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' GLU . . . . . 0.815 ' HG3' ' H ' ' B' ' 2' ' ' ALA . 22.9 pt-20 . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 120.797 0.332 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.815 ' H ' ' HG3' ' B' ' 1' ' ' GLU . . . -144.52 73.28 1.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.108 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.942 ' HA ' ' HB2' ' B' ' 51' ' ' ASP . 1.5 mp0 -138.32 171.46 14.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.962 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.808 ' O ' ' HA ' ' B' ' 49' ' ' THR . 66.6 p -117.24 -159.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.136 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -109.4 145.47 36.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.962 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.907 ' CG2' HG22 ' B' ' 8' ' ' THR . 87.4 m -149.94 156.47 41.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.034 -179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.458 ' N ' HG22 ' B' ' 6' ' ' THR . 71.2 m -122.61 -8.26 8.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.286 -178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.907 HG22 ' CG2' ' B' ' 6' ' ' THR . 9.4 t -74.52 82.95 1.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.9 0.381 . . . . 0.0 111.099 -179.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.885 HG21 ' ND2' ' B' ' 48' ' ' ASN . 76.4 t -128.59 176.23 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.071 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.844 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -84.17 128.15 63.6 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.053 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.924 ' HB3' HG21 ' B' ' 41' ' ' VAL . 97.6 Cg_exo -42.45 -66.25 0.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.795 2.33 . . . . 0.0 112.416 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.89 ' NH1' ' HD2' ' B' ' 11' ' ' PRO . 0.1 OUTLIER -54.16 -29.9 47.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.823 179.076 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.707 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 87.3 mt-10 -93.82 22.71 5.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.844 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 98.8 mtt180 -98.91 141.54 31.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.552 ' O ' ' HD1' ' B' ' 46' ' ' TYR . 84.9 mm-40 -88.18 80.04 7.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.945 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 1.058 HD22 ' N ' ' B' ' 17' ' ' CYS . 0.1 OUTLIER -24.36 138.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.585 179.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' CYS . . . . . 1.058 ' N ' HD22 ' B' ' 16' ' ' ASN . 40.9 t -133.09 2.82 3.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.041 0.448 . . . . 0.0 110.559 -179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.879 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -156.83 -136.5 2.13 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.286 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.907 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 12.3 p90 -105.74 171.54 4.77 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-O 120.819 0.342 . . . . 0.0 111.007 179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.907 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 30.4 Cg_endo -64.05 -10.01 21.5 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.821 2.348 . . . . 0.0 112.386 -178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.772 ' HA2' ' CZ3' ' B' ' 43' ' ' TRP . . . -128.93 29.07 4.02 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.606 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.879 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 35.7 m -49.66 161.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.92 0.391 . . . . 0.0 111.264 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 1.082 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 66.7 p -135.95 176.41 2.85 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.767 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 1.082 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 10.8 Cg_endo -54.03 -42.22 68.72 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.597 2.198 . . . . 0.0 112.088 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -81.07 -46.42 15.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.858 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.747 ' HG2' ' OG1' ' B' ' 23' ' ' THR . 15.2 mm100 -57.04 -38.63 73.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.999 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.0 t -73.76 -54.77 7.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.759 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.1 -35.7 7.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.83 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -54.03 -28.33 37.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.798 178.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.81 ' HZ2' ' HB3' ' B' ' 30' ' ' LYS . 2.7 mmmp? -100.17 -26.95 13.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.731 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.5 60.58 1.79 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.592 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . 0.527 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 78.6 m -142.88 176.41 9.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.851 0.358 . . . . 0.0 110.91 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.661 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.0 m -74.27 148.66 41.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.765 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.635 ' CE1' HG23 ' B' ' 22' ' ' VAL . 75.6 t80 -126.76 130.8 51.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.885 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.571 ' OD2' ' NH2' ' B' ' 14' ' ' ARG . 27.5 t0 -148.19 80.02 1.46 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.873 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.733 ' HA ' ' CD1' ' B' ' 43' ' ' TRP . 24.4 p-10 -84.44 53.45 2.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 75.0 p -120.04 -4.84 10.06 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.621 HG12 HG22 ' B' ' 41' ' ' VAL . 61.8 t -132.7 106.87 11.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.159 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.668 ' C ' ' H ' ' B' ' 41' ' ' VAL . 79.7 mtm180 -71.28 -171.81 0.65 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.925 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 57.66 -10.88 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.385 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.924 HG21 ' HB3' ' B' ' 11' ' ' PRO . 34.9 m -131.49 164.98 38.79 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 120.88 0.371 . . . . 0.0 111.1 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.755 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 57.7 Cg_endo -71.31 144.17 45.33 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.751 2.301 . . . . 0.0 112.309 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.772 ' CZ3' ' HA2' ' B' ' 21' ' ' GLY . 27.1 m0 -93.25 -50.7 5.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.794 179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' CYS . . . . . 0.825 ' H ' HG21 ' B' ' 22' ' ' VAL . 52.9 t -87.66 122.85 31.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.727 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.779 ' CE1' ' HD3' ' B' ' 14' ' ' ARG . 47.8 p90 -148.19 149.58 32.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.552 ' HD1' ' O ' ' B' ' 15' ' ' GLN . 81.0 m-85 -46.81 150.57 1.25 Allowed Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.851 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.77 174.08 12.4 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.747 2.298 . . . . 0.0 112.37 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.885 ' ND2' HG21 ' B' ' 9' ' ' VAL . 34.6 m-80 -128.29 144.26 51.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.846 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.808 ' HA ' ' O ' ' B' ' 4' ' ' THR . 93.9 m -101.23 129.76 47.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.155 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.505 HG22 ' N ' ' B' ' 51' ' ' ASP . 63.2 mt -156.64 156.94 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.327 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.942 ' HB2' ' HA ' ' B' ' 3' ' ' GLN . 16.5 t70 -159.72 -171.8 3.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.836 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.711 ' H ' ' CG ' ' B' ' 51' ' ' ASP . 61.0 t -106.57 114.12 62.3 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.208 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . 0.473 ' HG3' ' HB3' ' B' ' 59' ' ' GLU . 56.7 Cg_endo -70.98 173.17 12.47 Favored 'Trans proline' 0 N--CA 1.465 -0.18 0 C-N-CA 122.726 2.284 . . . . 0.0 112.273 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.57 -51.51 0.4 Allowed 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.908 2.405 . . . . 0.0 112.175 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -124.73 -164.99 1.33 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.961 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -104.22 19.66 19.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.511 ' O ' ' HG2' ' B' ' 57' ' ' GLU . 41.6 tt0 -126.84 1.49 6.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.858 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 60' ' ' PHE . 73.0 m -126.85 67.43 1.26 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.91 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.819 ' HG3' ' CD2' ' B' ' 60' ' ' PHE . 12.6 pt-20 -152.01 -33.88 0.14 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.85 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.819 ' CD2' ' HG3' ' B' ' 59' ' ' GLU . 94.6 m-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.836 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 1' ' ' GLU . 12.5 pt-20 . . . . . 0 N--CA 1.487 1.375 0 CA-C-O 120.819 0.342 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.718 ' O ' ' HB2' ' A' ' 51' ' ' ASP . . . -160.02 121.55 3.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.161 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.81 ' HG3' ' HB2' ' A' ' 51' ' ' ASP . 1.3 mp0 -142.8 100.39 3.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.771 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 1.008 ' N ' HG23 ' A' ' 50' ' ' ILE . 71.6 p -169.87 138.55 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.091 -178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 1.045 ' HG3' HD11 ' A' ' 50' ' ' ILE . 37.3 mt-10 -61.5 -174.92 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.607 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.976 ' C ' HD22 ' A' ' 48' ' ' ASN . 95.7 m -128.13 164.93 21.39 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.803 177.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.609 ' N ' HG22 ' A' ' 6' ' ' THR . 70.9 m -130.31 -22.88 2.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.842 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.521 HG22 ' CG2' ' A' ' 6' ' ' THR . 8.9 t -74.37 51.33 0.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.056 179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.878 ' CG2' HD21 ' A' ' 48' ' ' ASN . 62.8 t -90.06 177.8 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.095 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.875 ' HB3' ' HB2' ' A' ' 13' ' ' GLU . . . -76.05 132.11 74.52 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.939 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.657 ' HA ' ' NE ' ' A' ' 14' ' ' ARG . 88.6 Cg_exo -46.92 -74.61 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.746 2.297 . . . . 0.0 112.425 -179.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.718 ' HB2' ' OE2' ' A' ' 13' ' ' GLU . 37.2 mmt180 -52.6 -30.65 32.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.975 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.875 ' HB2' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -89.66 35.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.946 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.808 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.0 mtt180 -107.89 124.04 49.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.976 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.571 ' CB ' ' HD2' ' A' ' 46' ' ' TYR . 1.0 OUTLIER -79.93 92.71 5.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.928 -179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 15' ' ' GLN . 27.4 t-20 -30.31 150.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.974 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.637 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 43.5 t -135.96 4.67 3.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.336 179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -175.19 -138.28 2.73 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.336 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.956 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 30.4 p90 -105.75 172.38 4.04 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.778 0.323 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.956 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 46.1 Cg_endo -68.79 -31.59 24.97 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.715 2.277 . . . . 0.0 112.325 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.644 ' H ' ' HD2' ' A' ' 19' ' ' PHE . . . -74.27 -27.98 64.91 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.527 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.932 HG21 ' HB2' ' A' ' 44' ' ' CYS . 34.4 m -26.21 152.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.89 0.376 . . . . 0.0 111.266 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.67 ' OG1' ' HG3' ' A' ' 26' ' ' GLN . 74.8 p -122.33 164.53 25.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.074 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.747 ' HG3' ' CE1' ' A' ' 34' ' ' PHE . 50.2 Cg_exo -53.48 -32.48 63.16 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.709 2.273 . . . . 0.0 112.349 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 47.8 t -84.83 -46.45 11.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.67 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 26.3 mt-30 -59.71 -46.59 88.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.8 t -76.48 -48.34 19.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 24' ' ' PRO . . . -63.74 -15.29 58.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.086 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 25' ' ' SER . 42.9 t30 -83.4 -14.84 51.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.873 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -92.25 -35.96 13.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 132.74 11.79 1.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.568 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.775 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 71.7 m -113.81 170.62 8.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.83 0.348 . . . . 0.0 110.941 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 76.8 m -88.17 155.07 19.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.747 ' CE1' ' HG3' ' A' ' 24' ' ' PRO . 45.2 t80 -133.14 119.42 19.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 37' ' ' THR . 16.4 t70 -130.64 79.99 1.92 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.872 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.794 ' HA ' ' CD1' ' A' ' 43' ' ' TRP . 24.3 p-10 -78.18 21.54 0.34 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 35' ' ' ASP . 75.0 p -90.84 -16.77 27.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.772 HG12 HG22 ' A' ' 41' ' ' VAL . 62.8 t -108.66 126.71 65.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.093 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.521 ' C ' ' H ' ' A' ' 41' ' ' VAL . 82.9 mtm180 -91.09 176.41 6.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.95 -33.46 0.29 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.466 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.915 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.3 m -106.27 170.64 5.56 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.72 0.295 . . . . 0.0 111.119 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.915 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 60.0 Cg_endo -72.63 153.65 54.47 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.673 2.248 . . . . 0.0 112.223 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.794 ' CD1' ' HA ' ' A' ' 36' ' ' ASP . 34.1 m0 -97.81 -30.29 12.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.964 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.932 ' HB2' HG21 ' A' ' 22' ' ' VAL . 47.4 t -100.04 117.38 34.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.778 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.751 ' O ' ' HB3' ' A' ' 32' ' ' CYS . 52.2 p90 -143.57 170.05 16.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.571 ' HD2' ' CB ' ' A' ' 15' ' ' GLN . 25.6 m-85 -76.97 134.94 67.63 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.978 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.775 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 18.0 Cg_endo -61.02 -150.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.52 -0.195 0 C-N-CA 122.976 2.45 . . . . 0.0 112.606 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.976 HD22 ' C ' ' A' ' 6' ' ' THR . 41.9 m-80 -119.01 -178.55 3.59 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.48 -0.782 . . . . 0.0 111.357 177.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.801 ' O ' ' HA ' ' A' ' 5' ' ' GLU . 9.9 t -68.68 171.04 8.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.336 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 1.045 HD11 ' HG3' ' A' ' 5' ' ' GLU . 76.4 mt -141.06 165.78 19.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.198 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.81 ' HB2' ' HG3' ' A' ' 3' ' ' GLN . 1.7 m-20 -99.92 -164.95 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.718 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.653 ' N ' ' HG3' ' A' ' 3' ' ' GLN . 60.5 t -132.72 119.92 16.31 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.227 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.582 ' HD3' ' HG2' ' A' ' 3' ' ' GLN . 55.5 Cg_endo -70.07 147.67 61.37 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.733 2.289 . . . . 0.0 112.304 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 53' ' ' PRO . 14.1 Cg_exo -69.49 -7.02 19.87 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.975 2.45 . . . . 0.0 112.251 -179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.536 ' O ' ' HG3' ' A' ' 56' ' ' GLU . 0.5 OUTLIER -79.23 70.19 5.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.899 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 55' ' ' GLU . 87.0 mt-10 -163.44 -2.62 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.879 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -141.23 -136.61 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.886 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.786 ' O ' ' HB2' ' B' ' 58' ' ' CYS . 50.1 t -94.5 -70.56 0.7 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.78 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.633 ' HB3' ' HB3' ' B' ' 58' ' ' CYS . 17.3 pt-20 -143.67 14.11 1.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.868 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 63.3 t80 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.915 -179.703 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' B' ' 1' ' ' GLU . 64.3 tt0 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.799 0.333 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.76 136.6 25.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.064 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -157.27 134.98 10.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . . . . . . . . . 74.9 p -156.67 135.92 12.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.105 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' B' ' 47' ' ' PRO . 0.5 OUTLIER -92.07 156.88 17.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.966 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.87 HG22 ' H ' ' B' ' 8' ' ' THR . 93.6 m -149.21 165.58 31.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.08 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.644 ' N ' HG22 ' B' ' 6' ' ' THR . 76.1 m -112.05 18.41 18.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.942 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.87 ' H ' HG22 ' B' ' 6' ' ' THR . 9.0 t -86.9 84.96 7.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.024 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.91 HG11 ' HA ' ' B' ' 14' ' ' ARG . 58.8 t -125.31 165.28 22.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.208 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.852 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -93.5 131.53 32.29 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.986 178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.892 ' HB3' HG21 ' B' ' 41' ' ' VAL . 79.0 Cg_exo -40.07 -32.05 0.59 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.793 2.329 . . . . 0.0 112.516 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.906 ' NH2' HG12 ' B' ' 41' ' ' VAL . 2.0 mmp_? -90.25 -29.89 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.931 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' B' ' 10' ' ' ALA . 12.2 mm-40 -93.05 -5.93 49.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.085 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.91 ' HA ' HG11 ' B' ' 9' ' ' VAL . 99.4 mtt180 -69.29 122.2 18.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.823 179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 1.009 ' HA ' HE21 ' B' ' 15' ' ' GLN . 0.0 OUTLIER -79.9 91.18 5.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.869 -178.28 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 1.098 HD22 ' N ' ' B' ' 17' ' ' CYS . 0.1 OUTLIER -32.64 140.07 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.753 179.029 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' CYS . . . . . 1.098 ' N ' HD22 ' B' ' 16' ' ' ASN . 43.1 t -127.8 1.69 6.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.178 0.513 . . . . 0.0 110.526 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 1.067 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -172.39 -134.45 1.8 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.084 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.897 ' CE1' HG12 ' B' ' 22' ' ' VAL . 37.8 p90 -106.15 156.58 36.59 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 120.732 0.301 . . . . 0.0 110.895 178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.562 ' O ' ' CE3' ' B' ' 43' ' ' TRP . 36.4 Cg_endo -65.51 -18.91 60.56 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.681 2.254 . . . . 0.0 112.229 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.639 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -94.14 8.13 72.76 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.47 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.897 HG12 ' CE1' ' B' ' 19' ' ' PHE . 34.6 m -61.67 155.55 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.849 0.357 . . . . 0.0 111.129 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.846 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 78.3 p -121.06 174.71 2.85 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.12 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.846 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 76.8 Cg_exo -50.26 -56.08 3.46 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.681 2.254 . . . . 0.0 112.309 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 79.5 p -58.35 -55.05 39.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.836 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.828 HE21 ' H ' ' B' ' 23' ' ' THR . 24.6 mt-30 -50.04 -72.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' CYS . . . . . 0.598 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 49.6 t -32.02 -53.15 0.28 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.73 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -52.33 -35.79 51.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.689 ' N ' ' O ' ' B' ' 26' ' ' GLN . 42.1 t30 -49.64 -32.58 13.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.553 178.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.787 ' HZ3' ' C ' ' B' ' 26' ' ' GLN . 2.2 mppt? -95.63 -15.5 22.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.795 176.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.94 38.31 16.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.532 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . 0.724 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 79.6 m -119.46 161.8 19.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.938 0.399 . . . . 0.0 110.979 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.579 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 78.2 m -65.43 155.19 36.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.851 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.585 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 57.8 t80 -129.56 118.06 21.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.011 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.564 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 16.6 t70 -128.55 100.04 5.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -91.75 24.7 3.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . 0.564 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 69.0 p -89.11 -62.39 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.066 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.857 HG21 ' HG3' ' B' ' 11' ' ' PRO . 61.1 t -80.52 120.79 32.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' B' ' 41' ' ' VAL . 83.6 mtm180 -89.15 -177.55 5.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.99 -35.52 0.29 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.528 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.906 HG12 ' NH2' ' B' ' 12' ' ' ARG . 27.5 m -100.44 170.43 6.66 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.745 0.307 . . . . 0.0 111.137 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.894 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 41.1 Cg_endo -67.41 127.99 17.49 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.681 2.254 . . . . 0.0 112.183 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.562 ' CE3' ' O ' ' B' ' 20' ' ' PRO . 49.7 m0 -78.9 -47.54 16.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.882 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' CYS . . . . . 0.66 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 50.2 t -91.16 123.79 34.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.777 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.724 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 50.0 p90 -142.67 168.94 18.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.997 -179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.529 ' O ' ' HD1' ' B' ' 45' ' ' PHE . 88.2 m-85 -75.73 154.08 85.26 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.94 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.561 ' HB2' ' HB3' ' B' ' 5' ' ' GLU . 56.7 Cg_endo -70.69 -177.75 2.34 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.798 2.332 . . . . 0.0 112.415 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.882 HD21 ' CG2' ' B' ' 9' ' ' VAL . 33.8 m-80 -132.93 105.63 7.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.934 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.531 ' OG1' ' HG3' ' B' ' 5' ' ' GLU . 94.3 m -84.57 100.29 11.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.113 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 62.0 mt -99.43 143.55 13.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.514 ' CG ' ' HD3' ' B' ' 53' ' ' PRO . 24.3 p-10 -134.55 172.0 13.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.584 ' O ' HG23 ' B' ' 52' ' ' VAL . 33.2 m -129.34 58.48 37.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.143 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . 0.514 ' HD3' ' CG ' ' B' ' 51' ' ' ASP . 56.2 Cg_endo -70.45 155.63 63.25 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.66 2.24 . . . . 0.0 112.307 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.633 ' O ' ' HG3' ' B' ' 55' ' ' GLU . 56.3 Cg_endo -70.35 -84.06 0.01 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.166 0 C-N-CA 122.806 2.337 . . . . 0.0 112.326 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . 0.76 ' OE2' ' HB2' ' A' ' 58' ' ' CYS . 44.4 mt-10 -165.34 -167.21 1.11 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.817 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -102.79 -141.19 0.35 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -88.08 110.67 20.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.903 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' CYS . . . . . 0.786 ' HB2' ' O ' ' A' ' 58' ' ' CYS . 77.0 m -99.05 106.74 19.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.988 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -139.14 102.62 4.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.942 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 61.7 t80 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.827 -179.888 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.852 ' HA ' HE22 ' A' ' 3' ' ' GLN . 64.3 tt0 . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.441 ' N ' ' OE1' ' A' ' 3' ' ' GLN . . . -118.07 46.79 1.7 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.134 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.852 HE22 ' HA ' ' A' ' 1' ' ' GLU . 1.2 mp0 -87.92 144.24 26.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 3' ' ' GLN . 82.8 p -163.59 145.3 9.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.17 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.722 ' HG2' HG22 ' A' ' 49' ' ' THR . 62.3 mt-10 -95.87 128.59 42.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.884 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.844 ' HB ' ' HB2' ' A' ' 48' ' ' ASN . 93.9 m -102.1 165.29 11.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.123 179.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.635 ' N ' HG22 ' A' ' 6' ' ' THR . 72.0 m -146.5 19.38 1.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.979 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.794 HG22 ' CG2' ' A' ' 6' ' ' THR . 9.5 t -100.22 63.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.11 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.851 HG22 HD21 ' A' ' 48' ' ' ASN . 61.2 t -103.44 168.08 2.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.182 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.859 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -78.47 120.94 82.92 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.104 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.78 ' HA ' ' CD ' ' A' ' 14' ' ' ARG . 88.5 Cg_exo -46.58 -37.75 20.71 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.691 2.26 . . . . 0.0 112.456 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.735 ' HG3' ' HG3' ' A' ' 13' ' ' GLU . 14.5 ptm180 -71.17 -29.91 65.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.925 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.735 ' HG3' ' HG3' ' A' ' 12' ' ' ARG . 87.2 mt-10 -111.09 42.44 1.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.965 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.859 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.3 mtt180 -107.23 117.85 35.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.944 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.645 ' O ' ' O ' ' A' ' 16' ' ' ASN . 84.6 mm-40 -87.55 100.14 12.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.822 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.665 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.4 t-20 -24.92 150.08 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.814 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.817 ' HB2' ' N ' ' A' ' 46' ' ' TYR . 53.0 t -140.79 2.17 1.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.54 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.5 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -148.44 -138.99 3.1 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.294 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 1.097 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 43.9 p90 -105.82 -177.9 0.55 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.595 0.236 . . . . 0.0 110.745 179.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 1.097 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 38.3 Cg_endo -67.49 -62.1 0.07 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.49 2.127 . . . . 0.0 112.38 -178.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.659 ' C ' ' CE2' ' A' ' 19' ' ' PHE . . . -78.03 29.91 1.85 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.55 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.999 HG13 ' O ' ' A' ' 19' ' ' PHE . 27.5 m -56.95 133.05 21.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 111.359 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.855 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 79.2 p -117.01 178.24 1.04 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.954 178.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.855 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 50.6 Cg_exo -53.81 -40.05 81.73 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.677 2.252 . . . . 0.0 112.271 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.643 ' O ' ' HB2' ' A' ' 29' ' ' ASN . 47.8 t -88.35 -31.56 18.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 -178.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.799 ' HB2' ' H ' ' A' ' 23' ' ' THR . 52.9 mt-30 -73.46 -33.8 65.06 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.896 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.938 ' SG ' ' HB2' ' A' ' 32' ' ' CYS . 52.2 t -87.48 -50.2 6.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.32 70.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.003 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.643 ' HB2' ' O ' ' A' ' 25' ' ' SER . 38.1 t-20 -57.04 -21.0 27.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -102.45 -28.85 11.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.946 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 118.48 -6.36 14.43 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.405 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.938 ' HB2' ' SG ' ' A' ' 27' ' ' CYS . 85.4 m -70.67 -170.07 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.821 0.343 . . . . 0.0 110.904 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.842 ' O ' ' HA ' ' A' ' 44' ' ' CYS . 72.3 m -116.11 155.06 28.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.87 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 36' ' ' ASP . 66.3 t80 -131.35 118.25 20.03 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.932 179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.594 ' HB3' ' NH1' ' A' ' 14' ' ' ARG . 16.9 t70 -131.03 79.89 1.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 34' ' ' PHE . 24.7 p-10 -72.94 13.47 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.921 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.576 ' OG1' ' OD2' ' A' ' 35' ' ' ASP . 76.4 p -79.56 -16.41 55.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.081 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.703 HG21 ' CG ' ' A' ' 11' ' ' PRO . 63.2 t -131.39 109.63 16.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.095 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.813 ' HG2' ' H ' ' A' ' 40' ' ' GLY . 59.9 ttt180 -79.01 -176.93 5.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.813 ' H ' ' HG2' ' A' ' 39' ' ' ARG . . . 73.07 -38.45 0.79 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.383 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.852 ' HB ' ' HD2' ' A' ' 42' ' ' PRO . 33.0 m -98.44 168.03 10.54 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 120.768 0.318 . . . . 0.0 111.049 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.852 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 48.1 Cg_endo -68.75 120.9 7.78 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.708 2.272 . . . . 0.0 112.207 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.8 m0 -67.43 -45.24 76.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.842 ' CB ' HG21 ' A' ' 22' ' ' VAL . 42.5 t -91.87 116.13 28.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.741 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.574 ' C ' ' CB ' ' A' ' 17' ' ' CYS . 52.1 p90 -139.17 168.91 18.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.965 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.817 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 83.6 m-85 -68.71 135.08 90.24 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.687 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . 61.3 Cg_endo -73.35 -156.7 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.193 0 C-N-CA 122.758 2.305 . . . . 0.0 112.318 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.851 HD21 HG22 ' A' ' 9' ' ' VAL . 77.3 m-20 -139.55 93.53 2.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.937 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.722 HG22 ' HG2' ' A' ' 5' ' ' GLU . 67.3 p -77.77 118.42 20.11 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.156 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 3' ' ' GLN . 61.7 mt -128.36 147.21 32.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.027 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.741 ' HB3' ' HG3' ' A' ' 3' ' ' GLN . 4.5 p30 -160.43 153.74 21.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.008 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.791 ' O ' HG12 ' A' ' 52' ' ' VAL . 57.7 t -135.8 34.08 0.24 Allowed Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.011 179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 52' ' ' VAL . 56.8 Cg_endo -71.15 157.73 56.72 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.722 2.282 . . . . 0.0 112.328 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.99 69.62 2.31 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.767 2.311 . . . . 0.0 112.311 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.534 ' OE1' ' HG2' ' A' ' 53' ' ' PRO . 12.4 pt-20 -132.32 -38.33 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.814 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -97.35 -75.34 0.55 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.824 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.623 ' OE1' ' HA ' ' A' ' 57' ' ' GLU . 6.2 mm-40 -94.24 140.76 29.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.876 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.613 ' SG ' ' N ' ' B' ' 59' ' ' GLU . 51.5 t -116.6 -51.48 2.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.901 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -84.45 -87.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.842 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 62.0 t80 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.925 -179.882 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' GLU . . . . . 0.614 ' O ' ' HG3' ' B' ' 1' ' ' GLU . 10.3 tp10 . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . 0.442 ' O ' ' NE2' ' B' ' 3' ' ' GLN . . . -108.09 154.18 22.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.033 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.758 ' HB3' ' CG2' ' B' ' 49' ' ' THR . 85.0 mm-40 -155.34 154.88 32.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.689 ' O ' ' HA ' ' B' ' 49' ' ' THR . 75.0 p -148.27 139.37 23.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.054 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.738 ' HA ' ' O ' ' B' ' 48' ' ' ASN . 21.1 mp0 -101.56 130.03 47.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.867 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.946 HG22 ' H ' ' B' ' 8' ' ' THR . 86.7 m -138.84 171.53 14.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.057 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.731 ' N ' HG22 ' B' ' 6' ' ' THR . 75.7 m -109.9 3.91 21.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.008 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.946 ' H ' HG22 ' B' ' 6' ' ' THR . 9.1 t -73.8 92.24 2.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.127 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.893 HG11 ' HA ' ' B' ' 14' ' ' ARG . 59.1 t -128.98 157.14 41.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.159 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.907 ' O ' ' HG3' ' B' ' 14' ' ' ARG . . . -74.06 114.08 29.51 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.96 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.741 ' HA ' ' CD ' ' B' ' 14' ' ' ARG . 88.4 Cg_exo -40.31 -28.67 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.813 2.342 . . . . 0.0 112.461 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . 0.652 ' HG3' ' HG3' ' B' ' 13' ' ' GLU . 16.6 ptp180 -90.13 -29.82 18.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.726 ' HB2' ' HB3' ' B' ' 10' ' ' ALA . 44.6 mt-10 -104.58 9.59 35.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.076 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.907 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 99.4 mtt180 -69.89 145.93 51.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.921 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' B' ' 45' ' ' PHE . 17.6 mp0 -89.99 97.42 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.901 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.662 ' OD1' ' N ' ' B' ' 17' ' ' CYS . 36.5 t-20 -48.0 149.12 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.018 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' CYS . . . . . 0.883 ' SG ' ' HD3' ' B' ' 30' ' ' LYS . 44.7 t -135.26 1.02 2.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.013 0.435 . . . . 0.0 110.764 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.611 ' N ' ' OD1' ' B' ' 16' ' ' ASN . . . -170.96 -134.42 1.76 Allowed Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.289 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 0.863 ' CZ ' ' HA ' ' B' ' 22' ' ' VAL . 35.4 p90 -105.35 167.65 9.47 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.774 0.321 . . . . 0.0 111.041 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.797 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 42.3 Cg_endo -68.15 -25.15 37.57 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.762 2.308 . . . . 0.0 112.436 -178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.711 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -95.56 6.44 67.87 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.535 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.863 ' HA ' ' CZ ' ' B' ' 19' ' ' PHE . 35.0 m -49.55 137.05 6.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 111.275 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 0.944 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 80.2 p -110.95 -179.64 0.68 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.971 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.944 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 75.9 Cg_exo -49.79 -50.09 14.17 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.594 2.196 . . . . 0.0 112.393 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 53.0 m -74.7 -27.68 60.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.924 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.771 ' HB2' ' H ' ' B' ' 23' ' ' THR . 10.2 mm-40 -73.84 -32.09 63.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.014 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' CYS . . . . . 0.684 ' SG ' ' O ' ' B' ' 32' ' ' CYS . 42.1 t -83.65 -53.87 5.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.817 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.55 -38.95 67.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.988 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -49.94 -32.24 14.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.811 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.883 ' HD3' ' SG ' ' B' ' 17' ' ' CYS . 63.0 tttp -98.79 -25.8 14.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.79 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.88 66.82 1.13 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.665 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . 0.82 ' HB2' ' SG ' ' B' ' 44' ' ' CYS . 76.4 m -149.99 160.6 43.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.799 0.333 . . . . 0.0 110.928 178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' B' ' 44' ' ' CYS . 82.2 m -60.58 154.78 20.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.791 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.615 ' HE2' ' O ' ' B' ' 22' ' ' VAL . 52.0 t80 -132.71 117.65 18.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.915 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.421 ' OD1' ' OG1' ' B' ' 37' ' ' THR . 32.3 t0 -138.16 83.81 2.0 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.871 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -83.87 58.33 4.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.917 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . 0.421 ' OG1' ' OD1' ' B' ' 35' ' ' ASP . 78.3 p -113.23 -25.29 8.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.108 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 63.4 t -122.77 118.83 56.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.149 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . 0.81 ' HG2' ' H ' ' B' ' 40' ' ' GLY . 37.4 ttm180 -75.31 -178.18 3.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.849 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . 0.81 ' H ' ' HG2' ' B' ' 39' ' ' ARG . . . 70.64 -37.08 0.47 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.44 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.753 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.1 m -99.5 165.19 15.19 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.822 0.344 . . . . 0.0 111.08 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.753 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 43.9 Cg_endo -68.18 130.94 22.39 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.763 2.309 . . . . 0.0 112.167 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.555 ' HE3' ' O ' ' B' ' 22' ' ' VAL . 50.2 m0 -78.31 -18.86 54.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.845 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' CYS . . . . . 0.82 ' SG ' ' HB2' ' B' ' 32' ' ' CYS . 51.4 t -121.3 124.32 44.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.681 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 36.9 p90 -142.56 170.5 15.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -80.3 154.86 74.55 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.87 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -69.4 -170.58 0.38 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.681 2.254 . . . . 0.0 112.216 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.833 HD21 HG21 ' B' ' 9' ' ' VAL . 34.5 m-80 -149.64 140.84 23.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.957 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.758 ' CG2' ' HB3' ' B' ' 3' ' ' GLN . 93.8 m -115.62 104.91 12.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . . . . . . . . . 62.4 mt -86.91 148.1 4.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.105 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.697 ' HB3' HE22 ' B' ' 3' ' ' GLN . 24.4 p-10 -117.67 128.01 54.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.861 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.752 ' O ' HG23 ' B' ' 52' ' ' VAL . 33.3 m -96.87 86.01 0.36 Allowed Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.198 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . 0.692 ' HD3' ' O ' ' B' ' 51' ' ' ASP . 56.0 Cg_endo -70.2 161.18 46.95 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.713 2.275 . . . . 0.0 112.279 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.562 ' O ' ' CD ' ' B' ' 55' ' ' GLU . 54.8 Cg_endo -70.09 -110.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.682 2.255 . . . . 0.0 112.247 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . 0.608 ' OE1' ' HA ' ' B' ' 55' ' ' GLU . 6.4 mm-40 -164.22 -152.37 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.861 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.568 ' O ' ' HG3' ' B' ' 56' ' ' GLU . 23.0 pt-20 -98.04 99.21 10.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.915 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.969 ' OE1' ' N ' ' B' ' 57' ' ' GLU . 7.4 pm0 -143.47 -14.18 0.67 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.896 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' CYS . . . . . 0.659 ' SG ' ' HD1' ' B' ' 60' ' ' PHE . 50.2 t -88.75 -137.54 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.908 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . 0.643 ' N ' ' SG ' ' B' ' 58' ' ' CYS . 41.7 tt0 -134.45 -8.95 2.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.916 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . 0.659 ' HD1' ' SG ' ' B' ' 58' ' ' CYS . 50.0 m-85 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.886 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.905 ' OE1' ' N ' ' A' ' 1' ' ' GLU . 10.8 mp0 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.861 0.363 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.602 ' O ' ' CD ' ' A' ' 3' ' ' GLN . . . -76.77 106.3 8.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.041 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 1.017 HE21 ' HA ' ' A' ' 51' ' ' ASP . 12.4 mm100 -152.16 101.55 2.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.751 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 3' ' ' GLN . 70.7 p -170.44 -159.91 0.2 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -176.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.948 ' HG2' HG22 ' A' ' 49' ' ' THR . 53.2 mt-10 -99.78 124.84 45.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.666 178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.795 ' CG2' HG22 ' A' ' 8' ' ' THR . 95.0 m -111.68 162.36 15.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.382 -178.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.574 ' N ' HG22 ' A' ' 6' ' ' THR . 72.5 m -143.19 -2.3 1.01 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.033 179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.795 HG22 ' CG2' ' A' ' 6' ' ' THR . 9.8 t -71.91 62.26 0.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.147 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.857 ' CG2' HD21 ' A' ' 48' ' ' ASN . 58.4 t -106.56 165.62 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.214 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.846 ' O ' ' HG3' ' A' ' 14' ' ' ARG . . . -91.6 123.62 63.11 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.898 ' HB3' HG21 ' A' ' 41' ' ' VAL . 80.7 Cg_exo -44.91 -39.4 14.15 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.728 2.285 . . . . 0.0 112.395 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -66.63 -29.98 70.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.796 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -112.41 39.26 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.061 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.846 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 96.6 mtt180 -108.26 152.91 23.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.715 ' NE2' ' C ' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -108.24 93.79 4.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.066 -179.057 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.683 ' OD1' ' N ' ' A' ' 17' ' ' CYS . 37.5 t-20 -27.7 150.32 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.683 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 42.1 t -138.02 0.82 2.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.084 0.469 . . . . 0.0 110.518 -179.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.564 ' N ' ' OD1' ' A' ' 16' ' ' ASN . . . -177.54 -139.28 3.29 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.725 -0.67 . . . . 0.0 112.36 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.865 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 39.7 p90 -105.71 170.93 5.33 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.867 0.365 . . . . 0.0 110.986 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.865 ' HD2' ' HB2' ' A' ' 19' ' ' PHE . 58.4 Cg_endo -71.84 -36.5 6.12 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.767 2.312 . . . . 0.0 112.415 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.571 ' O ' ' O ' ' A' ' 22' ' ' VAL . . . -58.63 -38.98 92.75 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.525 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.828 HG21 ' CB ' ' A' ' 44' ' ' CYS . 34.2 m -30.34 155.04 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.805 0.336 . . . . 0.0 111.224 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.866 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 75.3 p -122.74 176.22 2.22 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.096 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.866 ' HD2' ' HB ' ' A' ' 23' ' ' THR . 53.1 Cg_exo -52.43 -49.09 18.62 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.679 2.253 . . . . 0.0 112.343 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -77.33 -42.33 37.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.931 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.708 ' HG3' ' OG1' ' A' ' 23' ' ' THR . 26.4 mt-30 -59.43 -37.9 79.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.536 ' HB3' ' HB2' ' A' ' 34' ' ' PHE . 53.9 t -72.53 -59.24 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.865 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -54.92 -26.87 38.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.107 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -67.98 -11.66 59.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.84 ' HD3' ' C ' ' A' ' 30' ' ' LYS . 7.8 tmtt? -100.37 -51.98 3.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.846 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 142.44 37.69 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.484 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.894 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 71.2 m -149.56 163.07 38.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.832 0.348 . . . . 0.0 111.069 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.858 ' SG ' ' HB3' ' A' ' 47' ' ' PRO . 72.6 m -76.15 155.12 34.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.695 178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.72 ' CG ' ' HA ' ' A' ' 24' ' ' PRO . 77.3 t80 -122.47 136.82 54.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.012 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.663 ' CB ' HH12 ' A' ' 14' ' ' ARG . 26.6 t0 -155.72 79.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.885 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.702 ' HA ' ' CG ' ' A' ' 43' ' ' TRP . 24.5 p-10 -88.18 40.5 0.95 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 76.5 p -113.45 -13.9 12.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.12 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.708 HG12 HG22 ' A' ' 41' ' ' VAL . 62.7 t -113.89 104.09 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.119 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.522 ' C ' ' H ' ' A' ' 41' ' ' VAL . 98.5 mtt180 -70.47 175.52 4.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 68.86 -20.19 0.4 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.397 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.898 HG21 ' HB3' ' A' ' 11' ' ' PRO . 33.0 m -119.87 163.1 29.69 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.784 0.325 . . . . 0.0 111.162 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.693 ' HD2' ' HB ' ' A' ' 41' ' ' VAL . 55.5 Cg_endo -70.08 127.29 14.14 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.696 2.264 . . . . 0.0 112.266 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.702 ' CG ' ' HA ' ' A' ' 36' ' ' ASP . 49.9 m0 -72.16 -50.21 29.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.965 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.828 ' CB ' HG21 ' A' ' 22' ' ' VAL . 47.3 t -93.81 112.27 24.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.738 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.8 ' CE1' ' HD3' ' A' ' 14' ' ' ARG . 40.0 p90 -136.44 163.72 29.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.955 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.547 ' HD2' ' CB ' ' A' ' 15' ' ' GLN . 35.2 m-85 -57.81 134.72 83.14 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.666 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.894 ' HD3' ' HA ' ' A' ' 32' ' ' CYS . 96.8 Cg_endo -80.85 -156.53 0.07 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.842 2.361 . . . . 0.0 112.578 -178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.857 HD21 ' CG2' ' A' ' 9' ' ' VAL . 78.0 m-20 -139.53 81.34 1.82 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.851 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.948 HG22 ' HG2' ' A' ' 5' ' ' GLU . 68.5 p -91.78 103.42 15.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.076 -179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 4' ' ' THR . 33.3 mt -135.95 131.17 49.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.943 0.401 . . . . 0.0 111.12 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 1.017 ' HA ' HE21 ' A' ' 3' ' ' GLN . 24.7 p-10 -161.82 151.09 15.99 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.94 -177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.047 ' N ' ' HD3' ' A' ' 53' ' ' PRO . 31.7 m -113.01 8.89 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.548 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 1.047 ' HD3' ' N ' ' A' ' 52' ' ' VAL . 13.5 Cg_exo -69.32 177.26 5.45 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.682 2.254 . . . . 0.0 112.142 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.606 ' HB2' ' OE1' ' A' ' 55' ' ' GLU . 57.0 Cg_endo -71.01 -121.62 0.01 OUTLIER 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.769 2.313 . . . . 0.0 112.301 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.974 ' OE1' ' N ' ' A' ' 55' ' ' GLU . 7.2 pm0 -151.61 -138.19 0.08 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.499 ' N ' ' HG2' ' A' ' 55' ' ' GLU . 12.6 pt-20 -90.61 9.21 30.55 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.565 ' H ' ' HG2' ' A' ' 55' ' ' GLU . 45.1 mt-10 -136.35 102.49 4.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 80.1 m -117.46 -34.06 4.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.833 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -116.08 40.2 2.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.929 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.927 -179.781 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.816 0.341 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.5 120.02 5.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.097 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLN . . . . . 0.658 ' CG ' ' OD1' ' B' ' 51' ' ' ASP . 1.2 mp0 -82.82 167.21 18.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.854 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.717 ' O ' ' HA ' ' B' ' 49' ' ' THR . 68.3 p -163.73 143.86 8.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.21 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.912 ' HB3' ' HB2' ' B' ' 47' ' ' PRO . 62.6 mt-10 -86.53 124.93 33.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.875 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.701 ' CG2' HG22 ' B' ' 8' ' ' THR . 93.7 m -116.71 167.53 11.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.158 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . 0.67 ' N ' HG22 ' B' ' 6' ' ' THR . 71.6 m -118.26 -25.2 6.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.997 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' THR . . . . . 0.701 HG22 ' CG2' ' B' ' 6' ' ' THR . 9.0 t -76.7 80.16 3.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.059 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.844 HG21 ' CG ' ' B' ' 48' ' ' ASN . 66.6 t -129.22 177.4 6.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.247 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.83 ' N ' HG12 ' B' ' 9' ' ' VAL . . . -85.38 151.87 57.0 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.173 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.927 ' HG3' HG11 ' B' ' 38' ' ' VAL . 43.2 Cg_exo -56.36 -16.57 18.3 Favored 'Trans proline' 0 C--O 1.231 0.131 0 C-N-CA 122.787 2.325 . . . . 0.0 112.321 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -82.92 -29.92 28.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.063 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLU . . . . . 0.755 ' HB2' ' CG1' ' B' ' 9' ' ' VAL . 45.1 mt-10 -94.8 -20.07 19.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.853 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' ARG . . . . . 0.677 ' HG3' ' O ' ' B' ' 10' ' ' ALA . 96.5 mtt180 -63.29 94.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.636 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLN . . . . . 0.651 ' O ' ' O ' ' B' ' 16' ' ' ASN . 8.3 tt0 -79.66 98.75 7.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . 0.744 ' ND2' ' H ' ' B' ' 18' ' ' GLY . 2.6 t-20 -23.61 149.76 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.257 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' CYS . . . . . 0.549 ' O ' ' HD3' ' B' ' 30' ' ' LYS . 42.6 t -141.89 4.45 1.68 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.535 178.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.744 ' H ' ' ND2' ' B' ' 16' ' ' ASN . . . -166.96 -137.68 2.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.892 -0.671 . . . . 0.0 112.395 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' PHE . . . . . 1.033 ' HB2' ' HD2' ' B' ' 20' ' ' PRO . 29.1 p90 -105.32 175.42 2.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.788 0.327 . . . . 0.0 110.84 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 1.033 ' HD2' ' HB2' ' B' ' 19' ' ' PHE . 38.4 Cg_endo -67.11 -32.74 33.5 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.604 2.203 . . . . 0.0 112.482 -178.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.733 ' C ' ' CE2' ' B' ' 19' ' ' PHE . . . -93.84 5.2 72.7 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.602 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.946 HG13 ' O ' ' B' ' 19' ' ' PHE . 27.0 m -37.86 153.06 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 111.316 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' THR . . . . . 1.044 ' HB ' ' HD2' ' B' ' 24' ' ' PRO . 76.1 p -128.35 173.89 5.05 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.816 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 1.044 ' HD2' ' HB ' ' B' ' 23' ' ' THR . 15.3 Cg_endo -57.46 -32.0 92.92 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.58 2.187 . . . . 0.0 112.221 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 80.3 p -85.14 -50.06 7.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.898 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' GLN . . . . . 0.435 ' HB2' ' H ' ' B' ' 23' ' ' THR . 52.7 mt-30 -61.01 -32.73 72.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' CYS . . . . . . . . . . . . . 42.4 t -78.92 -55.4 5.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.787 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' B' ' 31' ' ' GLY . . . -48.35 -33.87 9.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 42.4 t30 -49.8 -29.44 7.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.424 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' LYS . . . . . 0.549 ' HD3' ' O ' ' B' ' 17' ' ' CYS . 27.9 mtpp -97.82 -13.53 21.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.544 176.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' B' ' 28' ' ' ALA . . . 78.27 49.47 6.81 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.555 179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' CYS . . . . . 0.745 ' HB3' ' O ' ' B' ' 45' ' ' PHE . 71.0 m -126.33 166.98 16.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.782 0.325 . . . . 0.0 110.947 178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' CYS . . . . . . . . . . . . . 77.8 m -75.08 149.52 39.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' PHE . . . . . 0.548 ' HE1' ' O ' ' B' ' 22' ' ' VAL . 73.4 t80 -126.95 126.92 44.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.635 ' OD1' HG23 ' B' ' 38' ' ' VAL . 16.6 t70 -149.83 80.47 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.961 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . 0.803 ' HA ' ' CG ' ' B' ' 43' ' ' TRP . 24.5 p-10 -72.14 4.6 3.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' THR . . . . . . . . . . . . . 72.3 p -75.3 -7.07 52.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.052 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.927 HG11 ' HG3' ' B' ' 11' ' ' PRO . 68.1 t -115.75 112.46 39.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.181 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -89.01 149.18 23.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.879 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.32 -37.3 3.8 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.412 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . 0.911 ' HB ' ' HD2' ' B' ' 42' ' ' PRO . 33.3 m -112.43 169.76 6.0 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.834 0.35 . . . . 0.0 111.108 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' PRO . . . . . 0.911 ' HD2' ' HB ' ' B' ' 41' ' ' VAL . 51.7 Cg_endo -69.35 121.0 7.77 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.744 2.296 . . . . 0.0 112.229 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' TRP . . . . . 0.803 ' CG ' ' HA ' ' B' ' 36' ' ' ASP . 36.7 m0 -62.13 -45.02 95.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' CYS . . . . . 0.812 ' CB ' HG21 ' B' ' 22' ' ' VAL . 51.0 t -86.31 120.91 28.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.803 178.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . 0.745 ' O ' ' HB3' ' B' ' 32' ' ' CYS . 52.5 p90 -148.81 162.14 40.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.855 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' TYR . . . . . 0.452 ' O ' ' HD1' ' B' ' 45' ' ' PHE . 92.6 m-85 -68.94 155.92 92.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' PRO . . . . . 0.912 ' HB2' ' HB3' ' B' ' 5' ' ' GLU . 28.2 Cg_endo -62.8 -173.48 0.15 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.774 2.316 . . . . 0.0 112.179 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ASN . . . . . 0.844 ' CG ' HG21 ' B' ' 9' ' ' VAL . 35.0 m-80 -134.33 81.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.109 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' THR . . . . . 0.864 ' HB ' ' HG2' ' B' ' 5' ' ' GLU . 8.0 t -85.96 90.18 8.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.853 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ILE . . . . . 0.719 HG22 ' N ' ' B' ' 51' ' ' ASP . 61.7 mt -107.96 170.07 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.392 -177.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ASP . . . . . 0.719 ' N ' HG22 ' B' ' 50' ' ' ILE . 1.4 m-20 -108.79 177.33 4.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.758 179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . 0.879 ' H ' ' HD3' ' B' ' 53' ' ' PRO . 57.3 t -155.21 23.88 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' PRO . . . . . 0.879 ' HD3' ' H ' ' B' ' 52' ' ' VAL . 71.5 Cg_endo -74.82 134.3 17.97 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.677 2.251 . . . . 0.0 112.374 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' B' ' 53' ' ' PRO . 13.8 Cg_exo -69.59 160.37 49.99 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.882 2.388 . . . . 0.0 112.184 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' GLU . . . . . . . . . . . . . 87.2 mt-10 -119.98 -164.42 1.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.936 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' GLU . . . . . 0.491 ' N ' ' OE1' ' B' ' 56' ' ' GLU . 21.2 mp0 -94.73 -139.77 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.433 ' CD ' ' N ' ' B' ' 57' ' ' GLU . 0.5 OUTLIER -82.97 168.47 16.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.938 179.837 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' CYS . . . . . . . . . . . . . 26.7 p -133.64 103.39 5.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 64.4 tt0 -105.15 -71.5 0.74 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.902 179.738 . . . . . . . . 0 0 . 1 stop_ save_